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CHAPTER 1
General introduction
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According to the World Health Organization (WHO), public health is a discipline 
that aims to prevent disease, prolong life, and promote health and general well-
being by working with and in society.1 Through organized preventive efforts, 
public health experts aim to foster their goal of a healthy population.2 Public 
health experts aim to inform and empower society to make healthy decisions 
that prevent disease, prolong life, and promote health since informed and 
empowered individuals are more able to take responsibility over their health.2-4 
In daily life, people make decisions about their health and the health of others, as 
is for instance the case in parental decision-making about childhood vaccination.5 
When making health-related decisions, there can be different options to choose 
from. For instance, a parent can decide to accept, refuse, or partially accept 
childhood vaccinations; or a smoker can decide to quit smoking or switch from 
smoking regular cigarettes to electronic cigarettes (e-cigarettes). Public health 
professionals often inform individuals only about a recommended option, i.e. 
the option that is scientifically proven to be the healthiest. For example, they 
provide a brochure in order to inform parents about vaccinating their children 
according to the National Immunization Program (NIP) schedule.6,7 However, this 
recommended option might not be suitable for all individuals due to different 
personal values, priorities with regard to health, experiences, opinions, and 
the norms of their social environment. Consequently, in these cases people 
can choose options that match their individual values and goals but that are 
considered by public health professionals as, for example, ‘next to best’. Next 
to best health options are – from a public health and scientific point of view – 
less harmful or less healthy than the unrecommended health option, but not less 
harmful or less healthy compared to the recommended health option. Another 
option people may choose is the unrecommended option, which is considered 
as being unhealthy by public health experts and science. 
Acknowledging that people may choose other options than the recommended 
health option as defined by public health experts, and wanting to support decision-
making, raises an interesting question for public health: should public health experts 
communicate about all health options, or should they focus their efforts on the 
recommended health option? Communicating about all three options could result 
in those who preferred an unrecommended option to switch to the recommended 
or next to best option, resulting in public health gain. However, it could also result 
in those who preferred the recommended health option or next to best health 
option to switch to the unrecommended health option, which could potentially 
mean a public health loss. These potentially different outcomes result in a dilemma 
for public health experts regarding whether they should communicate about 
these options in order to support decision-making and improve public health. In 
order to provide insight into the consequences of either communicating about all 
health options or only the recommended health option, and to ultimately develop 
evidence-based health communication, it is first important to understand how 
people decide on these health options, an area that will be addressed in this thesis. 
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Two cases, namely, smoking behavior and childhood vaccination, will be the 
focus in this thesis. We have chosen these two exemplary cases since an increase 
in next to best health options – partially accepting childhood vaccinations and 
e-cigarette use – was observed for both cases in recent years.7-18 In the case of 
smoking behavior, a next to best option for quitting or refraining from smoking 
could be deciding to use e-cigarettes, as these are in general considered less 
harmful than tobacco cigarettes (i.e. the unrecommended option), although 
certainly not harmless.10,16,18-22 In the case of childhood vaccination, accepting 
all childhood vaccinations according to the NIP can be considered the 
recommended health option, partially accepting childhood vaccinations can be 
considered a next to best option, and refusing all vaccinations is regarded as the 
unrecommended option from a public health perspective. This chapter provides 
the context of decision-making in public health, introduces the two cases, 
and presents the outline of this thesis. We start by describing two prevailing 
narratives, stereotypes as it were, to explain a societal shift from law-abiding 
citizens to decision empowerment. 
History of informed health-related decisions
Prior to 1950, the public could be characterized as law-abiding citizens who 
followed the government, religious leaders, a monarch, or a physician. These 
relationships were based on trust. Physicians – who were perceived as all-knowing 
beings at the center of the health care system – have long determined which 
course of action best fitted healthy behavior and served the common good.23-26 
The main responsibility of the physician was to bestow trust in the course of action 
determined. It was believed that informing patients about risks, consequences, 
and alternatives of treatment would destroy the trusting relationship between the 
physician and the patient.23-26 Since physicians had this knowledge, they knew 
the best option for the patient’s well-being.23,26 The information and knowledge 
asymmetry between the patient and the health care provider changed in the 
US and several other countries after 1950.27 From then on, physicians were 
obligated by law to offer information about the risks, consequences, nature, and 
alternatives to the treatment and explain it,26 and individuals have since had 
the right to be informed and the right for self-determination.23 The right to be 
informed and the right for self-determination were defined as the right to make 
an informed choice in the form of an informed consent.23,27 In the Netherlands, 
this right was established in 1994.28 In the informed decision approach to health 
care25, patients had to be informed about the risks, consequences, nature, and 
alternatives to the treatment in order to make a decision that reflects scientific 
evidence, and the decision-maker’s values and preferences.23,25,29 At the same 
time that the informed decision approach in health care progressively developed, 
disease prevention decisions, such as exercising and not smoking, were more 
and more regarded as individual decisions rather than a public responsibility.30 
1
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Informed decisions in public health
In the 19th century, health and lifestyle were seen by hygienists (i.e. public health 
experts) as a collective responsibility to prevent disease and improve health on 
a local level via such means as effective sewage systems and clean drinking 
water.30 The success of public health in the 19th century was the result of a very 
strong moral responsibility for prevention of disease and the efforts of public 
health experts which, although organized on a local level, were enforced by the 
government.30 The (implicit) underlying assumption was that by disseminating 
knowledge from the “all-knowing” experts to the public, the public would be 
motivated to make healthy decisions and change their unhealthy behavior.4,25,31-35 
However, and as demonstrated by previous research,4,32,36-43 knowledge 
dissemination alone often does not change people’s unhealthy behavior. In 
the Netherlands, a change could be observed in the 1970s resulting in fewer 
obedient citizens who did not question authority.4,30,31,44 From then on, public 
health experts increasingly aimed to empower and inform the public to make 
healthy, autonomous, informed decisions by working with and in society.1,2,29,45-48 
Public health experts were the main source providing (scientific) information to 
present information the general public needed.4,49,50 With the rapid growth of 
the internet in the 1990s, information became easily available for the public, 
allowing the general public to pro-actively look for and verify information, which 
also resulted in the objectivity of scientific evidence being offered by public 
health experts no longer being taken for granted by everyone.30,51,52 Due to large-
scale information sharing and statements that science could be regarded as just 
another opinion,44 the veracity and objectivity of scientific evidence and health 
professionals 51,52 are no longer taken for granted. People can look for information 
from different sources, including information provided by parties with a vested 
interest,53 which can sometimes be categorized as untrustworthy information.54-58 
Conceptualization of informed decision-making
To support informed decision-making among the public, it is important 
to investigate what constitutes informed decision-making and what the 
consequences of not making an informed decision could be. Originating 
from a Rational Decision model,59,60 there are multiple definitions of what 
makes a decision informed. Several definitions suggest that individuals need 
to be informed about the risks, consequences, nature, and alternatives about 
the decision subject with correct scientific evidence, and a decision should 
reflect decision-makers’ values and preferences.45,61-70 In this thesis we use the 
definition of informed decision-making of van den Berg et al.71 This definition 
states that a choice can be classified as informed if the decision-maker has made 
the decision based on relevant evidence-based knowledge about the subject, 
made a choice that reflects their attitude (i.e. they are value-consistent), and has 
deliberated the different choice options.64,65,67,68,71,72 For our studies, although we 
used this definition to conceptualize the criteria of informed decision-making, 
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no classification of informed or uninformed decisions were made based on 
this definition because this dichotomization is a crude distinction that does not 
reflect the variety of levels of informed and uninformed decisions.31,71,73
This latter criterion, the process of deliberation, is an important step in informed 
decision-making, in which the decision-maker weighs the pros and cons of each 
available option, and deliberates alternatives to determine the expected utility of 
an outcome.59 For example, the decisional balance of considering the perceived 
susceptibility to lung cancer later in life if a smoker were to quit smoking, or 
considering the pros and cons of smoking cessation before making a decision, is 
a deliberation process.42,74-80 This deliberation of available information has been 
identified in several decision-making theories as key to an informed decision-
making process.36-40 In addition, socio-cognitive theories, such as the health belief 
model,74-76 the protection motivation theory,77,78 and the Integrated Behavioral 
Model42,79,80 also recognize the importance of deliberation in health decisions. 
In addition, supporting informed decision-making may reduce decisional conflict, 
and reducing decisional conflict may support decision-making.45,81,82 With regard 
to childhood vaccination, increasing informed decision-making and decreasing 
decisional conflict may reduce vaccine hesitancy83-85 and may positively affect 
intention to accept childhood vaccinations, and thus also positively affect the 
vaccination coverage.47 With regard to smoking behavior, increasing informed 
decision-making about smoking cessation and lowering decisional conflict 
regarding smoking cessation may support smokers in their efforts to quit 
smoking.86 According to the Elaboration Likelihood Model87, people can make a 
decision through two types of routes: the central route or the peripheral route.87 
To make an informed decision, it is important that people use the central route 
of processing since this could lead to decisions that are less vulnerable to 
unobjective information51,52 or decisional regret45, and to more maintenance of 
sticking to a healthy choice.87
For both smoking behavior and childhood vaccination, the Dutch National 
Institute for Public Health and the Environment (RIVM) offers information to 
the public. Research is needed to provide insight into how people decide on 
the recommended, unrecommended, or next to best health option, and how 
decision-making could be supported. These insights may also shed light on 
whether public health experts should communicate about various health options 
in addition to the recommended option, and how to communicate about next to 
best options. We will now present the next to best options in smoking behavior 
and childhood vaccination.
Next to best health decisions
E-cigarette use
Electronic Nicotine Delivery Systems (ENDS) are devices that vaporize a solution 
of additives, glycerin, and propylene glycol that is inhaled by the user.13-15,88 
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The solution may, or may not, contain nicotine.13-15,88 Electronic cigarettes are 
the most common type of ENDS. The variety of electronic cigarette (e-cigarette) 
devices available on the market is rapidly increasing. While early models mimic 
conventional cigarettes (in shape and size), newer models vary in product 
specifications (shape, size, battery, and tanks) 14,15,88-90. 
In addition to product specifications, such as wattage and resistance, design and 
flavor characteristics are increasingly elaborate and appealing.91-93 Research in 
recent years has demonstrated that since their introduction in 2003 on the market, 
the appeal of e-cigarettes has increased rapidly.14,15,88-90,94,95 The prevalence 
of e-cigarette use is increasing in the United States, mostly among cigarette 
smokers, but recent research suggests that e-cigarette use is also increasing 
among non-smokers, and may even be a gateway to smoking.14,88,93,96-107 The 
majority of the e-cigarette users are currently former cigarette smokers that either 
switched completely to e-cigarettes or use e-cigarettes in addition to tobacco 
cigarettes.10-15 Concerns exist that e-cigarette use may attract (adolescent) never-
users and thus affect public health adversely, and even lead to dual use and a 
nicotine addiction.16-18 Indeed, a recent study in the US showed that e-cigarette 
use is very popular among youth.108 
E-cigarette use in the Netherlands
The number of people who smoke in the Netherlands is decreasing.109,110 In 
2017, 23% of the adult Dutch population smoked cigarettes.110 Of these 23%, 
75% smoke daily. Of all smokers, higher educated people smoke less often (17%) 
compared to middle (27%) or lower (26%) educated people; more men smoke 
(27%) than women (19%).110 Of the Dutch population, young adults, 20 – 24 years 
old, smoke more often than older adults. Sixteen percent of the Dutch adult 
smoking population are considered heavy smokers (i.e. smoking more than 20 
cigarettes a day).110 Three percent of Dutch adults use an e-cigarette. Of Dutch 
adults, higher educated people use e-cigarettes less often (2.5%), compared to 
middle (3.7%) and low (3.0%) educated people.110 Ten percent of the current 
smokers sometimes use an e-cigarette, and daily smokers (12%) compared to 
non-daily smokers (4%) use an e-cigarette more often. Of the 3% of e-cigarette 
users, seventy-five percent of the e-cigarette users also smoke.110 
Types of users and frequency of use
Definitions of types of users and frequency of use differ. For the purpose of this 
thesis, four groups were defined. Never-users are individuals who reported to 
have never smoked or used e-cigarettes. Smokers are participants who reported 
to currently exclusively use cigarettes on a daily or weekly basis. Dual users are 
individuals who reported concurrently using cigarettes and e-cigarettes on a 
daily or weekly basis.111 E-cigarette users are individuals who reported to be 
currently exclusively using e-cigarettes on a daily or weekly basis.111 
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In the Netherlands, the RIVM investigates the harmfulness of cigarettes and 
e-cigarettes for public health in order to inform the public.112 Although not using 
tobacco or nicotine products would be most beneficial for all types of users, 
exclusive e-cigarette use 111 – and not dual use of both cigarettes and e-cigarettes, 
which has an adverse public health effect 14,16,111 – has potential health benefits for 
smokers compared to cigarette smoking.22,113-116 However, exclusive e-cigarette 
use is not without risks itself. Consequently, from a public health point of view it 
is recommended to prevent e-cigarette use among non-smokers.16 Motives for 
e-cigarette use among smokers have been investigated.90,117-127 In addition, other 
research on e-cigarette use focused on e-cigarettes as a tool for smoking cessation 
or changing smoking behavior with behavior change techniques.128-131 Since 
decision-making about e-cigarette use is largely uninvestigated, it is unclear how 
people make a decision about refraining from cigarette or e-cigarette use, smoking, 
or e-cigarette use. This thesis investigates decisions about never-use, smoking, 
and e-cigarette use among never-users and users about these specific decisions 
in order to develop health communication aimed to support these decisions. 
Partially accepting childhood vaccinations
Childhood vaccinations are very successful interventions to protect against 
vaccine-preventable diseases (VPDs).33,132-134 In the Netherlands, the National 
Immunization Program (NIP) offers vaccinations free of charge and on a voluntary 
basis since 1957.7 Currently, within the NIP, vaccinations are offered against 12 
childhood diseases (polio (IPV), diphtheria (D), tetanus (T), pertussis (aP), rubella (R), 
measles (M), mumps (M), disease caused by Haemophilus influenzae type b (Hib), 
meningococcal ACWY disease (MenACWY), hepatitis B (HBV), pneumococcal 
disease (PCV) and cervical cancer caused by human papillomavirus (HPV), see 
Figure 1.1.7 The RIVM is responsible for organizing the NIP and for offering 
information about the NIP in the Netherlands. The vaccines itself are administered 
in primary care facilities (Child Welfare Centers i.e. CWCs) specialized in child 
health care 6. These centers provide children from zero to four years old with 
health check-ups and administer vaccines according to the vaccination schedule. 
When the child is four to six weeks old, the parents receive an invitation for 
the first consult at the CWC with information on vaccination including the NIP 
schedule, VPDs, and side-effects and practical information. The vaccination 
status of children is recorded in a national register at the RIVM, called Praeventis. 
Vaccination coverage in the Netherlands
Every year, the RIVM publishes a report on the vaccination coverage in the 
Netherlands. The latest figures showed that the vaccination coverage seemed to 
be stabilizing compared to a decline in previous years. At age two, born in 2014, 
91.2% of all Dutch two-year-olds received all vaccines according to the NIP, 3.6% 
did not receive any vaccines according to the NIP and 5.2% received or delayed 
some vaccines (i.e. the next to best option).135 At age two, born in 2015, 92.4% 
of the children received the DTaP vaccine and 92.9% of the children received 
the MMR vaccine.135 In addition, 90.2% of all Dutch two-year-olds, born in 2015, 
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received all vaccines according to the NIP, 4.6% did not receive any vaccines 
according to NIP and 5.2% received or delayed some vaccines (i.e. the next to 
best option).135 These figures seem to be stabilizing, since of all Dutch two-year-
olds born in 2016 90.2% received all vaccines according to the NIP, 4.6% did not 
receive any vaccines according to the NIP and 5.2% received or delayed some 
vaccines (i.e. the next to best option).135  
However, the vaccination coverage alone does not provide insight into whether 
parents have questions or doubts regarding their decision. For example, parents 
who accept all childhood vaccinations, may still have doubts about their decision 
or even experience regret.83,85,136 This is why it is important to investigate decision-
making regarding childhood vaccination. 
Parents’ decision regarding childhood vaccination
For the purpose of this study we chose to include parents of children born 
between 2013-2015 to be able to classify parents in three groups based on 
their decision about the five vaccination moments in the first two years of life 
(see figure 1.1): acceptors, refusers, and partial acceptors. Acceptors are parents 
of children who received all vaccinations according to the Dutch NIP schedule. 
Refusers are parents of children who did not receive any vaccinations according 
to the Dutch NIP schedule. Partial acceptors are parents who refuse or delay 
some vaccines for their child. For example, some of these children did not 
receive any vaccine against PCV, but they did receive all four doses of the DTaP-
IPV-Hib-HBV vaccine, or their first DTaP-IPV-Hib-HBV vaccine was delayed. 
In the Netherlands, the RIVM monitors the NIP, and informs the public about 
childhood vaccinations.112 The RIVM is responsible for presenting the public with 
information about childhood vaccination, for example through an information 
brochure and a website.6,7 Although accepting childhood vaccinations would be 
most beneficial for public health,137 partially accepting childhood vaccination – 
and not refusing all vaccines of the NIP, which has an adverse public health and 
possible adverse individual effect – has potential individual and public health 
benefits compared to refusing all vaccines.137-139 However, partially accepting 
childhood vaccinations leads to lower herd immunity and may not be without 
risks for the individual.140,141 Consequently, it is not recommended from a 
public health point of view. The motives for accepting or refusing childhood 
vaccinations have been investigated from a behavioral perspective with socio-
cognitive models,33,138,142-148, and to a lesser extent also the motives for partially 
accepting childhood vaccination. In addition, while some research looked into 
decision-making about accepting childhood vaccinations,143,149-152 decision-
making about refusing and partially accepting childhood vaccinations among 
those who accept, partly accept or refuse vaccination has not been studied. This 
thesis focusses on decision-making regarding accepting, refusing, and partially 
accepting childhood vaccination by asking all parents questions concerning 
accepting, refusing, and partially accepting childhood vaccination. By focusing 
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on these decisions, we increase our understanding of these decisions so that we 
can develop health communication aimed to support decision-making. 
Figure 1.1 Schedule of the Dutch National Immunization Program. 
Picture copyright 2018 © RIVM. Centre for infectious disease control 7
Note, the schedule of the Dutch NIP changed due to the introduction of maternal 
pertussis vaccine in 2019.
Thesis outline
To understand decision-making about smoking behavior and childhood 
vaccination, we present two objectives. First, we aimed to explore determinants 
of the decisions about smoking behavior and childhood vaccination, both 
qualitatively and quantitatively. Second, we aimed to provide insight into the 
extent to which decisions about smoking behavior and childhood vaccination 
adhere to the criteria of informed decision-making as defined in this thesis. With 
this aim in mind we investigated the level of knowledge, attitudes, and value-
consistency toward a decision about the various choice options and levels of 
deliberation with regard to smoking behavior or childhood vaccination. These 
objectives are addressed in three parts through a series of studies (figure 1.2). 
The following section outlines the studies conducted. 
Part 1 of this dissertation presents information on factors related to decisions 
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about never-use, smoking, and vaping. Chapter 2 starts by offering an 
overview in the form of a systematic narrative review of reasons of use and 
perceptions among never-users, smokers, exclusive e-cigarette users, and dual 
users concerning e-cigarettes. The overview presented in chapter 2 and the 
conceptualization of informed decision-making based on a Rational Decision 
Model 71 was used to develop the interview protocol used in a semi-structured 
focus group study among never-users, smokers, and e-cigarette users. Chapter 
3 describes the results of this qualitative study concerning decisions with regard 
to smoking behavior among never-users, smokers, and e-cigarette users. The 
results of the qualitative study presented in chapter 3 were used to develop 
a questionnaire about the recommended, unrecommended, and next to best 
health options with regard to smoking behavior to investigate socio-cognitive 
factors related to informed decision-making among never-users and users. In 
order to examine the role played by flavors in the decision regarding e-cigarette 
use, chapter 4 presents the results of a quantitative analysis into the interplay of 
individual flavor choice and socio-cognitive factors related to e-cigarette use. 
Chapter 5 provides insights into features that distinguish a dual user from an 
exclusive e-cigarette user, derived from a quantitative survey. 
Chapter 1 General Introduction
Part 1 Exploring factors related to decision-making about smoking behavior.
Chapter 2: Overview of reasons and perceptions regarding 
e-cigarettes.
Chapter 3: Exploring factors mentioned by never-users, smokers and 
e-cigarette users regarding decision-making about never-use, smoking, 
and switching from cigarettes to e-cigarettes.
Chapter 4: Exploring attractive aspects of e-cigarettes among never-
smokers and never-users, smokers, and e-cigarette users.
Chapter 5: Exploring features to distinguish a dual user from an 
exclusive e-cigarette user.
Part 2 Exploring factors related to decision-making about childhood vaccination.
Chapter 6: Exploring factors mentioned by acceptors, refusers, and 
partial acceptors regarding decision-making about accepting, refusing, 
and partially accepting childhood vaccinations. 
Chapter 7: Exploring determinants and decisional conflict among 
acceptors, refusers, and partial acceptors regarding their decision 
about childhood vaccinations. 
Part 3 Exploring whether the decisions about smoking behavior and childhood 
vaccinations adhere to informed decision-making criteria
Chapter 8: Exploring knowledge, attitudes, and deliberation of those 
who opted for the recommended, unrecommended, and next to best 
health options 
Chapter 9 General Discussion
Figure 1.2 Schematic outline of this thesis
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Part 2 of this dissertation presents information on factors related to the decisions 
concerning childhood vaccination among parents who accept, refuse, or partially 
accept childhood vaccinations for their child with regard to these three health 
options. Chapter 6 starts by providing insights into socio-cognitive factors related 
to the decisions regarding childhood vaccinations among vaccine acceptors, 
refusers, and partial acceptors gained by means of focus groups. The results of 
the qualitative study presented in chapter 6 were used to develop a questionnaire 
to investigate the identified factors related to decision-making about childhood 
vaccination among parents. In addition, to conceptualize the uncertainty about 
this decision, decisional conflict among parents was investigated. Chapter 7 
explores differences in determinants and decisional conflict experienced by 
parents who accepted, partially accepted, or refused childhood vaccinations, 
with regard to these three health options. 
Part 3 of this dissertation discusses whether the decisions regarding smoking 
behavior and childhood vaccination adhere to the conceptualization of informed 
decision-making. For this study, we used the quantitative survey results from parts 
1 and 2. Chapter 8 describes whether the decisions about the recommended, 
unrecommended, and next to best health options in the case of smoking behavior 
and childhood vaccinations adhered to the criteria of informed decision-making: 
knowledge, attitudes, and deliberation. 
Finally, chapter 9 summarizes and discusses the major findings of the studies 
presented in this thesis. Practical recommendations and suggestions for further 
research are given. 
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Abstract 
This paper aims to provide an in-depth understanding of the attractiveness 
of e-cigarettes for several different groups. For this purpose, perceptions of 
and reasons for e-cigarette use were systematically reviewed as reported by 
e-cigarette users, cigarette smokers, dual users, and never-users, among both 
adults and youth. MEDLINE® (Please define if appropriate) and Scopus were 
used to search for relevant articles, and references of included studies were 
also investigated. Two reviewers screened all titles and abstracts independently, 
blinded to authors and journal titles (Cohen’s Kappa = 0.83), resulting in 72 
eligible articles. Risk perceptions, perceived benefits, and reasons for e-cigarette 
use were categorized in themes and sub-themes. Risk perceptions included 
harmfulness in general, and specific health risks. Perceived benefits included 
improved taste and smell, and safety for bystanders. Reasons for use included 
(health) benefits, curiosity, smoking cessation, and friends using e-cigarettes. The 
findings highlight that there is a variety of perceptions and reasons mentioned 
by adult and youth e-cigarette users, cigarette smokers, dual users, and never-
users. As such, this overview provides valuable information for scientists, public 
health professionals, behavior change experts, and regulators to improve future 
research, risk communication, and possibilities to effectively regulate e-cigarettes.
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Introduction 
Electronic Nicotine Delivery Systems (ENDS) are devices that vaporize a solution 
of nicotine, additives, glycerin, and propylene glycol that is inhaled by the 
user.1-4 Electronic cigarettes are the most common type of ENDS. The variety 
of electronic cigarette (e-cigarette) devices available on the market is rapidly 
increasing. While early models mimic conventional cigarettes (in shape and 
size), newer models vary in product specifications (shape, size, battery, and 
tanks).2-6 In addition to product specifications, design and flavor characteristics 
are increasingly elaborate and appealing.7-9 Research in recent years has 
demonstrated that the appeal of e-cigarettes has increased rapidly.2-6,10 The 
prevalence of e-cigarette use is increasing, mostly among cigarette smokers, 
but recent research suggests that e-cigarette use is also increasing among non-
smokers, and may even be a gateway to smoking.2,3,9,11-22 Glasser et al. 3 noted 
that, regardless of smoking status, e-cigarettes are perceived as less harmful 
and addictive, and effective as a smoking cessation aid. Nevertheless, risk 
perceptions and perceived benefits for e-cigarette use might be different for 
e-cigarette users than never-users. Moreover, 6 and Glasser et al. 3 indicated that 
reasons for e-cigarette use go beyond smoking cessation 23 among e-cigarette 
users. However, as the appeal of e-cigarettes is increasing among never-users, 
it is interesting to study the reasons never-users report that could lead them to 
initiate e-cigarette use, and whether these reasons differ from cigarette smokers 
switching to e-cigarettes. In order to better understand the process of switching 
from cigarettes to e-cigarettes or experimenting with e-cigarettes, it is important 
to have an insight into perceptions of e-cigarettes and reasons for use among 
different types of users.6,11,19-26 This paper therefore provides an overview of such 
perceptions and reasons among adult and youth e-cigarette users, cigarette 
smokers, dual users, and never-users. 
The current overview provides scientists, public health professionals, behavior 
change experts, and regulators with key constructs for the development and 
validation of measures to assess perceptions of e-cigarettes and reasons for 
e-cigarette use. Public health professionals are able to use the overview on 
perceptions and reasons when developing health education and behavior 
change programs. On a population level, policy makers are able to use this 
inclusive overview to intensify smoking bans to avoid dual use and to target 
product characteristics of e-cigarettes attractive for specific user groups.
Methods 
Search
The search strategy developed for the purpose of this narrative review aimed 
to retrieve articles focusing on perceptions and reasons related to e-cigarette 
use without any restrictions on location. Databases searched (and interfaces) 
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were MEDLINE (Ovid) and Scopus (without date restrictions) till February 2018. 
Concepts included in the search were “electronic cigarette”, “perception”, 
“reason”, “opinion”, and “smoking cessation” (see Appendix 1 for the full search 
strategy). The references of all included articles in our review were examined for 
additional references. To check the completeness of our search strategy, the final 
list of records was checked for inclusion of prior identified relevant research. 
Study Selection
Following the Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) guidelines (see Figure 2.1. The PRISMA flow diagram), 
retrieved citations were screened, duplicates were eliminated, and the remaining 
citations were organized in EndNote.27 Authors Kim A.G.J. Romijnders and 
Reinskje Talhout reviewed all titles using a previously agreed-upon exclusion 
criteria list (see Appendix 2). First, they independently screened a random sample 
of 86 titles and abstracts in which they were blinded to authors and journal titles, 
and reached strong agreement (Cohen’s Kappa = 0.83) 28. Second, two authors 
(Kim A.G.J. Romijnders, Reinskje Talhout) independently screened all titles and 
abstracts, still blinded to authors and journal titles, using an Excel workbook 
designed specifically for screening.29 Exclusion criteria were hierarchical in order, 
meaning that if the first exclusion criterion applies, the other exclusion criteria 
were not checked. Exclusion criteria were the following: (1) The article was not 
about e-cigarettes; (2) The article discussed toxicology and vaping behavior; (3) 
The article was an opinion piece; (4) The article discussed the market or marketing 
of e-cigarettes; (5) The article was about harm reduction; (6) The topic of the 
article was regulation; (7) The article did not include subjective reports; (8) The 
article described the gateway effect; or (9) It was not an article.27 The full exclusion 
decision tree can be found in Appendix 2. Full-text articles were reviewed to 
determine final eligibility with the same exclusion decision tree (Appendix 2),30 
but two additional exclusion criteria applied: (10) Conflict of interest, and (11) 
Age restrictions. To make a distinction between adults (>18) and youth (<18), 
studies needed to apply clearly defined age restrictions (adults >18 and youth 
<18). An article was considered for inclusion if it was a quantitative or qualitative 
study focusing on subjective reports of participants, reporting on perceptions 
and/or reasons for e-cigarette use. The Excel workbooks are available upon 
request from the first author.
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1328 records identified from all
sources 
426 duplicates excluded
902 titles & abstracts to screen
732 
237 
111 
103 
80 
88 
78 
18 
15 
2
Total excluded 
#1_Topic does not revolve around e-cigarettes 
#2_Topic revolves around toxicology or vaping 
behavior 
#3_An opinion article about e-cigarettes 
#4_Topic market or marketing of e-cigarettes 
#5_Harm reduction 
#6_Topic revolved around the regulation of e-
cigarettes 
#7_No perceptions or reasons reported 
#8_Gateway use of e-cigarettes reported without 
subjective reports of users 
#9_not a scientific article 
170 full text records to review
0 items not available for review
170 full text records available to
review 
124 
8 
8 
5 
10 
73 
1 
2 
17
Total Full text articles excluded 
#1_Topic does not revolve around e-cigarettes 
#2_Topic revolves around toxicology, 
composition, topography  
#4_Topic: market or marketing of e-cigarettes 
#5_Harm reduction 
#7_No perceptions or reasons reported 
#9_Not an article 
#10_Conflict of interest 
#11_age restrictions apply 
46 publications included
Reporting on 41 studies
26 publications added after
literature update 
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Figure 2.1 The Preferred Reporting Items for Systematic Reviews and Meta-analyses 
(PRISMA) guidelines. (a) Identification contains all records identified during the search. 
(b) Screening lists all reasons why articles were excluded based on title and abstract. 
(c) Eligibility records all the records available for full-text review. (d) Included reports all 
exclusion criteria used during full-text review.
Data Extraction
Kim A.G.J. Romijnders extracted all relevant findings from the included studies 
(see Appendix 3). Due to the variety in research designs, it was not possible to 
generate a single quality score according to STROBE.31 A single quality score, 
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generated by the STROBE checklist, would limit the scope of this narrative review 
for generating an extensive list of perceptions and reasons regarding e-cigarettes. 
The results were not limited to cross-sectional surveys with probability samples, 
or close-ended response options, but also include qualitative work. A deductive 
thematic analysis was performed to identify themes that appeared salient to the 
constructs: perceptions regarding e-cigarettes and reasons for e-cigarette use. 
The main constructs “Perceptions” and “Reasons” were used to categorize the 
major relevant findings in Appendix 3. The themes (for example, for reasons 
for e-cigarette use: “expected benefits” and “social environment”) were used 
to extract major relevant findings (Appendix 3). Kim A.G.J. Romijnders and 
Reinskje Talhout formulated sub-themes after extracting relevant findings for 
perceptions about e-cigarettes and reasons for e-cigarette use. The sub-themes 
were salient to the themes, for example, for the theme “perceived safety of use”, 
the sub-theme “perceived safety of ingredients” emerged as pertinent from 
the major relevant findings. Kim A.G.J. Romijnders coded the major relevant 
findings found in Appendix 3 according to the themes and sub-themes (e.g., 
for theme “expected benefits” the sub-themes “weight control” and “helps 
with concentration” were applied). Kim A.G.J. Romijnders and Reinskje Talhout 
agreed upon the themes and sub-themes before the coding of the major relevant 
findings took place. The coding led to an overview of perceptions of risks of 
e-cigarettes, perceived benefits of e-cigarettes, and reasons for e-cigarette use. 
To ensure the reliability of the meaning of themes and sub-themes during coding 
of articles, triangulation was used.
After coding, results were stratified by type of user and age. Adults were 
categorized as eighteen years or older, and youth were categorized as younger 
than eighteen years old. For each type of user, there was variability in reporting. 
For example, some studies report current use of e-cigarettes among current 
cigarette smokers without categorizing them as dual users, whereas other studies 
reported the current use of e-cigarettes with simultaneous current tobacco 
cigarette use as dual use32,33 Therefore, measures for type of user were recorded 
for each included study as defined by the respective authors (Appendix 3). 
This review categorized perceptions and reasons regarding e-cigarettes using 
the classification of users as stated in the original study. E-cigarette users are 
users of e-cigarettes without differentiating for frequency of use, co-current use 
or past use of cigarettes. Similarly, no distinction was made among cigarette 
smokers concerning frequency, lifetime use, co-current or past use of other 
tobacco products or e-cigarettes. If an included study mentioned perceptions or 
reasons regarding e-cigarettes among dual users, this review categorized these 
perceptions and reasons among dual users. Similarly, never-users were classified 
as not using e-cigarettes or cigarettes. No distinction was made between 
former users or users that had never smoked. Summarizing, type of users were 
categorized according to their original type of user classification without an 
attempt to synthesize type of user across studies. 
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Results
A total of 65 studies from 72 articles met the eligibility criteria (see Figure 2.1).25,32-
102 Articles report perceptions and reasons regarding e-cigarettes in 49 studies 
among e-cigarette users, 39 studies among cigarette smokers, 11 studies among 
dual users, and 19 studies among never-users, which are listed in an overview. 
The sample size ranged from 14 to 25,029 respondents. Most studies were 
conducted in the U.S. (n = 49), but studies were also conducted in the UK (n 
= 11), New Zealand (n = 6), Canada (n = 4), France (n = 2), Switzerland (n = 3), 
Australia (n = 2), and Belgium (n = 1) (see Appendix 3 for a full overview). Fifty-
five articles reported data on adults, and seventeen on youth. Thirty-four studies 
had a cross-sectional design, seventeen had a qualitative design, three had a 
mixed methods approach, six were longitudinal, and twelve were cohort studies 
(see Appendix 3). Due to a variety of research designs, sample size, and changes 
over time, this paper is not a synthesis of most cited, most important, or most 
expressed perceptions and reasons by participants.23 This section provides an 
overview of risk perceptions, perceived benefits, and reasons for e-cigarette use.
Risk Perceptions Related to E-Cigarettes
Perceived risks pertained to risks for individual e-cigarette users (e.g., unsafe 
components of e-liquids), and risks for the social environment of these users 
(e.g., risks for bystanders and the risk for an unborn child if used during 
pregnancy).25,32,34,36,37,39-41,45,47,49,50,52,54,56,57,59-61,63,65,66,68,70,72,73,77-79,81,83,85,86,88,89,93-95,97,98,
101,102 Table 2.1 summarizes the different risk perception themes and sub-themes 
identified. This section reports perceptions mentioned by user groups. First, 
studies suggest that, compared to cigarettes, e-cigarettes were perceived by 
all user groups as being healthier, safer, and less addictive, as well as being 
safer for one’s social environment, and safer to use during pregnancy than 
cigarettes.32,37,39-41,43,44,47-49,57,59,61,63,65,68,73,76,81,85,88,89,94,95,102 Second, studies performed 
in earlier years showed that e-cigarettes were perceived as being overall less 
harmful than cigarettes, while in later years this reduced harm perception changed. 
25,32,34,36,37,39-41,45,47,49,50,52,54,56,57,59-61,63,65,66,68,70,72,73,77-79,81,83,85,86,88,89,93-95,97,98,101,102 In more 
recent studies e-cigarettes were perceived as equally or more harmful than 
cigarettes among adult cigarette smokers,25,36,37,47,52,59,66 never-users,54,60,72,73,85,93,94 
as well as youth cigarette smokers,25,36,37,52,56,59,66 and never-users.25,47,52 Third, 
specific flavors (candy and fruit flavors) were considered less harmful than other 
(tobacco) flavors among adult 49 and youth 56 e-cigarette users, adult 78 and 
youth 25,56 cigarette smokers, and never-users 56. Summarizing, different themes 
and subthemes with regard to perceived risks for the individual e-cigarette user 
and risks for their social environment were specified. Flavors influence the risk 
perception of e-cigarettes among both adults and youth, and current data show 
that the risk perception of e-cigarettes increased compared to previous years.  
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Table 2.1 Risk perceptions about e-cigarettes reported by individual studies, clustered 
by type of user.
Themes and Sub-
themes of Risk 
Perceptions
Never-users d Smokers b Dual Users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth 
Risk Perceptions for the User
Harmfulness 54,60,72,
73,85
25,47,52 34,39,41,45
,50,54,59,6
0,70,72,77,
83,85,88,93
,97,98,101
25,36,37,
52,56,59,
66
32 40,49,54,
57,59,73,
79,85,86,
94
25,36,37,
47,52,59,
66
Harmfulness of 
flavors
56 78 25,56 49 56
Secondary harm as 
a gateway drug
94
Health risks 65 49,65 37,47
Reduced athletic 
performance 
49
Trouble breathing/
Coughing
49 47
Cancer 49 47
Hearth attack 49
Dental health 
issues
49
Safety of use 63,68,88,
89
37,59 63 37,40,57,
59,102
37,59
Lack of safety of 
ingredients liquids
59 59
Risk Perception for the Social Environment of a user
Harmful for 
bystanders
85 40,57,81,
85
Safety of use 
during pregnancy
61,73
Note: a “E-cigarette users” are users of e-cigarettes as defined in the original study. For 
example, Bold, Kong, Cavallo, Camenga, Krishnan-Sarin 44 included only ever users of 
e-cigarettes in their study, without differentiating for frequency of use, co-current use 
or past use of cigarettes. b “Smokers” are those who smoke cigarettes as defined in the 
original studies. For example, Biener, Song, Sutfin, Spangler, Wolfson 43 defined cigarette 
smokers as those who had smoked at least 100 cigarettes in their lifetime and smoked 
every day or some days. No distinction is made among cigarette smokers concerning 
frequency, lifetime use, co-current or past use of other tobacco products or e-cigarettes. 
c “Dual users” are those who use e-cigarettes and cigarettes simultaneously as defined 
in the original studies. For example, Cheney, Gowin, Wann 48 defined dual users as 
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current use of both e-cigarettes and cigarettes within the past week. If an included study 
mentioned perceptions or reasons regarding e-cigarettes among dual users, this review 
categorized these perceptions and reasons among dual users. d “Never-users” are those 
who did not use e-cigarettes or cigarettes at the time of included study as defined in 
the original study. For example, Patel, Davis, Cox, et al. 76 defined never-users as those 
who report “not at all” to the question whether they had smoked cigarettes or used 
e-cigarettes. Never-users were classified as not using e-cigarettes or cigarettes, and no 
difference was made between former users and never users.
Perceived Benefits of E-Cigarettes
Perceived benefits of e-cigarettes mentioned in the literature are summarized in 
Table 2.2 and include (expected and actual) positive experiences (such as taste), 
social acceptance, avoidance of smoking restrictions, a cool and fashionable 
product, an effective smoking aid, and the safety for bystanders. In this section, 
perceived benefits of e-cigarettes for the user groups are shown. First, adult 
e-cigarette users 40,49,57,58,73,81,88,90,102 and adult cigarette smokers 37,39,42,50,63,68,70,78
,88,89,99 noted health benefits and positive experiences of e-cigarette use. Dual 
users and never-users did not identify health benefits or positive experiences, 
although they did note some benefits for reducing cravings and safety for the 
e-cigarette user compared to cigarette smokers. Second, adult e-cigarette 
users,40,41,49,57,81,85 dual users 81, and never-users 58,85,94,95 also saw benefits for 
bystanders of e-cigarette users. Third, youth noted only a few perceived benefits 
of e-cigarette use for individual use. They perceived e-cigarettes as safe to 
use for e-cigarette users and fashionable (youth e-cigarette users,37,47,59 youth 
cigarette smokers,37,59 and youth never-users47,55). Summarizing, individual user 
benefits revolved around convenience and attractiveness of the product, health 
benefits, positive experiences, safety, smoking cessation benefits, and social 
acceptability. Perceived benefits for the social environment of the user were 
mentioned by adult user groups (safety for bystanders and the environment). 
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Table 2.2 Perceived benefits of e-cigarettes reported by individual studies, categorized 
by type of user.
Perceived Benefits for Users
Themes and Sub-
themes of Perceived 
Benefits
Never-users d Smokers b Dual users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth
Addictiveness Perceived as 
equally 
addictive 
Perceived as 
equally 
addictive 
Perceived as 
less addictive
Perceived as 
less addictive
73,94 47 39,41 59 32,81 73,81,94 47,59
Avoidance of smoking 
restrictions
73 50,63,68,
88,89
37 63 49 37
A cool and fashionable 
product
73 47,55 37 73 37,47
Health benefits 90
Healthier than cigarettes 42 37 37
Improved breathing 63 63
Improved general well-
being
63,78 63
Decreased coughing 63 63
Less likely to cause 
cancer
78
Lower costs compared 
to cigarettes
50
Positive experiences
Mimics smoking routine 55 37 37 37
Enjoyable taste 73 81 81
Throat hit 81 81
Weight control 81 81
Increases concentration 47
Safety of use 63,68,88,
89
37,59 63 40,57,102 37,59
Safety of ingredients 
liquids
47,55 59 73 59
Smoking cessation 
purposes 
Nicotine replacement 
therapy
58,61,73,
88,94
39,50,70,
99
32,89 49,58,73,88
Perceived Benefits for Users
table continues
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Themes and Sub-
themes of Perceived 
Benefits
Never-users d Smokers b Dual users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth
Cut back on cigarettes 50
Deal with cravings 58 89
Social acceptability 58,94,95 81 41,49,81
Perceived Benefits for the Social Environment of a User
Safer for bystanders 85 81 40,57,81,85
Safer for the environ-
ment (less pollution)
57
Note: a “E-cigarette users” are users of e-cigarettes as defined in the original study. For 
example, Bold, Kong, Cavallo, Camenga, Krishnan-Sarin 44 included only ever users of 
e-cigarettes in their study, without differentiating for frequency of use, co-current use or 
past use of cigarettes. b “Smokers” are those who smoke cigarettes as defined in the 
original studies. For example, Biener, Song, Sutfin, Spangler, Wolfson 43 defined cigarette 
smokers as those who had at least smoked 100 cigarettes in their lifetime and smoked 
every day or some days. No distinction is made among cigarette smokers concerning 
frequency, lifetime use, co-current or past use of other tobacco products or e-cigarettes. 
c “Dual users” are those who use e-cigarettes and cigarettes simultaneously as defined in 
the original studies. For example, Cheney, Gowin, Wann 48 defined dual users as current 
users of both e-cigarettes and cigarettes within the past week. If an included study 
mentioned perceptions or reasons regarding e-cigarettes among dual users, this review 
categorized these perceptions and reasons among dual users. d “Never-users” are those 
who did not use e-cigarettes or cigarettes at the time of included study as defined in 
the original study. For example, Patel, Davis, Cox, et al. 76 defined never-users as those 
who report “not at all” to the question of whether they had smoked cigarettes or used 
e-cigarettes. Never-users were classified as not using e-cigarettes or cigarettes, and no 
difference was made between former users or never user
Reasons for E-Cigarette Use 
This section reports reasons for use among e-cigarette users, cigarette smokers, 
dual users, and never-users. Never-users were asked about possible reasons for 
them to personally initiate e-cigarette use. Reasons for explaining the appeal of 
e-cigarettes go beyond smoking cessation (Table 2.3 32,33,35,37,39-44,46,48-51,53,54,57,62,64-
67,69-71,74-76,79,81-86,90,91,98,102). Other reasons include expected benefits (enjoyable 
taste and a variety of flavors), experienced benefits (reduces stress and enables 
control of weight gain), avoidance of smoking restrictions by dual use of tobac-
co products and e-cigarettes, convenience of the product, curiosity, and influ-
ences from the social environment (e.g., recommended by friends). Smoking 
cessation was the most often reported reason for initiation of e-cigarette use 
among adult e-cigarette users,33,35,40-42,44,48,49,51,53,54,57,62,64-66,69,75,76,79,81,82,85,86,90,91,102 
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cigarette smokers,39,42,43,46,50,69-71,76,83,84,98 dual users,32,33,67,81,82 and never-users76. 
In addition, other expected benefits were reported by adult35,40,41,48,49,53,65,76,79,81,90 
and youth44,59,75 e-cigarette users, adult46,76,84 and youth59 cigarette smokers, dual 
users,32,48, and adult never-users76 (see Table 2.3). In addition to expected ben-
efits, adult33,35,40,41,48,53,65,74,76,79,81,85,90,91 and youth44,59,75 e-cigarette users and dual 
users32,33,48,81 reported additional experienced benefits such as health benefits 
and finding a new hobby. In summary, reasons for e-cigarette use go beyond 
smoking cessation. While smoking cessation is the reason most often reported 
in large-scale population surveys, most other reported reasons revolved around 
the health benefits of e-cigarette use compared to smoking.
Table 2.3 Reasons for e-cigarette use as reported by individual studies by type of user.
Themes and Sub-
themes of Reasons for 
E-cigarette use
Never-users d Smokers b Dual Users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth
Expected benefits
Enjoyable taste 46 40,53,65,
81
Expected health benefits
Healthier than cigarettes 32,33 33,40,41,
49,53,57,
81
44,75,80
Improved breathing 37 91 37,47
Increased concentration 47 32
Satisfy nicotine need 32 38,90
Availability of variety of 
flavors
76 76,84 59 48 35,40,41,
48,49,65,
76,79
44,59
Weight control 41,81 75
Experienced benefits
Avoidance of smoking 
restrictions by dual use 
of tobacco products and 
e-cigarettes
76 95 42,43,50,
69,76,83,
84
37 82 35,65 37,92,
100
Possibility to alter 
technical specifications
40,74,90
Weight control 41,81
Mimics smoking routine 37 33 33,40,49,
54,79,91
37
Experienced health 
benefits
37 32,33 33,40,48,
49,53,81
37,75
table continues
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Themes and Sub-
themes of Reasons for 
E-cigarette use
Never-users d Smokers b Dual Users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth
Regain a sense of smell 
and taste
40,53
Improved breathing
Decreased coughing
Improved dental health
Increased athletic 
performance
47,75
Increased alertness 
New hobby (more 
friends)
33,48 33,48,91
Aid to concentration 47 32
Pleasure of product use 33 33,40,53,
85,91
Reduces stress 84 81 48,81
Taste of flavors 76 76,84 59 32,33 35,40,41,
48,65,76,
79,81
44,59
Throat hit 84 81 40,81
Convenience of product 91
Easily accessible 71 37 40,48,71,
91
37,80
Lower costs compared 
to cigarettes
37 32,33 33,38,40,
41,69,74,
79,85,87,
96
37,75,
100
Discreet in use  
(no lingering smell, able 
to hide use)
44
Practical in use (no 
lighter, no ashtray, one 
puff, and able to store 
the device)
76 71,76 48,76 40,48,71,
76,91
Curiosity
A cool product 39,76 39,71,76,
98
66 81 35,69,76,
79,81,87,
96,98
44,47,66,
100
A fashionable product 37 37
Novelty (curious about 
novel product)
76 39,43,69,
71,76,84,
98
35,53,65,
69,70,76,
79,81,85
44,62,64,
66,92,
100
table continues
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Themes and Sub-
themes of Reasons for 
E-cigarette use
Never-users d Smokers b Dual Users c E-Cigarette 
Users a
Adults Youth Adults Youth Adults Youth Adults Youth
Smoking cessation 
purposes
Alternative for smoking 
cigarettes
69 38,57,86
Avoidance of withdrawal 
of nicotine
38,53
Cut back cigarettes 50,83 32,33,81 33,42,79
,81,87,96
75,92,
100
Use as smoking 
cessation aid
76 39,42,43,
46,50,70,
76,83,84,
98
100 32,33,67 33,35,38,
40-42,44,
51,53,54,
62,64-66,
69,75,76,
79,81,85,
87,90,91,
102
44,51,62,
64,66,75,
92
Deal with cravings 76 71,76 32,33,82 40,54,76,
79,82,85,
96
Social environment
Fitting in 47
Pressure of social 
environment 
47 [41]
Recommended by 
friends or family
69 96 92,100
Role models use 
e-cigarettes
41,49 92
Note: a “E-cigarette users” are users of e-cigarettes as defined in the original study. For 
example, Bold, Kong, Cavallo, Camenga, Krishnan-Sarin 44 included only ever users of 
e-cigarettes in their study, without differentiating for frequency of use, co-current use or 
past use of cigarettes. b “Smokers” are those who smoke cigarettes as defined in the 
original studies. For example, Biener, Song, Sutfin, Spangler, Wolfson 43 defined cigarette 
smokers as those who had at least smoked 100 cigarettes in their lifetime and smoked 
every day or some days. No distinction is made among cigarette smokers concerning 
frequency, lifetime use, co-current or past use of other tobacco products or e-cigarettes. 
c “Dual users” are those who use e-cigarettes and cigarettes simultaneously as defined 
in the original studies. For example, Cheney, Gowin, Wann 48 defined dual users as 
current use of both e-cigarettes and cigarettes within the past week. If an included study 
mentioned perceptions or reasons regarding e-cigarettes among dual users, this review 
categorized these perceptions and reasons among dual users. d “Never-users” are those 
who did not use e-cigarettes or cigarettes at the time of included study as defined in 
the original study. For example, Patel, Davis, Cox, et al. 76 defined never-users as those 
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who report “not at all” to the question of whether they had smoked cigarettes or used 
e-cigarettes. Never-users were classified as not using e-cigarettes or cigarettes, and no 
difference was made between former users and never users.
Discussion
This review provides a comprehensive overview of risk perceptions, perceived 
benefits, and reasons for use of e-cigarettes, as reported in Tables 2.1 – 2.3.
Perceptions and Reasons Among Users and Never-users
Current data showed a variety of perceptions about e-cigarettes and reasons 
for e-cigarette use reported by e-cigarette users, cigarette smokers, dual users, 
and never-users. For example, e-cigarettes were perceived as being less harmful 
by e-cigarette users. This perception of reduced harm could lead to use or, vice 
versa, by initiating e-cigarette use, the perception of harm may decrease. How-
ever, research showed that the perceived harm of e-cigarettes as compared to 
tobacco cigarettes has increased among all types of users over the years,3 and 
e-cigarettes are currently perceived as equally or more harmful than cigarettes. 
With regard to available flavors, which were shown to influence risk perceptions, 
fruit or candy flavored e-liquids were perceived as less risky compared to tobac-
co flavored e-liquids. E-cigarette users and cigarette smokers perceived benefits 
of e-cigarettes. In addition, adult e-cigarette users, dual users, and never-us-
ers noted advantages for the social environment when switching from cigarette 
smoking to e-cigarette use. Youth highlighted the trendiness of e-cigarettes as a 
perceived benefit, and perceived less health benefits than adults. The overview 
in this paper shows several positive perceptions and reasons which influence the 
initiation of e-cigarette use.
Based on these findings, tailored communication on risks and benefits of e-cig-
arette use could increase awareness about risks and benefits of e-cigarette use 
among user groups. For example, targeted risk communication on risks of e-cig-
arette use for never-users, and benefits of e-cigarette use compared to smoking 
for cigarette smokers would increase factual knowledge about risks of e-ciga-
rette use among these user groups. If the latter were to perceive e-cigarettes as 
less harmful, they may be more inclined to switch to e-cigarettes. Furthermore, if 
never-users were not to perceive fruit- and candy-flavored e-liquids as harmless, 
they might be less inclined to initiate e-cigarette use. Summarizing, risks and 
benefits could be communicated to increase knowledge about e-cigarette use 
among user groups.
E-cigarette users expected (before initiation) and experienced (after continuation 
of use) benefits from e-cigarette use. In addition, this paper noted that reasons for 
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initiation of e-cigarette use evolved to reasons for continuation of e-cigarette use 
14. When positive outcome expectancies (theme: expected benefits, see Table 
2.3)32,33,40-43,46,47,49,50,53,75,100,103 were realized by positive experiences when initiating 
e-cigarette use (theme: experienced benefits, see Table 2.3),32,33,40,41,49,53,75,84 peo-
ple may continue using e-cigarettes. For example, all e-cigarette users expected 
health benefits from e-cigarette use compared to cigarettes.32,33,40-43,46,49,53,75,100 If 
health improvements are indeed experienced, this may lead to continued use of 
e-cigarettes and possibly quitting cigarette use32,33,40,49,53,75 (see Table 2.3).
Cigarette smokers and never-users also mentioned expected benefits from 
e-cigarette use. However, not all cigarette smokers continue with e-cigarette use 
after initiation or initiate e-cigarette use. In some cases, the expected benefits of 
e-cigarettes for cigarette smokers—the ability to mimic smoking behavior—did 
not result in the expected experience. Cigarette smokers who tried e-cigarettes 
often expressed the inability to mimic smoking behavior with an e-cigarette (e.g., 
as a result of taste, the weight of the device, not being able to hold the device 
in the same way as a tobacco cigarette).33,41-43,49 The experience of e-cigarettes 
did not live up to the outcome expectations of cigarette smokers. Consequently, 
managing outcome expectations (by assisting with device specifications choices 
or e-liquid flavors) in behavior change strategies for cigarette smokers may pre-
vent dual use of e-cigarettes and cigarettes. Managing outcome expectations 
could also be used to prevent initiation among never-users, by focusing on ex-
pected disadvantages of use and negative experiences (such as stressing that it 
is not cool or fashionable to use e-cigarettes).
Applications
Perceptions and reasons regarding e-cigarette use provide additional input for 
public health education, behavioral change programs, and regulation. Regula-
tion, such as warning labels on tobacco products, is used to target mispercep-
tions regarding tobacco products on a population level. Public health education 
can use the overview, presented in this study of perceptions on risks and bene-
fits, to highlight factual risks and benefits of e-cigarette use in tailored commu-
nication. For example, tailored risk communication on the reduced harmfulness 
of e-cigarettes compared to cigarettes may reduce misperceptions among cig-
arette smokers initiating e-cigarette use for smoking cessation purposes. With 
risk communication tailored to specific personal needs and personal outcome 
expectancies, behavior change experts are able to target these personal misper-
ceptions and confirm factual risk perceptions and perceived benefits. 
Policy makers can also use this overview for product regulation measures. For ex-
ample, available e-liquid flavors play an important role in the initiation of e-ciga-
rette use for both cigarette smokers looking for an alternative for cigarettes and 
for curious never-users.9 From a public health point of view, it is not desirable 
for never-users to be attracted by flavors in e-liquids, with the chance of initiat-
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ing e-cigarette use. Future research should therefore focus on differences and 
overlap in specific flavor preferences among cigarette smokers and never-users 
to facilitate switching from cigarettes to e-cigarettes and discourage initiation of 
e-cigarette use among never-users.22,25
Future Research
Heterogeneity in the reporting of types of users made it difficult to classify 
types of users. For future research, it is therefore of vital importance to formu-
late standard definitions for ever, current, and dual use of e-cigarettes to assess 
population effects of e-cigarette use. In defining e-cigarette use, it is important 
to distinguish between experimental and daily use. For example, asking about 
e-cigarette use during the previous 30 days does not distinguish between exper-
imental and daily use.
This review noticed the lack of reporting on perceptions towards e-cigarettes 
and reasons for use among adult dual users and never-users, and youth never-us-
ers and dual users. Future research needs to identify the rates of dual use among 
youth. Overall, only perceptions of harm were assessed in extensive cross-sec-
tional, cohort, and longitudinal studies compared to other risk perceptions, and 
less regarding perceptions in general.
E-cigarette use is a complex behavior, and response options in questionnaires 
assessing perceptions and reasons in general may not be representative for all 
users, cigarette smokers, dual users, and never-users. Our overview, in addition 
to the work of Gibson et al. 26 and Pearson et al. 24, validated measures such as 
the Fagerström test for nicotine dependence104 and the International Tobacco 
Control measures105, and adds insight into developing and validating items for 
measuring e-cigarette use, risk perceptions of e-cigarettes, perceived benefits of 
e-cigarettes, and reasons for e-cigarette use. Summarizing, validated measures 
provide insight into e-cigarette use to develop tailored information based on the 
needs of e-cigarette users, cigarette smokers, dual users, and never-users. 
Limitations
Heterogeneity between the different papers in statistical methods and report-
ing makes it difficult to generalize findings across countries and study samples. 
Therefore, the results do not display analyses across countries. For this reason, 
the current paper was unable to display changes in risk perception over time. 
Due to the variability in reporting type of users and frequency of use, users 
were classified according to the classification of original articles. Consequently, 
this overview was unable to differentiate between former and never e-cigarette 
users, or to clearly differentiate between cigarette smokers and dual users, as 
not all cigarette smokers currently using e-cigarettes were classified in original 
studies as dual users of tobacco and e-cigarettes. In addition to a variety in study 
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designs, more studies were found reporting on adult perceptions and reasons 
than youth, and cigarette smokers than never-users. This means that some per-
ceptions and reasons regarding e-cigarettes could have been missed among the 
understudied user groups.
Conclusions
This study is an exploratory narrative review into perceptions and reasons re-
garding e-cigarette use. Different perceptions of risks and benefits, and rea-
sons for e-cigarette use were summarized for different types of users in themes 
and sub-themes, such as convenience, social environment, and disadvantages. 
Adults’ perceptions and reasons for e-cigarette use are often related to smoking 
cessation, while youth like the novelty of the product. Tailored information about 
e-cigarettes for the different user groups is necessary to correct misperceptions 
about e-cigarettes and highlight the risks and benefits of e-cigarette use.
For public health professionals, behavior change experts, and regulatory sci-
ence, our overview of risk and benefit perceptions of e-cigarettes, and reasons 
for e-cigarette use provides insight into the initiation of e-cigarette use. 
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Abstract
E-cigarettes are increasingly popular among both cigarette smokers and never-
users. Although smoking cessation yields the most individual and population 
health benefits, switching to exclusive e-cigarette use offers some individual 
health benefits for cigarette smokers. However, e-cigarette use is not harmless, 
and its use among non-cigarette smokers should be prevented. Our study 
aims to explore the decision-making process about e-cigarettes among an 
e-cigarette users, cigarette smokers, and never-users. We conducted 12 semi-
structured focus group interviews with e-cigarette users, cigarette smokers, 
and never-users. We performed a thematic analysis of the interview transcripts. 
First, knowledge reported by e-cigarette users was mainly based on other users’ 
experiences. Second, cigarette smokers and never-users were more negative 
towards e-cigarettes than e-cigarette users. Third, e-cigarette users considered 
switching from cigarette smoking to e-cigarette use by deliberating relevant 
information, and weighing up the benefits and disadvantages of e-cigarette use 
versus smoking. Additionally, important factors in the decision-making process 
were a perception of risks and benefits of e-cigarettes compared to cigarettes, 
a supportive social environment about e-cigarette use, and trust in information 
offered about the risks and benefits of e-cigarettes. Our findings provide 
insight into what we can learn from the conscious decision-making process of 
e-cigarette users who switched from cigarettes to e-cigarettes. This information 
can be considered to develop targeted communications strategies to stimulate a 
conscious decision-making process, these may highlight benefits of switching to 
e-cigarettes for cigarette smokers, discussing the risks of smoking, and correcting 
misperceptions about the perceived risks and benefits of e-cigarette use.
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Introduction
Electronic cigarettes (e-cigarettes) vaporize a solution of glycerin, propylene 
glycol, additives, and sometimes nicotine1-5. While early models mimic 
conventional cigarettes (in shape, flavor, and size), the design characteristics of 
newer models and e-liquid flavors available are elaborate and attractive to both 
cigarette smokers and never-users.3,6-12 In 2018, 3.1% of the Dutch population 
ever used an e-cigarette. In addition, 23.1% of the Dutch population were 
smokers, of which one-third were between twenty and twenty-four years old.13
E-cigarettes have the potential to reduce the harm of cigarette smoking on 
smokers’ health.10 Recent studies have argued that—while quitting the use of 
tobacco and related products yields the most health benefits—the health effects 
associated with exclusive e-cigarette use (and not dual use of cigarettes and 
e-cigarettes) are less harmful than those related to cigarette smoking.11,14-19 Still, 
e-cigarette use is not harmless, and consequently, the initiation of e-cigarette 
use among never-users needs to be prevented.10,11,20-22 To aid tobacco control 
that yields the most public health benefits for cigarette smokers and never-users, 
insight into differences in the decision-making process of e-cigarette users, 
smokers, and never-users is needed about e-cigarette use initiation. In particular, 
it is important to know whether the decision made by former cigarette smokers 
to switch to e-cigarettes, or by never-users to refrain from e-cigarette use, is 
consciously deliberated. 
Previous research among different types of users and different age groups has 
described differences in reasons why initiating e-cigarette use is attractive.23-25 
For example, cigarette smokers have argued that the expected health benefits 
of e-cigarette use compared to cigarette smoking and design similarities with 
cigarettes are reasons to initiate e-cigarette use.25-27 Non-using youth (<18 years) 
have stated curiosity as a reason to initiate e-cigarette use.25 Despite previous 
research into reasons for initiating e-cigarette use,25,27 insight into the process 
of making a choice (decision-making) about e-cigarette use initiation lacks. This 
information is crucial to facilitate a conscious decision among cigarette smokers 
about switching to e-cigarettes and among never-users about refraining from 
experimenting with e-cigarettes.
A conscious decision-making process is defined by deliberating available and 
relevant information about the options, and by weighing advantages and 
disadvantages of the choice in the context of the decision-maker’s attitudes28-30 
Previous research found that smokers have not made a conscious and informed 
decision to initiate cigarette smoking, but that this decision is rather passive.28,29,31-34 
Our study explores the deliberation process of successful switching among current 
e-cigarette users (former smokers), and the deliberation process of refraining 
from e-cigarette use among cigarette smokers and never-users. To the best of 
our knowledge, this is the first study to examine the decision-making process of 
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e-cigarette use among cigarette smokers and never-users. We explored whether 
e-cigarette users, cigarette smokers, and never-users have similar knowledge 
and attitudes regarding e-cigarettes, and if they used this knowledge to consider 
pros and cons of switching to, or refraining from e-cigarette use. By comparing 
differences in this process of e-cigarette use initiation between e-cigarette users, 
cigarette smokers, and never-users, we offer new information on the views and 
experiences of e-cigarette users who switched from cigarettes to e-cigarettes.
Methods
To explore the decision-making process about e-cigarette use, we conducted 
focus groups with three homogeneous groups consisting of adult e-cigarette 
users, adult cigarette smokers, and adolescent never-users who used neither 
cigarettes nor e-cigarettes. For each of these types of users, four focus groups 
were conducted. The study was approved by the Medical Ethics Committee of 
Zuyderland—Zuyd (16-N-84).
Recruitment
In June 2016, participants were recruited in the Netherlands, through an 
advertisement on Facebook©, Instagram©, Twitter©, and scholieren.com (a 
website targeted at adolescents in the Netherlands). Inclusion criteria were: 
awareness of e-cigarettes, being a current smoker (18+), e-cigarette user (18+), 
or never-user (13 to 17 years old), and fluency in Dutch. Adolescent never-users 
were selected because previous research showed differences in reasons for 
e-cigarette initiation among adult e-cigarette users, adult cigarette smokers, 
and adolescent never-users.25 Appendix 4 shows the characteristics of included 
participants. 
Procedure
The group discussions were based on a semi-structured protocol with open-
ended questions and minimal steering to allow participants to freely discuss 
e-cigarettes.35 The topic list of this protocol was developed to investigate decision-
making according to the definition of van den Berg, Timmermans, ten Kate, van 
Vugt, van der Wal 29 and previous qualitative research conducted by Gray, Hoek, 
Edwards 31 This topic list was tested in a pilot focus group and subsequently 
revised. While the same moderator (K.A.G.J.R.) led all group discussions, the 
observers varied. All focus groups were audio recorded, and flipcharts were used 
for participants to visualize the topics that had been discussed (see Appendix 5 
for a detailed summary of the semi-structured protocol).
The focus groups were conducted between June and July 2016 and lasted 
approximately two hours. Informed consent was obtained before the start of 
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the focus group and after participation, the participants received an incentive 
of 30 euros. The focus group started with a general introduction. The discussion 
proceeded in four steps exploring participants’ knowledge regarding e-cigarettes, 
their attitude towards e-cigarettes, their deliberation regarding e-cigarette use 
initiation, and their information needs (see Appendix 5 for a detailed summary).
Qualitative Coding and Analysis 
All group discussions were transcribed verbatim. Qualitative data analysis 
comprised of three phases.36 In the first phase, the first author applied descriptive 
level coding to a randomly selected focus group transcript, to deduce relevant 
themes and subthemes. The first author and the second coder (T.J.) then 
developed a descriptive thematic analysis. The second coder identified little 
additional text fragments to be relevant. In the second phase, the first and the 
second coder resolved minor differences in coding themes and subthemes to 
create a final coding taxonomy. A third coder (M.B.), who did not participate in 
the first phase of the coding process, reviewed the final coding taxonomy with 
the first author and minor adjustments were made. In the final and third phase, 
the first author and third coder coded all the transcribed focus groups.
Results
We conducted four focus groups with adult e-cigarette users (n = 26), four focus 
groups with adult cigarette smokers (n = 17), and four focus groups adolescent 
never-users (n = 23). All e-cigarette users reported to be former smokers. Overall, 
the sample was 47% female and 53% male, the average age of adult participants 
was 29.3 years (±13.0, min = 18, max = 58), and adolescents 15.3 (±1.1, min = 13, 
max = 17), and the sample was highly educated (applied sciences or university 
degree; 65%). Table 3.1 summarizes the demographic variables for e-cigarette 
users, cigarette smokers, and never-users. The following section describes 
themes, which were considered important in the overall decision-making process 
of e-cigarette users, smokers and never-users with illustrative quotes. Because of 
the explorative and qualitative nature of this study, the results are not meant to 
convey generalizability beyond the studied population. To describe themes and 
patterns in the data, we distinguish between rarely and commonly mentioned 
aspects.37
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Table 3.1 Demographic information of the study participants.
Demographics Never-users Cigarette smokers E-cigarette users
Age µ (±) 15.2 (±1.1) 19.8 (±3.2) 31.8 (±12.2)
Education n(%)
High 5 (22%) 7 (41%) 2 (8%)
Middle 8 (35%) 6 (35%) 15 (58%)
Low 10 (43%) 4 (24%) 9 (35%)
Gender n(%)
Male 8 (35%) 8 (47%) 19 (73%
Female 15 (65%) 9 (53%) 7 (27%)
Note: Demographic information is displayed for each user group. 
Knowledge
When participants were asked to talk about what they knew about e-cigarettes, 
many participants were able to mention some facts about e-cigarettes. For 
example, many participants stated the variety of e-liquid flavors available, the 
rechargeable batteries of e-cigarettes, the lack of a burning process and tar, the 
variety of devices, and the ability to avoid smoking bans (quote 1). 
‘You use an e-liquid, there are a lot of flavors, you can choose whether 
you want with or without nicotine, and there are many different types…’ 
(#3_smoker about e-cigarettes)
Compared to cigarette smokers and never-users, e-cigarette users described 
more detailed information about e-cigarettes. E-cigarette users reported to have 
acquired much information in order to make a decision about e-cigarette use 
initiation, for example, about product characteristics, ingredients of e-liquids, 
and legislation regarding e-cigarettes. Knowledge reported by e-cigarette users 
was mainly based on user experiences. When asked how informed they felt, 
cigarette smokers and never-users stated that they did not search for information 
about e-cigarettes and expressed they did not know much about e-cigarettes. 
E-cigarette users felt very informed.
Attitude 
Participants shared experiences, both positive and negative, with e-cigarettes 
and cigarettes. Cigarette smokers and never-users, were negative towards 
e-cigarette use, in general mentioning it was ‘weird’ (quote 2):
‘I think it’s [e-cigarettes] really weird and pathetic. Everybody will be 
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laughing at you.’ (#23_never-user)
All groups mentioned that using e-cigarettes has the advantage of avoiding 
smoking restrictions (quote 3). 
‘It [e-cigarettes] is really easy to use […] and you can even use it inside, 
great if you’re in the bus […] Or you can use it for a just bit, instead of 
smoking an entire cigarette. I think I’d enjoy that…’ (#17_smoker)
Compared to e-cigarette users and never-users, many cigarette smokers were 
positive towards cigarette smoking. Regardless of the negative health effects 
associated with cigarette smoking, smokers expressed they really enjoy smoking. 
Several of the e-cigarette users reported a positive attitude about e-cigarettes 
and negative attitude towards smoking, based on knowledge acquired 
beforehand. In general, e-cigarette users emphasized the positive aspects of 
e-cigarette devices and positive experiences, such as the variety of flavors and 
the adjustability of nicotine levels. 
Deliberation 
Many e-cigarette users consciously deliberated initiation of e-cigarette use versus 
continuation of cigarette smoking by using knowledge acquired and weighing 
up the benefits of e-cigarette use and disadvantages of cigarette smoking. 
For example, the personal health benefits of e-cigarette use, and the negative 
health issues for their social environment associated with secondhand smoking. 
They described this decision process of switching from cigarette smoking to 
e-cigarette use as a deliberation of benefits and disadvantages (quote 4):
‘Switching from cigarettes to e-cigarettes […] it was a deliberate choice. 
I had an e-cigarette laying around and I tried it a few times. I liked the 
flavor and the satisfaction it gave me [throat hit from nicotine]. In the end I 
ordered a really nice one because I decided I was going to quit smoking. So 
yeah, it was a really deliberate choice…’ (#13_e-cigarette user)
Many cigarette smokers and never-users reported that they had not contemplated 
using e-cigarettes. Deliberation was often limited to brief passive moments when 
they were confronted with an e-cigarette in their environment (quote 5).
‘One of my friends had one [e-cigarette] and I thought: That might be a way 
to quit smoking.’ (#14_smoker)
When asked to compare e-cigarette use initiation with cigarette smoking 
initiation, e-cigarette users and cigarette smokers agreed that cigarette smoking 
initiation was not a conscious or deliberate choice. Many cigarette smokers 
expressed they passively discovered themselves to be smokers months or years 
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after they initiated smoking (quote 6).
‘Everybody smoked, so I started too […] there wasn’t a point where I 
thought: OK, from now on I’m a smoker. All of a sudden, you just are one. 
Smoking is not a deliberate choice you make, something you really think 
about.’ (#1_smoker)
In general, never-users did not show an interest in e-cigarettes or cigarettes. 
Pros and cons were not actively deliberated among never-users, but sometimes 
curiosity was reason enough to passively experiment with e-cigarettes or 
cigarettes. 
Information Need of E-Cigarettes 
When asked about their information need, all three groups stated they had 
several unanswered questions, such as, ‘Are e-cigarettes harmful?’, ‘What are 
the benefits of e-cigarette use compared to cigarette smoking?’, and ‘What are 
the negative long-term health effects of e-cigarette use?’. E-cigarette users, 
compared to smokers and never-users had more questions about product 
characteristics, such as ‘Are there results of quality tests of e-liquids available?’. 
Cigarette smokers and never-users wanted to know more about the successful 
quit attempts with e-cigarettes. They wanted to see a risk–benefit analysis of 
e-cigarette use versus smoking, and they wanted to know what the average 
duration of use was for e-cigarette use as a smoking cessation tool. All groups 
agreed that this information should be communicated to the public to facilitate 
smoking cessation for cigarette smokers. Many participants explained that there 
is a large body of information available, but that it is difficult to filter useful and 
correct information from the internet. 
Additional aspects 
This section describes additional aspects participants mentioned that played a 
role in their decision about e-cigarette use.
Risk perception 
The risks of e-cigarettes versus cigarettes were discussed. E-cigarette users did 
not perceive any health risks of e-cigarette use (quote 7). 
‘So I thought: ‘it’s just vape. That can’t be really harmful for you or your 
lungs. So if I just vape, and I don’t do it every day […] that won’t be so 
wrong.’ (#4_e-cigarette user)
Cigarette smokers stated that although they knew about the common risks of 
cigarettes, the specifics of how cigarettes cause smoking-related diseases were 
not clear. They also perceived the health risks of cigarettes as a problem for the 
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distant future, something to worry about later, when they were older. E-cigarette 
users tended to deliberate the risks and severity of cigarette smoking related 
diseases and acknowledged that the risks applied to them as former long-time 
cigarette smokers (quote 8):
‘My grandfather smoked, like me, and you can see his health is getting 
worse and worse. He suffers from emphysema, I don’t want that. So I 
wanted to quit.’ (E-cigarette user_#26)
While never-users were aware of the risks of cigarette smoking, the risks of 
e-cigarettes were unclear to them. Similar to e-cigarette users, they mentioned 
that if it is just vape, it did not seem harmful (quote 7). E-cigarette users perceived 
e-cigarette use compared to cigarette smoking not as a risk, but as a lifestyle 
(quote 9):
‘I often say that besides a hobby it’s [e-cigarette use] also a lifestyle.’ 
(#21_e-cigarette user)
Similar to e-cigarette users, cigarette smokers perceived cigarette smoking as an 
addiction, and they described triggers for the desire to smoke, such as alcohol 
consumption. Never-users perceived both e-cigarette use and cigarette smoking 
as addictive behaviors.
Social environment 
All groups described the importance of their social environment with regard to 
e-cigarette use and cigarette smoking. In the initiation of e-cigarette use, the 
social environment was an important factor for many e-cigarette users (quote 10). 
‘My mother had one [e-cigarette], so I tried it too.’ (#17_e-cigarette user)
Several e-cigarette users further noted that social support for e-cigarette use 
from their social environment grew after initiation of use, which they described 
as a sense of belonging to an e-cigarette community (quote 11):
‘It’s a community […] Very similar to bikers! You know how they all greet each 
other on the road? The vaping community is the same.’ (#21_e-cigarette user)
In general, participants expressed it was more acceptable to smoke than to use 
e-cigarettes. While cigarette smokers and never-users categorized e-cigarette 
use as “weird”, cigarette smoking was still considered as acceptable by the 
several of participants and their social environment. When asked about the 
role of their social environment in their decision to initiate cigarette smoking 
compared to switching to e-cigarette use, cigarette smokers expressed that 
friends who smoked often influenced their decision (quote 12): 
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‘One of my friends told me: ‘Try a cigarette!’ So I did, and I liked it and I 
continued smoking.’ (#15_smoker)
Cigarette smokers did not describe the influence of friends as pressure, but they 
did describe the disappointment their parents expressed in response to finding 
out about their smoking behavior as embarrassing (quote 13): 
‘I was really afraid to tell my parents that I smoke […] they were so 
disappointed.’ (#11_smoker)
Never-users viewed e-cigarette use and cigarette smoking not as a social activity, 
but as peer pressure and addiction, not a choice. Never-users felt strongly about 
parental disappointment related to cigarette smoking and noted this as a specific 
reason why they would not start smoking cigarettes or start using e-cigarettes.
Trust in information
Due to the large body of information available about e-cigarettes, it was difficult 
for participants to make sure the available information is correct. E-cigarette 
users and cigarette smokers mistrusted evidence-based information, and relied 
on anecdotal user experiences (quote 14):
‘Researchers often don’t know what they are doing (#20_e-cigarette user) 
[…] yes we need to know about the experiences of e-cigarette users.’ 
(#16_e-cigarette user)
Unlike e-cigarette users and cigarette smokers, never-users explained they rather 
receive scientific information because they trust this information to be true.
Discussion
We explored the decision-making process of e-cigarette use initiation among adult 
e-cigarette users, adult cigarette smokers, and adolescent never-users. Compared 
to e-cigarette users, cigarette smokers and never-users did not make a conscious 
decision to refrain from e-cigarette use. They have acquired different information 
and have different attitudes. Several of e-cigarette users perceived the risks of 
cigarette smoking as personally relevant. They acquired information and formed 
an attitude about e-cigarettes. Finally, their knowledge, attitudes, pros, and cons 
were deliberated and a conscious decision was made to initiate e-cigarette use. 
Additionally, lack of information seeking, perception of risk of smoking related 
diseases, perception of risks and benefits of e-cigarette use compared to cigarette 
smoking, support to switch to e-cigarettes, a sense of belonging to e-cigarette 
users, and trust in information offered about e-cigarettes showed to be important 
factors for a participant in a decision-making process about e-cigarette use. 
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A possible barrier in the decision-making process is the large body of contradicting 
information available and lack of trust in scientific evidence. Although e-cigarettes 
users appear knowledgeable, their reported knowledge did not match scientific 
consensus. We categorized this type of knowledge as beliefs, and these beliefs 
were primarily based on anecdotal user experiences found online. This finding 
matches research that shows that experienced e-cigarette users are eager to share 
their advice and experiences about switching with cigarette smokers.38 Due to 
these beliefs, e-cigarette users perceived e-cigarettes as harmless. Research has 
showed that confirmation bias and online information may lead to misperceptions 
about the safety of e-cigarettes.39-42 These beliefs and misperceptions about the 
harmfulness of e-cigarettes may hinder the process of making a conscious and 
informed decision about e-cigarette use initiation. Thus, there is a clear need for 
further research on targeted communication strategies to facilitate the conscious 
deliberation of relevant and evidence-based information about e-cigarette use. 
These strategies need to highlight advantages and disadvantages of switching 
to, or refraining from e-cigarette use, and correcting misperceptions about 
perceived risks and benefits of e-cigarettes.43 This will emphasize the public and 
individual health benefits of e-cigarette use initiation for cigarette smokers and 
the disadvantages for never-users.
Cigarette smokers did not contemplate to switch to e-cigarettes, or consciously 
decide to continue smoking. Our results indicate that though cigarette smokers 
are aware of the health risks of cigarette smoking, they do not perceive the long-
term health risks of smoking as personally relevant. Additionally, they perceive 
e-cigarettes as weird, smoking as a normal, social behavior,44 and, possibly due 
to their young age (19.8 (±3.2)), display an optimism bias about their ability to 
quit in time before serious health effects occur.30,45 This optimism bias greatly 
diminishes cigarette smokers’ interest to acquire knowledge about the benefits 
and disadvantages of switching to exclusive e-cigarette use, and deliberate these 
pros and cons of e-cigarette use compared to smoking.30,45,46 Low perceived 
susceptibility and severity of risks associated with cigarette smoking, a lack of 
knowledge, and a social environment in which e-cigarette use is considered 
weird and smoking is considered normal or encouraged, hinders smokers to 
deliberate the pros and cons of switching to e-cigarettes or smoking cessation. 
Similar to cigarette smokers, never-users did not actively deliberate e-cigarette 
use initiation. Adolescent never-users mentioned that if they were to start 
e-cigarette use, it would be out of curiosity. The risks of e-cigarette use were 
unclear to never-users, but because it was just vape, e-cigarette use was 
perceived as harmless. This lack of perceived personal risks of e-cigarette use 
may diminish the interest to acquire knowledge about the disadvantages of 
e-cigarette use. Without information seeking and information about advantages 
and disadvantages of e-cigarette use for never-users, no deliberation can take 
place.29 A lack of deliberation of the risks associated with e-cigarette use, and 
curiosity about e-cigarette use may result in a tendency to initiate experimenting 
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with e-cigarettes among some adolescents. Low perceived risk of e-cigarettes 
and a lack of knowledge hinder never-users to make a deliberate decision to 
refrain from e-cigarette use. 
This qualitative study shows that cigarette smokers and never-users did not 
consciously deliberate information about the risks and benefits of e-cigarettes 
use to make a decision to refrain from e-cigarette use initiation. The differences 
and similarities in the decision-making process of e-cigarette use among the 
different user groups raise a question. Namely, can insights into the conscious 
decision-making process of e-cigarettes users who switched from cigarette to 
e-cigarettes be used to stimulate cigarette smokers to consciously deliberate 
something they consider ‘weird’? Further research is necessary to investigate 
how cigarette smokers can be stimulated to consciously deliberate a switch to 
e-cigarettes. 
Because of the explorative nature of this study, the results are not meant to 
convey generalizability beyond the study population, and thus, these findings 
are limited to a specific geographic context and time. Respondents were asked 
to participate in a two-hour discussion, which may have attracted individuals 
more inclined to talk about cigarette smoking and e-cigarette use. Additionally, 
we asked e-cigarette users, cigarette smokers, and never-users to consider 
their decisions about initiation in retrospect, knowledge and attitudes may be 
different when first faced with the decision. Participants’ knowledge, attitudes, 
and deliberation process might be influenced by their level of education, and 
living in different areas of the Netherlands. Further research is necessary to 
explore the impact of education on a decision about e-cigarettes. 
Conclusions
To conclude, our exploration of the decision-making process of e-cigarette 
initiation identifies distinct differences between the decision-making process of 
current cigarette smokers, e-cigarette users, and never-users. Current e-cigarette 
users (former smokers) in this study made a conscious decision to switch from 
cigarettes to e-cigarettes, but current cigarette smokers and never-users did not 
contemplate or deliberate e-cigarette use initiation. E-cigarettes have a potential 
public and individual health benefit for cigarette smokers, as switching to 
exclusive e-cigarette use is less harmful than cigarette smoking. E-cigarette use 
is not harmless, initiation of e-cigarette use and cigarette smoking should thus 
be prevented among never-users. Several of the e-cigarette users deliberated 
personally relevant risks of cigarette smoking, which made them interested in 
switching to a less harmful alternative. These findings underline the importance 
to explore the possibility to learn from the decision-making process of e-cigarette 
users, in order to support cigarettes smokers with their decision about switching 
to e-cigarettes and never-users with their decision to refrain from e-cigarette use.
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Abstract
Appealing product characteristics, such as flavors, may stimulate e-cigarette use. 
While switching to e-cigarettes may reduce harm for smokers, concerns exist 
about e-cigarette use among never-smokers. The role of flavors in the decision 
to switch to or refrain from vaping is unclear. This study used a bottom–up 
approach to investigate the relation between flavor preferences and individual 
factors related to vaping between various user groups. A cross-sectional survey 
was conducted among never-users (n = 407), smokers (n = 138), dual users 
(n = 122), and exclusive vapers (n = 61) in the Netherlands. Demographics, 
attractiveness of product characteristics, flavor preferences, and individual 
factors related to vaping (knowledge, trust, perceived susceptibility, attitude, 
social influence, deliberation, and intention) were assessed. The availability of 
different flavors was the most attractive characteristic of e-cigarettes. Dual users 
and exclusive vapers had most often used tobacco and menthol/mint flavors 
when they first started vaping. Compared to dual users, exclusive vapers currently 
used more fruit and sweet flavors. Never-users who were interested in trying an 
e-liquid flavor had more knowledge about and a more positive attitude towards 
e-cigarettes. Smokers who were interested in trying a flavor had a more positive 
attitude towards e-cigarettes and experienced the social influence towards not 
using e-cigarettes as less strong than those who did not want to try any flavor. 
Hence, individual factors related to vaping differed depending on whether never-
users and smokers wanted to try an e-liquid flavor. This means that flavors may 
moderate differences found in individual factors related to vaping, or vice versa.
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Introduction
Although vaping prevalence in the Netherlands is currently rather low (3%),1 the 
use of electronic cigarettes (e-cigarettes) increased worldwide in recent years.2,3 
The majority of e-cigarette users are former or current smokers4-6 and literature 
has showed that e-cigarette use (i.e., vaping) may be associated with smoking 
cessation and reduction.7,8 In the Netherlands, e-cigarettes are more often 
used by daily smokers (12%) compared to non-daily smokers (4%). Worldwide, 
vaping is also becoming increasingly popular among adolescent non- and 
never-smokers.3,9,10 The regulation of e-cigarettes in order to optimize public 
health benefits is challenging and is currently an important topic of debate. 
Compared to cigarette smoking, vaping may reduce harm among smokers,11-14 
but literature showed that e-cigarettes contain toxic ingredients.11 In addition, 
concerns have been raised that vaping may contribute to nicotine addiction 
and the renormalization of cigarette smoking in adolescent never-smokers.3,15-18 
Consequently, from a public health perspective, the initiation of vaping by current 
non- and never-smokers and, thereby, exposure to potentially toxic ingredients 
should be prevented.18
Research is needed to better understand differences between the initiation 
of e-cigarette use by current smokers versus non-smokers in order to inform 
regulators about policy making regarding e-cigarettes in order to develop 
targeted health communication for smokers, non-smokers, and e-cigarette 
users. Previous studies found differences in individual factors related to 
e-cigarettes among never-users, smokers, dual users, and e-cigarette users.19 
Individual factors that were found to differ included, for example, knowledge, 
perceived susceptibility, severity, trust, attitudes, deliberation, social influence, 
and intention.19-23 Furthermore, literature showed that the importance of product 
characteristics such as design, price, and flavors may differ between adult smokers 
and adolescent non-smokers.24-27 However, the relation between e-cigarette 
product characteristics and individual-level factors has been neglected.
A recent study hypothesized that there is an important interplay between 
individual-level factors and the characteristics of tobacco products.28 Since 
product characteristics (e.g., flavors, design, and price) influence e-cigarette 
appeal24-27 and may influence a person’s attitude towards e-cigarettes,24,28 such 
an interplay may also exist for e-cigarettes. However, thus far, most studies on 
e-cigarettes focused either on product characteristics,29 or on socio-cognitive 
factors related to vaping behavior.30 In contrast, researchers in the food and 
nutrition domain have already recognized the importance of the interaction 
between product characteristics and individual-level decision-making factors in 
food choice.31-33 For example, a model by Shepherd 31 shows that food choice is 
influenced by the interaction between physical or chemical properties of food, 
such as flavors (product factor), and the individual’s perception of and attitude 
towards those sensory properties (individual-level factors). Furthermore, flavors 
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and other sensory properties are recognized as by far the most important factors 
in the acceptance and rejection of food products.32
Similarly, since e-liquid flavors are recognized as an important reason for 
e-cigarette use,24 flavors may interact with individual-level factors related to 
vaping. Moreover, the availability of many different, mostly sweet, e-liquid flavors 
is an important reason for vaping among different types of users.24,29 Research 
showed that for most e-cigarette users, and in particular for youth, the first and 
current e-liquid had a flavor other than tobacco.26,34,35 In addition, flavors increase 
the probability of choosing e-cigarettes in an online discrete choice experiment 
among youth, for both never-users and ever-users of e-cigarettes.36 Therefore, 
besides investigating product characteristics as reasons for e-cigarette use, 
additional research is needed to investigate the interaction between flavors as 
an e-cigarette product characteristic and individual factors related to vaping.
To increase our understanding of differences in e-cigarette appeal between user 
groups, this study firstly investigates which product characteristics are found 
attractive by Dutch never-users, smokers, dual users, and exclusive vapers. 
Secondly, we aim to determine the flavor preferences of Dutch never-users, 
smokers, dual users, and exclusive vapers. Thirdly, we aim to explore whether 
eight individual factors related to vaping differ between never-users and smokers 
who reported to be interested in trying an e-liquid flavor compared to those who 
reported not to be interested in trying any e-liquid flavor.
Methods
A cross-sectional survey was conducted in the Netherlands among never-users 
of e-cigarettes and cigarettes, cigarette smokers, dual users of e-cigarettes and 
cigarettes, and e-cigarette users. The survey was administered in May 2017 
through the online survey panel Flycatcher, which is an ISO-certified independent 
research panel specialized in online research.37 The study was approved by the 
Medical Ethics Committee of Zuyderland – Zuyd (17-N-88). The recruitment, 
participant characteristics, and survey were previously described in Romijnders, 
Pennings, van Osch, de Vries, Talhout 38.
Recruitment and Participant Characteristics
In total, 12,750 invitations were sent to panelists who met the following 
inclusion criteria: being able to understand Dutch; being aware of e-cigarettes; 
aged 13–17 years (adolescents) or 18 years and older (adults). Sample size 
was determined based on a power of 80% to identify a minimal difference 
of 1 on a 7-point Likert scale for attitude (based on previous literature39) as 
significant at p < 0.05. The sample cannot be considered representative of the 
Dutch population, as oversampling for the smokers and e-cigarette users was 
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performed in order to achieve sufficient observations. Participants were asked to 
provide consent before the start of the survey. Parents of panelists under the age 
of 18 had previously provided consent for participation of their child in research 
questionnaires. Overall, 1307 surveys were completed, and the response rate was 
10.3% (69.7% for adults, n = 694; 5.2% for adolescents, n = 613). For the current 
study, respondents were eligible if they met the definition of one of the following 
user groups (see Appendix 6): never-users are participants who reported to 
never have smoked and never used an e-cigarette; smokers are participants who 
reported to currently exclusively use cigarettes on a daily or weekly basis; dual 
users are participants who reported to currently simultaneously use cigarettes 
on a daily or weekly basis and e-cigarettes on a daily or weekly basis; vapers are 
participants who reported to currently exclusively use e-cigarettes on a daily or 
weekly basis.40
It should be noted that these definitions, similar to studies performed before,39 
includes individuals who had no history of smoking prior to becoming an exclusive 
vaper. In addition, and due to the cross-sectional nature of the data, no transitory 
phases for dual users and exclusive vapers can be determined.40 We aimed for 
mutually exclusive groups. Hence, as the group of exclusive vapers may also 
include former smokers and the group of exclusive smokers may also include 
former vapers, former users were not included as a separate group. An overview 
of the items used to determine whether respondents met our definitions can 
be found in Appendix 6. In total, 728 participants met the eligibility criteria of 
this study. Of those, 394 were adults (62.4% female) and 334 were adolescents 
(46.7% female).
Survey
The current study included measures on basic demographics, attractiveness of 
e-cigarettes, flavor preferences, and individual factors related to vaping. The 
survey included routing to ensure that participants were asked about relevant 
items only (e.g., never-users were not asked which flavor their first e-cigarette 
had). A full overview of the items and concepts is available in Appendix 6.
First, participants were asked about basic demographics, and smoking and 
vaping characteristics.19,24,40-44 Educational level was determined based on the 
Dutch version of the International Standard Classification of Education (ISCED).45
Second, participants were asked to evaluate the attractiveness of eight product 
characteristics of e-cigarettes from a predetermined list using a check all that 
apply (CATA) approach that was based on previous research 19,24. For the 
items that were used to assess demographics and attractiveness of product 
characteristics, see Appendix 6.
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Third, interest in trying an e-liquid flavor (for never-users and smokers), and 
the first and current e-liquid flavors used (for dual and e-cigarette users) 
were assessed. For the items that were used to assess flavor preferences, see 
Appendix 6. To assess flavor interest among never-users and smokers, multiple 
flavor categories46 (CATA) or the option “none of the flavors” were selected. 
If the latter answer option was selected, no flavor category could be selected 
simultaneously. E-cigarette users and dual users were asked about their current 
and first e-liquid flavor used: “Which flavor do you currently use most? If 
possible, please specify the name of the flavor” and “Which flavor did you try 
first? If possible, please specify the name of the flavor.” For both current and 
first flavor used, dual users and e-cigarette users could select only one flavor 
category46 and had to specify their choice through an open question. The answer 
options for never-users, smokers, dual users and e-cigarette users were: tobacco, 
menthol/mint, nuts, herbs, spices, coffee/tea, cocktails, alcohol, other, sodas, 
sweet (chocolate, vanilla, desserts, or other), fruit, milk products, candy, floral, 
unflavored, and none of the flavors. The closed answer options that were used 
to assess flavor preference in all user groups were recoded according to the 
thirteen main categories of the recently published e-liquid flavor wheel,47 except 
for the option “none of the flavors”. Recoding the reported flavor preferences 
resulted in the in the following thirteen main categories: tobacco (survey item: 
tobacco), menthol/mint (survey item: menthol/mint), nuts (survey item: nuts), 
spices (survey items: herbs, spices), coffee/tea (survey items: coffee; tea), alcohol 
(survey items: alcohol, cocktail; alcohol, other), other beverages (survey items: 
soda; sweet, other), fruit (survey item: fruit), dessert (survey items: sweet, dessert; 
milk product), other sweets (survey items: sweet, chocolate; sweet, vanilla), 
candy (survey items: sweet, candy), other flavors (survey items: floral; other) and 
unflavored (survey item: unflavored). Open answers from dual and e-cigarette 
users were assessed by two authors (KR and EK) to support recoding of the closed 
answers according to the categories of the e-liquid flavor wheel.47 In some cases, 
multiple survey items were associated with one flavor category (e.g., the survey 
answer options “sweet, chocolate” and “sweet, vanilla” were both recoded to 
the other sweets flavor category). For equal weight of the flavor categories, 
each participant could obtain a maximum score of “1” for each flavor category. 
Thus, participants who reported being interested in both chocolate- and vanilla-
flavored e-liquids received a total score of “1” for the other sweets flavor category.
Fourth, individual factors related to vaping were assessed (see Appendix 6 
for the items that were used). Evidence-based knowledge about smoking and 
vaping was measured with 12 statements that were either correct or incorrect. 
We consider evidence-based knowledge as knowledge that is based on scientific 
consensus—that is, information provided by the Dutch National Institute of 
Public Health and the Environment (RIVM) and previous research.19,48,49 The 
knowledge items were summed (1 = correct, 0 = incorrect; ‘I don’t know’ was 
categorized as incorrect). Furthermore, a 7-point Likert scale was used to assess 
trust in information (two items),50 perceived susceptibility towards e-cigarettes 
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(three items: item A, item B, item C),51,52 severity related to vaping (four 
items 51,52), attitude towards e-cigarettes (four items),39,48 social influence (one 
item),53 deliberation about vaping (three items),48 and intention to start using 
e-cigarettes (one item). A scale was computed for trust in information, severity 
related to vaping, attitude towards e-cigarettes, and deliberation of the pros and 
cons of vaping, by averaging the scores of the two items for trust (Cronbach’s 
α = 0.915), the four items for severity (Cronbach’s α = 0.639), the four items of 
attitude (Cronbach’s α = 0.927), and the three items for deliberation (Cronbach’s 
α = 0.656). No scale could be computed for perceived susceptibility towards 
e-cigarettes (Cronbach’s α ≤ 0.6)—thus, for each user group, the three mean 
scores for perceived susceptibility towards e-cigarettes and the three mean 
scores for perceived susceptibility towards cigarettes (for each individual survey 
item) were used. Similarly, for each user group, the mean score for each item 
regarding intention and social influence was determined.
Data Analysis
IBM statistics SPSS version 24 (IBM, Armonk, NY, USA)54 was used for data 
analysis. No data were excluded. Attractiveness of product characteristics, and 
the e-liquid flavor categories preferred (for never-users and smokers, excluding 
those who selected the answer option “I don’t want to try any flavor”) and 
firstly and currently used (for dual and exclusive vapers) were analyzed using 
frequencies. Flavor preferences were presented in a pie chart as the percentage 
of the total number of responses.
Spearman correlation analyses showed that age (p < 0.05), gender, and level of 
education (<0.05) were significantly associated with individual factors related to 
vaping. However, these Spearman correlations were small, ranging from −0.211 
to 0.169. Age, level of education, and gender were therefore excluded from 
further analyses due to small or non-significant correlations.
Individual factors were compared between both never-users and smokers 
interested in trying an e-liquid flavor and those not interested in trying a flavor 
(answer option: “none of the flavors”) using t-tests. Results were considered 
significant if p < 0.05.
Results
Of the 728 never-users, smokers, dual users, and exclusive e-cigarette users, 
23.7% was highly educated (50.0% low education level and 26.2% middle 
education level), and the average age was 34.1 (± 20.2, min = 13, max = 84) 
(see Table 4.1).
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Table 4.1 Participants’ demographics and the attractiveness of e-cigarette product 
characteristics. Data are presented for adult and adolescent never-users (n = 407), 
smokers (n = 138), dual users (n = 122), and exclusive vapers (n = 61).
Participants’ demographics and 
the attractiveness of e-cigarette 
product characteristics
Never-
users 
(n = 407)
Smokers (n 
= 138)
Dual users 
(n = 122)
Exclusive 
vapers 
(n = 61)
Mean age 
(±SD)
31 (18.6) D 35 (20.6) 37 (18.8) N 37 (19.4)
Gender Male 44.0% 37.7% 53.3% 49.2%
Female 56.0% 62.3% 46.7% 50.8%
Education Low 52.1% 52.9% 43.4% 39.3%
Middle 20.6% D,E 30.4% 35.2% N 44.3% N
High 27.3% 16.7% 21.3% 16.4%
Attractive 
characteristics 
of e-cigarettes 
(%)
All the different 
flavors
10.3% 30.4% 34.4% 68.9%
The product looks 
nice
6.6% 19.6% 22.1% 44.3%
The nicotine level 
can be varied
4.7% 13.8% 15.6% 31.1%
It is possible to 
alter the setting of 
the e-cigarette to 
my wishes
3.7% 10.9% 12.3% 24.6%
Its varying designs 3.2% 9.4% 10.7% 21.3%
You can blow nice 
smoke clouds with 
it (cloud chasing)
2.5% 7.2% 8.2% 16.4%
Price of the 
product
2.0% 5.8% 6.6% 13.1%
Price of the 
e-liquids
2.0% 5.8% 6.6% 13.1%
N,D,E Superscripts indicate significant differences in a row between user groups (p < 0.05), 
with N = never-users, D = dual users, and E = exclusive vapers. Significant differences 
between user groups were determined for age, gender, and education using Bonferroni 
post-hoc corrections. General note: due to rounding, percentages may not add up to 100%.
Attractiveness of Product Characteristics
Table 4.1 shows attractiveness of e-cigarette product characteristics, stratified 
by user group. From the e-cigarette product characteristics assessed, all groups 
reported flavors as the most attractive.
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E-Liquid Flavor Preferences
Of the 407 never-users, 68% selected the option “none of the flavors” (n = 
278 participants) and 32% selected to be interested in trying one or more 
e-liquid flavor” and 32% (n = 248 responses)). Of the 138 smokers, 20% (n = 27 
participants) were interested in none of the flavors and 80% (n = 208 responses) 
selected to be interested in trying one or more e-liquid flavor categories.
Figure 4.1 shows e-liquid flavor preferences as the percentage of each flavor category 
for never-users and smokers. Never-users were mostly interested in trying e-liquid 
flavors from the menthol/mint (19% of 248 responses) and sweet categories, such 
as other sweets (19%) and fruit (14%). Smokers were mostly interested in e-liquids 
with tobacco flavor (30%), followed by menthol/mint (18%) and other sweets (9%).
Of the 122 dual users, 120 reported the flavor of their first e-cigarette used 
and 121 reported the flavor they currently use (see Figure 4.2). Of the 61 
exclusive vapers, 58 reported the flavor of both their first and current e-cigarette. 
Among dual users, the most frequently reported flavors of their current and first 
e-cigarette used were similar: tobacco (52% vs. 53%), menthol/mint (26% vs. 
27%), other sweets (10% vs. 11%), and fruit (7% vs. 6%). Among exclusive vapers, 
differences were observed in the most frequently reported flavors of their current 
and first e-cigarette used: tobacco (43% vs. 53%), menthol/mint (19% vs. 28%)), 
and fruit (14% vs. 9%) and other sweets (14% vs. 7%).
Never-users Smokers
Total=248 Total=208
Tobacco
Menthol/mint
Nuts
Spices
Coffee/tea
Alcohol
Other beverages
Fruit
Dessert
Candy
Other sweets
Other flavors
5%
19%
4%
6%
7%
2%
3%14%
4%
6%
19%
10%
5%
8%
2%
5%
9%
4%
30%
18%
2%6%
6%
4%
Unflavored
Figure 4.1 Interest in trying e-liquid flavors among never-users (left) and smokers (right). 
Never-users (n= 278; 68%) and smokers (n = 27; 20%) who selected the option “none of 
the flavors” were excluded from this visualization, and hence the pie charts visualize 248 
responses from 32% of the never-users and 208 responses from 80% of the smokers. Data 
are presented as percentages of the total number of responses, not of the total sample 
sizes.
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Figure 4.2 Flavors used on current (top) and first (bottom) e-cigarette exposure among 
dual (left) and exclusive vapers (right). Participants could select only one flavor category 
to indicate the flavor of their current and first e-cigarette used. Data are presented as 
percentages of the total number of responses, not of the total sample sizes.
Individual Factors Related to Vaping
Table 4.2 shows differences in individual factors related to vaping between 
never-users and smokers. In addition, differences within the groups of never-
users and smokers between those who were interested in trying an e-liquid flavor 
and those who did not want to try any flavor are shown. Never-users who were 
interested in trying a flavor had significantly less knowledge about e-cigarettes 
compared to never-users who did not want to try any e-liquid flavor (p < 0.05). 
Not surprisingly, never-users and smokers who were interested in trying a flavor 
were significantly more positive towards e-cigarettes and had a significant higher 
intention to start vaping, compared to never users and smokers who reported 
not wanting to try any e-liquid flavor (p < 0.05), within both never-users and 
smokers. Never-users who were interested in trying a flavor reported a lower 
perceived susceptibility (item C) than never-users who did not want to try a flavor 
(p < 0.05). In addition, smokers who were interested in trying a flavor considered 
the social influence towards not using e-cigarettes as less strong, which means 
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that the smokers who were not interested in trying an e-cigarette flavor more 
often find that society thinks that one should not vape (p < 0.05).
Table 4.2 Individual factors related to vaping. Data are presented for never-users and 
smokers.
Individual factors 
related to vaping
Never-users
(n = 407)
Smokers 
(n = 138)
Knowledge about 
e-cigarettes and 
cigarettes (±SD)
Overall 9.3 (1.5) * 8.4 (1.8) *
Those interested in trying a flavor 8.9 (1.7) ° 8.4 (1.7)
Those who did not want to try 
any flavor
9.4 (1.4) ° 8.3 (2.1)
Trust in information 
(±SD)
Overall 5.2 (1.1) 4.9 (1.4) 
Those interested in trying a flavor 5.2 (1.0) 4.9 (1.4)
Those who did not want to try 
any flavor
5.2 (1.4) 5.1 (1.5)
Perceived 
susceptibility about 
vaping (±SD)
A Overall 4.9 (1.3) * 4.3 (1.2) *
Those interested in trying a flavor 4.8 (1.3) 4.2 (1.2)
Those who did not want to try 
any flavor
4.9 (1.3) 4.4 (1.2)
B Overall 5.0 (1.2) * 4.3 (1.2) *
Those interested in trying a flavor 4.8 (1.2) 4.3 (1.2)
Those who did not want to try 
any flavor
5.1 (1.2) 4.5 (1.2)
C Overall 4.9 (1.2) * 4.3 (1.2) *
Those interested in trying a flavor 4.8 (1.3) ° 4.2 (1.2)
Those who did not want to try 
any flavor
5.0 (1.2) ° 4.6 (1.2)
Severity of vaping 
(±SD)
Overall 4.6 (1.1) * 4.4 (1.1) *
Those interested in trying a flavor 4.6 (1.1) 4.4 (1.2)
Those who did not want to try 
any flavor
4.6 (1.1) 4.1 (1.1)
Attitude towards 
e-cigarettes (±SD)
Overall 2.1 (1.1) * 3.5 (1.1) *
Those interested in trying a flavor 2.6 (1.2) ° 3.7 (1.0) °
Those who did not want to try 
any flavor
1.9 (1.0) ° 2.9 (1.2) °
Social influence 
(±SD)
Overall 5.1 (1.7) * 4.4 (1.5) N
Those interested in trying a flavor 4.9 (1.7) 4.2 (1.5) °
Those who did not want to try 
any flavor
5.2 (1.7) 5.1 (1.2) °
table continues
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Individual factors 
related to vaping
Never-users
(n = 407)
Smokers 
(n = 138)
Deliberation on the 
pros and cons of 
e-cigarette use (±SD)
Overall 2.8 (1.5) 3.0 (1.5) 
Those interested in trying a flavor 2.9 (1.6) 3.1 (1.4)
Those who did not want to try 
any flavor
2.7 (1.5) 2.7 (1.7)
Intention to start 
vaping (±SD)
Overall 1.2 (±0.8) * 2.5 (±1.7) *
Those interested in trying a flavor 1.4 (1.1) ° 2.7 (1.7) °
Those who did not want to try 
any flavor
1.1 (0.6) ° 1.6 (1.4) °
* Indicates significant differences (p < 0.05) in a row between user groups. ° Indicates 
a within-group significant difference (p < 0.05) between those who were interested in 
trying any e-liquid flavor and those who were not interested in trying any e-liquid flavor 
(only for never-users and smokers). Knowledge was determined using 12 statements. A 
higher score represents more knowledge, with 0 = no correct answers and 12 = correct 
answers for all statements. Trust was assessed with two items, using a 7-point Likert scale; 
1 low to 7 = high level of trust in information provided. Perceived susceptibility assessed 
the chance of developing cancer as a result of vaping with three statements: (A) If I vape, 
then my risk of developing some form of cancer during my lifetime is…; (B) I think that 
if I vape, my risk of developing some form of cancer during my lifetime is …; (C) My 
feeling is that if I vape, the risk of developing some form of cancer during my lifetime 
is…; 1 = low to 7 = perception of cognitive risk of health risks related to e-cigarette use. 
Severity was assessed with four items, on a 7-point Likert scale ranging from very bad to 
not bad at all (1–7); Attitude was assessed with four items, using a 7-point Likert scale, 
with 1 = very negative towards e-cigarette use and 7 = very positive towards e-cigarette 
use. Deliberation was assessed with three items on a 7-point Likert scale, with 1 = no 
deliberation about E-cigarette use to 7 = very extensive deliberation about E-cigarette 
use. Intention to start vaping was reported on a 7-point Likert scale, with 1= very low 
intention to start vaping and 7 = very high intention to start vaping. 
Discussion
This study shows that the availability of different flavors was reported to be the 
most attractive product characteristic of e-cigarettes by all user groups, and 
that flavor preferences differ between never-users, smokers, dual users, and 
exclusive vapers. The first e-cigarette used by dual users and vapers mostly had 
a tobacco or menthol/mint flavor, but compared to dual users, we observed that 
exclusive vapers use more sweet- and fruit-flavored e-liquids than dual users. 
While tobacco was the most appealing flavor category among smokers, never-
users were mostly interested in trying menthol- and sweet-flavored e-liquids. 
In addition, individual factors related to vaping differed within the groups of 
never-users and smokers. That is, never-users interested in trying a flavor had 
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less knowledge about cigarettes and e-cigarettes than those who did not want 
to try any flavor. Attitude was more positive, and intention to start vaping was 
higher among both never-users and smokers who were interested in trying a 
flavor compared to those not interested in trying a flavor. Perceived susceptibility 
of health consequences was lower among never-users who were interested in 
trying a flavor, and social influence regarding not using e-cigarettes was lower 
among smokers who were interested in trying a flavor. Thus, similarly to the 
role of flavors in food choice,31,32 our results indicate that interest in flavors may 
moderate the differences in individual factors related to vaping.
While concerns have been raised about potential e-cigarette use among never-
users,3,9,55 the never-users in our study had a low intention to start vaping and 
more than two-third (68%) of the never-users did not want to try any e-liquid 
flavor. However, nearly one-third of the never-users were still interested in trying 
an e-liquid flavor. Not surprisingly, they perceived a lower susceptibility towards 
negative health consequences of vaping, had a more positive attitude towards 
e-cigarettes, less knowledge about cigarettes and e-cigarettes, and a higher 
intention to start vaping than never-users who did not want to try any flavor. It 
should, however, be noted that a causal relation between these findings was 
not examined. For example, never-users could report to find e-liquid flavors 
interesting because they were already interested in trying e-cigarettes. On the 
other hand, they may have become interested in trying e-cigarettes because 
of the appealing flavors that they recognize from palatable food products. This 
means that being interested in flavors has a positive effect on the decision to 
start using e-cigarettes, or vice versa. Nevertheless, our findings regarding 
the interest of never-users in e-liquid flavors indicate that never-users may be 
vulnerable to flavor marketing of e-cigarettes.26,27,56,57 For example, marketing 
of appealing e-liquid flavors may make never-users even more positive towards 
vaping, thereby potentially influencing their choice to initiate or refrain from 
vaping.19 This suggests that the reverse can also be true: adapting product 
characteristics, for example restricting e-liquid flavors or regulating other product 
characteristics, may reduce attractiveness and consequently make never-users 
more negative about vaping. Some characteristics of e-liquids are currently 
regulated by Tobacco Regulation in the Netherlands.58,59 However, legislation 
regarding e-liquid flavors currently does not exist. Further research is needed to 
help regulators decide whether and how the regulation of e-liquid flavors can 
improve public health.
This study showed that smokers who were interested in trying an e-liquid flavor 
had a more positive attitude towards e-cigarettes than smokers who were not 
interested in trying a flavor. In addition, smokers who were interested in trying 
a flavor considered the social influence towards not using e-cigarettes as less 
strong, which means that the smokers who were not interested in trying an 
e-cigarette flavor more often find that society thinks that one should not vape. 
Furthermore, two-third of the smokers reported interest in an e-liquid flavor 
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other than tobacco. This indicates that flavors could support the decision of 
smokers to switch to vaping,57 for example by allowing the marketing of e-liquid 
flavors and other product characteristics that smokers find attractive.4 The role of 
e-liquid flavors in supporting both the decision to switch towards e-cigarette use 
(for smokers) and to refrain from using e-cigarettes (for never-users) demonstrates 
the complexity of developing future regulations on e-liquid flavors.
Additional support for the interest in flavors moderating differences in individual 
factors related to vaping is provided by the different patterns of e-liquid flavors 
used by dual users and exclusive vapers. In line with previous research, both 
groups mostly used tobacco and mint flavored e-cigarettes at initiation, but 
exclusive vapers currently used more fruit and sweet e-liquid flavors than dual 
users.5,34,60-62 This could be interpreted as vapers switching from tobacco to non-
tobacco flavors over time, which is supported by a previous study.5 Because 
most adult exclusive vapers included in this study used e-cigarettes for 1 to 5 
years and most dual users reported to vape for only less than 6 months (data 
not shown), it is possible that the dual users may switch to fruit or sweet e-liquid 
flavors in the future. Longitudinal research is needed to investigate whether 
and how e-liquid flavors could support dual users in their decision to switch to 
exclusive vaping. In addition, it would be interesting to investigate the process 
of e-liquid flavors (or other product characteristics) eventually not living up to 
dual users’ expectation, thereby leaving them to quit vaping and relapse into 
exclusive cigarette smoking. This information could be used to, for example, 
stimulate an exchange of knowledge and experiences between exclusive vapers 
and dual users about the flavored e-liquids they use.63
Future Research
Previous studies assessing individual factors related to vaping mostly focused 
their survey items on e-cigarettes in general. This means that participants are 
typically asked about their mental representation or beliefs of an unspecified 
e-cigarette, thereby not taking into account that the e-cigarette is a product 
that is available in various shapes, sizes, colors, flavors, and more. As our results 
suggest that flavors may moderate the differences in individual factors related 
to vaping, we recommend using survey items that represent a specific flavor or 
other product characteristic. For example, instead of only focusing on perceived 
susceptibility attitude towards e-cigarettes in general,64,65 researchers should 
also assess perceived susceptibility attitudes towards a specific e-liquid flavor 
categories, such as fruit, candy, and tobacco.47
In addition, as other product characteristics may moderate differences found in 
individual factors related to vaping, the impact of for example price, labeling, 
and packaging of e-cigarettes and e-liquids on individual factors related to 
vaping should be investigated in different user groups66 to determine which 
characteristics make up their “ideal” e-cigarette.
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Furthermore, it would be interesting to use sensory research to investigate 
differences in e-liquid flavor liking between user groups, and how this relates 
to individual factors related to vaping. Finally, research is needed to investigate 
the interaction between product characteristics and individual factors related 
to new and emerging products, such as heated tobacco products and products 
containing nicotine salts. This will provide insight into which specific product 
characteristics are most appealing to vulnerable user groups, such as never-users 
and youth, and thus need to be regulated.
Limitations
Ideally, our sample size would be large enough to stratify our sample into different 
age groups and different flavor categories. However, our sample size was too small 
to determine differences in the preference of specific flavor categories between 
age groups (adults vs. adolescents), and differences in individual factors related 
vaping between specific flavor categories. In addition, response rates among 
adolescents was very low, and the rather high education level of participants in 
this study was not be representative of the Dutch population.67,68 In addition, 
the sample cannot be considered representative of the Dutch population, as 
oversampling for the smokers and e-cigarette users was performed in order to 
have sufficient observations. As a result, the percentages of smokers and vapers 
in our study do not reflect the actual percentages of smokers and vapers in the 
Dutch population.
Conclusions
This study demonstrates that being interested in flavors moderates the 
differences in individual factors related to vaping for never-users and smokers, 
or vice versa. While the availability of different flavors was reported to be the 
most attractive product characteristic of e-cigarettes in all user groups, the 
specific flavor preferences varied between never-users, smokers, dual users, and 
exclusive vapers. Importantly, individual factors related to vaping (knowledge, 
perceived susceptibility attitude, social influence, and intention to start vaping) 
differed between never-users and/or smokers who were interested in trying an 
e-liquid flavor and those who did not want to try a flavor. Our results confirm the 
importance and complexity of regulating e-liquid flavors in a way that both the 
decision to switch towards vaping (for smokers) and the decision to refrain from 
vaping (for never-users) are supported. Ideally, regulation should allow marketing 
of e-liquid flavors that stimulate smokers and dual users to keep or start using 
e-cigarettes. To make never-users more negative about and keep them from using 
e-cigarettes, product appeal should be reduced by, for example, restricting the 
marketing and promotion of e-liquid flavors that they find particularly appealing.
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Abstract
Although total cessation of nicotine and tobacco products would be most 
beneficial to improve public health, exclusive e-cigarette use has potential health 
benefits for smokers compared to cigarette smoking. This study investigated 
differences between dual users and exclusive e-cigarette users provide 
information to optimize health communication about smoking and vaping. 
A cross-sectional survey (n = 116) among 80 current, adult dual users and 36 
current, adult-exclusive e-cigarette users was conducted in the Netherlands. The 
questionnaire assessed four clusters of factors: (1) Past and current smoking and 
vaping behavior, (2) product characteristics used, (3) attractiveness and reasons 
related to cigarettes and e-cigarettes, and (4) socio-cognitive factors regarding 
smoking, vaping, and not smoking or vaping. We used random forest—a machine 
learning algorithm—to identify distinguishing features between dual users and 
e-cigarette users. We are able to discern a dual user from an exclusive e-cigarette 
user with 86.2% accuracy based on seven factors: Social ties with other smokers, 
quantity of tobacco cigarettes smoked in the past (e-cigarette users) or currently 
(dual users), self-efficacy to not vape and smoke, unattractiveness of cigarettes, 
attitude towards e-cigarettes, barriers: accessibility of e-cigarettes, and intention 
to quit vaping (A). This combination of features provides information on how to 
improve health communication about smoking and vaping.
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Introduction
The use of electronic cigarettes (e-cigarettes) has increased worldwide in recent 
years.1,2 The majority of the e-cigarette users are currently former cigarette 
smokers that either switched completely to e-cigarettes or use e-cigarettes in 
addition to tobacco cigarettes.2-7 Concerns exist that e-cigarette use may attract 
(adolescent) never users, and thus, affect public health adversely, or even lead 
to dual use and a nicotine addiction.8-10 Although never use or total cessation 
of all nicotine and tobacco products would be most beneficial for all,8,11,12 
exclusive e-cigarette use—and not dual use of both cigarettes and e-cigarettes, 
which has an adverse public health effect6,8,13—has potential health benefits for 
smokers compared to cigarette smoking.13-18 However, exclusive e-cigarette 
use, especially among never-users, is not without risks itself.8 Consequently, 
it is recommended to be prevented among non-smokers.8 To improve public 
health, it is important to optimize health communication about smoking and 
vaping to the needs of never users, non-current users, exclusive smokers, dual 
users, and exclusive e-cigarette users. Since dual users and exclusive e-cigarette 
users are distinct groups,13 their information and communication needs are likely 
different. The present paper aims to increase our understanding of these two 
distinct groups and provide insight into factors that can be targeted with health 
communication. 
Research has presented several differences between exclusive e-cigarette users 
and dual users, but the variability in results and definitions used makes it difficult 
to compare these differences.19 Review of relevant literature has identified four 
clusters of differences between dual users and e-cigarette users.9,13,19-34 While 
previous research looked at differences between dual users and exclusive 
e-cigarette users on an individual factor level or combined two clusters in an 
analysis, the goal of our study is to provide aggregated data by combining all 
the clusters of factors identified with machine learning.9,13,19-34 First, differences 
were found in current smoking behavior among dual users or past smoking 
behavior among e-cigarette users, and current vaping behavior. Research has 
found that dual users smoked for a longer time (i.e., more pack years) compared 
to e-cigarette users.9,21 Additionally, the number of cigarettes smoked per day 
increased the likelihood of initiating e-cigarette use,9,22 but no differences were 
found between dual users and e-cigarette users.23 Smith, Gawron, Balwicki, et 
al. 9 have demonstrated that experimenting with e-cigarette use increased over 
time from 20% in 2011 to 70% in 2016 in Poland, and while rates of exclusive 
daily smoking declined, rates of exclusive daily vaping increased.
Second, there is variability in differences reported in product characteristics of 
e-cigarettes used by dual users versus exclusive e-cigarette users. One study 
reported that dual users were more likely than exclusive e-cigarette users to use 
nicotine-containing e-liquids.9 In comparison, other studies found that nicotine 
concentration in e-liquids used did not differ between dual users and exclusive 
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e-cigarette users.23,24 Similarly, this variability in reported differences is observed 
in e-liquid flavors used. While one study found no differences between dual 
users and e-cigarette users in flavors used,9 another study found that tobacco 
e-liquid flavors were more popular among dual users than e-cigarette users.25 
These differences in product characteristics of e-cigarettes used may partly be 
explained by differences in regulations across countries. In the Netherlands, 
product characteristics of e-cigarettes, such as maximum levels of nicotine per 
e-liquid (20mg/ml in the Netherlands), and the maximum volume of e-liquids 
(10ml in the Netherlands) are regulated through the Tobacco regulation.35,36
Third, differences have been observed in the perceived attractiveness of product 
characteristics of cigarettes and e-cigarettes.19,25-28 Dual users and exclusive 
e-cigarette users differed in how they perceived the attractiveness of the ability 
to avoid smoking restrictions with e-cigarettes,29 lower costs of e-cigarettes 
compared to cigarettes,24 and the variety of e-liquid flavors available.19,26 These 
attractive aspects are a reason to initiate e-cigarette use and may influence a 
person’s attitude towards e-cigarettes.32,33 Although attractiveness and reasons 
related to e-cigarette use have previously been reported to differ between dual 
users and exclusive e-cigarette users.19,21,23 Fourth, socio-cognitive determinants 
regarding e-cigarette use differed between dual users and exclusive e-cigarette 
users. Dual users were less positive towards e-cigarettes than exclusive e-cigarette 
users.19,24 In addition, dual users perceived fewer risks of e-cigarettes compared 
to smoking than exclusive e-cigarette users.21 Risk perception differed between 
dual users and exclusive e-cigarette users.19 More often, partners, family, friends, 
and colleagues of e-cigarette users were fellow e-cigarette users.24,30 E-cigarette 
users also had less desire for cigarette smoking than dual users, and they found 
it easier than dual users not to smoke.23,24,30 Furthermore, while some situations 
triggered dual users to smoke cigarettes, these situations did not trigger 
exclusive e-cigarette users.23,24,34 For example, if dual users experienced stress, 
were with friends, or had just eaten dinner, they preferred cigarette smoking 
over vaping.23,24,34 Dual users were found to be less motivated to quit cigarette 
smoking or quit nicotine intake altogether than exclusive e-cigarette users.24,25
While previous research looked at differences between dual users and exclusive 
e-cigarette users on an individual factor level or combined two clusters in an 
analysis, the goal of our study is to provide aggregated data37,38 from the combined 
four clusters of factors found in previous research with machine learning.9,13,19-34 
With machine learning, we are able to provide the most relevant features from 
a variety and a large number of factors identified in the four clusters. These 
aggregated data could provide information to support the development and 
improvement of health communication about e-cigarettes in order to prevent 
the adverse health effects of dual use. With insight into the most relevant 
features, health communication may be able to target the differences between 
dual users and exclusive e-cigarette users to aid dual users who would like to 
switch to exclusive use in the future, or prevent dual use among exclusive users. 
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To explore relevant distinguishing features between adult dual users and adult-
exclusive e-cigarette users in a cross-sectional survey, the following four clusters 
were combined with random forest: (1) Past and current smoking and vaping 
behavior; (2) product characteristics used; (3) attractiveness and reasons related 
to cigarettes and e-cigarettes; and (4) socio-cognitive factors regarding smoking, 
vaping, and not smoking or vaping.9,13,19-34
Methods 
For the purpose of this study, a cross-sectional survey was conducted among 
adult (18+), current dual users; and adult (18+), current exclusive e-cigarette 
users. Adult individuals who currently smoke and use e-cigarettes (i.e., vape) 
concurrently on a daily or weekly basis, are defined as dual users in the current 
study.13 In contrast, adult individuals who exclusively use e-cigarettes on a daily 
or weekly basis are defined as exclusive e-cigarette users.13 A full overview of 
the items reflecting all four clusters of factors used can be found in Appendix 6. 
The study was approved by the Medical Ethics Committee of Zuyderland—Zuyd 
(17-N-88). 
Recruitment
In June 2016, participants were recruited in the Netherlands through an online 
survey panel (Flycatcher).39 This online panel consists of more than 10,000 Dutch 
individuals and panel participants, who voluntary and actively opt-in (double-
active-opt-in). Every year, panelists are asked to update their information. 
On average panelists complete eight surveys a year. Twelve thousand seven 
hundred fifty panelists were sent an invitation by email who met the inclusion 
criteria (being able to understand Dutch, being aware of e-cigarettes, being 13 
years or older (adolescent (13–17 years old) and adults (18+))). The questionnaire 
was administered online, and participants were asked to provide consent 
before the start of the survey. With a response rate of 10.3%, 1307 participants 
completed the survey. To distinguish a dual user from an exclusive e-cigarette 
user, participants were eligible for our current study if they were adults who met 
the definition of either a dual user or exclusive e-cigarette user. In total, 116 
participants (n = 80 adult dual users; n = 36 adult-exclusive e-cigarette users) of 
this subsample met the definition of dual users and exclusive e-cigarette users. 
User groups were determined with three questions: Type of user: ‘I smoke or 
vape…’; frequency of use: ‘How often do you smoke?’; and ‘How often do you 
vape?’ (see Appendix 6). 
Questionnaire
The current study included measures (see Appendix 6) on basic demographics 
and the four identified clusters of differences. The questionnaire was only 
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accessible to Flycatcher panel members with a personalized link. Participants 
first answered a verification question to make sure that the questionnaire was 
filled in by the selected participants. All items used were mandatory. Responses 
were checked on quality by: Time to fill in the questionnaire, consistency in 
responses, open answer options, and straight lining (e.g. if the same response is 
chosen in a series of the statement). 
Sociodemographic Measures 
Sociodemographic measures included age, gender, and education. Educational 
level was determined based on the Dutch version of the International Standard 
Classification of Education (ISCED) (see Appendix 6).40
Past and Current Smoking and Vaping Behavior
All participants were asked to report their vaping and smoking behavior. These 
measures included the type of user, lifetime smoking status,41 frequency of 
smoking and vaping, duration of smoking and vaping, and several others (see 
Appendix 6). 
 
Product Characteristics Used
Product characteristics used were investigated by asking about e-liquid flavors 
used, nicotine concentrations, cigarette brands smoked and several others (see 
Appendix 6). 
Attractiveness and Reasons Related to Cigarettes and E-Cigarettes
Attractiveness and reasons related to cigarette and e-cigarette users were 
investigated by asking: ‘The E-cigarette is attractive because (more than one 
answer possible)’. Similar, reasons for cigarette use were investigated by asking: 
‘Which of the following statements applies to you? I smoke/I used to smoke: 
(More than one answer possible)’ (see Appendix 6).
Socio-Cognitive Factors
To investigate socio-cognitive factors related to smoking, vaping, and not 
smoking and vaping, items were included in triplicate to investigate vaping, 
smoking behavior and not using e-cigarettes or cigarettes. For example, the 
attitude was assessed with four semantic-differentials about not smoking or 
vaping, cigarette smoking, and e-cigarette use by asking if participants thought 
‘not smoking or vaping was good or bad on a 7-point Likert scale’. To establish 
scales for attitude, deliberation, trust in information provision, social ties, self-
efficacy, and barriers of accessibility of e-cigarettes a reliability analysis was 
performed to establish scales. If the reliability analysis showed sufficient internal 
consistency (Cronbach’s alpha α ≥ 0.60), then items were included in a scale. An 
overview of internal consistency of scales can be found in Appendix 6. Unless 
otherwise stated, all determinants used a 7-point Likert scale as answer options, 
such as either 1 equals totally disagree to 7 equals totally agree or semantic-
differentials, such as 1 equals really bad to 7 equals really good.
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Data Analysis
SPSS data were exported and further preprocessed in Microsoft Excel for 
statistical data analysis in R statistical software version 3.5.142 using the random 
Forest package. Descriptive analyses were performed to gain insight into the 
participant characteristics of the study sample. Chi-square tests and analyses of 
variance (t-tests) were performed to assess differences in characteristics between 
dual users and exclusive e-cigarette users.
To determine which aspects were important to distinguish a dual user from 
an e-cigarette user, analyses were performed using random forest.43 Random 
forest (RF) is a machine learning algorithm that classifies an outcome (dual use 
versus e-cigarette use) of an individual using an ensemble of decision trees with 
predictor variables (including demographics, smoking and vaping behavior, 
product characteristics, attractiveness and reasons related to cigarettes and 
e-cigarettes, and socio-cognitive factors). For the RF, a data table with 163 items 
and concepts (features) for 80 dual users and 36 exclusive e-cigarette users was 
used. Using 5-fold cross-validation, the data were randomly split into subsets 
containing approximately the same ratio of dual users and e-cigarette users: 
In a training set (80% of the data) and test set (20% of the data). In each cross-
validation the training set was used to build an RF classifying model consisting 
of 1000 trees to predict if a participant in the test set is either a dual user or an 
exclusive e-cigarette user, this was done five times. After the five cross-validation 
runs, the overall prediction accuracy was calculated. Additionally, RF assessed 
the relative importance of each prediction variable by determining how much 
the error increased as a result of random rearrangement of the data for that 
variable (R settings: Type = 1, scale = TRUE). The resulting variable importance 
factor (averaged per factor across the five cross-validations) was used to calculate 
the corresponding p-value, which was adjusted to the Benjamini-Hochberg False 
Discovery Rate (FDR)44 to correct for multiple testing. The variables with FDR 
adjusted p-values (FDR < 0.05) were used for a new round of RF classification to 
confirm the accuracy that could be obtained with these markers.
Results
Participants Characteristics
Of the 116 dual users and exclusive e-cigarette users, 43.1% was male and 
56.9% female, 28.4% was highly educated (26.7% low education level, and 
44.8% middle education level), and the average age was 49.1 (±12.5, min = 
21, max = 79). Age did not significantly differ between dual users and exclusive 
e-cigarette users.
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Differences between Dual Users and Exclusive E-Cigarette Users
All differences between dual users and exclusive e-cigarettes on the 163 
predictor variables included in our analysis are reported in Appendix 7. Table 
5.1 reports the significant differences found between dual users and exclusive 
e-cigarette users. 
Differences in Past and Current Smoking and Vaping Behavior
Significant differences in tobacco and e-cigarette behavior were observed 
(see table 5.1) between dual users (that currently both smoke and vape) and 
exclusive e-cigarette users (former smokers that are currently only vaper-only) 
concerning onset of tobacco smoking, quantity of tobacco cigarettes smoked in 
their past or current smoking behavior, and lifetime status of tobacco smoking 
(Fägerstrom index) (p < 0.05). All exclusive e-cigarette users smoked more than 
100 cigarettes in their lifetime. The onset of smoking was longer ago among 
e-cigarette users (i.e., more pack years) than dual users. In addition, when they 
still smoked (n = 36, all current e-cigarette users have a history of smoking), 
exclusive e-cigarette users smoked more cigarettes a day than current dual users 
smoke at the moment of the survey (p < 0.05). No differences were observed in 
how long dual users and exclusive e-cigarette users have been vaping (i.e., onset 
of vaping).
Differences in Product Characteristics Used
No significant differences between dual users and exclusive e-cigarette users 
were observed in product characteristics used, such as current or first used 
concentrations of nicotine in e-liquids, or e-liquid flavors (see Appendix 7). 
Differences in Attractiveness and Reasons Related to Cigarettes 
and E-Cigarettes
Differences were observed between dual users and exclusive e-cigarette users 
in the perceived attractiveness of e-cigarettes (see table 5.1). Compared to 
exclusive e-cigarette users, dual users more often found e-cigarettes to look 
nice, and the variety of e-liquid flavors appealing (p < 0.05). Dual users reported 
more often than exclusive e-cigarette users that avoiding smoking restrictions 
and the novelty of e-cigarettes were reasons to vape (p < 0.05). For cigarettes, 
dual users found the flavor of tobacco and the variety of brands to be more 
attractive than exclusive e-cigarette users (p < 0.05). E-cigarette users found the 
adjustable settings and nicotine concentrations of e-cigarette more attractive 
than dual users (p < 0.05). Compared to dual users, e-cigarette users reported 
health benefits and e-cigarettes as an alternative for smoking more often as 
reasons for e-cigarette use (p < 0.05). In addition, e-cigarette users found the 
cigarette to be unattractive more often than dual users (p < 0.05). In particular, 
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they found it unattractive how smokers smell after smoking a cigarette (p < 0.05). No 
differences were observed in unattractive product characteristics of the e-cigarette, such 
as the design, the e-liquid flavors, or the price.
Differences in Socio-Cognitive Factors 
E-cigarette users had a more positive attitude towards e-cigarettes and had a more 
negative attitude towards smoking compared to dual users (p < 0.05) (see table 5.1). 
Compared to exclusive e-cigarette users, dual users felt more connected—their social ties 
with smokers were stronger—to other smokers and they more often had a partner, family, 
friends, and colleagues who smoked (Social influence (f), p < 0.05). Dual users had higher 
levels of deliberation about not smoking or vaping, and although they had a higher 
intention to quit vaping than exclusive e-cigarette users (p < 0.05), their self-efficacy to 
quit vaping and smoking was lower (p < 0.05). Dual users also perceive fewer risks related 
to smoking compared to e-cigarette users (p < 0.05). Significant differences were also 
found in information-seeking behavior, dual users less often used a Dutch Vape forum as 
a source of information than exclusive e-cigarette users (p < 0.05), and they would like to 
receive more information about e-liquids than exclusive e-cigarette users (p < 0.05). Dual 
users would find information independent if it was presented under the auspices of the 
national government (p < 0.05). Finally, exclusive e-cigarette users would find information 
more independent and reliable if researchers report no conflict of interest (p < 0.05).
Table 5.1 Significant differences between dual users and exclusive e-cigarette users.
Dual Users 
(n = 80)
E-Cigarette 
Users 
(n = 636)
(1) Past and current smoking and vaping behavior n = 80 n = 36
Quantity of tobacco cigarettes smoked in the past 
(e-cigarette users) or currently (dual users) 
Current 
smoking 
quantity A 
Past 
smoking 
quantity A 
< ½ package p. day 16.3% 2.8%
½ −1 package p. day 63.7% 36.1%
1 package p. day 13.8% 22.2%
> 1 package p. day 6.3% 38.9%
Lifetime status of tobacco smoking
<100 cigarettes in life 6.30% 0.00%
>100 cigarettes in life 93.70% 100.00%
Onset of tobacco smoking
<6 months 1.3% 2.8%
6−12 months 1.3% 0.0%
1−5 years 8.8% 0.0%
5−10 years 11.3% 0.0%
>10 years 77.5% 97.2%
table continues
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Dual Users 
(n = 80)
E-Cigarette 
Users 
(n = 636)
Onset of vaping
<6 months 35.0% 13.9%
6−12 months 20.0% 16.7%
1−5 years 41.3% 61.1%
5−10 years 3.8% 8.3%
(2) Product characteristics used n = 80
No significant differences were found
(3) Attractiveness and reasons related to cigarettes and 
e-cigarettes
n = 80 n = 36
Attractiveness of e-cigarettes
The product looks nice 18.8% 5.6%
Due to all the different flavors 46.3% 25.0%
Because it is possible to alter the setting of the 
E-cigarette to my wishes
20.0% 38.9%
Because the nicotine level can be varied 45.0% 66.7%
Not applicable, I do not find the E-cigarette/vaper 
attractive
8.8% 0%
Attractive characteristics of cigarettes (yes%)
The product looks nice 7.5% 0%
Due to all the different flavors 30.0% 11.1%
Because you can smoke different brands 26.3% 5.6%
Not applicable, I do not find the cigarette attractive 28.8% 72.2%
Unattractiveness of cigarettes
The price of the product 35.0% 58.3%
Because you stink after you have smoked a cigarette 43.8% 66.7%
Reasons for e-cigarette use
For their health advantages: effects on health, fewer 
ingredients than a cigarette.
42.25% 72.2%
As an alternative to cigarettes: it is like the smoking or 
because of the throat hit 
28.8% 50.0%
To get around the smoking ban (to be able to vape in 
places where smoking is normally forbidden). 
22.5% 5.6%
To try something new: out of curiosity about new 
products, different flavors, different apparatus/designs, 
for pleasure, as a hobby, or because it is cool/trendy/
classy.
11.3% 0%
table continues
Factors to Distinguish a Dual User from an Exclusive E-Cigarette User 109
5
Dual Users 
(n = 80)
E-Cigarette 
Users 
(n = 636)
(4) Socio-cognitive factors regarding cigarette use, 
e-cigarette use, and not smoking or vaping
n = 80 n = 36
Attitude towards e-cigarettes 4.5 (0.8) 5.0(0.8)
Attitude towards smoking 3.5(1.2) 2.7(1.2)
Barrier: accessibility of e-cigarettes 5.2(1.1) 4.8(1.5)
Deliberation not using e-cigarettes and cigarettes 4.5(1.4) 3.9(1.3)
Independency of information: (e) 50.0% 72.2%
Independency of information: (h) 18.8% 5.6%
Information need: (j) 7.9% 0%
Information source used: not applicable 6.3% 0%
Information source used (h) 6.3% 22.2%
Intention to quit vaping A. 3.8(2.0) 2.9(1.8)
Intention to quit vaping B. 3.6(2.4) 2.3(1.8)
Reliability of information (e) 51.3% 75.0%
Risk perception of smoking (cognitive) A 4.7(1.3) 5.3(1.1)
Self-efficacy to not vape or smoke 3.9(1.2) 4.8(1.2)
Social Influence A 4.2(1.7) 3.2(1.6)
Social influence D 33.8% 13.9%
Social influence F 3.6(1.1) 4.1(1.1)
Social Ties with other smokers (n = 79) 3.3(1.1) 2.3(1.2)
Note: Data on are presented as means (SD) or percentages of dual users, and exclusive 
e-cigarette users. All factors presented here are significant. A complete overview of 
all included variables in the random forest can be found in Appendix 6. A Quantity of 
tobacco cigarettes smoked in the past or currently displays the current smoking behavior 
of dual users, and the past smoking behavior of exclusive e-cigarette users before they 
switched to exclusive e-cigarette use; Independency of information: (e) If the researchers 
themselves have no vested interest in the results; Independency of information: (h) If the 
research is under the auspices of the national government, if there is a governmental 
logo; Information need: (j) I would like more information about the e-liquids available; 
Information source used: Not applicable: I never search for information; Information 
source used: (h) Dutch Vape forum or Acvoda (Active for vaping); Intention to quit vaping 
A. Please indicate on a scale from 1 to 7 your intent to quit vaping in the next 6 months; 
Intention to quit vaping B. Please indicate which of the statements indicates your intention 
best; Reliability of information: (e) I find research reliable if the researchers have no conflict 
of interest to declare; Risk perception of smoking (cognitive) A: If I smoke, then my risk of 
developing some form of cancer during my lifetime is…; Social Influence A: Society thinks 
that you should not smoke E-cigarettes; Social influence D: Smoking status partner (% of 
yes); Social Influence F: How many of your family, friends or colleagues use cigarettes? 
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Identifying Unique Factors that Discriminate Dual User from an 
Exclusive E-Cigarette User
Random forest analysis on dual use versus e-cigarette use identified 7 of the 
163 factors as contributing significantly to the prediction accuracy (FDR 5%). 
Together, these seven factors allowed for 86.2% prediction accuracy. Figure 5.1 
shows the 25 highest-ranking relevant distinguishing features, with the top seven 
significant factors after adjusting for multiple testing. The seven most relevant 
factors to distinguish a dual user from an exclusive e-cigarette user are (FDR 
5%): Social ties with other smokers, quantity of tobacco cigarettes smoked in 
the past (e-cigarette users) or currently (dual users), self-efficacy to not vape and 
smoke, unattractiveness of cigarettes, attitude towards e-cigarettes, barriers: 
accessibility of e-cigarettes, and intention to quit vaping (A) (see table 5.1 for 
significant differences between dual users and exclusive e-cigarette use).
 
 
 
Social ties with other smokers 
Quantity of tobacco cigarettes smoked in the past or currently 
Self-efficacy: e-cigarette use 
Unattractiveness cigarettes: I find cigarettes unattractive 
Attitude vaping 
Barrier: accessibility of e-cigarettes 
Intention to quit vaping A:  I intent to quit vaping (1-7)  
Onset of tobacco smoking 
Social Influence A: Society thinks you should not vape 
Attractiveness of cigarettes: the different brands 
Social influence D: smoking status partner 
Information source used h: Dutch vape forum 
Attitude towards information about e-cigarettes 
Reasons for e-cigarette use: health benefits 
Intention to quit vaping B: please indicate which indicates your intention  
Deliberation about not using E-cigarettes or cigarettes 
Social influence F: How many of your friends smoke? 
Attitude smoking 
Social ties with other vapers 
Unattractiveness of cigarettes: price of cigarettes 
Risk perception of smoking (cognitive) A: Risk of cancer if I smoke   
Reasons for e-cigarette use: to avoid smoking restrictions 
Attractiveness of e-cigarettes: adjustable settings 
Onset of vaping 
Reasons for e-cigarette use: Nicotine Replacement Therapy (NTR) 
Importance 
Figure 5.1. Top twenty-five factors to distinguish between dual users and e-cigarette 
users. Bar lengths indicate the variable importance factors, the seven significant (FDR 5%) 
factors are shown in dark gray.
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Discussion
We used random forest—a machine learning algorithm—to identify important 
and unique distinguishing features between dual users and exclusive e-cigarette 
users. Based on the random forest, adult, current dual users and adult, current 
exclusive e-cigarette users can be distinguished from each other with 86.2% 
accuracy based on three out of four included clusters of factors: Current and 
past smoking behavior, unattractiveness of cigarette product characteristics, 
and socio-cognitive factors regarding smoking, vaping, and not smoking and 
vaping. Similar to previous research,9,23,24 our random forest analysis found no 
distinguishing features between dual users and exclusive e-cigarette users in 
product characteristics used. 
First, regarding current and past smoking behavior, previous research found that 
dual users reduce the number of cigarettes smoked a day.25,45 Our findings also 
indicate that adult, current dual users (n = 80) currently smoked fewer cigarettes 
a day than e-cigarette users did in the past, when they were cigarette smokers 
(n = 36).25,45 Research found that the number of cigarettes smoked per day 
increased the likelihood of initiating e-cigarette use,9,22 the reduced level of 
current smoking quantity a day among dual users may hint at a transitory phase 
of switching completely to exclusive e-cigarette use.46. Similar to PATH 47 studies 
in the US, longitudinal research in the Netherlands is needed to investigate 
transitory phases of smoking and vaping to increase our understanding of dual 
use and exclusive e-cigarette use. 
Second, exclusive e-cigarette users found cigarettes more unattractive than 
dual users. This unattractive aspect of cigarettes was a distinguishing feature 
between dual users and exclusive e-cigarette users. Further research is 
necessary to understand if increasing the unattractiveness of cigarettes might 
facilitate smokers—including dual users—to switch to exclusive e-cigarette use. 
Additionally, similarly to earlier results, dual users found the variety of e-liquid 
flavors available an attractive characteristic of both e-cigarettes and cigarettes, 
which is similar to earlier results, and they more often than exclusive e-cigarette 
users vape to avoid smoking restrictions.19,25-29 Consequently, research is 
needed to gain insight into attractive aspects of e-cigarettes and unattractive 
aspects of cigarettes for smokers and dual users to identify factors that health 
communication can target. By targeting the identified distinguishing factors, 
health communication strategies can stress the pros of e-cigarettes and the cons 
of cigarettes for smokers and dual users. Furthermore, research into attractive 
and unattractive aspects of cigarettes and e-cigarettes is needed among never 
smokers and vapers to target preventive health communication strategies at 
vulnerable non-smokers and non-vapers.19,24,30
Third, in contrast with previous research,23 our results show that various socio-
cognitive factors are important to distinguish a dual user from an exclusive 
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e-cigarette user. Dual users experienced more social ties with other smokers 
than exclusive e-cigarette users, and contrary to dual users, exclusive e-cigarette 
users had higher levels of perceived self-efficacy to not smoke or vape.30,34 In 
addition, dual users had a more negative attitude towards e-cigarettes than 
exclusive e-cigarette users, which is supported by previous research.24 Lastly, dual 
users, more often than exclusive e-cigarette users, had a partner who smoked. 
These factors could be targeted with health communication to aid smokers and 
dual users who want to switch to exclusive e-cigarette use or quit smoking. 
Finally, the results from our random forest analysis provide insight into factors 
that had a unique contribution in distinguishing the dual users from exclusive 
e-cigarette users, which may have a practical implication for the improvement of 
health communication about smoking and vaping. Further research is needed to 
test effective communication strategies that target these factors to prevent the 
adverse health effects of dual use. The seven features provide a first insight into 
the most relevant features that health communication may be able to target to 
aid dual users who would like to switch to exclusive use in the future, or prevent 
dual use among exclusive users. Health communication strategies that stress the 
pros of e-cigarettes for cigarette smokers; that provide tools on how to cope 
with the pressure of a social environment to smoke cigarettes; and that provide 
tools on how to better cope with not smoking cigarettes to increase motivation 
to fully switch from cigarettes to e-cigarettes should be tested. Factors that 
can be targeted in health communication could focus on supporting smoking 
cessation among smokers and dual users by managing outcome expectancies of 
e-cigarette use compared to cigarette smoking, improving social ties of smokers 
and dual users with exclusive e-cigarette users,24,30,34 making cigarettes seem less 
attractive,48 strengthening positive attitudes towards e-cigarettes as a smoking 
cessation tool with inoculation messages and build resistance for a pro-smoking 
social environment of smokers and dual users,49 and providing guidance in the 
deliberation process of smoking cessation.50
Limitations
To ensure one-time smokers or exclusive e-cigarette users were excluded in our 
analysis, the subset of dual users and exclusive e-cigarette users was relatively 
small, but sufficient in size for classification by methods, such as random 
forest. Due to our small sample, further research is needed to investigate the 
generalizability of the features found in the current study. In addition, due to 
the cross-sectional study design, no causal conclusions can be drawn on the 
most relevant distinguishing features. Selection bias may have occurred, as an 
online panel was used, which include individuals who are motivated to fill in 
questionnaires.
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Conclusions 
This study combined factors from four different research angles into a single 
machine learning analysis to identify the most relevant distinguishing features 
for discerning a dual user from an exclusive e-cigarette user. Our results 
demonstrate that it is a combination of features from three clusters that discern 
a dual user from an exclusive e-cigarette user: Current and past smoking 
behavior, the unattractiveness of cigarette product characteristics, and socio-
cognitive factors regarding smoking and vaping. This particular combination 
provides new and relevant information regarding the differences between dual 
users and e-cigarettes users that can be applied to develop improved health 
communication targeted to prevent adverse health effects related to dual use. 
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PART 2

CHAPTER 6
A deliberate choice? 
Exploring factors related to 
informed decision-making about 
childhood vaccination among 
acceptors, refusers, and partial 
acceptors
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Scheltema M, et al. 
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Abstract
In light of the decline in childhood vaccination coverage, the question rises 
concerning what factors play a role in informed decision-making about childhood 
vaccination. Insight into factors related to this decision helps us to support 
parents’ informed decision-making about childhood vaccination. We conducted 
12 semi-structured focus group interviews across the Netherlands based on the 
definition of informed decision-making: three with acceptors, three with refusers, 
and six with partial acceptors to ask about knowledge, attitudes, deliberation, 
and information needs. We performed a thematic analysis of the transcripts. 
Acceptors viewed the decision to participate in the National Immunization 
Program (NIP) as self-evident. Refusers and partial acceptors, however, reported 
extensively deliberating the pros and cons of accepting or refusing the NIP 
in much detail. Their answers indicated that their knowledge was not always 
evidence-based. In addition, refusers and partial acceptors perceived fewer risks 
of vaccine-preventable diseases (VPDs), more risks of side-effects of vaccines, 
less social support from their environment, and less trust in child welfare 
centers (CWCs) and information provided than acceptors. We observed distinct 
differences in factors related to decision-making about childhood vaccination 
between acceptors, refusers, and partial acceptors. Acceptors may perceive 
accepting childhood vaccinations as self-evident, refusers may rely mostly on 
anecdotal information rather than evidence-based information to weigh up the 
pros and cons of side-effects of vaccines and the VPDs, and partial acceptors may 
elaborately deliberate the pros and cons of each vaccine and VPD individually, 
which was time-consuming, and difficult. To strengthen and support decision-
making among parents, more elaborate dialogues are needed between Child 
Vaccine Providers (CVPs) and parents. These discussions could also build trust 
between parents and CVPs, discuss the evidence-based advantages of childhood 
vaccinations, and decrease parents’ susceptibility to anecdotal information and 
misperceptions about childhood vaccinations shared by parents.
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Introduction 
Childhood vaccinations are very successful interventions to protect against 
vaccine-preventable diseases (VPDs).1-4 In the Netherlands, the National 
Immunization Program (NIP) offers vaccinations free of charge and on a 
voluntary basis.5 Nowadays within the NIP, vaccinations are offered against 12 
childhood diseases (i.e., polio, diphtheria, tetanus, pertussis, rubella, measles, 
mumps, disease caused by Haemophilus influenzae type b, meningococcal 
ACWY disease, hepatitis B, pneumococcal disease and cervical cancer caused 
by human papillomavirus (HPV)).5 In recent years, vaccination coverage has 
declined in various countries, including the Netherlands (from 95.4% in 2014 to 
92.6% in 2018, for DTaP-IPV vaccination estimated for two-year-olds).5,6 Due to 
this decline, the question arises of whether this is an informed decision and how 
their decision could be supported or strengthened. 
In recent years, informed decision-making has gained more attention in the context 
of childhood vaccination.2 Often, research classifies decisions as informed when 
decision-makers have relevant knowledge about the subject and the decision 
reflects the attitudes of the decision-maker.7 In behavior theories, an informed 
decision is defined as informed when also the consequences are deliberated, and 
the pros and cons are considered in-depth.8 Lehmann, de Melker, Timmermans, 
Mollema 2 quantified how many parents accepting and refusing vaccinations 
made an informed decision about accepting childhood vaccinations. They found 
that refusers made a more informed decision about childhood vaccination than 
acceptors. While refusers elaborately deliberated the decision, acceptors had 
more evidence-based knowledge about vaccinations. In addition to knowledge, 
values, and deliberation, research has revealed additional important factors 
related to the decision about accepting childhood vaccinations. For example, 
risk perception, positive beliefs about the effectiveness and safety of vaccines, 
anticipated regret about VPDs and side-effects, trust in the NIP and information 
about the NIP, decisional conflict, positive social environment towards accepting 
the NIP, and low perceived barriers, such as vaccinations being free of charge 
2,8-15. Research has focused on decision-making about accepting vaccinations 
among parents 2,16,17, but insight into whether parents also consider other 
options, such as refusing or partially accepting vaccinations is lacking. This may 
yield important information on how to support parents in making an informed 
decision about childhood vaccinations, and how supporting informed decision-
making may reduce decisional conflict and vaccine hesitancy,18-20 positively affect 
intention to accept childhood vaccinations, and thus, the vaccination coverage.21
Consequently, this qualitative study explores similarities and differences in 
factors related to decision-making about childhood vaccination among parents 
who accept (acceptors), refuse (refusers), or partially accept (partial acceptors) 
childhood vaccinations with regard to accepting, refusing, or partially accepting 
childhood vaccinations. We examined whether acceptors, refusers, and partial 
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acceptors have similar knowledge and attitudes about childhood vaccinations, 
and how they evaluated the pros and cons of accepting, refusing, and partially 
accepting childhood vaccinations. 
Methods
To explore differences in factors related to informed decision-making of acceptors, 
refusers, and partial acceptors, we set up three focus groups with acceptors, 
three with refusers, and six with partial acceptors (three with parents are delaying 
vaccinations and three with parents who are refusing some vaccinations. As no 
new themes emerged in the last of the three focus group sessions, it was deemed 
that saturation was reached. Eligibility was determined based on the age of their 
child (two years old, born in 2013 and 2014, see table 6.1). We chose to include 
the age of the child as an eligibility criterion to be able to classify parents of these 
children in the three groups: acceptors, refusers, and partial acceptors, based on 
their decision at the time of the focus groups about five vaccination moments 
(child is approximately two years old)). These five vaccinations moments were 
chosen to limit recall bias, and to make sure that parents made a conscious 
decision not to vaccinate, rather than through circumstances, such as sickness. 
Focus group discussions were chosen to stimulate an interactive discussion 
among peers.22,23 This study was approved by the Medical Ethics Committee of 
Zuyderland – Zuyd (16-N-84).
Recruitment
We invited 300 acceptors, 399 refusers, and 464 partial acceptors. Participants 
were randomly selected within each group from Praeventis, the individual 
vaccination database in the Netherlands of the RIVM. Possible participants 
received an invitation. Three large municipalities were selected from various parts 
of the Netherlands to promote a diverse selection of participants. The invitees 
received a letter of invitation containing the goal and procedure of the study. We 
did not differentiate between mothers and fathers, but only one parent from the 
same household could participate in a focus group. The parents could choose 
themselves which of the two would participate. Interested parents could register 
by following a link to an online registration form; a registration number was used 
to access the registration form. This number was checked for duplicates, so only 
one parent from the same household was included in the study. We asked about 
age, gender, level of education, availability, and contact information of parents. 
The final selection of participants for focus groups was based on the parents’ 
availability and vaccination status of the child to ensure an open discussion 
among parents. Age, gender, and level of education were used to reduce 
selection bias. Education level was determined based on the Dutch version of 
the international standard classification of education (ISCED).24 Parents received 
an e-mail containing information on the date, time, and place of the focus group 
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from the first author. All parents were also contacted by phone by the first author 
to ensure participation. Of the total of 1163 invited parents, we received 197 
applications (109 (55%) acceptors, 32 (16%) refusers, 56 (29%) partial acceptors). 
A complete overview of participant characteristics is reported in Appendix 8. 
Table 6.1 Definitions of acceptors, refusers, and partial acceptors
Parental group Definition
Acceptors Acceptors are parents (at least one of whom was born in the 
Netherlands) of children born in 2013 or 2014, who received all 
vaccinations scheduled according to the Dutch NIP.
Refusers Refusers are parents (at least one of whom was born in the 
Netherlands) of children born in 2013 or 2014 who received none of 
the vaccinations scheduled according to the Dutch NIP.
Partial acceptors 
Parents who partially accept childhood vaccinations are parents (at 
least one of whom was born in the Netherlands) who refuse or delay 
some vaccines of children born in 2013 or 2014. For example, some 
of these children did not receive any PCVa, but received four doses 
of DTaP-IPV-Hib-HBV a vaccines; or they did not receive four doses of 
DTaP-IPV-Hib-HBV a vaccines but did receive three doses of PCV a
vaccine; or their first DTaP-IPV-Hib-HBV a vaccine was delayed more 
than four months. 
Note: childhood vaccination status was determined by reported vaccination status for 
DTaP-IPV-Hib-HBV, PCV, MenC, BMR vaccination status in the Dutch Praeventis status for 
vaccination uptake reporting. a D = Diphtheria, HBV = Hepatitis B, Hib = Hib disease, M 
= Measles, Men C = Meningococcal disease type C, B = Mumps, PCV = Pneumococcal 
disease, IPV = Polio, R = Rubella, T = Tetanus, aP = Whooping cough
Procedure
The focus group sessions were conducted between February 13, 2017 and March 
2, 2017 at convenient locations in three large cities across the Netherlands. 
Written informed consent was obtained before the start of the session, and 
after participation the parents received a 30 euro incentive. The number of 
participants per focus group varied between two and eight but on average a 
focus group consisted of five parents, and a session lasted approximately two 
hours. A semi-structured protocol based on the definition of informed decision-
making8 with open-ended questions was used to ensure minimal steering from 
the moderator and to allow participants to discuss all relevant subjects.25 All 
focus group sessions were audio recorded, and flipcharts were used so that 
participants could visualize the topics that had been discussed.
The topic list of this protocol was developed according to the definition of 
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informed decision-making of van den Berg, Timmermans, ten Kate, van Vugt, 
van der Wal 8 and previous research conducted by Lehmann, de Melker, 
Timmermans, Mollema 2 to investigate decision-making. A pilot focus group 
session was conducted with colleagues to test the topic list, after which the 
topic list was revised. The revised and final topic list was used during all focus 
group sessions, but specific phrasings of questions were adapted to fit specific 
groups (Appendix 9).
The first author (K.A.G.J.R. a female, academic behavioral scientist) moderated 
all focus group sessions, but the observers varied between authors: SS, MS, and 
LM. The focus group session started with a general introduction, and an opening 
question asking about participants’ knowledge of childhood vaccination, using a 
mind map to visualize the topics mentioned for participants. In the second part 
of the session, participants were asked about their attitude and positive and 
negative aspects towards accepting, refusing, and partially accepting childhood 
vaccination. Participants were asked to provide individual positive and negative 
aspects that might have influenced their decision, on Post-its. These were shared 
in the group after everybody had time to consider their answers. Deliberation 
and Information needs were explored by discussing to what extent participants 
considered all risks and benefits of accepting, refusing, or partially accepting 
childhood vaccinations, and their need and understanding of information. The 
semi-structured protocol with open-ended questions allowed participants to 
discuss additional aspects related to their decision-making with each other. 
Analysis
All focus groups were audio recorded and anonymously transcribed using 
transcription software F4.26 All observers kept field notes, and these were 
used during the transcription of the focus group session and to add context 
to a transcript. For example, if one participant made a comment and another 
participant was vigorously shaking his or her head in disagreement, this was 
noted in the transcript, or during the mind map exercise; if a participant walked 
in late for a session, this was reported in the transcript. 
The focus group transcripts were thematically analyzed using Nvivo 923,27 to 
identify factors that appeared to be related to decision-making about childhood 
vaccination. The qualitative data analyses consisted of four phases. In the first 
phase, two observers (SS and MS) and the first author deduced relevant themes 
and subthemes from a random selection of the transcript of the first focus group 
(acceptors), and discussed and improved these with the first and last authors.2,8 
Second, the observers SS and MS used these relevant themes and subthemes to 
develop a coding list. They then used this list to code another random selection 
of the transcript of the first focus group and explore possible additional relevant 
codes. After this, the first author and two observers discussed the code list, and 
the initial coding of a section of the first focus group transcript. Third, the two 
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observers independently coded the entire transcript of the first focus group to 
look for additional codes, using the improved code list. The first author also 
coded this transcript to check for additional relevant codes. The coding list was 
discussed among the observers and the first author to resolve any differences 
and to add additional codes to create a final coding taxonomy. In the fourth 
and final phases, the final coding taxonomy was used to code the transcripts 
individually by KR, SS, and MS. The first author checked two additional transcripts 
of two other focus groups (refusers and partial acceptors) to ensure the coding 
taxonomy was used accordingly and checked for additional relevant codes; in 
this phase, no new codes were deemed necessary.28 Examples of the final coding 
taxonomy are: anticipated regret regarding infectious diseases, beliefs about 
the importance of herd immunity, beliefs about the competence of the immune 
system of their child, Child Welfare Center, source of information, knowledge, 
and trust in competence of the CVP.
Results
We set up three focus groups with acceptors (n=19), three with refusers (n=12), 
and six with partial acceptors (n=24), of which three with parents delaying 
vaccinations and three with parents refusing some vaccinations. Since no clear 
differences were found between parents who delay some vaccinations and 
parents who reject some vaccinations, we discuss the findings of these parents 
as one group. Of the 55 participants, 75% were female and 25% were male, with 
an average age of 39 years (±5.7, min=27, max =58), 96% of the participants 
were highly educated (i.e. university education) (Appendix 9). Because of the 
explorative and qualitative nature of this study, the results are not intended to be 
generalized beyond the study population.29
Knowledge about childhood vaccination
When asked to talk about what they knew about childhood vaccination, most 
parents were able to mention some facts. For example, they shared facts 
about the NIP schedule, inclusion of combination vaccines in the NIP, the tasks 
of the CWCs, the high vaccination coverage in the Netherlands, low risk for 
susceptibility of VPDs in the Netherlands, differences in vaccination schedules 
between the Netherlands and other European countries, religious reasons 
parents may have to refuse childhood vaccinations, and the importance of herd 
immunity. While acceptors were able to report most evidence-based information 
about childhood vaccination during a mind mapping exercise, they expressed 
the most doubts about being well-informed when asked how informed they felt. 
Refusers and partial acceptors reported different information based on studies 
and anecdotal evidence acquired on, for example, vaccine-critical websites and 
social media. When asked about how informed they felt, they stated that they 
felt very informed (quote 1): 
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My knowledge of vaccines and immunization is high… I think that some of 
these diseases are really good for the development of a child, as part of 
their natural development. I know that there are studies that show that the 
hand-eye coordination of a child improves after they got sick [from a VPD]. 
… I really think that by experiencing diseases [VPDs] you’ll be stronger later 
in life. (quote 1 – #49_refuser)
Refusers mainly shared justifications based on knowledge that was discordant 
with scientific consensus, and rather referred to anecdotal evidence they acquired 
from vaccine-critical websites and social media (quote 2). 
Herd immunity is based on a lie. Herd immunity doesn’t exist! It’s all got 
to do with hygiene, that’s why all the VPDs have disappeared. (quote 2 – 
#49_refuser)
Attitudes about childhood vaccination
Parents shared their thoughts, both positive and negative, on childhood 
vaccination. The overall attitude of acceptors and partial acceptors was positive 
towards vaccinations (quote 3). 
Vaccines are one of the best inventions ever! (quote 3 – #37_partial 
acceptors)
Most acceptors mentioned that they did not just perceive individual benefits, 
but they also perceived aiding the herd immunity with childhood vaccinations as 
a great public benefit (quote 4). 
The public benefit of vaccination is a really important aspect for me. (quote 
4 – #21_acceptor)
Acceptors were mostly negative towards refusing vaccinations, except for the 
vaccine against hepatitis B. Acceptors noted that they did not see the added 
benefit of the recently added hepatitis B vaccination (quote 5) (note: hepatitis B 
vaccination was introduced in the Netherlands in 2011):
This is one vaccine that makes me wonder: ‘do we really need it?’ We didn’t 
receive this vaccine growing up, but because there are risk groups, all our 
children have to receive Hepatitis B in a cocktail…? (quote 5 – #23_acceptor)
Partial acceptors consciously assessed the pros and cons of accepting or refusing 
each individual vaccination, and were therefore not outspokenly negative or 
positive. Refusers were mostly negative about the NIP and vaccinations. They 
discussed negative aspects about the Dutch NIP and vaccines, such as the 
perceived early start of vaccinations, the lack of possibility to discuss alternatives 
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and doubts with people in their social environment or with CVPs, the rigidity 
of a standardized schedule, the lack of transparency of the NIP, combination 
vaccines, and the perceived mandatory nature of the NIP.
Deliberation about childhood vaccination
During the focus group sessions, parents were asked to discuss deliberating 
childhood vaccinations. Most acceptors reported not giving the pros and cons 
of childhood vaccinations much thought, but when asked about their perceived 
pros and cons, all were able to share theirs. This lack of deliberation was not 
perceived as negative, since acceptors viewed childhood vaccination not as 
a choice but as self-evident. They mentioned that there is not much thought 
needed to deliberate the pros of childhood vaccination (quote 6). 
For us, childhood vaccination is really self-evident. It’s not that I didn’t 
think about alternatives, I knew you could decide to delay vaccines. But 
I considered it self-evident, why would the NIP exist if it wasn’t good…? 
(quote 6 – #26_acceptor)
Compared to acceptors, refusers and partial acceptors did deliberate the pros 
and cons of childhood vaccinations. Refusers and partial acceptors deliberated 
the pros and cons of the VPDs versus side-effects of vaccines. They also 
consciously deliberated the pros and cons of accepting or refusing each individual 
vaccination. They mentioned that this was an elaborate, time-consuming, and 
difficult process. They explained it was difficult to find trustworthy information 
and that they did not feel supported in their decision-making. When asked how 
deliberate they perceived their decision, refusers and partial acceptors reported 
to have made a very deliberate choice. When asked how they had made a 
deliberate choice, parents explained (quote 7):
You look at the pros and cons for each disease, plus… I like statistics. So 
I look at the diseases and at the statistical risks of the disease. You read 
about vaccinations in general, those pros and cons you consider as well. We 
looked at each disease separately, what is the story behind the vaccine… 
then you make a decision. (quote 7 – #51_refuser)
Information need about childhood vaccination 
When asked about their information needs, parents stated that several of their 
questions remained unanswered. They reported concerns about contradictory 
information being available, which they find difficult to navigate. Most parents in 
this study mentioned that when they asked their CVPs about the contradicting 
information they received no or unsatisfactory answers, such as childhood 
vaccinations are safe. Most parents explained they wanted to know why 
vaccinations were safe or why vaccinations worked (quote 8): 
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Childhood vaccination is really a diabolical dilemma… do we know what it 
does to you? What is going into my child? (quote 8 – #6_acceptor)
Most parents agreed that the information provision about the NIP was currently 
inadequate (brochures and CVPs). They mentioned that the tone of voice of 
information about the NIP by CVPs is patronizing, which made parents feel that 
they were perceived as stupid and bad parents (quote 9). 
We need to start open discussions and not just a one-way flow of information 
from the government or health professionals: ‘you are just a stupid citizen 
and you should listen and follow our advice’. We ARE equal and we want an 
open dialogue. (quote 9 – #34_partial acceptor)
Refusers and partial accepters noted that information about symptoms and case 
fatality rates of the VPDs was lacking. They also reported that information about 
the consequences of their choice about childhood vaccinations, for example 
how they should act if their child shows symptoms of one of the VPDs, was 
not available. Acceptors and partial acceptors realized that their search for 
information about childhood immunization is influenced by their beliefs and that 
they will search for information that confirms their initial opinions. 
Additional factors related to decision-making about childhood 
vaccination
Risk perception: severity and susceptibility of VPDs and side-effects of 
vaccines
Both the severity and susceptibility of VPDs and side-effects of vaccines were 
expressed as being influential in the decision to accept, refuse, or partially 
accept vaccines. Acceptors perceived the severity and susceptibility of the 
VPDs as great, which increased their anticipated regret should they not accept 
all childhood vaccinations. Unlike acceptors, partial acceptors and refusers 
perceived the risks of alleged side-effects of vaccines as great. For example, 
epilepsy, lactose intolerance, and an underdeveloped immune system were 
mentioned. They also mentioned other strategies to boost the immune system 
of their child (quote 10):
Delaying the NIP was a deliberate choice because I was breastfeeding 
my child. Her immune system would strengthen through me, through 
breastfeeding… (quote 10 – #16 partial acceptor)
Neither refusers nor partial acceptors perceived all VPDs as being a risk. These 
parents mentioned that experiencing a disease would aid the development of 
their child (quote 1). Among refusers and partial acceptors, the severity and 
susceptibility of each VPD was debated separately (quote 11). 
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It really depends on the type of disease [VPD]. I’m thinking, really… how 
likely is it he or she will get polio? The risk is so small, that’s why I was 
comfortable with my decision to refuse this vaccine. (quote 11 – #13_partial 
acceptor)
In the end, acceptors and partial acceptors described the anticipated regret of 
the risk of a VPD as being a decisive factor in their decision about childhood 
vaccination (quote 12):
You would just never forgive yourself if your child would get sick… that’s 
why you vaccinate your child. The risk is too great. (quote 12 – #39 partial 
acceptor)
Norms in parents’ social environment towards childhood vaccination
The importance of norms in their social environment often recurred as a factor 
related to decision-making about childhood vaccination. Acceptors stated that 
their decision was confirmed by a strong social norm expressed by friends, 
parents, and the CWC, which reinforced their decision to accept vaccinations. 
Acceptors explained that they and society perceive the refusal of vaccination as 
being negative or the wrong choice, describing it as selfish. Refusers and partial 
acceptors felt criticized by the same social norm in society, and among friends 
and family for their decision (quote 13), since the majority of society perceived 
accepting childhood vaccination as self-evident (quote 6). 
The debate makes me very uncomfortable… You enter a war zone as soon 
as you mention you refused the NIP, I didn’t tell my family… I just didn’t feel 
like starting a war with them (quote 13 – #11_refuser)
Refusers and partial acceptors stated that their social environment changed due 
to their choice; for example, they no longer had the same friends. 
Trust in information provision
Due to the tone of voice of the information (brochure and information from 
CVPs) about the NIP, many participating parents experienced a lack of trust in 
this information (quote 14): 
The information brochure of the NIP is presented so black and white, and 
blunt, that I start mistrusting it… (quote 14 – #23_acceptor)
Lack of trust was related to one-sided information provided, and parents 
concluded that trustworthy information would discuss both pros and cons of 
childhood vaccination and would appeal to a variety of parents. 
Trust and confidence in child vaccine providers
Most participating parents lack confidence in the knowledge of CVPs at CWCs 
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about childhood vaccinations and their skills to address their doubts about 
childhood vaccinations. When asked what they would like to change about the 
CWC, they all stated that they needed room for a dialogue in which parents and 
CVPs are equal, without a condescending tone of voice. In particular, the lack 
of time CVPs took to discuss childhood vaccinations was perceived as negative, 
and the tone of voice of the CVPs was experienced as haughty. Some refusers 
or partial acceptors even mentioned that the latter was a reason to refuse or 
partially accept vaccinations (quote 15). 
I wanted to discuss childhood vaccination, but that was not possible… they 
just didn’t want to discuss it with me. At the time, I was still trying to decide 
what to do; it was not my intention to refuse… (quote 15 – #28_refuser)
Discussion
We explored whether Dutch parents made an informed decision about 
childhood vaccination and factors related to informed decision-making about 
accepting, refusing, or partially accepting childhood vaccination .Our qualitative 
study was based on the definition of informed decision-making8 and assessed 
factors associated with the ongoing assessment phase of parents’ informed 
decision-making.17 Knowledge, attitudes, and deliberation differed among 
parents. Acceptors perceived accepting childhood vaccinations as self-
evident, refusers relied mostly on anecdotal information rather than evidence-
based information to weigh up the pros and cons of side-effects of vaccines 
and the VPDs, and partial acceptors described an elaborate, time-consuming, 
and difficult deliberation to weigh up the pros and cons of each vaccine and 
VPD individually. In line with previous research,2,8,9,11-15,30-34 besides knowledge, 
attitudes, and deliberation, other factors were reported in relation to informed 
decision-making. For example, all participating parents mentioned their 
information needs about childhood vaccination in general and about vaccine 
safety, a need for a supportive social environment, and a strong social norm 
to vaccinate their children. While acceptors trusted the information provided, 
refusers and partial acceptors considered that there was a lack of open dialogue 
with CVPs, one-sided information provision about the NIP, and lack of trust in the 
CWC. While acceptors reported the severity and susceptibility about VPDs and 
anticipated regret about their child getting sick from a VPD when not vaccinating 
as factors related to decision-making, refusers and partial acceptors mentioned 
side-effects of vaccines. 
Acceptors could recall more evidence-based information about the NIP than 
refusers and partial acceptors; they were negative about refusing childhood 
vaccinations and positive about the NIP. Although previous research indicates that 
acceptors tend to be uninformed,17 and acceptors in our study felt uninformed, 
we found that they were able to provide more evidence-based information than 
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other parent groups. Acceptors strongly believed that childhood vaccination is 
an action that benefits not only their child (individual benefit), but also herd 
immunity (societal benefit) and they described a positive and strong social norm 
in place regarding this belief, which is confirmed by Brunson 17. This strong social 
norm was also perceived by refusers and partial acceptors, but they perceived this 
norm as judgmental.35 Overall, acceptors did not perceive uptake of childhood 
vaccinations as a choice which needs much deliberation because they considered 
it as self-evident, and this finding is confirmed by previous research.2,36
All participating parents mentioned inadequate information provision, stating 
that the mere response of ‘vaccines are safe’ is not satisfactory. Similar to refusers 
and partial acceptors, acceptors perceived this type of information provided 
by the CWC as condescending. This may also be why acceptors did not feel 
informed. Stimulating an open dialogue between parents and CVPs may increase 
parents’ feeling of being informed 30,35,37-39. The lack of discussion with CVPs, the 
perception that childhood vaccination is self-evident, and the patronizing tone of 
voice of CVPs may leave parents vulnerable for anti-vaccination messages about 
alleged risks and side-effects of childhood vaccination.30-34,39-41 As suggested by 
Benin, Wisler-Scher, Colson, Shapiro, Holmboe 37, attitudes towards childhood 
vaccination are continuously developing and shifting. Therefore, it is important 
to strengthen existing positive attitudes about childhood vaccination and 
build resistance for future anti-vaccination messages, as well as to discuss the 
arguments and anecdotal evidence used on anti-vaccination websites.42
Refusers may base their arguments against vaccination mainly on anecdotal 
evidence and were negative about childhood vaccinations in general. They 
indicated that they had consciously deliberated the pros, but mostly the cons 
of participating in the NIP, and some mentioned that they did not know about 
alternative vaccination schedules at the time of decision-making. Compared to 
acceptors, refusers may believe that the risks of vaccine side-effects are more 
severe than the risks of VPDs, and that they do not trust the information about the 
NIP offered by CVPs. Refusers mostly preferred to acquire anecdotal evidence 
from vaccine-critical websites and social media platforms, such as Facebook©. 
They reported searching and gathering information supporting anti-vaccination 
arguments.43,44 In addition, using search engines to gather information about 
childhood vaccination leads to selection bias due to previously used search 
terms and the ranking of websites by search engines.45
Partial acceptors may elaborately deliberate the pros and cons of each vaccine 
and VPD individually, which resulted in a feeling of decisional conflict regarding 
the benefits and risks of vaccines versus the perceived benefits and risks of 
experiencing VPDs. Some parents lost their trust in the competence of CVPs 
when their questions were ignored, or when the CVPs were not able to answer 
their questions. Because their questions remained unanswered, their decisional 
conflict increased.17,18 This feeling of decisional conflict may lead parents to 
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search for anti-vaccination arguments and diminishes the positive attitude of 
parents about childhood vaccination. In addition, partial acceptors described a 
lack of social support from friends, family, and CVPs with regard to their choice to 
partially accept childhood vaccinations. Research shows that decisional conflict 
and lack of discussion between parents and CVPs at the CWC influences the 
information seeking behavior of parents navigating anti-vaccination websites.39,41 
In an open discussion among CVPs and parents, inoculation messages about 
childhood vaccination can strengthen existing positive attitudes and build 
resistance for anti-vaccination messages.42 These messages are similar to a 
vaccination, parents could be trained to resist attacks on their positive beliefs 
about childhood vaccination by practicing their response to anti-vaccination 
messages.42 
Finally, many participants expressed the need for more information about 
childhood vaccination.30-34 This information need was not met by the CVPs. 
Refusers and partial acceptors mentioned that they accessed vaccine-critical 
websites because their questions are ignored by CVPs. Furthermore, they 
view the current information provision as insufficient, and they distrust the 
information provision about the NIP. All groups agree that the tone of voice of 
CVPs at the CWC is condescending. The inadequate information provision and 
condescending tone of voice do not meet the information needs of parents, 
and our research confirms findings from Benin, Wisler-Scher, Colson, Shapiro, 
Holmboe 37 indicating that this leads to a lack of trust among parents regarding 
CVPs and CWCs. Our results demonstrate that merely disseminating evidence-
based knowledge does not lead to a trusting relationship between parents and 
the CVP. Research found that some CVPs find it difficult to discuss alternative 
vaccination decisions with parents.46,47 CVPs need to have knowledge about 
the NIP, time, and skills to discuss childhood vaccinations with all parents 
37. In particular, it is important to not exclude parents refusing or partially 
accepting childhood vaccination. In this way, evidence-based information can 
be exchanged, misperceptions and doubts can be addressed, positive attitudes 
can be strengthened, questions can be answered, and the various options for 
childhood vaccination can be discussed. To increase factual knowledge about 
childhood vaccination and facilitate discussion skills among CVPs to build 
trusting relationships with parents, the Dutch public health institute developed 
an e-learning tool, and funds were made available by the government to reduce 
time constraints to discuss childhood vaccination with parents in 2017-2018.48 The 
e-learning tool was adopted by over one thousand CVPs in 2017.9 While further 
research and monitoring is needed to evaluate the implementation, adoption, 
and effectiveness of this tool, these changes and measures may stimulate an 
open dialogue, increase informed decision-making, reduce decisional conflict, 
and increase trust between parents and CVP professionals.10,48,49
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Application and further research 
To gain more insight into which factors played a role in informed decision-
making about childhood vaccination among acceptors, refusers, and partial 
acceptors, population surveys are necessary. The outcome of such quantification 
can be used to support informed decision-making on the part of parents about 
childhood vaccination.
Acceptors, refusers, and partial acceptors agree that the information provision 
is currently not sufficient. Refusers and partial acceptors would like more 
information on consequences of and susceptibility to VPDs and possible side-
effects of childhood vaccinations. Such information is a potential measure to 
counter anti-vaccination messages, and to increase informed decision-making 
about childhood vacations.3,11,37,44,50 Betsch, Renkewitz, Haase 43 showed that 
numeric information, in combination with narratives about the susceptibility 
to VPDs and side-effects of vaccines had the greatest impact on parents’ risk 
perception towards childhood vaccination. Further research is necessary to test 
how a combination of numeric risk communication and narratives can inform 
parents about the low level of individual susceptibility of VPDs, which may have 
severe consequences; and the greater individual susceptibility of side-effects 
after a childhood vaccination, which are mild, pass quickly, and have no lasting 
effects.3,34,38,39,41,43 The information on risk communication and narratives can be 
used in a communication approach of CVPs at the CWC to answer the questions 
of parents in detail and thus build a trustworthy relationship. In addition, our 
results show that while parents accepting childhood vaccinations are not 
interested in refusing or partially refusing childhood vaccinations, refusers and 
partial acceptors are highly interested in elaborate information about various 
vaccination options. Refusers appeared to be interested in hearing more about 
partially accepting childhood vaccination instead of refusing the NIP. Compared 
to refusing childhood vaccinations, there are more health benefits associated 
with partially accepting the NIP. Still, accepting all childhood vaccinations yields 
the most individual and public health benefits for children, so the possible 
adverse effects of informing parents – such as acceptors switching to refusers 
or partial acceptors – need to be prevented. Further research is necessary to 
investigate the individual and public health effect of informing parents about 
these options of childhood vaccinations. 
Strengths and limitations
This study explored whether parents make an informed decision, and factors 
related to the decision about childhood vaccination (e.g. accepting, refusing, or 
partially accepting), by examining parents’ knowledge, attitude, and deliberation, 
and additional factors concerning accepting, refusing, and partially accepting 
childhood vaccinations. There are several limitations in this study.22 Selection 
bias may have occurred. Respondents were asked to participate in a two-hour 
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discussion, which may have attracted individuals more inclined to talk about 
childhood vaccination. In addition, 96% of the persons in our sample were highly 
educated, and this percentage is not a reflection of the Dutch population. We 
drew a randomly selected sample within each municipality, but mainly higher 
educated parents responded to our invitation. We suggest that further research 
consciously includes other segments of the population, and that differences 
between low and higher educated parents should be investigated. Because 
of the overrepresentation of higher educated parents, and the explorative and 
qualitative nature of this study, the results are not able to be generalized to 
Dutch parents.29
We asked parents to consider their decision in retrospect, thereby possibly 
introducing recall bias. However, children were not older than two years old and 
the last vaccinations for which parents had made a decision was no later than ten 
months prior to the focus group sessions. Even though the moderator followed 
rigorous training for focus groups, interviewer bias may be a factor. There was 
one moderator to standardize a possible bias, and the moderator took measures 
to remain as neutral as possible in dress, tone, and body language. 
Conclusion 
To conclude, our exploration of informed decision-making and factors related 
to decision-making about childhood vaccination identifies distinct differences 
in knowledge, attitudes, and deliberation of parents. The findings can facilitate 
informed decision-making among parents by promoting an open dialogue at 
the CWC, and improving the type and form of information presented. An open 
dialogue between parents and CVPs may increase deliberation among parents, 
strengthen positive attitudes, prevent misperceptions, and resolve decisional 
conflict. 
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Every day we make decisions about our own health and the health of others, 
for example, when a parent makes a decision about childhood vaccination. 
When making health-related decisions, there can be different options to 
choose from. Public health professionals often inform the public about an 
option they recommend based on scientific evidence. However, this healthiest, 
recommended option might not be suitable for everyone, due to their personal 
values, priorities with regard to health, experiences, opinions, and the norms 
of their social environment. Consequently, in these cases people may choose 
options that match their individual values and goals but that are considered 
by public health professionals to be, for example, next to best. From a public 
health and scientific point of view, next to best health options are less harmful 
or less healthy than the unrecommended health option, but not less harmful 
or less healthy compared to the recommended health option. Another option 
people may choose is the unrecommended option, which is considered as being 
unhealthy by public health experts and science.
Not smoking, and accepting childhood vaccination are both choice options 
that are recommended by public health experts since they promote health.1-8 
Whether people consider that the advantages of these recommended choice 
options outweigh those of alternative choice options depends on their values, 
preferences, experiences, and social environment.9-16 In this thesis we explored 
two examples of decisions we identified as a next to best health decision: 
e-cigarette use and partially accepting childhood vaccinations. To expand our 
understanding of these next to best health decisions, we had two aims. First, 
we aimed to examine determinants that influence the decision about smoking 
behavior and childhood vaccination, both qualitatively and quantitatively. 
Second, we examined the extent to which decisions regarding smoking behavior 
and childhood vaccination adhere to the criteria of informed decision-making. 
With the insights into the factors related to the decision and whether the decisions 
adhered to the criteria of informed decision-making, we are able to better 
facilitate and support decision-making about smoking behavior and childhood 
vaccination. In this thesis, we used the three criteria knowledge, attitude, and 
deliberation of informed decision-making of van den Berg, Timmermans, ten 
Kate, van Vugt, van der Wal 17 to investigate how people made a decision about 
the recommended, unrecommended, and next to best health option. We defined 
a decision as being informed if the decision-maker has relevant evidence-based 
knowledge about the subject, has an attitude towards the subject that reflects 
his or her choice (i.e. the choice is value-consistent), and has deliberated all 
options.17-23 This definition of informed decision-making is based on a Rational 
Decision model, which reflects a rational style in decision-making with an 
emphasis on thorough and logical processing.24,25 It is important to investigate 
the criteria of informed decision-making because supporting informed decision-
making may reduce decisional conflict, and reducing decisional conflict may 
support decision-making.26-28 With regard to smoking behavior, increasing 
informed decision-making about smoking cessation and lowering decisional 
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conflict regarding smoking cessation may support smokers in their efforts to quit 
smoking.29 With regard to childhood vaccination, increasing informed decision-
making and decreasing decisional conflict may reduce vaccine hesitancy30-32 and 
it may positively affect intention to accept childhood vaccinations, and therefore 
also positively affect the vaccination coverage.33 According to the Elaboration 
Likelihood Model34, people can make a decision through two types of routes: 
the central route or the peripheral route.34 To make an informed decision, it is 
important that people use the central route of processing. Central processing 
could lead to decisions that are less vulnerable to unobjective information,35,36 
or decisional regret27 and result in a higher level of sticking to a healthy choice.34
With the studies described in this thesis, we aimed to increase our understanding 
of the next to best health decisions in order to improve health communication 
and support decision-making. Part 1 of this thesis provided an exploration of 
factors related to the decision about never-use, smoking, and e-cigarette use. 
Part 2 explored factors related to the decision about accepting, refusing, and 
partially accepting childhood vaccination, and decisional conflict experienced 
by parents with regard to their decision to accept, refuse, or partially accept 
childhood vaccinations. Part 3 operationalized the criteria of informed decision-
making 17 about smoking behavior and childhood vaccination. As such, it 
provides insights into the extent to which recommended, unrecommended, and 
next to best health decisions adhere to the criteria of an informed decision. 
To conclude this thesis, the current chapter summarizes the main findings and 
discusses the conclusions and implications of these findings for research, health 
communication, and policy.
Main findings
Part 1 Exploring the decision about never-use, smoking, and 
e-cigarette use
In part 1, we focused on determinants that are related to the decision regarding 
never-use, smoking, and e-cigarette use (first aim of this thesis). Our systematic 
narrative review of chapter 2 about reasons and perceptions regarding 
e-cigarettes among never-users, smokers, and e-cigarette users (i.e. both dual 
users of cigarettes and e-cigarettes, as well as exclusive e-cigarette users) 
showed that e-cigarette users perceived e-cigarettes as being less harmful than 
cigarettes. Different reasons and benefits were reported by never-users, smokers, 
dual users, and e-cigarette users. Reasons and benefits of e-cigarettes reported 
by never-users were the novelty of the product and its potential to aid their 
concentration. Smokers mentioned that it mimics the smoking routine, whereas 
dual users reported benefits of avoiding smoking restrictions. E-cigarette users 
reported benefits of increased athletic performance and that e-cigarettes are 
discrete to use. In addition to these reported individual benefits, several benefits 
were mentioned for the social environment of a user, such as that e-cigarette use 
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is safer for bystanders and that there is less environmental pollution.
Chapter 3 described – through qualitative analysis – determinants reported by 
never-users, smokers, and e-cigarette users in relation to the decision concerning 
smoking behavior and e-cigarette use. Besides knowledge, attitudes, and 
deliberation, these were perception of risks and benefits of e-cigarettes compared 
to cigarettes, influence of the social environment concerning e-cigarette use, 
and trust in information about the risks and benefits of e-cigarettes from the 
government. Additionally, we found that e-cigarette users used user experiences 
(i.e. a vape forum) as their main source of information about e-cigarette use and 
they reported that switching from cigarettes to e-cigarettes was a deliberate 
decision. Results from the qualitative exploration of chapter 3 also revealed that 
e-cigarette users, compared to never-users and smokers, reported anecdotal 
information found on e-cigarette users fora, perceived few risks of e-cigarettes 
compared to cigarettes, reported a sense of community and support with and 
by other users. Never-users and smokers perceived e-cigarettes as being less 
harmful than cigarette smoking, which we also found in our narrative literature 
review (chapter 2).
A limitation of many studies looking at determinants is that they do not take 
into account the attractiveness of e-cigarette product characteristics. However, 
e-liquid flavors were reported to be an important reason to use e-cigarettes in 
chapter 2. Hence, the role of product characteristics and, in particular, e-liquid 
flavors regarding e-cigarette use was explored in depth in chapter 4. Our 
results – from a quantitative analysis described in chapter 4 – demonstrated that 
menthol/mint and sweet e-liquid flavors were reported to be preferred by never-
users. Tobacco and menthol/mint e-liquid flavors were preferred by smokers 
and dual users, and sweet and fruit flavors were preferred by e-cigarette users 
compared to other flavor categories.
Finally, our exploration of differences – through quantitative analysis – between 
dual users and exclusive e-cigarette users in chapter 5 identified seven 
distinguishing features, namely: compared to exclusive e-cigarette users, dual 
users felt more connected with other smokers (i.e. their social ties with smokers 
were stronger), exclusive e-cigarette users smoked more in the past than dual 
users do in the present, self-efficacy to quit vaping and smoking was lower among 
dual users, e-cigarette users found the cigarette to be unattractive more often 
than dual users, e-cigarette users had more positive attitudes towards vaping 
than dual users, dual users perceived more barriers to accessing e-cigarettes, 
and finally, dual users had a higher intention to quit vaping than e-cigarette users.
Part 2 Exploring the decision about childhood vaccination
In part 2 we focused on factors related to the decision about accepting, refusing, 
and partially accepting childhood vaccinations (first aim of this thesis). Chapter 
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6 of this dissertation explored – through a qualitative study – the decision 
regarding childhood vaccination among parents who accepted, refused, and 
partially accepted childhood vaccination. Our findings demonstrated that partial 
acceptors mentioned perceiving few risks of vaccine-preventable diseases 
(VPDs), risks of side effects of vaccines, low social support from their environment, 
low trust in Child Welfare Centers (CWCs), and information provided from these 
CWCs.
Chapter 7 described the results of a quantitative analysis on determinants and 
decisional conflict related to decision-making among acceptors, refusers, and 
partial acceptors. Overall, trust in the National Immunization Program (NIP) was 
high among acceptors but moderate among refusers and partial acceptors. 
Acceptors perceived the susceptibility of side effects of vaccines as being lower 
compared to the susceptibility of VPDs if you refuse (some) vaccines. Refusers 
and partial acceptors perceived the susceptibility of side effects of vaccines as 
being higher compared to the VPDs. While anticipated regret towards negative 
consequences of VPDs was high among acceptors when considering refusing 
childhood vaccinations, anticipated regret among refusers and partial acceptors 
with regard to potential side effects for the child was high when considering 
accepting vaccines. All parents reported a social norm favoring accepting 
childhood vaccinations. Partial acceptors experienced more barriers with 
regard to vaccination than refusers and acceptors. On the decisional conflict 
scale, acceptors scored highest on uninformed, refusers scored highest on 
unsupported, and partial acceptors scored highest on uncertainty.
Part 3 Exploring knowledge, attitudes, and deliberation
In chapter 8 we examined to what extent decisions about smoking behavior 
and childhood vaccination adhere to the criteria of informed decision-making 
(second goal of this thesis). Our results showed that never-users and acceptors 
both had relatively low levels of deliberation. In addition, our findings indicate 
that cognitive beliefs of refusers and partial acceptors are not in accordance 
with scientific evidence about childhood vaccination. Partial acceptors scored 
in-between refusers and acceptors on knowledge, scores on attitudes, and 
deliberation with regard to accepting, refusing, and partially accepting 
childhood vaccination. In contrast, vaccine refusers had deliberated their 
decision thoroughly, smokers were found to report low levels of deliberation. 
Smokers and e-cigarette users were most positive about not smoking or using 
e-cigarettes, and acceptors, refusers, and partial acceptors were most positive 
towards their own behavior.
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Reflection on main findings
Exploring smoking behavior and childhood vaccination
This thesis is structured around the exploration of the next to best health 
decisions regarding smoking behavior and childhood vaccinations. To expand 
our understanding of these next to best health decisions, we first reflect on the 
criteria of informed decision-making, such as knowledge and cognitive beliefs, 
attitudes, and deliberation and the extent to which these decisions about smoking 
behavior and childhood vaccination adhered to the criteria of informed decision-
making. Second, we reflect on additional factors related to the decisions about 
smoking behavior and childhood vaccinations, such as perceived susceptibility 
and severity, trust in information, anticipated regret, social support, and self-
efficacy.
Knowledge and cognitive beliefs
This thesis indicates that those who opted for the recommended option (i.e. 
never-users and vaccine acceptors) had higher levels of knowledge about 
smoking behavior and childhood vaccinations, respectively, than those choosing 
unrecommended and next to best health options (e.g. smokers, e-cigarette use, 
vaccine refusers and partial acceptors). Other studies also found that never-
users and vaccine acceptors had high levels of knowledge about smoking and 
childhood vaccinations, respectively.5,37,38 With regard to the unrecommended 
option (i.e. smokers and vaccine refusers) and next to best choice (i.e. e-cigarette 
users and partial acceptors) option, our results demonstrated that although 
smokers and e-cigarette users, as well as refusers and partial acceptors, stated 
that they were familiar with the common health risks of smoking or refusing 
childhood vaccinations, respectively (chapters 3 – 8), the level of evidence-
based knowledge among those who chose the unrecommended and next to 
best health options was low. These findings are in line with studies reporting low 
levels of knowledge among smokers in the United States, 38,39 Canada, the United 
Kingdom, and Australia.39 In addition, findings from a previous study among 
vaccine refusers and partial acceptors also showed low levels of knowledge 
among these groups.5 To the best of our knowledge, no such previous findings 
with regard to low or high levels of knowledge about e-cigarettes could be 
identified among e-cigarette users.
Even though our results showed low levels of evidence-based knowledge 
among those choosing the unrecommended and next to best options, chapter 
3 and chapter 7 demonstrated that e-cigarette users, vaccine refusers, and 
partial acceptors felt very informed. Interestingly, no such findings could be 
identified in previous research. A possible explanation may be that e-cigarette 
users, vaccine refusers, and partial acceptors all reported extensively searching 
for information with regard to their decision. However, e-cigarette users, vaccine 
refusers, and partial acceptors – but not necessarily smokers – mainly shared 
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justifications based on information that was discordant with scientific consensus 
in our qualitative studies (chapters 3 and 6), and these findings were confirmed 
in our quantitative studies (chapter 8). This information may lead to or stimulate 
cognitive beliefs – found in chapters 3, 6, and 8 – that are not in accordance with 
scientific evidence, which has been reported in previous literature.40-42 In addition, 
their information-seeking behavior, such as using non-scientific sources rather 
than searching for scientific information, may confirm their cognitive beliefs or 
decision. Examples of such non-scientific sources could be user experiences, 
vaccine-critical websites, or social media9,43-50 where parents share experiences 
with childhood vaccinations.9,51-56 This phenomenon of looking for information to 
confirm a decision taken is also called bolstering: the reinforcement of a chosen 
option over the alternatives by selective information-seeking and processing. 
Janis and Mann57 have suggested that bolstering may facilitate arriving at a 
decision or occur after a decision has been made. In the latter case, refusers or 
partial acceptors, for example, would look for information that reinforces their 
chosen option over accepting vaccinations, and will therefore for instance use 
vaccine-critical websites.58 Among smokers specifically, an explanation for low 
levels of evidence-based knowledge might be found in the cognitive dissonance 
theory of Festinger 59. Their actions – smoking – may be in conflict with their 
scientifically correct knowledge about smoking behavior, causing cognitive 
dissonance.9,60 This conflict between their smoking behavior and their knowledge 
of the health risks of smoking may lead them to rely on cognitive beliefs that are 
in line with their behavior and decision, which might be why they answer the 
knowledge statements incorrectly.
Attitude
We identified attitudes about all three health options among those who chose 
for the recommended, unrecommended, and next to best health options. Those 
who opted for the recommended health option were most positive towards their 
own decision, and not outspokenly negative or positive towards the next to best 
health option. Those who opted for the next to best health decisions reported 
most positive attitudes towards their own behavior. In addition, e-cigarette 
users were not outspokenly negative or positive towards not smoking and not 
using e-cigarettes (i.e. never-use), but outspokenly negative towards smoking 
(chapters 3, 4 and 8). Partial acceptors on the other hand were not outspokenly 
negative or positive towards accepting or refusing childhood vaccinations 
(chapters 6, and 8). Although positive attitudes among partial acceptors towards 
accepting childhood vaccination have been identified before,5 to the best of 
our knowledge no such findings could be identified about attitudes towards the 
unrecommended or next to best health options. The not outspoken negative or 
positive attitudes towards accepting, refusing, and partially accepting childhood 
vaccinations among parents who partially accepted childhood vaccinations may 
indicate an ambivalence with regard to their decision.61 In addition, with regard 
to those who chose the unrecommended option, our findings suggest that while 
vaccine refusers were very positive towards their own choice – which is in line with 
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previous research5 – smokers were negative towards smoking. Previous research 
confirmed that smokers are often negative towards their own behavior,62 and 
findings of the ITC Netherlands National Report 63 revealed that Dutch smokers 
had a negative opinion about their own behavior. A possible explanation is 
cognitive dissonance related to smoking. In this case their knowledge about 
the health consequences of smoking is in conflict with their behavior, causing 
negative attitudes and dissonance.9,60
Deliberation
Deliberation about smoking behavior and childhood vaccination was highest 
among those who opted for the next to best health option. Research previously 
identified high levels of consideration among partial acceptors and e-cigarette 
users.5,64
With regard to the next to best health option, e-cigarette users consciously 
deliberated initiation of e-cigarette use versus continuation of cigarette smoking 
by using knowledge acquired and by weighing the benefits of e-cigarette use 
and disadvantages of cigarette smoking (chapters 3 and 8). Partial acceptors 
deliberated accepting, refusing, and partially accepting childhood vaccinations 
(chapter 8). Our findings from chapters 6, 7, and 8 suggest that partial acceptors 
made a decision about each vaccine offered to them separately, and not an 
overall decision to partially accept childhood vaccinations. They – as well as 
vaccine refusers – described an elaborate, time-consuming, and complex 
deliberation process (chapter 6).
With regard to the recommended health option, never-users and vaccine 
acceptors reported giving their decision little thought. Vaccine acceptors specified 
this was not perceived as negative because they viewed their decision about 
childhood vaccination as self-evident. Since the current vaccination coverage is 
high (90%), but is decreasing65, it could be argued that low levels of deliberation 
among parents accepting all the childhood vaccination is not a problem.65 
However, parents who are not making a deliberate decision might be vulnerable 
for negative messages about their decision, 9 and it is therefore important that 
they understand why they decided for the recommended option and deliberate 
this decision in order to build resilience.66 Deliberation about e-cigarette use 
was relatively low among smokers compared to levels of deliberation about 
childhood vaccinations among refusers. A possible explanation of low levels of 
deliberation among smokers about a less harmful alternative may be provided 
by their nicotine addiction, which may make it difficult for them to consider an 
alternative to smoking.67-69
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Exploring informed decision-making
This thesis described the differences and similarities found in knowledge, 
attitude, and deliberation. Overall, those who opted for the recommended 
health option lacked deliberation about their decision. Those who opted for the 
unrecommended or next to best health options had low levels of knowledge. 
In addition, smokers did not deliberate much and were relatively negative with 
regard to their own behavior. With regard to the second goal of this thesis, the 
findings of chapters 2 – 6, and 8 show that in our studies, the decisions about 
smoking behavior and childhood vaccination did not adhere to at least one of 
the criteria of the definition of an informed decision. Although similarities were 
found in the three criteria of informed decision-making for the recommended, 
unrecommended, and next to best health options, there are differences in the 
context of these exemplary cases.
With regard to the two different contexts in which these decisions are made, 
several aspects could be considered. Smoking is an addictive behavior, which 
may make it difficult to make an informed decision about smoking cessation or 
switching to e-cigarettes.67-69 In our studies too, smokers lacked evidence-based 
knowledge, had relatively negative attitudes towards their own behavior, had 
relatively low levels of deliberation regarding smoking, e-cigarette use, or not 
smoking or using e-cigarettes. Vaccination decisions were not characterized by 
addictive features. Another possible explanation of the lack of commonalities 
in these unrecommended decisions may be that smokers are confronted with 
the health consequences of smoking by health warnings, pictorial warnings, or 
stories about sick smokers on a daily basis, for example, when they buy a pack of 
cigarettes.70-73 Vaccine refusers, compared to smokers, are not often confronted 
with the possible health consequences of their decision about childhood 
vaccination due to the herd immunity realized by the high vaccination coverage. 
Furthermore, parents are invited to actively make a decision about childhood 
vaccination for their child through a letter of invitation and an information 
brochure.74,75 Although there is no invitation for never-users to actively decide 
about not initiating cigarettes or e-cigarettes, never-users and vaccine acceptors 
both had high levels of evidence-based knowledge, positive attitudes towards 
their own decision, and low levels of deliberation. The findings of our thesis 
suggest that although there is no invitation for never-users to deliberate their 
decision, similar factors, such as high levels of evidence-based knowledge, trust 
in evidence-based information, positive attitudes towards the recommended 
option, perceptions of high susceptibility and severity of consequences of the 
unrecommended and next to best health options, and positive social norms about 
the recommended options play a role in the decision about the recommended 
health option in general. Both never-users and vaccine acceptors might be 
vulnerable for negative messages about their decision,9 and it is therefore 
important that they understand why they decided on the recommended option 
and deliberate this decision in order to build resilience.66 The following section 
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describes additional factors that may be related to informed decision-making. 
Additional factors related to decision-making about smoking 
behavior and childhood vaccination
Perceived susceptibility and severity
Our findings and previous research6,76 suggest that for those who opted for the 
unrecommended or next to best health options, perceived susceptibility and 
severity were reported to be in relation to their decisions (chapters 2 – 7), which 
is in line with previous research about the unrecommended option.43,44,46,66,76-119 
With regard to the next to best health options, our findings suggest that partial 
acceptors, similar to vaccine refusers, do not perceive the susceptibility and 
severity of VPDs as being as high as the susceptibility and severity of side effects 
of vaccines. Previous studies have shown that the greater perceived susceptibility 
and severity of possible side effects versus the lower perceived susceptibility 
and severity of VPDs influenced decisions about accepting or refusing childhood 
vaccination.66,77-87 The perceived susceptibility and severity of side effects of 
vaccines and VPDs if a parent had partially accepted vaccines was not previously 
investigated. A possible explanation for the perceived higher risks of side effects 
versus the risks of a VPD among vaccine refusers and partial acceptors might 
be the cognitive beliefs of vaccine refusers and partial acceptors.51,120-122 For 
example, cognitive beliefs with regard to long-term side effects of vaccines, a 
belief that vaccines are no longer necessary because VPDs no longer occur in 
the Netherlands, or about the ineffectiveness of vaccines (chapter 8) may explain 
why some parents perceive the severity of side effects of vaccines to be greater. 
Additionally, a possible explanation for a moderate perceived severity of VPDs 
might be that partial acceptors – and to some extent refusers – perceive some 
VPDs as childhood diseases that are essential for the development of their 
child.85 Another explanation might be that parents see children experience the 
mild side effects of a vaccine more often than the severe consequences of a VPD 
and therefore, they perceive the susceptibility and severity as greater.
With regard to e-cigarette use as a next to best decision compared to smoking 
cessation or not initiating cigarettes or e-cigarettes, our results demonstrated 
that e-cigarette users perceived fewer risks of e-cigarettes than never-users and 
smokers (chapters 2, 3, and 4), which was also found in other research.43,44,46,88-111 
An explanation of this low perception of harm of e-cigarettes among e-cigarette 
users may be due to the use of e-cigarettes itself. For example, e-cigarette users 
expected (before initiation) and experienced (after continuation of use) health 
benefits from e-cigarette use. It is possible that positive outcome expectancies 
and experiences lead to a low perception of harm.43,90,94,105,123-126 In addition, 
we found that while never-users and e-cigarette users reported the health 
risks associated with smoking as important (chapters 2 and 3), smokers are 
unrealistically optimistic about their own susceptibility to bad outcomes, which 
was supported by previous findings.67,127-129 This optimism bias may explain why 
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these smokers did not (yet) switch to a less harmful alternative.
Trust in information
Trust in information about smoking behavior (in general) and childhood 
vaccination (i.e. information brochure 74,75) provided by public health experts was 
higher among never-users and vaccine acceptors than among those who chose 
for the unrecommended or next to best health option (chapters 3, 4, 6, and 7), 
which was also found in previous studies on both subjects.51,120,130-132
With regard to vaccine acceptors, in previous research trust was shown to 
be one of the decisive factors in the decision regarding accepting childhood 
vaccinations.51,86,121,133 In our studies, acceptors reported trusting the NIP and 
the information about the NIP (chapters 6 and 7), and this trust in information 
may explain why acceptors scored higher on evidence-based knowledge 
about childhood vaccination. A possible explanation for their trust in the NIP 
may be that because the NIP was developed by the government, it engenders 
an inherent sense of trust.134 Additionally, parents who accepted vaccines 
perceived childhood vaccination as being self-evident (chapter 6). According 
to previous research, it may be that because acceptors trust the NIP and the 
information about the NIP, they do not think this information needs much further 
deliberation51,86,121,133 which may in part explain why they scored high on feeling 
uninformed about childhood vaccination (chapter 7).79,81,135,136 However, they 
reported having made a conscious decision to accept all childhood vaccinations 
(chapters 6 and 8). It seems that because acceptors trust the NIP, in their opinion 
trust is the reason that they feel they made a conscious decision.51,66,87,120-122 The 
lower levels of trust found among refusers and partial acceptors versus acceptors 
may be related to scoring high on not feeling supported (chapter 7) in decision-
making about childhood vaccinations.78,85,137 This may be because Child Vaccine 
Providers (CVPs) were reported to not have enough time or knowledge to answer 
questions (chapter 7), which was also identified in previous research51,120,130,131, or 
because the tone of voice of the information provided by the government was 
perceived as condescending and untrustworthy (chapter 7).85,138-140
With regard to decisions about smoking behavior, we found that never-users, 
smokers, and e-cigarette users trusted information about smoking from the 
government or public health experts (chapter 3), which was in line with previous 
research.132 Possibly this is because the health risks of smoking were regarded 
as common knowledge and the information about consequences of smoking 
are widespread due to health warnings and pictorial warnings.70-73 E-cigarette 
users however distrusted information provided by public health experts about 
e-cigarettes; to the best of our knowledge, this was not investigated before. A 
possible explanation might be bolstering, which was explained above.
Anticipated regret
The role of anticipated regret in healthy behavior, such as exercising, 
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practicing safe sex, eating healthily, and not using drugs, has previously been 
documented.66,79,81,135,136,141-146 Anticipated regret seemed to be an important factor 
related to the decision about childhood vaccination, but was not mentioned in 
the qualitative study (chapter 3) in relation to decisions about smoking behavior. 
Therefore, measures of anticipated regret were not included in our questionnaire 
about smoking behavior.
Vaccine acceptors mentioned anticipated regret with regard to their child 
experiencing a VPD if they were to refuse vaccines for their child as an important 
consideration in their decision to accept childhood vaccinations (chapter 6). 
With regard to the next to best option, partial acceptors reported high levels 
of anticipated regret if they were to accept all childhood vaccinations and their 
child were to experience side effects due to a vaccine (chapter 7), and high 
levels of anticipated regret if they were to refuse all childhood vaccinations and 
their child were to experience a VPD. For some vaccines, partial acceptors may 
experience anticipated regret with regard to accepting this vaccine because 
they may consider the side effects of a vaccine to be more serious than their 
child experiencing a VPD. In the case of other vaccines, partial acceptors may 
experience anticipated regret if they were to refuse these vaccines because 
sometimes the side effects of the vaccine were not considered to be more 
serious than their child experiencing the disease.66,147 This assessment of the 
anticipated regret of regarding vaccines and VPDs may be made for each vaccine 
of the Dutch NIP, separately. In addition, possible anthroposophical convictions, 
such as a conviction that some VPDs are childhood diseases or some VPDs aid 
the development of child may also influence anticipated regret.56,66,85,86 This 
experienced anticipated regret in combination with perceived susceptibility and 
severity may explain why partial acceptors refuse some vaccines and accept 
others.85
Social norms
For both smoking behavior and childhood vaccinations, this thesis revealed 
strong social norms in place with regard to not smoking and not using 
e-cigarettes, and accepting childhood vaccination, which have been identified 
previously.43,47,66,78,129,148-160 E-cigarette users, partial acceptors, and refusers 
specifically reported not feeling supported in their decision because they felt 
criticized by this strong positive social norm regarding accepting childhood 
vaccinations and not smoking or using e-cigarettes (chapters 3, 6 and 7), which 
was also found in studies conducted in the US.52,53,87,152
With regard to the next to best health options, e-cigarette users noted the 
importance of social support with regard to e-cigarette use (chapters 3 and 
5). They described a sense of community among e-cigarette users, similar to 
for instance the sense of belongingness described by bikers (chapter 3). The 
importance of support when switching from cigarettes to e-cigarettes was also 
previously reported by e-cigarette users.148,150,161 Additionally, partial acceptors 
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reported not feeling supported by their social environment or CVPs (chapters 6 
and 7). One of the reasons they did not feel supported in their decision about 
childhood vaccination were barriers experienced, such as believing that the staff 
at the CWC did not acknowledge their questions about vaccinations (chapters 
6 and 7). 
Self-efficacy
While practical barriers, such as conveniently located CWCs,87 were previously 
found to be important in decision-making concerning childhood vaccination,162 
our results indicate that parents perceived no practical barriers with regard to 
making an appointment at the CWC or the accessibility of a CWC (chapter 7). 
This might be because the NIP of the Netherlands is well organized.32,66,163 Partial 
acceptors did report difficulty when sorting through the information with regard 
to an alternative vaccination schedule. With regard to smoking behavior, research 
has shown that self-efficacy is an important factor in this decision.148,149,164 Schoren, 
Hummel and de Vries148 showed that e-cigarette users were most confident in 
their ability to not use e-cigarettes in particular situations compared to smokers 
and dual users, which was confirmed by the findings of our study described in 
chapter 5. Chapter 5 showed that dual users were less confident in their ability 
to not use e-cigarettes or not smoke compared to e-cigarette users.
E-cigarette product characteristics
This thesis demonstrated that product characteristics seem to be important 
in the decision about e-cigarette use. Product characteristics of e-cigarettes 
were mentioned by never-users, smokers, dual users, and e-cigarette users as 
reasons to use e-cigarettes, and several characteristics, such as the availability 
of many e-liquid flavors, were mentioned as benefits (chapters 2 and 3). Indeed, 
the variety of flavor 43,90,91,93,95,97,100,103,165-167 and the ability to alter technical 
specifications90,119,168 were previously found to be reasons for e-cigarette use. 
The attractiveness of several product characteristics was investigated in this 
thesis, and we found that all types of users (i.e. never-users, smokers, dual users, 
and exclusive e-cigarette users) found the availability of different e-liquid flavors 
to be the most attractive feature of e-cigarettes (chapter 4).
While concerns have been raised about potential initiation of e-cigarette use 
among never-users,169-171 the never-users in our study had a low intention to start 
vaping and more than two-thirds (68%) of the never-users did not want to try any 
e-liquid flavor. Our findings suggest that although never-users found e-liquid 
flavors to be the most attractive aspect of e-cigarettes, attractiveness may not 
translate into an intention to try e-cigarettes among the never-users. Furthermore, 
two-thirds of the smokers reported interest in an e-liquid flavor other than tobacco. 
This may indicate that e-liquid flavors could support the decision of smokers to 
switch to vaping,172 for example by allowing the marketing of e-liquid flavors and 
other product characteristics that smokers find attractive.173 Different patterns of 
e-liquid flavors used by dual users and exclusive vapers were found. In line with 
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previous research,91,174-178 both dual users and exclusive e-cigarette users mostly 
used tobacco- and mint-flavored e-cigarettes at initiation, but exclusive vapers 
currently used more fruit and sweet e-liquid flavors than dual users. This could 
be interpreted as vapers switching from tobacco to non-tobacco flavors over 
time, which is supported by a previous study.178 Because most adult exclusive 
vapers included in this study had been using e-cigarettes for one to five years, 
and most dual users reported vaping for only less than six months (appendix 7), 
it is possible that the dual users may switch to fruit or sweet e-liquid flavors in 
the future. The role of e-liquid flavors in supporting both the decision to switch 
towards e-cigarette use (for smokers) and to refrain from using e-cigarettes (for 
never-users) demonstrates the complexity of developing future regulations on 
e-liquid flavors.
Methodological considerations
To explore the decisions regarding smoking behavior and childhood vaccination, 
both qualitative and quantitative methods were used to provide a broad overview 
of factors that are important in these decisions. Additionally, this thesis was the 
first to compare findings of factors important in smoking behavior and childhood 
vaccination, and to discuss similarities and differences. Several methodological 
considerations were discussed in the individual chapters of this thesis. Here we 
will discuss the most important considerations, such as a lack of guidelines on 
what sufficient knowledge and deliberation means, what an informed decision 
actually is, response bias, and definitions of smokers and e-cigarette users.
With regard to how we measure knowledge, no consensus could be found 
in literature of informed decision-making with regard to a definition of 
knowledge.42,134 In this thesis, knowledge42 was defined as an evidence-based 
and justified belief based on scientific consensus and information.5,75,160,179-181 
Knowledge was assessed by asking whether a statement was considered ‘true’, 
‘false’, or ‘I don’t know’ and categorized according to the definition of informed 
decision-making17 into sufficient (i.e. correct answers) and insufficient (i.e. 
incorrect and ‘I don’t know’  answers) using Abbott’s blind guessing formula. 
Cognitive beliefs were also investigated. These beliefs were defined as a mental 
representation, or a conviction that something is true,182 and assessed by asking 
whether someone completely disagreed or agreed with a statement. If one’s 
beliefs were in accordance with what experts consider to be true, the belief 
is equivalent to knowledge.134 According to previous research, people make a 
decision based on what they believe to be true – and not necessarily evidence-
based knowledge – so it is not surprising that people answered the knowledge 
statements in accordance with what they believe.183-185 In addition, answering a 
question with ‘I don’t know’ does not equal ‘false’, and thus the categorization of 
sufficient and insufficient knowledge does not cover whether people are aware 
what is true according to scientific evidence. Consequently, using the current 
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definitions of informed decision-making17 it remains unclear whether people 
know what is correct according to scientific evidence, whether people are not 
aware of what is true according to scientific evidence, or whether they do not 
believe the scientific evidence. Hence, to gain more insight into these aspects, 
it may be relevant to combine awareness of what is true according to scientific 
evidence (i.e. knowledge) and relevant cognitive beliefs. The combination of 
two such measures would increase our understanding of which information 
participants use to make a decision, whether participants are informed but 
do not believe the information – which means providing them with scientific 
information will not increase their knowledge186-195 – or whether they are actually 
not informed or misinformed, which means they need additional information.42
With regard to knowledge, it is unclear when a decision is based on sufficient 
information as there are no guidelines on what people would need to know to 
qualify as sufficiently informed.17,42 While the definition of informed decision-
making is very rigid and strict, it is not based on uniform standards of knowledge. 
A similar case could be made for levels of deliberation. In accordance with the 
definition of informed decision-making of van den Berg, Timmermans, ten Kate, 
van Vugt, van der Wal 17, we used the midpoint of the scale to determine whether 
levels of deliberation were high or low. However, similar to knowledge, there 
are no guidelines on when a decision-maker deliberated a decision sufficiently. 
Moreover, according to the decision-maker, these levels of sufficient knowledge 
or deliberation may vary according to the subject, and the decision-maker may 
therefore favor a different decision style for each decision.134,196 Additionally, 
in the case of value-consistency in decision-making, attitudes are often used 
as a proxy for values in current studies but it is unclear whether attitudes are 
informative enough to be used as a proxy of values related to decision-making.197 
Research is needed to investigate what people exactly would need to know (i.e. 
in terms of content), how much information people need (i.e. sufficient versus 
insufficient), how to measure knowledge, to what extent they need to deliberate 
to make a decision, or what makes the decision value-consistent. Research is also 
needed on how to balance the amount of information to make a decision and 
the information that is deemed relevant and necessary by the public in making a 
decision about smoking behavior and childhood vaccination.
Moreover, it is important to reflect further on the nature of what an informed 
decision is, as some questions have yet to be answered. Most definitions of 
informed decision-making suggest that individuals need to be informed and 
that the decision should reflect the decision-makers’ values.18-22,27,198-202 The 
conceptualization of informed decision-making that we used is based on the 
definition of van den Berg et al.17 since they have added the process of deliberation 
of different choice options. Furthermore, these definitions dichotomize the 
decisions into informed or uninformed.17-22,27,198-202 However, previous research 
debated whether it is wise to dichotomize the decisions into an informed versus 
uninformed decision as this results in a crude distinction that does not reflect 
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the variety in the levels of informed and uninformed decisions.17,134,203 This was 
one of the reasons that we did not dichotomize the decisions into informed or 
uninformed but investigated whether the decisions about smoking behavior and 
childhood vaccination adhered to one or more of the criteria of the definition 
of informed decision-making. Further research is needed to identify whether 
informed decision-making could also be regarded as a scale on which people can 
score differently. Second, should knowledge, value consistency, and deliberation 
all be equally important for defining and operationalizing informed decision-
making? It is unclear whether these three criteria constitute the criteria or factors 
that make a decision informed, and if all three are necessary for a decision to 
be informed. Research is needed to investigate if other determinants may be 
important in supporting decision-making, which may depend on the type of 
decision and on the style of the decision-maker. In addition, deliberation could 
be considered to entail a process of considering and thinking about a variety of 
factors, including perceived susceptibility and severity, trust, anticipated regret, 
social support, and self-efficacy; the importance of these factors may differ per 
decision, situation, and person. Consequently, given this unclarity, it also remains 
unclear how to best facilitate informed decision-making, and more research is 
needed to explore this complex process.
Moreover, by asking respondents to consider their decision in retrospect, we 
may have introduced response bias. It is likely that scores on factors important 
in the decisions about smoking behavior and childhood vaccination at the time 
of conducting this study do not fully reflect the scores of the factors at the time 
of decision-making, opening up the possibility of cognitive dissonance.59,204,205 
Asking participants to consider a decision that has not yet been made was not 
possible in our studies because we wanted to compare the factors that played a 
role in the decisions for the recommended, unrecommended, and next to best 
decisions. These categories were made based on the behavior of participants, 
and thus we needed to wait until participants performed the behavior to make a 
categorization. Further research is needed to explore if scores or the importance 
of determinants of decision-making change during the decision-making process. 
For example, by setting up a cohort of soon-to-be parents to follow these parents 
through time and vaccination decisions.
With regard to the definitions of never-users, smokers, and e-cigarette users, 
there was no consensus in the literature about these definitions. The decision 
to not smoke or vape, to initiate smoking, start dual using cigarettes and 
e-cigarettes, or switching to e-cigarette use is dynamic, as people may change 
products over time, which means that different transitory phases can be 
determined. Our current studies were all cross-sectional, which is why we only 
offer a snapshot of the types of users and frequency of use among never-users, 
smokers, and e-cigarette users (i.e. both dual users of cigarettes and e-cigarettes, 
and exclusive e-cigarette users). Further research is needed to investigate 
how to best present the dynamic behaviors of never-use, smoking, dual use, 
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and e-cigarette use in static definitions of use. Such research could build on 
the International Tobacco Control surveys,206,207 which use standardized survey 
measures to enable cross-country comparisons,207 so that the transitory phases 
of never-use, exclusive smoking, concurrent use of cigarettes and e-cigarettes, 
and exclusive e-cigarette use can be followed to investigate possible differences 
in tobacco product and e-cigarette use. Subsequently, a Delphi study – with 
experts in the field of e-cigarette use – could be asked to define characteristics 
of never-users, smokers, and e-cigarette users.208 These types of studies could 
be used to further specify definition of use, such as the classification system 
offered by Borland, Murray, Gravely, et al. 209, and to identify additional features 
to distinguish exclusive smokers, dual users, and exclusive e-cigarette users.
Recommendations for further research, health 
communication, and policy
Based on the research presented in this thesis, several recommendations for 
further research, health communication and policy can be identified.
Recommendations for further research
Various recommendations for further research were discussed in the individual 
chapters of this thesis. Here we will highlight the need for research with regard 
to the next to best health option.
Next to best health options
In the Netherlands, the RIVM is responsible for providing the public with 
information about smoking behavior and childhood vaccination, for example 
through an information brochure and a website.74,75,180,181,210 Although not smoking 
or using e-cigarettes and accepting childhood vaccinations can be considered 
as most beneficial for public health,211-215 e-cigarette use or partially accepting 
childhood vaccination has potential individual and public health benefits 
compared to smoking or refusing all vaccines.2,3,7,8,122,211,216-221 However, in itself, 
e-cigarette use and partially accepting childhood vaccinations are not beneficial 
for individual health nor without risks.214,222,223 Consequently, these options are not 
recommended from a public health perspective. People search for information 
that reinforces their chosen option or may facilitate arriving at the desired 
decision,57,58 and thus, it is important to provide evidence-based information 
about all options. Based on our results, we would recommend further research to 
investigate the effects of communicating about the recommended health options 
(e.g. not smoking or using e-cigarettes and accepting childhood vaccinations), 
the unrecommended option (e.g. smoking or refusing childhood vaccinations), 
and the next to best health options (e.g. e-cigarette use and partially accepting 
childhood vaccination). Such research – focused on for example childhood 
vaccination – could consist of testing the effect, appreciation, and acceptance 
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of providing information on the recommended, unrecommended, and next 
to best health options on decision-making and intention to accept childhood 
vaccination in comparison to standard information (i.e. the information currently 
provided by RIVM). These insights into the effects of communicating about the 
recommended, unrecommended, and next to best health options could aid 
public health experts in determining the goals of health communication and the 
communication needs of the public.
Recommendations for health communication
Building on the recommendation to investigate the effects of communicating 
about the recommended health options, the unrecommended option, and the 
next to best health options, specific suggestions can be provided with regard 
to the communication techniques relevant to achieve the different goals. 
With regard to communicating about recommended and other options, it is 
important to articulate clearly which particular goals public health experts want 
to achieve. They may consider it their goal to provide scientific information 
without providing advice or decisional support. Another goal may be to facilitate 
informed decision-making even though the consequence of this may be that 
more people will choose for the unrecommended or next to best option rather 
than the recommended option, thereby increasing public health risks. An 
alternative goal may be to make sure that as many people as possible choose the 
recommended health option to increase public health gain. With the latter aim, 
several motivational techniques can be applied to steer the public in the desired 
and recommended direction.224,225 Rigorous testing of possible decisional effects 
of providing information on all options will allow public health experts and 
policy-makers to make an informed decision on possible adaptation of current 
communication efforts. The following section describes several techniques that 
can be used to support informed decision-making and techniques that may be 
used to promote uptake of the recommended health option. Here, we will focus 
on knowledge and cognitive beliefs, attitude, and deliberation.
Knowledge, attitude, and deliberations
Chapters 3 – 8 suggested that evidence-based knowledge about smoking 
behavior and childhood vaccination was low among those who opted for the 
unrecommended or next to best health options, that people have positive 
attitudes towards their own decision, indicating a high level of value consistency, 
and that those who opted for the recommended health option generally 
displayed low levels of deliberation.
A goal of health communication may be to provide scientific information without 
providing advice or decisional support. In order to do so, several channels could 
be used, such as circulating the information brochures about the NIP.225 In addition, 
websites could be used to provide information with more detail but layered in 
order to provide the extent of information desired by the audience.9,225-229. Such 
Chapter 9212
techniques facilitate the sharing of scientific information.
Another goal of health communication may be to facilitate informed decision-
making. Several techniques could be used. One example could be the provision 
of an online decision aid to support informing decision-makers, reflecting on 
values that are important for the decision-maker, and stimulating the deliberation 
of choice options and information.29,136,230-235 In health decisions, decision aids 
proved successful in increasing knowledge compared to usual care, to improve 
judgements of the perceived susceptibility and severity that are in accordance 
with scientific evidence; they were also effective in choosing a health option 
that was in accordance with the decision-makers’ values, indicating a high 
level of value consistency, and were effective in reducing scores of decisional 
conflict to levels that indicate informed decisions.234 To increase knowledge, it is 
important to provide risk information in a combination of numeric and narrative 
risk information and to incorporate the beliefs and values of the decision-
maker.13,203,236-238 An example of an evidence-based technique to increase 
knowledge is elaboration of information.225 Elaboration stimulates the decision-
maker to add meaning to the information that is processed, it consists of easy 
and understandable information, with direct instruction to accomplish the goal 
of the decision-maker.34,225,239 For example, smokers could be triggered about 
the negative health effects of smoking by being provided with messages that are 
personally relevant, such as explaining short-term instead of long-term health 
consequences. To further support informed decision-making, it is important to 
support decision-makers to clarify values and attitudes with regard to the health 
options. An example of such a technique is counseling.225 During counseling, 
examples of different choices and why people make these choices are provided, 
including scenarios or testimonials to describe the choice options. Decision-
makers are encouraged to prioritize values that are important to them or are 
offered different features of health options with personal balance scales.240 A 
technique to support deliberation about all health options could be providing 
guidance in deliberating and considering the health options available to 
decision-makers.241-243 This can be provided in a decision aid 15,135,136,233,244-246 for 
example, by providing an option for decision-makers to make a list of advantages 
or disadvantages, risks, benefits, goals, and values ranked in order of what is 
important to them.241,242 about all options.
A goal of health communication could also be to make sure that as many 
people as possible choose the recommended health option to increase public 
health gain. An example of motivational techniques to increase knowledge 
to promote the recommended health option among those who chose for 
the unrecommended option and the next to best health option is persuasive 
communication in the form of narratives. This can be used to make sure the 
perception of susceptibility and severity of decision-makers is in line with 
scientific evidence. Due to identification with the characters in a narrative and 
the vividness of the risk information described, imaginability of the health threats 
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of the unrecommended health option is expected to increase, which in turn 
increases the likelihood of taking protective action. For example, in the case 
of childhood vaccination, the RIVM may use narratives to explain scientifically 
proven consequences of VPDs and vaccine side effects.6,12,75,180,247 These narratives 
may influence a parent to decide to accept childhood vaccinations, or they may 
potentially counter anti-vaccination messages and weaken negative beliefs 
because it easier to recall and understand the information about risks compared 
with providing scientific information.6,10,13,25,51,55,248,249 In addition, narratives are 
known to reduce defensive reacting or counterarguing to health messages.250,251 
Consequently, it may prove useful to use a more contextualized approach to 
inform parents who have persistent cognitive beliefs not in accordance with 
scientific evidence about evidence-based information. One technique that 
could be used is attitude inoculation.252 Attitude inoculation messages work 
very similarly to a vaccination; decision-makers are trained to resist attacks on 
their positive attitudes towards the recommended health option by practicing 
their response to positive messages to the unrecommended or next to best 
health option.252 In a decision-aid, inoculation messages could be used to 
strengthen existing positive attitudes, weaken attitudes that are positive towards 
unrecommended health options, and build resistance for marketing of tobacco 
and e-cigarettes and anti-vaccination messages, respectively.172,252-255 Another 
strategy could be motivational interviewing.225,256 Motivational interviewing 
pertains to an approach to enhance the internal motivation to switch to the 
recommended health option of a decision-maker based on their own arguments 
for change,225,256 and has previously been shown to be effective in changing 
vaccine hesitancy in Canada by increasing deliberation about the decision to 
accept childhood vaccinations.225,257
Considerations for policy-makers
With regard to policy, we can offer some recommendations concerning an 
informed public and the regulation of e-cigarettes.
Informed decision-making
If policy-makers want to foster informed choices among the public concerning 
health options, our research and research by others indicates that it is important to 
identify the best conditions for facilitating such rational and informed decisions. 
Most definitions of informed decision-making suggest that individuals need to be 
informed and that the decision should reflect the decision-makers’ values, and are 
based on a rational decision model.18-22,27,198-202 These definitions dichotomize the 
decisions into rational and informed or irrational and uninformed.17-22,27,198-202 Our 
results suggest that most participants may not have made optimal, rational, and 
informed decisions about smoking behavior or childhood vaccinations according 
to the criteria of informed decision-making. On the one hand, it could be that 
these three criteria are not absolute in explaining informed decision-making. 
On the other hand, the results may imply that public health policies are needed 
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to foster the identification of factors that facilitate informed decision-making 
among the general public, and to safeguard the public against factors that may 
hinder informed decision-making.194,258 In addition, it may not be preferable for 
the public to make rational and informed decisions in every case because it is 
cognitively tiring. Reconsideration and reorientation may be needed about what 
informed decisions are, which factors foster informed decision-making and which 
factors hinder it, and what or whether informed decision-making is desired.
E-cigarette product characteristics
The regulation of e-cigarettes in order to optimize public health benefits is 
challenging. Compared to cigarette smoking, e-cigarette use may reduce harm 
among smokers,259-262 but due to their toxic ingredients it is not a harmless 
product.259,263 In addition, concerns have been raised that e-cigarette use may 
contribute to nicotine addiction and the renormalization of cigarette smoking 
in adolescent never-smokers.171,264-267 Consequently, from a public health 
perspective, the initiation of vaping by current non- and never-smokers and, 
thereby, exposure to potentially toxic ingredients should be prevented.267 Our 
findings showed that product characteristics may be an attractive aspect of 
e-cigarettes. However, the relation between product characteristics on the one 
hand, and how this may influence positive attitudes and an intention to start or 
switch to e-cigarettes on the other hand, remains unclear. The findings of chapter 
4 indicate that e-liquid flavors are an attractive aspect of e-cigarettes for never-
users, smokers, and e-cigarette users. Therefore, more research is needed to 
investigate the relation between e-cigarette product characteristics, and attitude 
and intention concerning the next to best health option (i.e. e-cigarette use). 
Moreover, as e-cigarettes are marketed as an alternative to smoking, cessation 
research needs to monitor potential long-term side effects and when they occur, 
and whether usage of e-cigarettes are a real viable alternative for smoking 
cessation for certain groups.
General Discussion 215
9
References
1. Acheson D. Public health in England: the report of the Committee of Inquiry into 
the Future Development of the Public Health Function. London: The Stationery 
Office;1988.
2. World Health Organization. WHO REPORT ON THE GLOBAL TOBACCO 
EPIDEMIC, 2015. Geneva: World Health Organization;2015.
3. World Health Organization. Tobacco. Factsheet 2017. http://www.who.int/
mediacentre/factsheets/fs339/en/. Accessed November 30, 2018, 2018.
4. E.A. van Lier, P.J. Oomen, H. Giesbers, et al. Vaccine Coverage of NIP in 
the Netherlands. Bilthoven: National Instituut of Public Health and the 
Environment;2016.
5. Lehmann BA, de Melker HE, Timmermans DRM, Mollema L. Informed decision 
making in the context of childhood immunization. Patient Educ Couns. 
2017;100(12):2339-2345.
6. Brewer NT, Chapman GB, Gibbons FX, et al. Meta-analysis of the relationship 
between risk perception and health behavior: the example of vaccination. 
Health Psychol. 2007;26(2):136-145.
7. World Health Organization. Immunization Coverage. Immunization, Vaccines 
and Biologicals 2018. http://www.who.int/en/news-room/fact-sheets/detail/
immunization-coverage. Accessed June, 26, 2018.
8. World Health Organization. Ten Threats to Global Health in 2019. Vaccine 
Hesitancy 2019. https://www.who.int/emergencies/ten-threats-to-global-
health-in-2019. Accessed 26th of February, 2019.
9. Betsch C, Renkewitz F, Betsch T, Ulshofer C. The influence of vaccine-critical 
websites on perceiving vaccination risks. J Health Psychol. 2010;15(3):446-455.
10. Betsch C, Renkewitz F, Haase N. Effect of narrative reports about vaccine adverse 
events and bias-awareness disclaimers on vaccine decisions: a simulation of an 
online patient social network. Med Decis Making. 2013;33(1):14-25.
11. Betsch C, Sachse K. Dr. Jekyll or Mr. Hyde? (How) the Internet influences 
vaccination decisions: recent evidence and tentative guidelines for online 
vaccine communication. Vaccine. 2012;30(25):3723-3726.
12. Betsch C, Sachse K. Debunking vaccination myths: strong risk negations can 
increase perceived vaccination risks. Health Psychol. 2013;32(2):146-155.
13. Betsch C, Ulshofer C, Renkewitz F, Betsch T. The influence of narrative v. statistical 
information on perceiving vaccination risks. Med Decis Making. 2011;31(5):742-
753.
14. Borland R, Yong HH, Balmford J, et al. Do risk-minimizing beliefs about smoking 
inhibit quitting? Findings from the International Tobacco Control (ITC) Four-
Country Survey. Prev Med. 2009;49(2-3):219-223.
15. Betsch C, Wicker S. E-health use, vaccination knowledge and perception of own risk: 
Drivers of vaccination uptake in medical students. Vaccine. 2012;30(6):1143-1148.
16. Ahmed S, Bryant L, Hewison J. ‘Balance’ is in the eye of the beholder: providing 
information to support informed choices in antenatal screening via Antenatal 
Screening Web Resource. Health Expect. 2007;10(4):309-320.
Chapter 9216
17. van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G. 
Informed decision making in the context of prenatal screening. Patient Educ 
Couns. 2006;63(1-2):110-117.
18. Bekker H. Genetic screening: facilitating informed choices. In: Cooper DN, 
Thomas N, eds. Encyclopaedia of the Human Genome2001:926-930.
19. Bekker HL, Hewison J, Thornton JG. Applying decision analysis to facilitate 
informed decision making about prenatal diagnosis for Down syndrome: a 
randomised controlled trial. Prenat Diagn. 2004;24(4):265-275.
20. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. Psychosocial aspects 
of genetic screening of pregnant women and newborns: a systematic review. 
NIHR Health Technology Assessment programme: Executive Summaries: NIHR 
Journals Library; 2004.
21. Kohut RJ, Dewey D, Love EJ. Women’s knowledge of prenatal ultrasound and 
informed choice. J Genet Couns. 2002;11(4):265-276.
22. Rimer BK, Briss PA, Zeller PK, Chan ECY, Woolf SH. Informed decision making: 
What is its role in cancer screening? Cancer. 2004;101(5 SUPPL.):1214-1228.
23. Tepper AM, Kaslow FW. Informed decision-making capacity: a patient’s ability to 
participate in treatment determinations. Law Psychol Rev. 1981;6:49-67.
24. Simon HA. A behavioral model of rational choice. The quarterly journal of 
economics. 1955;69(1):99-118.
25. Baron J. Thinking and Deciding. 4th ed. Cambridge: Cambridge University 
Press; 2007.
26. Pot M. Improving HPV vaccination Acceptability by a web-based tailored 
intervetion [dissertation]. Amsterdam: Work and Social Psychology, Maastricht 
University; 2018.
27. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 
1995;15(1):25-30.
28. O’Connor A. user Manual - Decisional Conflict Scale. 1993 [updated 2010].
29. BinDhim NF, McGeechan K, Trevena L. Smartphone Smoking Cessation Application 
(SSC App) trial: a multicountry double-blind automated randomised controlled 
trial of a smoking cessation decision-aid ‘app’. BMJ Open. 2018;8(1):e017105.
30. Bedford H, Attwell K, Danchin M, et al. Vaccine hesitancy, refusal and access 
barriers: The need for clarity in terminology. Vaccine. 2018;36(44):6556-6558.
31. MacDonald N, Dube E, Butler R. Vaccine hesitancy terminology: A response to 
Bedford et al. Vaccine. 2019;37(30):3947-3948.
32. MacDonald NE, Hesitancy SWGoV. Vaccine hesitancy: Definition, scope and 
determinants. Vaccine. 2015;33(34):4161-4164.
33. Pot M, Paulussen TG, Ruiter RA, et al. Effectiveness of a Web-Based Tailored 
Intervention With Virtual Assistants Promoting the Acceptability of HPV 
Vaccination Among Mothers of Invited Girls: Randomized Controlled Trial. J 
Med Internet Res. 2017;19(9):e312.
34. Petty RR, Barden J, Wheeler SC. The Elaboration Likelihood Model of Pursuasion: 
Developing health promotions for sustained behavioral change. In: Diclimente 
RJ, Crosby RA, Kegler M, eds. Emerging theories in health promotion practice 
and research. 2nd ed. San Francisco: Jossey-Bass; 2009:185-214.
General Discussion 217
9
35. Pajor EM, Eggers SM, Curfs KCJ, Oenema A, de Vries H. Why do Dutch people 
use dietary supplements? Exploring the role of socio-cognitive and psychosocial 
determinants. Appetite. 2017;114:161-168.
36. Pajor EM. DIETARY SUPPLEMENT USE: Reasons, decisions, and health 
communication [Doctoral Thesis]. Maastricht: CAPHRI - Promoting Health & 
Personalised Care Health promotion, Maastricht University; 2019.
37. Yang J, Hammond D, Driezen P, Fong GT, Jiang Y. Health knowledge and 
perception of risks among Chinese smokers and non-smokers: findings from the 
Wave 1 ITC China Survey. Tob Control. 2010;19 Suppl 2:i18-23.
38. Klesges RC, Somes G, Pascale RW, et al. Knowledge and beliefs regarding the 
consequences of cigarette smoking and their relationships to smoking status in 
a biracial sample. Health Psychol. 1988;7(5):387-401.
39. Siahpush M, McNeill A, Hammond D, Fong GT. Socioeconomic and country 
variations in knowledge of health risks of tobacco smoking and toxic constituents 
of smoke: results from the 2002 International Tobacco Control (ITC) Four Country 
Survey. Tob Control. 2006;15 Suppl 3:iii65-70.
40. Koski K, Holst J. Exploring Vaccine Hesitancy Through an Artist-Scientist 
Collaboration : Visualizing Vaccine-Critical Parents’ Health Beliefs. J Bioeth Inq. 
2017;14(3):411-426.
41. Dube E, Farrands A, Lemaitre T, et al. Overview of knowledge, attitudes, beliefs, 
vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, 
Canada. Human vaccines & immunotherapeutics. 2019;15(1):113-120.
42. Hunt DP. The concept of knowledge and how to measure it. Journal of intellectual 
capital. 2003;4(1):100-113.
43. Coleman BN, Johnson SE, Tessman GK, et al. “It’s not smoke. It’s not tar. It’s not 4000 
chemicals. Case closed”: Exploring attitudes, beliefs, and perceived social norms 
of e-cigarette use among adult users. Drug Alcohol Depend. 2016;159:80-85.
44. Pepper JK, Emery SL, Ribisl KM, Rini CM, Brewer NT. How risky is it to use 
e-cigarettes? Smokers’ beliefs about their health risks from using novel and 
traditional tobacco products. J Behav Med. 2015;38(2):318-326.
45. Rohde JA, Noar SM, Horvitz C, et al. The Role of Knowledge and Risk Beliefs in 
Adolescent E-Cigarette Use: A Pilot Study. Int J Environ Res Public Health. 2018;15(4).
46. Tan AS, Lee CJ, Bigman CA. Comparison of beliefs about e-cigarettes’ harms 
and benefits among never users and ever users of e-cigarettes. Drug Alcohol 
Depend. 2016;158:67-75.
47. Chiou L, Tucker C, National Bureau of Economic R. Fake news and advertising 
on social media : a study of the anti-vaccination movement. Cambridge, Mass.: 
National Bureau of Economic Research; 2018: http://www.library.yorku.ca/e/
resolver/id/287744606.
48. Fernandez-Luque L, Bau T. Health and social media: perfect storm of information. 
Healthcare informatics research. 2015;21(2):67-73.
49. Mollema L, Harmsen IA, Broekhuizen E, et al. Disease detection or public 
opinion reflection? Content analysis of tweets, other social media, and online 
newspapers during the measles outbreak in The Netherlands in 2013. J Med 
Internet Res. 2015;17(5):e128.
Chapter 9218
50. Betsch C. Social media targeting of health messages. A promising approach for 
research and practice. Human vaccines & immunotherapeutics. 2014;10(9):2636-
2637.
51. Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative 
analysis of mothers’ decision-making about vaccines for infants: the importance 
of trust. Pediatrics. 2006;117(5):1532-1541.
52. Brunson EK. How parents make decisions about their children’s vaccinations. 
Vaccine. 2013;31(46):5466-5470.
53. Brunson EK. The impact of social networks on parents’ vaccination decisions. 
Pediatrics. 2013;131(5):e1397-1404.
54. Brunson EK. Identifying Parents Who Are Amenable to Pro-Vaccination 
Conversations. Glob Pediatr Health. 2015;2:2333794X15616332.
55. Glick M. Believing is seeing: Confirmation bias. J Am Dent Assoc. 2017;148(3):131-
132.
56. Harmsen IA, Doorman GG, Mollema L, et al. Parental information-seeking 
behaviour in childhood vaccinations. BMC Public Health. 2013;13(1):1219.
57. Janis IL, Mann L. Decision making: A psychological analysis of conflict, choice, 
and commitment. Free Press; 1977.
58. Mann L, Janis IL, Chaplin R. Effects of anticipation of forthcoming information 
on predecisional processes. Journal of Personality and Social Psychology. 
1969;11(1):10-16.
59. Festinger L. A theory of cognitive dissonance. Stanford, Ca.: Stanford University 
Press; 1962.
60. Fotuhi O, Fong GT, Zanna MP, et al. Patterns of cognitive dissonance-reducing 
beliefs among smokers: a longitudinal analysis from the International Tobacco 
Control (ITC) Four Country Survey. Tob Control. 2013;22(1):52-58.
61. van Harreveld F, Nohlen HU, Schneider IK. The ABC of Ambivalence : Affective, 
Behavioral, and Cognitive Consequences of Attitudinal Conflict. Advances in 
Experimental Scoial Psychology. 2015;52:285-324.
62. Jenks RJ. Attitudes and perceptions toward smoking: smokers’ views of 
themselves and other smokers. J Soc Psychol. 1994;134(3):355-361.
63. The International Tobacco Control Policy Evaluation Project. ITC Netherlands 
National Report. ZonMw, ASCoR, Maastricht University, University of Waterloo, 
The International Tobacco Control Policy Evaluation Project,;2015.
64. Wadsworth E, Neale J, McNeill A, Hitchman SC. How and Why Do Smokers Start 
Using E-Cigarettes? Qualitative Study of Vapers in London, UK. Int J Environ Res 
Public Health. 2016;13(7).
65. E.A. van Lier, P.J. Oomen, H. Giesbers, et al. Vaccine Coverage of NIP in the 
Netherlands 2018. Bilthoven: National Institute for Public Health and the 
Environment;2019.
66. Harmsen IA, Ruiter R, Paulussen T, et al. Development of a monitoring system to 
evaluate the acceptance of childhood vaccination. Bilthoven: RIVM; 2014.
67. Gray RJ, Hoek J, Edwards R. A qualitative analysis of ‘informed choice’ among 
young adult smokers. Tob Control. 2016;25(1):46-51.
General Discussion 219
9
68. Hoek J, Ball J, Gray R, Tautolo ES. Smoking as an ‘informed choice’: implications 
for endgame strategies. Tob Control. 2017;26(6):669-673.
69. Leventhal H, Glynn K, Fleming R. Is the smoking decision an ‘informed choice’? 
Effect of smoking risk factors on smoking beliefs. JAMA. 1987;257(24):3373-3376.
70. van Mourik DA, Candel M, Nagelhout GE, et al. How the New European Union’s 
(Pictorial) Tobacco Health Warnings Influence Quit Attempts and Smoking 
Cessation: Findings from the 2016-2017 International Tobacco Control (ITC) 
Netherlands Surveys. Int J Environ Res Public Health. 2019;16(21).
71. Borland R, Yong HH, Wilson N, et al. How reactions to cigarette packet 
health warnings influence quitting: findings from the ITC Four-Country survey. 
Addiction. 2009;104(4):669-675.
72. Thrasher JF, Swayampakala K, Borland R, et al. Influences of Self-Efficacy, 
Response Efficacy, and Reactance on Responses to Cigarette Health Warnings: A 
Longitudinal Study of Adult Smokers in Australia and Canada. Health Commun. 
2016;31(12):1517-1526.
73. Yong HH, Borland R, Hammond D, et al. Smokers’ reactions to the new larger 
health warning labels on plain cigarette packs in Australia: findings from the ITC 
Australia project. Tob Control. 2016;25(2):181-187.
74. E.A. van Lier, Geraedts JLE, P.J. Oomen, et al. [Vaccine Coverage of NIP in 
the Netherlands]. Bilthoven: National Institute for Public Health and the 
Environment;2018.
75. National Institute for Public Health and the Environment (RIVM). [National 
Immunization Program]. History 2018. http://www.rijksvaccinatieprogramma.nl/
Over_Rijksvaccinatieprogramma/Geschiedenis. Accessed June 19, 2018.
76. Czoli CD, Fong GT, Mays D, Hammond D. How do consumers perceive 
differences in risk across nicotine products? A review of relative risk perceptions 
across smokeless tobacco, e-cigarettes, nicotine replacement therapy and 
combustible cigarettes. Tob Control. 2017;26(e1):e49-e58.
77. Jarmolowicz DP, Reed DD, Francisco AJ, et al. Modeling effects of risk and social 
distance on vaccination choice. J Exp Anal Behav. 2018;110(1):39-53.
78. Tickner S, Leman PJ, Woodcock A. ‘It’s just the normal thing to do’: 
exploring parental decision-making about the ‘five-in-one’ vaccine. Vaccine. 
2007;25(42):7399-7409.
79. Paulussen TG, Hoekstra F, Lanting CI, Buijs GB, Hirasing RA. Determinants of 
Dutch parents’ decisions to vaccinate their child. Vaccine. 2006;24(5):644-651.
80. Bostrom A. Vaccine risk communication: Lessons from risk perception, decision 
making and environmental risk communication research. Risk. 1997;8:173.
81. Wroe AL, Turner N, Salkovskis PM. Understanding and predicting parental 
decisions about early childhood immunizations. Health Psychol. 2004;23(1):33-
41.
82. Dube E, MacDonald NE. Managing the risks of vaccine hesitancy and refusals. 
Lancet Infect Dis. 2016;16(5):518-519.
83. Karafillakis E, Larson HJ, consortium A. The benefit of the doubt or doubts 
over benefits? A systematic literature review of perceived risks of vaccines in 
European populations. Vaccine. 2017;35(37):4840-4850.
Chapter 9220
84. Harmsen IA, Lambooij MS, Ruiter RA, et al. Psychosocial determinants of 
parents’ intention to vaccinate their newborn child against hepatitis B. Vaccine. 
2012;30(32):4771-4777.
85. Harmsen IA, Mollema L, Ruiter RA, et al. Why parents refuse childhood 
vaccination: a qualitative study using online focus groups. BMC Public Health. 
2013;13(1):1183.
86. Harmsen IA, Ruiter RA, Paulussen TG, et al. Factors that influence vaccination 
decision-making by parents who visit an anthroposophical child welfare center: 
a focus group study. Advances in preventive medicine. 2012;2012.
87. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding 
vaccine hesitancy around vaccines and vaccination from a global perspective: a 
systematic review of published literature, 2007-2012. Vaccine. 2014;32(19):2150-
2159.
88. Anand V, McGinty KL, O’Brien K, et al. E-cigarette Use and Beliefs Among Urban 
Public High School Students in North Carolina. J Adolesc Health. 2015;57(1):46-
51.
89. Bauhoff S, Montero A, Scharf D. Perceptions of e-cigarettes: a comparison of 
adult smokers and non-smokers in a Mechanical Turk sample. The American 
journal of drug and alcohol abuse. 2017;43(3):311-323.
90. Baweja R, Curci KM, Yingst J, et al. Views of Experienced Electronic Cigarette 
Users. Addict Res Theory. 2016;24(1):80-88.
91. Berg CJ. Preferred flavors and reasons for e-cigarette use and discontinued use 
among never, current, and former smokers. Int J Public Health. 2016;61(2):225-
236.
92. Biener L, Song E, Sutfin EL, Spangler J, Wolfson M. Electronic Cigarette Trial 
and Use among Young Adults: Reasons for Trial and Cessation of Vaping. Int J 
Environ Res Public Health. 2015;12(12):16019-16026.
93. Bold KW, Kong G, Cavallo DA, Camenga DR, Krishnan-Sarin S. Reasons for 
Trying E-cigarettes and Risk of Continued Use. Pediatrics. 2016;138(3).
94. Chaffee BW, Gansky SA, Halpern-Felsher B, et al. Conditional risk assessment 
of adolescents’ electronic cigarette perceptions. Am J Health Behav. 
2015;39(3):421-432.
95. Cheney MK, Gowin M, Wann TF. Electronic Cigarette Use in Straight-to-Work 
Young Adults. Am J Health Behav. 2016;40(2):268-279.
96. Gowin M, Cheney MK, Wann TF. Knowledge and Beliefs About E-Cigarettes in 
Straight-to-Work Young Adults. Nicotine Tob Res. 2017;19(2):208-214.
97. Hilton S, Weishaar H, Sweeting H, Trevisan F, Katikireddi SV. E-cigarettes, a safer 
alternative for teenagers? A UK focus group study of teenagers’ views. BMJ 
Open. 2016;6(11):e013271.
98. Kahr MK, Padgett S, Shope CD, et al. A qualitative assessment of the perceived 
risks of electronic cigarette and hookah use in pregnancy. BMC Public Health. 
2015;15(1):1273.
99. Kim H, Davis AH, Dohack JL, Clark PI. E-Cigarettes Use Behavior and Experience 
of Adults: Qualitative Research Findings to Inform E-Cigarette Use Measure 
Development. Nicotine Tob Res. 2017;19(2):190-196.
General Discussion 221
9
100. Kistler CE, Crutchfield TM, Sutfin EL, et al. Consumers’ Preferences for Electronic 
Nicotine Delivery System Product Features: A Structured Content Analysis. Int J 
Environ Res Public Health. 2017;14(6):07.
101. Li J, Bullen C, Newcombe R, Walker N, Walton D. The use and acceptability 
of electronic cigarettes among New Zealand smokers. N Z Med J. 
2013;126(1375):48-57.
102. Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M. Knowledge, 
Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women. J 
Addict Med. 2015;9(4):266-272.
103. Patel D, Davis KC, Cox S, et al. Reasons for current E-cigarette use among U.S. 
adults. Prev Med. 2016;93:14-20.
104. Pineiro B, Correa JB, Simmons VN, et al. Gender differences in use and 
expectancies of e-cigarettes: Online survey results. Addict Behav. 2016;52:91-97.
105. Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing use patterns and 
perceptions of relative harm in dual users of electronic and tobacco cigarettes. 
Exp Clin Psychopharmacol. 2015;23(6):494-503.
106. Saddleson ML, Kozlowski LT, Giovino GA, et al. Enjoyment and other reasons 
for electronic cigarette use: Results from college students in New York. Addict 
Behav. 2016;54:33-39.
107. Sherratt FC, Marcus MW, Robinson J, Newson L, Field JK. Electronic cigarette 
use and risk perception in a Stop Smoking Service in England. Addiction 
Research & Theory. 2015;23(4):336-342.
108. Sherratt FC, Newson L, Marcus MW, Field JK, Robinson J. Perceptions towards 
electronic cigarettes for smoking cessation among Stop Smoking Service users. 
Br J Health Psychol. 2016;21(2):421-433.
109. Trumbo CW, Harper R. Use and perception of electronic cigarettes among 
college students. J Am Coll Health. 2013;61(3):149-155.
110. Zhu SH, Gamst A, Lee M, et al. The use and perception of electronic cigarettes 
and snus among the U.S. population. PLoS One. 2013;8(10):e79332.
111. Wackowski OA, Bover Manderski MT, Delnevo CD. Smokers’ sources of 
e-cigarette awareness and risk information. Prev Med Rep. 2015;2:906-910.
112. Ambrose BK, Rostron BL, Johnson SE, et al. Perceptions of the relative harm of 
cigarettes and e-cigarettes among U.S. youth. Am J Prev Med. 2014;47(2 Suppl 
1):S53-60.
113. Amrock SM, Lee L, Weitzman M. Perceptions of e-Cigarettes and Noncigarette 
Tobacco Products Among US Youth. Pediatrics. 2016;138(5).
114. Amrock SM, Zakhar J, Zhou S, Weitzman M. Perception of e-cigarette harm and its 
correlation with use among U.S. adolescents. Nicotine Tob Res. 2015;17(3):330-336.
115. Camenga DR, Fiellin LE, Pendergrass T, et al. Adolescents’ perceptions of 
flavored tobacco products, including E-cigarettes: A qualitative study to 
inform FDA tobacco education efforts through videogames. Addict Behav. 
2018;82:189-194.
116. Cooper M, Case KR, Loukas A, Creamer MR, Perry CL. E-cigarette Dual Users, 
Exclusive Users and Perceptions of Tobacco Products. Am J Health Behav. 
2016;40(1):108-116.
Chapter 9222
117. Maloney EK, Cappella JN. Does Vaping in E-Cigarette Advertisements Affect 
Tobacco Smoking Urge, Intentions, and Perceptions in Daily, Intermittent, and 
Former Smokers? Health Commun. 2016;31(1):129-138.
118. Pokhrel P, Fagan P, Kehl L, Herzog TA. Receptivity to e-cigarette marketing, 
harm perceptions, and e-cigarette use. Am J Health Behav. 2015;39(1):121-131.
119. Simmons VN, Quinn GP, Harrell PT, et al. E-cigarette use in adults: a qualitative 
study of users’ perceptions and future use intentions. Addict Res Theory. 
2016;24(4):313-321.
120. Chen NT. Predicting Vaccination Intention and Benefit and Risk Perceptions: The 
Incorporation of Affect, Trust, and Television Influence in a Dual-Mode Model. 
Risk Anal. 2015;35(7):1268-1280.
121. Glanz JM, Wagner NM, Narwaney KJ, et al. A mixed methods study of parental vaccine 
decision making and parent-provider trust. Acad Pediatr. 2013;13(5):481-488.
122. World Health Organization. Vaccination and trust: how concerns arise and the 
role of communciation in mitigating crisis. UN City, Marmorvej 51 DK-2100 
Copenhagen, Denmark: WHO Regional Office for Europe;2017.
123. Pokhrel P, Herzog TA, Muranaka N, Fagan P. Young adult e-cigarette users’ 
reasons for liking and not liking e-cigarettes: A qualitative study. Psychol Health. 
2015;30(12):1450-1469.
124. McQueen A, Tower S, Sumner W. Interviews with “vapers”: implications for 
future research with electronic cigarettes. Nicotine Tob Res. 2011;13(9):860-867.
125. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive 
e-cigarette use and dual e-cigarette use and tobacco use in adolescents. 
Pediatrics. 2015;135(1):e43-51.
126. White J, Li J, Newcombe R, Walton D. Tripling use of electronic cigarettes 
among New Zealand adolescents between 2012 and 2014. J Adolesc Health. 
2015;56(5):522-528.
127. Weinstein ND, Marcus SE, Moser RP. Smokers’ unrealistic optimism about their 
risk. Tob Control. 2005;14(1):55-59.
128. McMaster C, Lee C. Cognitive dissonance in tobacco smokers. Addict Behav. 
1991;16(5):349-353.
129. Lucherini M, Rooke C, Amos A. “They’re thinking, well it’s not as bad, I probably 
won’t get addicted to that. But it’s still got the nicotine in it, so...”: Maturity, 
Control, and Socializing: Negotiating Identities in Relation to Smoking and 
Vaping-A Qualitative Study of Young Adults in Scotland. Nicotine Tob Res. 
2019;21(1):81-87.
130. Haase N, Betsch C. Parents trust other parents: lay vaccination narratives 
on the Web may create doubt about vaccination safety. Med Decis Making. 
2012;32(4):645.
131. Siegrist M, Cvetkovich G. Perception of hazards: the role of social trust and 
knowledge. Risk Anal. 2000;20(5):713-719.
132. Vereen RN, Westmaas JL, Bontemps-Jones J, Jackson K, Alcaraz KI. Trust of 
Information about Tobacco and E-Cigarettes from Health Professionals versus 
Tobacco or Electronic Cigarette Companies: Differences by Subgroups and 
Implications for Tobacco Messaging. Health Commun. 2020;35(1):89-95.
General Discussion 223
9
133. Peretti-Watel P, Ward JK, Vergelys C, et al. ‘I Think I Made The Right Decision ... I 
Hope I’m Not Wrong’. Vaccine hesitancy, commitment and trust among parents 
of young children. Sociol Health Illn. 2019;41(6):1192-1206.
134. Douma LN. Colorectal Cancer Screening: Yes or No? Insights into public opinion 
and the individual decision-making process [Doctoral]. Amsterdam: Faculteit 
der Geneeskunde, Vrije Universiteit Amsterdam; 2019.
135. Shourie S, Jackson C, Cheater FM, et al. A cluster randomised controlled trial of a 
web based decision aid to support parents’ decisions about their child’s Measles 
Mumps and Rubella (MMR) vaccination. Vaccine. 2013;31(50):6003-6010.
136. Connolly T, Reb J. Toward interactive, Internet-based decision aid for vaccination 
decisions: better information alone is not enough. Vaccine. 2012;30(25):3813-
3818.
137. Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions 
about combination childhood vaccinations including MMR: a systematic review. 
Vaccine. 2010;28(26):4235-4248.
138. Mollema L, Staal JM, van Steenbergen JE, Paulussen TG, de Melker HE. An 
exploratory qualitative assessment of factors influencing childhood vaccine 
providers’ intention to recommend immunization in the Netherlands. BMC 
Public Health. 2012;12(1):128.
139. Mollema L, Wijers N, Hahne SJ, et al. Participation in and attitude towards the 
national immunization program in the Netherlands: data from population-based 
questionnaires. BMC Public Health. 2012;12:57.
140. Geelen E, van Vliet H, de Hoogh P, Horstman K. Taming the fear of voice: 
Dilemmas in maintaining a high vaccination rate in the Netherlands. Soc Sci 
Med. 2016;153:12-19.
141. Abraham C, Sheeran P. Deciding to exercise: the role of anticipated regret. Br J 
Health Psychol. 2004;9(Pt 2):269-278.
142. van der Pligt J, Richard R. Changing adolescents’ sexual behaviour: perceived 
risk, self-efficacy and anticipated regret. Patient Educ Couns. 1994;23(3):187-
196.
143. Richard R, van der Pligt J, de Vries NK. Anticipated affect and behavioral choice. 
Basic and Applied Social Psychology. 1996;18(2):111-129.
144. Leder S, Florack A, Keller J. Self-regulation and protective health behaviour: 
how regulatory focus and anticipated regret are related to vaccination decisions. 
Psychol Health. 2015;30(2):165-188.
145. Ziarnowski KL, Brewer NT, Weber B. Present choices, future outcomes: 
anticipated regret and HPV vaccination. Prev Med. 2009;48(5):411-414.
146. Wroe AL, Clements CJ. Feeling bad about immunising children. Aust N Z J 
Public Health. 2005;29(6):584.
147. Hamama-Raz Y, Ginossar-David E, Ben-Ezra M. Parental regret regarding 
children’s vaccines-The correlation between anticipated regret, altruism, coping 
strategies and attitudes toward vaccines. Isr J Health Policy Res. 2016;5:55.
148. Schoren C, Hummel K, Vries H. Electronic cigarette use: comparing smokers, 
vapers, and dual users on characteristics and motivational factors. Tobacco 
Prevention & Cessation. 2017;3(April). doi:10.18332/tpc/69392.
Chapter 9224
149. De Vries H, Mudde AN, Dijkstra A, Willemsen MC. Differential beliefs, perceived 
social influences, and self-efficacy expectations among smokers in various 
motivational phases. Prev Med. 1998;27(5 Pt 1):681-689.
150. East KA, Hitchman SC, McNeill A, Thrasher JF, Hammond D. Social norms 
towards smoking and vaping and associations with product use among youth in 
England, Canada, and the US. Drug Alcohol Depend. 2019;205:107635.
151. Hummel K, Willemsen MC, de Vries H, Monshouwer K, Nagelhout GE. Social 
Acceptance of Smoking Restrictions During 10 Years of Policy Implementation, 
Reversal, and Reenactment in the Netherlands: Findings From a National 
Population Survey. Nicotine Tob Res. 2017;19(2):231-238.
152. Gorukanti A, Delucchi K, Ling P, Fisher-Travis R, Halpern-Felsher B. Adolescents’ 
attitudes towards e-cigarette ingredients, safety, addictive properties, social 
norms, and regulation. Prev Med. 2017;94:65-71.
153. Lazuras L, Chatzipolychroni E, Rodafinos A, Eiser JR. Social cognitive predictors 
of smoking cessation intentions among smoker employees: the roles of 
anticipated regret and social norms. Addict Behav. 2012;37(3):339-341.
154. Peters RJ, Jr., Meshack A, Lin MT, Hill M, Abughosh S. The social norms 
and beliefs of teenage male electronic cigarette use. J Ethn Subst Abuse. 
2013;12(4):300-307.
155. Waters EA, Mueller-Luckey G, Levault K, Jenkins WD. Perceived Harms and 
Social Norms in the Use of Electronic Cigarettes and Smokeless Tobacco. J 
Health Commun. 2017;22(6):497-505.
156. Bruine de Bruin W, Parker AM, Galesic M, Vardavas R. Reports of social circles’ 
and own vaccination behavior: A national longitudinal survey. Health Psychol. 
2019;38(11):975-983.
157. Fadda M, Allam A, Schulz PJ. Arguments and sources on Italian online forums on 
childhood vaccinations: Results of a content analysis. Vaccine. 2015;33(51):7152-
7159.
158. Goldstein S, MacDonald NE, Guirguis S, Hesitancy SWGoV. Health 
communication and vaccine hesitancy. Vaccine. 2015;33(34):4212-4214.
159. Bozzola E, Spina G, Russo R, et al. Mandatory vaccinations in European countries, 
undocumented information, false news and the impact on vaccination uptake: 
the position of the Italian pediatric society. Ital J Pediatr. 2018;44(1):67.
160. Romijnders K, van Seventer SL, Scheltema M, et al. A deliberate choice? Exploring 
factors related to informed decision-making about childhood vaccination among 
acceptors, refusers, and partial acceptors. Vaccine. 2019;37(37):5637-5644.
161. Colditz JB, Welling J, Smith NA, James AE, Primack BA. World Vaping Day: 
Contextualizing Vaping Culture in Online Social Media Using a Mixed Methods 
Approach2017.
162. Marta F, Elisa G, Luisa R, et al. Validation of a scale to measure parental psychological 
empowerment in the vaccination decision. J Public Health Res. 2017;6(2):955.
163. F.A. Q, Mollema L, van Vliet JA, De Melker H, van Lier EA. Geen relatie tussen 
veranderingen in organisatorische aspecten met betrekking tot vaccineren 
binnen de jeugdgezondheidszorg en ontwikkeling in aantal gevaccineerden 
2013-2017. Bilthoven: RIVM;2018.
General Discussion 225
9
164. Pokhrel P, Herzog TA, Muranaka N, Regmi S, Fagan P. Contexts of cigarette 
and e-cigarette use among dual users: a qualitative study. BMC Public Health. 
2015;15:859.
165. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding 
clues in the use frequency distribution. Tob Control. 2016;25(e1):e24-29.
166. Pepper JK, Ribisl KM, Emery SL, Brewer NT. Reasons for starting and stopping 
electronic cigarette use. Int J Environ Res Public Health. 2014;11(10):10345-
10361.
167. Rutten LJ, Blake KD, Agunwamba AA, et al. Use of E-Cigarettes Among Current 
Smokers: Associations Among Reasons for Use, Quit Intentions, and Current 
Tobacco Use. Nicotine Tob Res. 2015;17(10):1228-1234.
168. McKeganey N, Dickson T. Why Don’t More Smokers Switch to Using E-Cigarettes: 
The Views of Confirmed Smokers. Int J Environ Res Public Health. 2017;14(6):16.
169. Cullen KA, Ambrose BK, Gentzke AS, et al. Notes from the Field: Use of Electronic 
Cigarettes and Any Tobacco Product Among Middle and High School Students - 
United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2018;67(45):1276-1277.
170. Miech R, Johnston L, O’Malley PM, Bachman JG, Patrick ME. Adolescent 
Vaping and Nicotine Use in 2017-2018 - U.S. National Estimates. N Engl J Med. 
2019;380(2):192-193.
171. McMillen RC, Gottlieb MA, Shaefer RM, Winickoff JP, Klein JD. Trends in 
Electronic Cigarette Use Among U.S. Adults: Use is Increasing in Both Smokers 
and Nonsmokers. Nicotine Tob Res. 2015;17(10):1195-1202.
172. Buu A, Hu YH, Piper ME, Lin HC. The association between e-cigarette use 
characteristics and combustible cigarette consumption and dependence 
symptoms: Results from a national longitudinal study. Addict Behav. 2018;84:69-
74.
173. Diamantopoulou E, Barbouni A, Merakou K, Lagiou A, Farsalinos K. Patterns of 
e-cigarette use, biochemically verified smoking status and self-reported changes 
in health status of a random sample of vapeshops customers in Greece. Intern 
Emerg Med. 2019;14(6):843-851.
174. Schneller LM, Bansal-Travers M, Goniewicz ML, et al. Use of flavored electronic 
cigarette refill liquids among adults and youth in the US-Results from Wave 2 
of the Population Assessment of Tobacco and Health Study (2014-2015). PLoS 
One. 2018;13(8):e0202744.
175. O’Connor RJ, Fix BV, McNeill A, et al. Characteristics of nicotine vaping products 
used by participants in the 2016 ITC Four Country Smoking and Vaping Survey. 
Addiction. 2019;114 Suppl 1(Suppl 1):15-23.
176. Amaro H, Blake SM, Morrill AC, et al. HIV prevention community planning: 
challenges and opportunities for data-informed decision-making. AIDS Behav. 
2005;9(2 Suppl):S9-27.
177. Harrell MB, Weaver SR, Loukas A, et al. Flavored e-cigarette use: Characterizing 
youth, young adult, and adult users. Prev Med Rep. 2017;5:33-40.
178. Russell C, McKeganey N, Dickson T, Nides M. Changing patterns of first 
e-cigarette flavor used and current flavors used by 20,836 adult frequent 
e-cigarette users in the USA. Harm Reduct J. 2018;15(1):33.
Chapter 9226
179. Romijnders K, van Osch L, de Vries H, Talhout R. A Deliberate Choice? Exploring 
the Decision to Switch from Cigarettes to E-Cigarettes. Int J Environ Res Public 
Health. 2019;16(4).
180. National institute for Public Health and the Environment (RIVM). [Tobacco]. 
2018. https://www.rivm.nl/tabak. Accessed June 19, 2019.
181. National Institute for Public Health and the Environment (RIVM). Tobacco and 
Drugs. 2019. https://www.rivm.nl/rivm/kennis-en-kunde/expertisevelden/tabak-
en-drugs. Accessed October 28, 2019.
182. Merriam-Webster.com. “Belief”. Merriam-Webster [Dictionary]. 2019. https://
www.merriam-webster.com/dictionary/belief. Accessed November 3, 2019.
183. Fabrigar LR, Petty RE, Smith SM, Crites SL, Jr. Understanding knowledge effects 
on attitude-behavior consistency: the role of relevance, complexity, and amount 
of knowledge. J Pers Soc Psychol. 2006;90(4):556-577.
184. Krosnick JA, Boninger DS, Chuang YC, Berent MK, et a. Attitude strength: 
One construct or many related constructs? Journal of Personality and Social 
Psychology. 1993;65(6):1132-1151.
185. Rosenstock IM. The health belief model and preventive health behavior. [S.l.]: 
[s.n.]; 1974.
186. Andreas G, Tilmann B. Modelling option and strategy choices with connectionist 
networks. Judgment and Decision Making. 2008;3(NA):215-228.
187. Beach LR, Mitchell TR. Image theory: Principles, goals, and plans in decision 
making. Acta Psychologica. 1987;66(3):201-220.
188. Fischhoff B. Assessing adolescent decision-making competence. Developmental 
Review. 2008;28(1):12-28.
189. Montgomery H. The search for a dominance structure in decision making: 
Examining the evidence. In: Klein GA, Orasanu JE, Calderwood RE, Zsambok C, 
eds. Decision making in action: Models methods: Ablex Publishing; 1989:182-
188.
190. Svenson O. Values, Affect, and Processes in Human Decision Making: A 
differentiation and consolidation theory perspective. In: Schneider SL, Shanteau 
J, eds. Emerging Perspectives on Judment and Decision research. Cambrigde: 
Cambridge University Press; 2003:287-326.
191. Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer BK, 
Viswanath K, eds. Health Behavior and Health Education: Theory, Research and 
Practice. 4th ed. New Jersey: John Wiley & Sons; 2008:45-66.
192. Montano DE, Kasprzyk D. Theory of Reasoned Action, Theory of Planned 
Behavior, and the Integrated Behavioral Model. In: Glanz K, Rimer BK, Viswanath 
K, eds. Health Behavior and Health Education: Theory, Research and Practice. 
4th ed. New Jersey: John Wiley & Sons; 2008:67-96.
193. Norman P, Boer H, Seydel ER. Protection motivation theory. In: Conner M, 
Normal P, eds. Predicting health behaviour: RESEARCH AND PRACTICE WITH 
SOCIAL COGNITION MODELS. Vol 81. 2nd ed. Maidenhead, Berkshire: Open 
University Press; 2005:81-126.
194. Horstman K. Kanttekeningen bij de moraal van ‘meer bewegen’. Huisarts en 
Wetenschap. 2011;2011(2):103-105.
General Discussion 227
9
195. Kasten S, van Osch L, Candel M, de Vries H. The influence of pre-motivational 
factors on behavior via motivational factors: a test of the I-Change model. BMC 
Psychol. 2019;7(1):7.
196. Levin IP, Huneke ME, Jasper JD. Information Processing at Successive Stages 
of Decision Making: Need for Cognition and Inclusion-Exclusion Effects. Organ 
Behav Hum Decis Process. 2000;82(2):171-193.
197. Boer D, Fischer R. How and when do personal values guide our attitudes and 
sociality? Explaining cross-cultural variability in attitude-value linkages. Psychol 
Bull. 2013;139(5):1113-1147.
198. Summers AM. Informed choice in prenatal screening. Can Fam Physician. 
1994;40:1688-1691, 1694-1687.
199. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health 
Expect. 2001;4(2):99-108.
200. Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer 
screening in communities and healthcare systems. American Journal of 
Preventive Medicine. 2004;26(1):67-80.
201. Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed 
choice: a validation study. Patient Educ Couns. 2002;48(1):87-91.
202. Michie S, Dormandy E, Marteau TM. Informed choice: understanding knowledge 
in the context of screening uptake. Patient Educ Couns. 2003;50(3):247-253.
203. Timmermans D. [What motivates the decision-maker? The meaning of a 
deliberate and informed decision for public health and prevention] VU medisch 
centrum 2013.
204. Polit DF, Beck CT. Chapter 13: Data collection in Quantitative research. Nursing 
research : generating and assessing evidence for nursing practice. Ninth edition. 
ed. Philadelphia: Wolters Kluwer Health; 2017:293-327.
205. Baron J, Hershey JC. Outcome bias in decision evaluation. J Pers Soc Psychol. 
1988;54(4):569-579.
206. Thompson ME, Fong GT, Hammond D, et al. Methods of the International 
Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl 3:iii12-18.
207. Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the 
International Tobacco Control (ITC) Policy Evaluation Project. Tob Control. 
2006;15 Suppl 3:iii3-11.
208. Polit DF, Beck CT. Chapter 11: Specific Types of Quantitative Research. Nursing 
research : generating and assessing evidence for nursing practice. Ninth edition. 
ed. Philadelphia: Wolters Kluwer Health; 2017:257-272.
209. Borland R, Murray K, Gravely S, et al. A new classification system for describing 
concurrent use of nicotine vaping products alongside cigarettes (so-called ‘dual 
use’): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. 
Addiction. 2019;114 Suppl 1:24-34.
210. National Institute for Public Health and the Environment (RIVM). E-Learning: 
Backgrounds NIP. 2017. https://www.nspoh.nl/bij-en-nascholing/e-learning-
achtergronden-rijksvaccinatieprogramma/. Accessed June 28th, , 2018.
211. Jackson ML. Challenges in comparing the safety of different vaccination 
schedules. Vaccine. 2013;31(17):2126-2129.
Chapter 9228
212. Kings College London. All evidence shows that e-cigarettes have potential to 
reduce the harms caused by smoking. 2015. http://www.kcl.ac.uk/ioppn/news/
records/2015/August/ecigarettes.aspx. Accessed March 30, 2017, 2017.
213. Maziak W. Harm reduction at the crossroads: the case of e-cigarettes. Am J Prev 
Med. 2014;47(4):505-507.
214. Visser W, Geraets L, Klerx W, et al. The health risks of using e-cigarettes. 
Bilthoven, the Netherlands: National Institute for Public Health and the 
Environment (RIVM);2015.
215. Visser WF, Klerx WN, Cremers H, et al. The Health Risks of Electronic Cigarette 
Use to Bystanders. Int J Environ Res Public Health. 2019;16(9).
216. Saada A, Lieu TA, Morain SR, Zikmund-Fisher BJ, Wittenberg E. Parents’ choices 
and rationales for alternative vaccination schedules: a qualitative study. Clin 
Pediatr (Phila). 2015;54(3):236-243.
217. Nadeau JA, Bednarczyk RA, Masawi MR, et al. Vaccinating my way--use of 
alternative vaccination schedules in New York State. J Pediatr. 2015;166(1):151-156.
218. World Health Organization. Tobacco Questions for Surveys. Atlanta, GA: 
Centers for Disease Control and Prevention;2011.
219. World Health Organization. Tobacco Free Initiative  (TFI). Electronic cigarettes 
(ecigarettes) or electronic nicotine delivery systems 2015. http://www.who.int/
tobacco/communications/statements/eletronic_cigarettes/en/. Accessed July 
12, 2017, 2016.
220. World Health Organization. Immunization Coverage. 2017. http://www.who.int/
mediacentre/factsheets/fs378/en/. Accessed June 19, 2017.
221. World Health Organization. Addressing Vaccine Hesitancy. 2018. https://www.
who.int/immunization/programmes_systems/vaccine_hesitancy/en/. Accessed 
June 14, 2019.
222. Feemster KA, Offit P. Delaying vaccination is not a safer choice. JAMA Pediatr. 
2013;167(12):1097-1098.
223. Glanz JM, Newcomer SR, Narwaney KJ, et al. A population-based cohort study 
of undervaccination in 8 managed care organizations across the United States. 
JAMA Pediatr. 2013;167(3):274-281.
224. Thaler RH, Sunstein CR. Nudge : improving decisions about health, wealth, and 
happiness. Revised and expanded edition. ed. New York: Penguin Books; 2009.
225. Bartholomew Eldredge LK. Intervention Mapping Step 3: Program Design. 
Planning health promotion programs : an intervention mapping approach. 
Fourth edition. ed. San Francisco, CA: Jossey-Bass & Pfeiffer Imprints, Wiley; 
2016:345-434.
226. Deng Z, Liu S. Understanding consumer health information-seeking behavior 
from the perspective of the risk perception attitude framework and social 
support in mobile social media websites. Int J Med Inform. 2017;105:98-109.
227. Grant L, Hausman BL, Cashion M, et al. Vaccination persuasion online: a 
qualitative study of two provaccine and two vaccine-skeptical websites. J Med 
Internet Res. 2015;17(5):e133.
General Discussion 229
9
228. Reinwand DA, Crutzen R, Kienhuis AS, Talhout R, de Vries H. Website Use 
and Effects of Online Information About Tobacco Additives Among the Dutch 
General Population: A Randomized Controlled Trial. J Med Internet Res. 
2017;19(3):e60.
229. Lazard AJ, Byron MJ, Vu H, et al. Website Designs for Communicating About 
Chemicals in Cigarette Smoke. Health Commun. 2019;34(3):333-342.
230. Jackson C, Cheater F, Peacock R, Leask J, Trevena L. Evaluating a web-based 
MMR decision aid to support informed decision-making by UK parents: A 
before-and-after feasibility study. Health Education Journal. 2010;69(1):74-83.
231. Moyo F, Archibald E, Slyer JT. Effectiveness of decision aids for smoking 
cessation in adults: a quantitative systematic review. JBI Database System Rev 
Implement Rep. 2018;16(9):1791-1822.
232. Warner DO, LeBlanc A, Kadimpati S, et al. Decision Aid for Cigarette Smokers 
Scheduled for Elective Surgery. Anesthesiology. 2015;123(1):18-28.
233. Willemsen MC, Wiebing M, van Emst A, Zeeman G. Helping smokers to decide 
on the use of efficacious smoking cessation methods: a randomized controlled 
trial of a decision aid. Addiction. 2006;101(3):441-449.
234. Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment 
or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.
235. O’Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing 
health treatment or screening decisions. Cochrane Database Syst Rev. 
2009(3):CD001431.
236. Ubel PA, Smith DM, Zikmund-Fisher BJ, et al. Testing whether decision aids 
introduce cognitive biases: results of a randomized trial. Patient Educ Couns. 
2010;80(2):158-163.
237. Wilson EA, Wolf MS. Working memory and the design of health materials: a 
cognitive factors perspective. Patient Educ Couns. 2009;74(3):318-322.
238. Morgan MG, Fischhoff B, Bostrom A, Atman CJ. Risk communication: A mental 
models approach. Cambridge University Press; 2002.
239. Feldman-Stewart D, O’Brien MA, Clayman ML, et al. Providing Information about 
options. In: Volk R, Llewellyn-Thomas H, eds. 2012 Update of the International Patient 
Decision Aids Standards (IPDAS) Collaboration’s Background Document 2012.
240. Pignone M, Fagerlin A, Abhyankar P, et al. Clarifying and Expressing Values. 
In: Volk R, Llewellyn-Thomas H, eds. 2012 Update of the International Patient 
Decision Aids Standards (IPDAS) Collaboration’s Background Document 2012.
241. Stacey D, Belkora J, Clay K, et al. Coaching and Guidance in Deliberation 
and Communication. In: Volk R, Llewellin EW, eds. 2012 Update of the 
International Patient Decision Aids Standrs (IPDAS) Collaboration’s Background 
Document2012.
242. Stacey D, Kryworuchko J, Belkora J, et al. Coaching and guidance with patient 
decision aids: A review of theoretical and empirical evidence. BMC Med Inform 
Decis Mak. 2013;13 Suppl 2:S11.
243. Stacey D, Murray MA, Legare F, et al. Decision coaching to support shared 
decision making: a framework, evidence, and implications for nursing practice, 
education, and policy. Worldviews Evid Based Nurs. 2008;5(1):25-35.
Chapter 9230
244. Tubeuf S, Edlin R, Shourie S, et al. Cost effectiveness of a web-based decision 
aid for parents deciding about MMR vaccination: a three-arm cluster randomised 
controlled trial in primary care. Br J Gen Pract. 2014;64(625):e493-499.
245. Wallace C, Leask J, Trevena LJ. Effects of a web based decision aid on parental attitudes 
to MMR vaccination: a before and after study. BMJ. 2006;332(7534):146-149.
246. Do HP, Tran BX, Le Pham Q, et al. Which eHealth interventions are most 
effective for smoking cessation? A systematic review. Patient Prefer Adherence. 
2018;12:2065-2084.
247. Haase N, Betsch C, Renkewitz F. Source Credibility and the Biasing Effect of 
Narrative Information on the Perception of Vaccination Risks. J Health Commun. 
2015;20(8):920-929.
248. Gianfredi V, Moretti M, Lopalco PL. Countering vaccine hesitancy through 
immunization information systems, a narrative review. Human vaccines & 
immunotherapeutics. 2019;15(11):2508-2526.
249. Weinstein ND. Why it won’t happen to me: perceptions of risk factors and 
susceptibility. Health Psychol. 1984;3(5):431-457.
250. de Wit JB, Das E, Vet R. What works best: objective statistics or a personal 
testimonial? An assessment of the persuasive effects of different types of 
message evidence on risk perception. Health Psychol. 2008;27(1):110-115.
251. Hinyard LJ, Kreuter MW. Using narrative communication as a tool for health 
behavior change: a conceptual, theoretical, and empirical overview. Health 
Educ Behav. 2007;34(5):777-792.
252. Compton J, Jackson B, Dimmock JA. Persuading Others to Avoid Persuasion: 
Inoculation Theory and Resistant Health Attitudes. Front Psychol. 2016;7:122.
253. Chen JC. Flavored E-cigarette Use and Cigarette Smoking Reduction and 
Cessation-A Large National Study among Young Adult Smokers. Subst Use 
Misuse. 2018;53(12):2017-2031.
254. Chen-Sankey JC, Kong G, Choi K. Perceived ease of flavored e-cigarette use 
and e-cigarette use progression among youth never tobacco users. PLoS One. 
2019;14(2):e0212353.
255. Villanti AC, Johnson AL, Ambrose BK, et al. Flavored Tobacco Product Use in 
Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014). 
Am J Prev Med. 2017;53(2):139-151.
256. Miller WR, Rollnick S. Motivational interviewing : helping people change. 3rd 
ed. ed. New York, NY: Guilford Press; 2013.
257. Gagneur A, Gosselin V, Dube E. Motivational interviewing: A promising tool to 
address vaccine hesitancy. Vaccine. 2018;36(44):6553-6555.
258. Horstman K. Een kwestie van betekenissen. Tijdschrift voor gezondheidsweten-
schappen. 2016;94(8):281-282.
259. Prochaska JJ. The public health consequences of e-cigarettes: a review by the 
National Academies of Sciences. A call for more research, a need for regulatory 
action. Addiction. 2019;114(4):587-589.
260. Chen J, Bullen C, Dirks K. A Comparative Health Risk Assessment of Electronic 
Cigarettes and Conventional Cigarettes. Int J Environ Res Public Health. 
2017;14(4).
General Discussion 231
9
261. Goniewicz ML, Gawron M, Smith DM, et al. Exposure to Nicotine and Selected 
Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: 
A Longitudinal Within-Subjects Observational Study. Nicotine Tob Res. 
2017;19(2):160-167.
262. Levy DT, Borland R, Lindblom EN, et al. Potential deaths averted in USA by 
replacing cigarettes with e-cigarettes. Tob Control. 2018;27(1):18-25.
263. Stratton K, Kwan L, Y., Eaton DL. Public health consequences of e-cigarettes. 
Washington, DC, United States: National Academies Press;2018. 9780309468343.
264. Kinouani S, Pereira E, Tzourio C. Electronic Cigarette Use in Students and Its 
Relation with Tobacco-Smoking: A Cross-Sectional Analysis of the i-Share Study. 
Int J Environ Res Public Health. 2017;14(11):1345.
265. Liu X, Lugo A, Davoli E, et al. Electronic cigarettes in Italy: a tool for harm 
reduction or a gateway to smoking tobacco? Tob Control. 2019.
266. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association Between Initial Use 
of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and 
Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017. 
doi:10.1001/jamapediatrics.2017.1488.
267. McRobbie H. Modelling the Population Health Effects of E-Cigarettes Use: 
Current Data Can Help Guide Future Policy Decisions. Nicotine Tob Res. 
2017;19(2):131-132.

Valorization Addendum
Valorization Addendum234
Valorization Addendum 
The main aim of this thesis was to explore two examples of decisions we 
identified as a next to best health decision. When making health-related 
decisions, there can be different options to choose from. For instance, a parent 
can decide to accept, refuse, or partially accept childhood vaccinations; or a 
smoker can decide to quit smoking or switch from smoking regular cigarettes 
to electronic cigarettes (e-cigarettes). Public health professionals often inform 
individuals only about a recommended option, i.e. the option that is scientifically 
proven to be the healthiest. For example, they provide a brochure in order to 
inform parents about vaccinating their children according to the schedule of 
the National Immunization Program (NIP).1,2 However, this recommended option 
might not be suitable for all individuals due to different personal values, priorities 
with regard to health, previous experiences, opinions, and the norms of their 
social environment. Consequently, in these cases people may prefer to choose 
options that match their individual values and goals; yet, these options may 
be considered by public health professionals as, for example, ‘next to best’. 
Next to best health options are – from a public health and scientific point of 
view – less harmful or healthier than the unrecommended health option, but less 
preferred than the recommended option. Another option people may choose is 
the unrecommended option, which is considered as being unhealthy by public 
health experts and science. 
To expand our understanding of these next to best health decisions, we had two 
aims. First, we examined determinants influencing the decision about smoking 
behavior and childhood vaccination, both qualitatively and quantitatively. 
Second, we examined the extent to which decisions regarding smoking behavior 
and childhood vaccination adhere to the criteria of informed decision-making. 
The results may facilitate and support communication programs that incorporate 
decision-making about smoking behavior and childhood vaccination. 
Relevance of research into next to best health decisions
E-cigarette use
In recent years a shift from recommended to next to best health options could 
be noticed. In the case of e-cigarettes, research has demonstrated that since 
their introduction in 2003, the appeal of e-cigarettes has increased rapidly.3-9 The 
number of people who smoke in the Netherlands is decreasing.10,11 In 2017, 23% 
of the adult Dutch population smoked cigarettes.11 Of these 23%, 75% smoke 
daily. Three percent of Dutch adults use an e-cigarette. Ten percent of the current 
smokers sometimes use an e-cigarette, and daily smokers (12%) use an e-cigarette 
more often compared to non-daily smokers (4%). However, decision-making 
about e-cigarette use is largely uninvestigated, it is unclear how people make a 
decision about smoking and vaping behavior. In this thesis these decisions were 
investigated in order to provide information for health communication aimed to 
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support these decisions. The current chapter will provide information how the 
findings of this thesis might be used for health communication strategies aimed 
to support decisions about smoking and vaping behavior. 
Partially accepting childhood vaccination
For childhood vaccination a decrease in the vaccination coverage and an increase 
in the unrecommended and next to best health option was found in previous 
years. Of all Dutch two-year-olds born in 2014 3.6%  did not receive any vaccines 
according to the NIP and 5.2% received or delayed some vaccines, and of Dutch 
two-year-olds born in 2015 4.6% did not receive any vaccines according to the 
NIP and 5.2% received or delayed some vaccines.12 However, the vaccination 
coverage does not provide insight into whether parents have questions or 
doubts regarding their decision or how parents made a decision about childhood 
vaccination. For example, parents who accept all childhood vaccinations, may 
still have doubts about their decision or even experience regret.13-15 Or parents 
who refused childhood vaccination may have based this decision on fear of side-
effects their child may experience due to a vaccine. Because little is known about 
the doubts and regret parents may face with regard to accepting, refusing, and 
partially accepting childhood vaccination it is important to investigate decision-
making. The current chapter will provide information about how the findings 
of this thesis might be used for health communication strategies aimed at 
supporting parents with decision-making about childhood vaccination.
Activities as a result from this thesis
Further steps for health communication 
With regard to the next to best health option, further research is needed. 
Although recommended health options can be considered as most beneficial 
for public health,6,16-19 next to best health options have potential individual 
and public health benefits compared to unrecommended health options.16,20-30 
However, in itself, next to best health options are not the most beneficial for 
individual health nor without risks.6,31,32 Consequently, these options are not 
recommended from a public health perspective. 
Even though an option may not be recommended by public health experts, people 
search for information that reinforces their chosen option or may facilitate arriving 
at their desired decision,33,34 and thus, it is important to provide evidence-based 
information about all options. Based on our results, we recommended further 
research to investigate the effects of communicating about the recommended 
health options, the unrecommended option, and the next to best health options. 
The current findings have instigated several efforts targeting the communication 
about childhood vaccination. Efforts have been made to investigate the effects 
of communicating about the recommended, unrecommended, and next to best 
health options on decision-making. In particular, the effect of communicating 
about these options on the intention to towards accepting or refusing the 
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recommend health option and on decisional conflict experienced. Insights 
generated from these studies will further aid public health experts and policy 
makers in determining the goals of health communication. In addition, the results 
of such a experimental study may generate input for the communication effort of 
the RIVM. For example, the brochure presented to parents may be adapted as a 
result of this study.1,2,35-37
Considerations for the RIVM
The RIVM is currently responsible for informing parents about the National 
Immunization Program. For this purpose, they use a standard brochure that all 
new parents receive after the birth of their child.1,2,35-37 With an experimental 
design researchers from the RIVM want to investigate what the effects are of 
communicating about accepting (i.e. the recommended health option), refusing 
(the unrecommended health option), and partially accepting (i.e. the next to 
best health option) versus solely communicating about accepting childhood 
vaccination, on two primary outcomes: decisional conflict38 related to the decision 
about childhood vaccination and intention towards childhood vaccination. The 
results of this study will inform policy makers about further steps needed in 
communication strategies.
Considerations for policy makers and health professionals
The results of this thesis and the experimental study may prove useful for policy 
makers. Policy makers may have different goals with providing information with 
regard to various health behaviors.39 If policy makers opt for providing scientific 
information without steering, they may want to facilitate informed decision-
making, which may lead to more people choosing the unrecommended health 
option. On the other hand, if policy makers and health professionals do not include 
information about alternative health options – and thus neglect other options 
that may be considered – and only inform the public about the recommended 
health option, the public may search for information about alternative health 
options on informal channels. Not providing information about unrecommended 
or next to best health options, may thus facilitate biased information processing 
among the public and decrease trust in public health experts due to a lack 
of transparency. The experimental study may thus generate insight for policy 
makers. For example, if experienced conflict is reduced and the intention to 
accept the recommended health option remains the same or increases, then 
communicating about all three health options does not harm public health, 
then supporting decision-making may be a possible goal of communication. 
However, if intention to accept the recommended health option is reduced due 
to communicating about all three health options, then communicating about 
all three health options may not be desired and persuasion may be a goal of 
communication.
The results of this thesis may furthermore prove useful for health professionals. 
Health professionals, such as GPs and general practice-based nurse specialists, 
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may be able to play an important role in the decision-making process about 
switching from cigarettes to e-cigarettes. Similarly, Child Vaccine Providers (CVPs) 
at the Child Welfare Centers (CWCs) may be important to assist in decision-
making about childhood vaccination. With insight into factors that can support 
the decision-making process, health professionals may be able to exchange 
evidence-based information, address misperceptions and doubts, strengthen 
positive attitudes, answer questions, and discuss the various choice options. 
Dissemination of results
This thesis resulted in several publications in scientific journals. These describe 
decision-making factors with regard to two relevant public health behaviors and 
provide implications for health communication. Our results about e-cigarette 
use and childhood vaccination generated media attention. For example, several 
news items were published by the RIVM, and a major Dutch newspaper. We 
discussed our findings at international and national conferences, and we were 
invited to speak at Yale University, the Virginia Common Wealth University at 
Richmond, and the Gillings School of Global Public Health in Chapel Hill. Policy 
makers, including the Dutch Secretary of Health, showed great interest in our 
results during multiple meetings. For example, policy makers were advised 
about a survey related to the attractiveness of e-cigarettes and we spoke 
about the decision-making of parents who refuse or partially accept childhood 
vaccination with the Dutch Secretary of Health. In addition, our results about 
the attractiveness of e-cigarettes were used by the Dutch secretary of health to 
strengthen his argument to ban the sales of non-tobacco e-liquid flavors and 
expand existing smoking bans to include e-cigarette use.40 These measures 
are part of the national prevention agreement that aims to achieve a smoke 
free generation in 2040.40 Results of our studies were also used in the yearly 
surveillance report of the Dutch National Immunization program, this led to 
multiple publications.1,12 Every year,  surveillance and scientific developments 
are presented in a report of the National Immunization Program, in 2018 and 
2019 our results were used to describe the scientific developments related to 
decision-making about childhood vaccination. 
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Health-related decisions often involve a variety of options. Public health 
professionals often inform the public about an option they recommend based 
on scientific evidence. However, this healthiest, recommended option might 
not be suitable for everyone due to their personal values, priorities with 
regards to health, previous experiences, opinions, and the norms of their social 
environment. Consequently, in these cases people may choose options that 
match their individual values and goals but are considered by public health 
professionals as, for example, ‘next to best’. Next to best health options are 
– from a public health and scientific point of view – less harmful or less healthy 
than the unrecommended health option, but not less harmful or less healthy 
compared to the recommended health option. Another option people may 
choose is the unrecommended option, which is considered as unhealthy by 
public health experts and science. 
In this thesis we explored two examples of decisions in which an increase in the 
next to best health decision (i.e. e-cigarette use and partially accepting childhood 
vaccinations) was observed. To expand our understanding of these next to best 
health decisions, the aim of this thesis was twofold. The two aims were related to 
improving our understanding of the next to best health decisions in the context 
of smoking behavior and childhood vaccination. First, this thesis aimed to explore 
which socio-cognitive factors, such as perceived susceptibility and severity, trust, 
anticipated regret, social support, and self-efficacy, are related to the decisions 
regarding smoking behavior and childhood vaccination. With this in mind, we 
conducted qualitative and quantitative studies to explore and determine socio-
cognitive factors related to the decisions regarding e-cigarette use among never-
users, smokers, dual users, and exclusive e-cigarette users, as well as decisions 
concerning childhood vaccination among parents who choose to accept, refuse 
or partially vaccinate their child. Second, this thesis investigated whether the 
decisions with regard to smoking behavior and childhood vaccinations adhered 
to the criteria of informed decision-making. To this end, we explored differences 
in knowledge, attitude, and deliberation, as well as decisional conflict of those 
who opted for the recommended, the unrecommended, and the next to best 
health options. It is important to investigate the criteria for informed decision-
making because supporting informed decision-making may reduce decisional 
conflict and support decision-making in general. 
Part I Exploring factors related to decision-making about smoking 
behavior
In the first part of the thesis, Chapters 2 – 5 focus on smoking behavior. 
Chapter 2 describes a narrative systematic review of perceptions and reasons 
for e-cigarette use. Results indicate that e-cigarette users perceive e-cigarettes 
as being less harmful than cigarettes. In addition, reasons for and benefits of 
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e-cigarette use reported by never-users were the novelty of the product and that 
it can aid concentration. Smokers mentioned that it mimics the smoking routine, 
whereas dual users reported benefits of avoiding smoking restrictions and the 
practicality of e-cigarettes. E-cigarette users reported benefits of increased 
athletic performance and that e-cigarettes can be used discretely. 
Chapter 3 presents results from a qualitative focus group study into factors that 
play a role in the decision regarding e-cigarette use. Socio-cognitive factors, such 
as knowledge, perceived risks of e-cigarettes compared to cigarettes, trust in 
information, attitudes, and social norms about e-cigarette use, and deliberation 
were reported to be of influence in decisions related to smoking behavior and 
e-cigarette use. 
Chapters 4 and 5 describe the results of a quantitative questionnaire into product 
characteristics of e-cigarettes and socio-cognitive factors related to the decision 
concerning smoking behavior. Results indicate that of all product characteristics 
investigated in chapter 4 (e.g. amendable nicotine levels or adjustable settings 
of e-cigarettes), e-liquid flavors were reported to be the most attractive aspect 
of e-cigarettes by all user groups. For example, menthol/mint and sweet e-liquid 
flavors were preferred by never-users, tobacco and menthol/mint e-liquid flavors 
were preferred by smokers and dual users, and sweet and fruit flavors were 
preferred by e-cigarette users compared to other flavor categories. In addition, 
dual users – dual use of tobacco cigarettes and e-cigarettes – and exclusive 
e-cigarette users – exclusive use of e-cigarettes – are two distinct e-cigarette 
user groups. 
Chapter 5 presents our quantitative exploration of distinguishing features 
between these groups, and results indicate that seven features are important 
to distinguish a dual user from an exclusive e-cigarette user with 86% certainty: 
(1) compared to exclusive e-cigarette users, dual users felt more connected to 
other smokers; (2) the quantity of tobacco cigarettes smoked in the past was 
higher among exclusive e-cigarette users than the quantity smoked currently 
by dual users; (3) self-efficacy to quit vaping and smoking was lower among 
dual users; (4) e-cigarette users found the cigarette unattractive more often than 
dual users did; (5) e-cigarette users had more positive attitudes towards vaping 
than dual users; (6) dual users perceived more barriers to accessing e-cigarettes; 
and (7) dual users had a stronger intention to quit vaping than e-cigarette users 
(chapter 5). The findings from part I expand our knowledge of factors related to 
the decision about the next to best health decision: e-cigarette use. 
Part II Exploring factors related to decision-making about 
childhood vaccination
In part II, chapters 6 – 7 focus on childhood vaccination. Chapter 6 presents 
results from a qualitative focus group study into factors that play a role in the 
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decision regarding childhood vaccination. Results indicate that several socio-
cognitive factors play a role in the decision to either accept, refuse, or partially 
accept childhood vaccinations, such as knowledge, perceived susceptibility and 
severity, trust in information, attitudes, anticipated regret, social norms, and 
deliberation.
Chapter 6 shows that partial acceptors perceived fewer risks of vaccine-
preventable diseases (VPDs), more risks of side-effects of vaccines, less social 
support from their environment, and less trust in child welfare centers (CWCs) and 
information provided by the CWCs than acceptors. Partial acceptors reported 
having made a deliberate decision, and described this process of deliberation as 
elaborate, time-consuming, and difficult. Acceptors and refusers indicated that 
they had not given much thought to partially accepting childhood vaccination, 
(chapters 6 and 7). 
Chapter 7 presents the results of a quantitative survey investigating factors 
related to the decision concerning childhood vaccination. Results demonstrate 
that acceptors perceived the susceptibility of side-effects of vaccines as lower 
compared to the susceptibility of VPDs if (some) vaccines are refused. Refusers 
and partial acceptors perceived the susceptibility of side-effects of vaccines to be 
higher compared to that of the VPDs. While anticipated regret towards negative 
consequences of VPDs was high among acceptors when considering refusing 
childhood vaccinations, anticipated regret among refusers and partial acceptors 
with regard to potential side-effects for the child was high when considering 
accepting vaccines. All parents reported a social norm favoring accepting 
childhood vaccinations. Trust in the National Immunization Program (NIP) was 
high among acceptors but moderate among refusers and partial acceptors. 
Partial acceptors experienced more barriers with regard to vaccination than 
refusers and acceptors. With regard to decisional conflict, on the decisional 
conflict scale, acceptors scored highest on uninformed, refusers scored highest 
on unsupported, and partial acceptors scored highest on uncertainty. The 
findings of part II expand our knowledge of factors related to the decision about 
the next to best health decision: partially accepted childhood vaccinations. 
Part III Decision-making
In part III, chapter 8 presents the results of two quantitative surveys investigating 
smoking behavior and childhood vaccination. The aim of these studies was 
to investigate whether the decisions about smoking behavior and childhood 
vaccination adhered to criteria – knowledge, attitudes, and deliberation – of 
informed decision-making. The results indicate that overall, decisions about 
smoking behavior and childhood vaccination did not adhere to at least 
one of the criteria of informed decision-making. Those who opted for the 
recommended health option (i.e. never-users and acceptors) had relatively low 
levels of deliberation about their decision or the alternative health options. In 
addition, cognitive beliefs of smokers, e-cigarette users, refusers, and partial 
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acceptors did not correspond with scientific evidence. Those who chose the next 
to best health option reported levels of knowledge, attitudes, and deliberation 
in-between those who chose the recommended and unrecommended health 
option. Whereas vaccine refusers had deliberated their decision thoroughly, 
smokers were found to report low levels of deliberation and were negative 
with regard to their own behavior. Those who chose for the next to best health 
decision were not outspokenly negative towards the recommended health 
option but e-cigarette users were outspokenly negative towards smoking. 
In the general discussion in chapter 9, it is observed that further research is 
needed to investigate how to communicate about next to best health options, 
such as e-cigarette use and partially accepting childhood vaccination. Although 
not smoking or not using e-cigarettes and accepting childhood vaccinations can 
be considered as most beneficial for public health, e-cigarette use or partially 
accepting childhood vaccination has potential individual and public health 
benefits compared to smoking or refusing all vaccines. However, e-cigarette use 
and partially accepting childhood vaccinations are not beneficial for individual 
health or without risks. Consequently, these options are not recommended from 
a public health perspective. Based on our results, we would recommend further 
research to investigate the effects of communicating about the recommended 
health options (e.g. not smoking or not using e-cigarettes, and accepting 
childhood vaccinations), the unrecommended option (e.g. smoking or refusing 
childhood vaccinations), and the next to best health options (e.g. e-cigarette 
use and partially accepting childhood vaccination). Such research could test 
the effect, appreciation, and acceptability of providing information on all health 
options on decision-making and intention to accept the recommended option 
in comparison to standard information. With regard to communicating about 
best and other options, it is important to articulate clearly which particular goals 
public health experts want to achieve. They may consider it their goal to provide 
scientific information without providing advice or decisional support. Another 
goal may be to facilitate informed decision-making even though the consequence 
of this may be that more people will choose the unrecommended or next to best 
option rather than the recommended option, thereby increasing public health 
risks. Alternatively, public health experts may choose to take a more directive 
approach to get as many people as possible to choose the recommended 
health option to increase public health gain. With this aim, several motivational 
techniques can be applied to steer the public in the desired and recommended 
direction. Rigorous testing of possible decisional effects of providing information 
on all options will allow public health experts and policy makers to make an 
informed decision on possible adaptation of current communication efforts. 
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Keuzes met betrekking tot gezondheid omvatten vaak verschillende opties. 
Vanuit het perspectief van volksgezondheid wordt het publiek geïnformeerd 
door experts over een optie die wordt aanbevolen op basis van wetenschappelijk 
bewijs. De gezondste, aanbevolen optie is mogelijk niet voor iedereen geschikt 
bijvoorbeeld vanwege persoonlijke waarden of prioriteiten met betrekking tot 
gezondheid. Ook kunnen eerdere ervaringen, meningen en de sociale omgeving 
een rol spelen. Daardoor kunnen mensen in deze gevallen opties kiezen die beter 
passen bij hun individuele waarden en doelen, maar die vanuit volksgezondheid 
worden beschouwd als een één na beste keuze. Één na beste keuzes zijn – vanuit 
het oogpunt van volksgezondheid en wetenschap – minder schadelijk of minder 
ongezond dan de niet-aanbevolen optie voor gezondheid, maar schadelijker 
of minder gezond vergeleken met de aanbevolen gezondheidsoptie. Een 
andere optie die mensen kunnen kiezen is de niet-aanbevolen optie, die door 
deskundigen op het gebied van de volksgezondheid en de wetenschap als 
ongezond wordt beschouwd.
In dit proefschrift heb ik twee voorbeelden onderzocht van gezondheid 
gerelateerde keuzes waarbij in de laatste jaren een toename van de één na 
beste keuze (dat wil zeggen het gebruik van e-sigaretten (ook wel dampen 
genoemd) en het gedeeltelijk accepteren van vaccinaties voor kinderen) werd 
waargenomen in Nederland. Om ons begrip over de één na beste keuzes te 
vergroten is dit proefschrift geschreven. Het doel beschreven in dit proefschrift 
is daarbij tweeledig. Ten eerste was het doel te onderzoeken welke sociaal-
cognitieve factoren verband houden met de keuze rondom rookgedrag en 
vaccineren van kinderen. Denk hierbij aan de perceptie met betrekking tot de 
kans en ernst van bijvoorbeeld infectieziekten, het vertrouwen in informatie over 
de e-sigaret, verwachte spijt over het weigeren van vaccinaties, sociale steun en 
zelfeffectiviteit. Met dit in gedachten hebben wij kwalitatieve en kwantitatieve 
onderzoeken uitgevoerd om sociaal-cognitieve factoren te onderzoeken en te 
bepalen of deze factoren een rol spelen bij de keuzes over het gebruik van 
e-sigaretten bij niet-gebruikers, rokers, exclusieve e-sigaretgebruikers, en 
‘dual users’ (dit zijn gebruikers die zowel tabakssigaretten als e-sigaretten 
gebruiken) en exclusieve e-sigaretgebruikers. Een vergelijkbaar onderzoek heb 
ik uitgevoerd met betrekking tot keuzes over vaccinatie van kinderen onder 
ouders die het Rijksvaccinatieprogramma volgen, die alle vaccinaties weigeren 
of die gedeeltelijk vaccineren. Ten tweede onderzochten wij in dit proefschrift 
of de keuzes rondom rookgedrag en vaccinaties voor kinderen voldeden aan 
de criteria van geïnformeerde besluitvorming. Daartoe heb ik de verschillen in 
kennis, houding en deliberatie onderzocht, evenals twijfels onder ouders die het 
Rijksvaccinatieprogramma volgen, die alle vaccinaties weigeren of die gedeeltelijk 
vaccineren. Het is belangrijk om de criteria voor geïnformeerde besluitvorming 
te onderzoeken omdat het ondersteunen van geïnformeerde besluitvorming 
twijfels kan verminderen en de kwaliteit van besluitvorming kan verbeteren.
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Deel I Onderzoek naar factoren gerelateerd aan de keuze rondom 
rookgedrag
In het eerste deel van dit proefschrift gaan de hoofdstukken 2 – 5 in op rookgedrag. 
Hoofdstuk 2 beschrijft een systematische review van percepties ten opzichte van 
de e-sigaret en redenen voor het gebruik van e-sigaretten. De resultaten geven 
aan dat e-sigaretgebruikers de e-sigaret als minder schadelijk beschouwden 
dan sigaretten. Niet-gebruikers gaven aan dat ‘de nieuwigheid van het product’ 
en ‘de verwachting dat het de concentratie kan bevorderen’ voordelen zijn van 
het gebruik van e-sigaretten. Rokers gaven aan dat de e-sigaret de rookroutine 
nabootst, terwijl ‘dual users’ voordelen rapporteerden zoals het vermijden van 
rookbeperkingen en het gemak van e-sigaretten. E-sigaret gebruikers meldden 
voordelen van verbeterde atletische prestaties en dat e-sigaretten discreet 
kunnen worden gebruikt.
Hoofdstuk 3 presenteert resultaten van een kwalitatieve focusgroep studie 
naar factoren die een rol kunnen spelen bij de beslissing over het gebruik van 
e-sigaretten. De resultaten laten zien dat sociaal cognitieve factoren van invloed 
zijn bij keuzes rondom rookgedrag en het gebruik van e-sigaretten. Hierbij valt 
te denken aan kennis, de perceptie van de kans en ernst van e-sigaretten in 
vergelijking met sigaretten, vertrouwen in informatie over de e-sigaret, houding 
en sociale normen over het gebruik van e-sigaretten, en deliberatie.
Hoofdstukken 4 en 5 beschrijven de resultaten van een kwantitatieve vragenlijst 
naar productkenmerken van e-sigaretten en sociaal cognitieve factoren 
gerelateerd aan de keuzes rondom rookgedrag. De resultaten geven aan dat 
van alle productkenmerken die in hoofdstuk 4 zijn onderzocht (bijvoorbeeld 
het kunnen aanpassen van nicotinegehalten of aanpasbare instellingen van 
e-sigaretten), de variatie aan smaken van e-vloeistoffen voor de e-sigaret door 
zowel niet-gebruikers als gebruikers als het meest aantrekkelijke aspect van 
e-sigaretten werd bevonden. Zo gaven niet-gebruikers de voorkeur aan menthol/
munt en zoete e-vloeistof smaken in vergelijking met andere smaakcategorieën. 
Rokers en ‘dual users’ gaven de voorkeur aan tabak en menthol/munt e-vloeistof 
smaken in vergelijking met andere smaakcategorieën. E-sigaretgebruikers 
gaven de voorkeur aan zoete smaken en fruitsmaken in vergelijking met andere 
smaakcategorieën. Bovendien laten de resultaten zien dat dual– en exclusieve 
e-sigaretgebruikers verschillende smaakvoorkeuren hadden met betrekking tot 
e-vloeistoffen terwijl beide gebruikersgroepen van e-sigaretten zijn.
Hoofdstuk 5 presenteert de kwantitatieve verkenning van onderscheidende 
kenmerken tussen de twee e-sigaretgebruikersgroepen. De resultaten geven 
aan dat zeven kenmerken belangrijk zijn om met 86% zekerheid een ‘dual user’ 
te onderscheiden van een exclusieve e-sigaretgebruiker: 
1) Vergeleken met exclusieve e-sigaretgebruikers, voelden ‘dual users’ zich 
meer verbonden met andere rokers; 
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2) De hoeveelheid tabak sigaretten die in het verleden werd gerookt is hoger 
onder exclusieve e-sigaretgebruikers dan de hoeveelheid die momenteel 
werd gerookt door ‘dual users’; 
3) De eigen-effectiviteit om te stoppen met ‘dampen’ en roken was lager bij 
‘dual users’; 
4) Exclusieve e-sigaretgebruikers vonden de sigaret vaker onaantrekkelijk dan 
‘dual users’; 
5) E-sigaretgebruikers hadden een positievere houding ten opzichte van 
‘dampen’ dan ‘dual users’; 
6) ‘Dual users’ zagen meer belemmeringen rondom de verkrijgbaarheid van 
e-sigaretten; 
7) ‘Dual users’ hadden een sterkere intentie om te stoppen met ‘dampen’ dan 
exclusieve e-sigaretgebruikers (hoofdstuk 5). 
De bevindingen van deel I vergroten de kennis over factoren die een mogelijke 
rol spelen bij de keuze rondom een één na beste keuze: het gebruik van de 
e-sigaret.
Deel II Onderzoek naar factoren gerelateerd aan de keuze rondom 
vaccinaties voor kinderen
In deel II gaan de hoofdstukken 6 – 7 in op de keuze van ouders rondom 
vaccinaties van kinderen. Hoofdstuk 6 presenteert resultaten van een kwalitatieve 
focusgroep studie naar factoren die een rol spelen bij de keuze rondom 
vaccinatie voor kinderen. De resultaten geven aan dat verschillende sociaal-
cognitieve factoren mogelijk een rol spelen bij de keuze om vaccinaties voor 
kinderen al dan niet te accepteren, te weigeren of gedeeltelijk te accepteren. 
Het gaat daarbij om de aspecten kennis, de perceptie van de kans en ernst van 
infectieziekten en bijwerkingen, vertrouwen in informatie, houding, verwachte 
spijt, sociale normen en deliberatie.
Hoofdstuk 6 laat zien dat ouders die hun kind gedeeltelijk vaccineren een 
lage perceptie hebben van de risico’s rondom de infectieziekten en een hoge 
perceptie van de risico’s rondom de bijwerkingen van vaccins. Ook ervaren zij 
weinig sociale steun vanuit hun omgeving met betrekking tot de keuze over 
vaccineren en rapporteren zij weinig vertrouwen te hebben in de (informatie van 
de) consultatiebureaus. Ouders die hun kind gedeeltelijk vaccineren meldden een 
weloverwogen keuze te hebben genomen en beschreven het deliberatieproces 
als uitgebreid, tijdrovend en moeilijk. Ouders die het Rijksvaccinatieprogramma 
wel of helemaal niet volgen gaven aan niet veel aandacht te hebben besteed 
aan de optie om hun kind gedeeltelijk te vaccineren van kinderen (hoofdstukken 
6 en 7).
Hoofdstuk 7 presenteert de resultaten van een kwantitatieve studie naar 
factoren die verband houden met de keuze rondom vaccinatie voor kinderen. 
Samenvatting 253
De resultaten tonen aan dat ouders die het Rijksvaccinatieprogramma volgen 
de kans op bijwerkingen van vaccins als lager inschatten dan de kans op het 
krijgen van een infectieziekte als zij (sommige) vaccins zouden weigeren. Ouders 
die vaccins weigeren of sommige vaccins accepteren gaven aan dat de kans 
op bijwerkingen door een vaccinatie hoger is dan de kans voor het kind om 
een infectieziekte op te lopen. Ouders die het Rijksvaccinatieprogramma 
volgen verwachtten een hogere mate van spijt met betrekking tot de negatieve 
gevolgen van infectieziekten als gevolg van het weigeren van vaccinaties. Ter 
vergelijking, ouders die alle vaccinaties weigeren of ouders die gedeeltelijk 
vaccineren verwachten een hogere mate van spijt met betrekking tot de 
mogelijke bijwerkingen voor het kind van vaccins als gevolg van het volgen van 
het Rijksvaccinatieprogramma. Alle ouders rapporteerden een positieve sociale 
norm die uitgaat van het zijn van een voorstander inzake het accepteren van 
vaccinaties voor kinderen. Het vertrouwen in het Rijksvaccinatieprogramma 
was hoog bij ouders die dit programma volgen, maar matig bij ouders die 
alle vaccinaties weigeren of gedeeltelijk vaccineren. Ouders die gedeeltelijk 
vaccineren ondervonden meer belemmeringen op het gebied van het maken 
van een keuze rondom vaccineren dan ouders die alle vaccinaties weigeren of 
accepteren. Wat betreft twijfels met betrekking tot de keuze, rapporteerden 
ouders die alle vaccinaties accepteren zich niet geïnformeerd te voelen. 
Ouders die alle vaccinaties weigeren gaven aan onvoldoende ondersteuning 
te ontvangen van hun omgeving. Ouders die gedeeltelijk vaccineren gaven aan 
onzeker te zijn over de keuze. De bevindingen van deel II geven inzicht in de 
factoren die verband houden met de één na beste keuze: het gedeeltelijk (laten) 
vaccineren van kinderen.
Deel III Besluitvorming 
In deel III – hoofdstuk 8 – worden de resultaten gepresenteerd van twee 
kwantitatieve studies naar rookgedrag en vaccinatie voor kinderen. Het doel van 
deze studies is om te onderzoeken of de keuzes rondom rookgedrag en vaccinatie 
voor kinderen voldoen aan criteria (voldoende kennis en deliberatie en een 
positieve houding t.a.v. het eigen gedrag) van geïnformeerde besluitvorming. 
De resultaten laten zien dat beslissingen over rookgedrag en vaccinatie bij 
kinderen in het algemeen niet voldeden aan ten minste één van de criteria voor 
geïnformeerde besluitvorming. 
Participanten die kozen voor de aanbevolen gezondheidsoptie (dat wil 
zeggen niet-gebruikers en ouders die het Rijksvaccinatieprogramma volgen) 
rapporteerden relatief weinig deliberatie rondom de gemaakte keuze en/of de 
alternatieve keuzeopties. 
De overtuigingen van participanten die gekozen hebben voor de niet aanbevolen 
en één na beste keuze kwamen niet overeen met het wetenschappelijk bewijs 
(hoofdstuk 3, 6 en 8). Deze overtuigingen zijn een mogelijke verklaring waarom 
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deze participanten niet voldeden aan het criterium van ‘voldoende kennis’. 
Participanten die voor de één na beste keuze optie kozen rapporteerden 
niveaus van kennis, houding en deliberatie die vallen tussen participanten die 
voor de aanbevolen en de niet-aanbevolen gezondheidsoptie kozen. Terwijl 
vaccinweigeraars hun keuze grondig hebben overwogen en positief waren 
over de gemaakte keuze, rapporteerden rokers een lage deliberatie en waren 
rokers negatief over hun eigen gedrag. Participanten die kozen voor de één 
na beste keuze waren niet uitgesproken negatief tegenover de aanbevolen 
gezondheidsoptie, maar opvallend was dat de e-sigaretgebruikers uitgesproken 
negatief waren over roken (dat wil zeggen de niet-aanbevolen optie).
Met betrekking tot participanten die voor de niet-aanbevolen optie gekozen 
hebben laten de resultaten zien dat vaccinweigeraars hun keuze grondig hadden 
overwogen en positief waren over de gemaakte keuze, terwijl rokers een lage 
deliberatie blijken te melden en dat rokers negatief waren over hun eigen 
gedrag. 
Algemene discussie 
In de algemene discussie in hoofdstuk 9 wordt opgemerkt dat verder onderzoek 
nodig is om te onderzoeken hoe men het beste kan communiceren over ‘één 
na beste keuzes’, zoals e-sigarettengebruik en gedeeltelijk vaccineren. Hoewel 
niet roken of niet ‘dampen’ en het volgen van het Rijksvaccinatieprogramma 
als het meest gunstig voor de volksgezondheid kan worden beschouwd, 
heeft e-sigaretgebruik of gedeeltelijk vaccineren potentiële individuele en 
volksgezondheidsvoordelen in vergelijking met traditioneel roken of het 
weigeren van alle vaccins. E-sigaretgebruik en gedeeltelijk vaccineren zijn 
niet per se gunstig voor de individuele gezondheid of zonder risico. Daarom 
worden deze één na beste keuzes niet aanbevolen vanuit het perspectief van 
de volksgezondheid. Dergelijk onderzoek zou het effect, de waardering en de 
aanvaardbaarheid kunnen testen van het verstrekken van informatie over alle 
gezondheidsopties rondom de besluitvorming. Ook is het dan mogelijk om de 
intentie om de aanbevolen optie te accepteren of te weigeren te testen bij het 
communiceren over alle drie de opties in vergelijking met de intentie om de 
aanbevolen optie te accepteren of te weigeren bij standaardinformatie. 
Wat betreft het communiceren over de aanbevolen en andere opties, 
is het belangrijk om duidelijk te verwoorden welke specifieke doelen 
volksgezondheidsdeskundigen willen bereiken. Zij kunnen het als hun doel 
beschouwen om wetenschappelijke informatie te verstrekken zonder advies 
of beslissingsondersteuning. Een ander doel kan zijn om geïnformeerde 
besluitvorming te ondersteunen, hoewel het gevolg hiervan kan zijn dat meer 
mensen de niet-aanbevolen of één na beste keuze optie zullen kiezen in plaats van 
de aanbevolen optie, waardoor de risico’s voor de volksgezondheid toenemen. 
Als alternatief kunnen deskundigen kiezen om een  meer sturende benadering te 
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volgen om zoveel mogelijk mensen de aanbevolen gezondheidsoptie te laten 
kiezen en de winst voor de volksgezondheid te vergroten. Met dit doel kunnen 
verschillende motivatietechnieken (persuasieve technieken) worden toegepast 
om het publiek in de gewenste richting te sturen. Volksgezondheidsdeskundigen 
en beleidsmakers kunnen op basis van de doorslaggegeven effecten van 
communiceren over alle drie de opties, een weloverwogen keuze maken over 
het aanpassen en het doel van de huidige communicatiestrategieën.
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Appendix 1 Search Strategy for OvidMedline®
Chapter 2
Perceptions and Reasons Regarding E-Cigarette Use among Users and Non-Users: 
A Narrative Literature Review
Data Source Provider/Interface Ovid
Database Medline®
Date searched 09-02-2016 
Database update 09-02-2017
Search developer(s) Wim ten Have & Kim Romijnders
Limiters 
& other 
information
English only? (default is 
"y")
y
Date restrictions 1950–present
Note: an asterisk is used as a wildcard symbol to broad the search by including words 
that start with the letters before the asterisk.
Search Strategy
1 (electr* adj (cigar* or nicotine)).tw. (803)
2 ((electronic or electrically) adj3 (cigar* or nicotine)).tw. (852)
3 (e-cig* or ecig* or e-cigarette* or ecigarette* or e-nicotine* or enicotine*).tw. 
(846)
4 electronic cigarettes/(439)
5 1 or 2 or 3 or 4 (1316)
6 (initiation or motivation* or motives or reason* or attitude* or belief* or 
expectan* or understanding or knowledge or reactions or awareness or 
perception* or opinion or views or debate* or discussion* or image or popularity 
or desirab* or demand).ti. (409599)
7 ((frequency adj5 ("use" or usage)) or (real-world adj5 ("use" or usage))).tw. 
(12469)
8 (("use" or usage) and (frequency or prevalence or among or change* or emerg* 
or factors or associations or trends or traditional or conventional or locations)).ti. 
(31844)
9 motivation/or perception/or awareness/or attitude/or attitude to health/or 
public opinion/or consensus/or focus groups/or social desirability/or consumer 
behavior/ (252874)
10 (internet or social media or Facebook or Twitter or YouTube).ti. or internet/ or 
social media/(59745)
11 5 and (6 or 7 or 8 or 9 or 10) (300)
12 (vaping or behavio?r*).ti. or (smoking sensation or smoking characteristics or 
sensation seeking).tw. or sensation/ or smoking/px or electronic cigarettes/px 
(247982)
13 5 and 12 (135)
table continues
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Search Strategy
14 harm reduction.ti. or harm reduction.ot. or harm reduction/ (2185)
15 5 and 14 (68)
16 (relative harm or product harm or cessation).ti. or (relative harm or product harm 
or cessation).ot. (11395)
17 smoking cessation/ or "tobacco use cessation"/ or health behavior/ or risk 
reduction behavior/ or treatment outcome/ (768920)
18 (effect or effects or efficacy or effectiv* or benefit or evidence* or consequences 
or impact or success* or public support or comparison or compared or control 
policies or strateg* or cochrane or foundation).ti. (2501872)
19 5 and (16 or 17) and 18 (58)
20 (marketing or advertis* or commercials or communicating or communicat*).ti. 
(60382)
21 marketing/ or commerce/ or communication/ or exp advertising as topic/ or 
advertisements.pt. (102541)
22 5 and (20 or 21) (131)
23 (policy or policies or strateg* or public health or legislat* or regulat* or guideline* 
or government* or ban or bans or taxes or tax or taxation*).ti. (635686)
24 health policy/ or public policy/ or public health/ or social control policies/ or 
social control, formal/ or government regulation/ or legislation, medical/ or 
smoke-free policy/ or air pollution, indoor/lj or workplace/lj or restaurants/lj or 
smoking/lj or taxes/ or health promotion/ (235485)
25 (guideline or legislation).pt. (15644)
26 5 and (23 or 24 or 25) (274)
27 (effect or effects or efficacy or effectiv* or benefit or evidence* or consequences 
or impact or success* or public support or comparison).ti. (2373199)
28 26 and 27 (24)
29 (tobacco product*.ti. or tobacco products/) and (harm*.ti. or harm*.ot. or harm 
reduction/) (72)
30 11 or 13 or 15 or 19 or 22 or 28 or 29 (605)
31 (english or dutch).lg. (20815326)
32 30 and 31 (591)
33 (letter or comment or news).pt. (1342230)
34 32 not 33 (505)
35 remove duplicates from 34 (498)
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Appendix 2 Decision tree of Exclusion criteria in 
hierarchical order.
Chapter 2
Perceptions and Reasons Regarding E-Cigarette Use among Users and Non-Users: A 
Narrative Literature Review
#1 not e-cigarette
Does the article describe a subject which 
is not the electronic cigarette (e-cigarette), 
vaping/vapor? often ‘’e-cigarette/vaping’’ 
etc. is not mentioned in the title? 
Does the article describe tobacco, smoking 
or alternative tobacco products without 
mentioning the e-cigarette? 
Does the article describe a subject which is Does the article describe a subject which is
Yes? EXCLUDED based on exclusion criterion, #1. 
No? Move on to exclusion criterion #2.
#2 toxicology and vaping behavior
Does the article discuss the chemical 
composition of alternative tobacco 
products (e-cigarettes are thus clearly 
mention (otherwise excluded at #1)? 
· psychopharmacological properties, 
· chemical characteristics, 
· also testing for toxicity or safety, 
toxicological properties
· pharmacological attributes of nicotine, 
· components of e-liquids (Gas 
Chromatography-Mass Spectrometry 
analyses), 
· mention aerosol, air quality,
· Topography, 
· Effectiveness (not in relation to harm 
reduction) of nicotine delivery
· Safety/risks of an e-cigarette (use), 
· or ingredients, 
· burden of disease or
· innovations regarding e-cigarettes?
· health as an outcome, 
· nicotine health risks, 
· lung disease, 
· cancer, 
· mental illness, 
· blood levels 
· nicotine intake, 
· cravings (not as a subjective reasons 
given for e-cigarette use, but tested 
(e.g., experimental setting)
· comorbidity/relation with disease/
mental 
· dependency (i.e., drug/alcohol use in 
combination with e-cigarette use) 
Does the article describe the physiological 
response to e-cigarette use?
Does the article describe toxicological 
effects of e-cigarette use?
Does the article describe the use of non-
human subjects?
Yes? EXCLUDED based on exclusion criterion #2. 
No? Move on to exclusion criterion #3.
table continues
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table continues
#3 opinion article
Does the title or abstract revolve around or 
phrased in a way an opinion or stands with 
regard to the e-cigarette?
For example, feelings about the e-cigarette 
debate, or opinions about the e-cigarette 
or titles that suggests an opinion towards 
the e-cigarette, or analyzing debates/
opinions? Usually, the title is framed as a 
question (e.g., ‘’E-cigarettes: a nicotine 
gateway?’’)
Yes? EXCLUDED based on exclusion criterion #3
No? Move on to exclusion criterion #4
#4 market or marketing
Does the article describe the market of 
alternative tobacco products (specifically 
mentioning e-cigarettes)? 
Not related to participants describing 
awareness of e-cigarettes as a result of 
marketing strategies
Does the article describe marketing/
advertising of alternative tobacco products 
(specifically mentioning e-cigarettes)?
Examples · Market trends, 
· Sale points of e-cigarettes, 
· Retail, 
· Types of e-cigarettes on the market, 
· The increase in sales of e-cigarettes 
· The role of advertising on use
Yes? EXCLUDED based on exclusion criterion #4.
No? move on to exclusion criterion #5.
#5 harm reduction
Is the article about harm reduction/
smoking cessation?  
EXCEPTION: But Not Perceptions Of 
Study Participants Regarding Perceptions 
Of Harm Or Perceived Effectiveness As 
Smoking Cessation. 
Other than participants describing the 
use of an e-cigarette as a form of harm 
perceptions or as a reason why the use 
the e-cigarette?
Does the article discuss smoking cessation, 
with the e-cigarette as a tool
· Measured effectiveness as smoking 
cessation aid
· Evaluated the intention to quit 
smoking using e-cigarettes
Does the article discuss the public health 
debate surround the e-cigarette? 
Yes? EXCLUDED based on exclusion criterion 5#
No? move on to exclusion criterion #6
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#6 e-cigarette regulation
Does the article revolve around policy 
work/regulation/tobacco control/policy 
recommendations?
· Asking for policy change, 
· Describes policy change with regard 
to the e-cigarette, 
· The e-cigarette as a form of harm 
reduction policy (other than users 
describing perceptions of harm), 
· The e-cigarette in relation to tobacco 
control?
Yes? EXCLUDED based on exclusion criterion #6
No? move on to exclusion criterion #7
#7 subjective reports
Does the article describe the use of the 
e-cigarette by as rehabilitation?
· The use of e-cigarettes in out-patient 
centers, 
· Psychiatric clinics etc.
· How to use the e-cigarette? 
· Opinion on use other than users’ 
opinions themselves
· No subjective reports of perceptions 
or reasons provided
· Only description of awareness and 
patterns of use.
· Alternative use for other drugs, such 
as marijuana.
Does the article describe the use of 
e-cigarettes in institutionalized participants 
(not stop smoking services)
Does the article describe patterns of 
awareness?
Does the article describe patterns of use?
Yes? EXCLUDED based on exclusion criterion #7
No? move on to exclusion criterion #8
#8 gateway effect
Does the article describe the uptake of 
e-cigarettes or e-cigarettes as a gateway 
to other tobacco/drug products by 
individuals? 
EXCEPTION: Not the perception of 
participants that e-cigarettes are a gateway 
drug
Does the article describe the risk 
factors leading to uptake of e-cigarettes 
without describing subjective reports of 
perceptions and reasons?
EXCEPTION: Not if risk factors are the 
perceptions & reasons provided by 
subjective reports of participants
Yes? EXCLUDED based on exclusion criterion #8
No? move on to exclusion criterion #9
#9 not an article
Is it not an article, but newspaper 
dissertations, narratives, commentaries, 
gray literature, and editorials were 
excluded etc.?
Yes, fill in ‘’NO’’, and as exclusion criterion #9
No? move on to exclusion criterion #10
No? Fill in ‘’MAYBE, appropriate for inclusion’’ 
(End of exclusion criteria screening, continue for full text)
table continues
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#10 conflict of interest
Is there a conflict of interest? · Financial relationship questionable
· Related to the tobacco industry
#11 age restriction apply
Does the article include samples with 
unclear age restrictions?
· The article mentions age restriction for 
grades, however, not specific for age. 
If the grade falls well within the age 
restriction of <18, that age restriction 
do not apply. If students can be 18 or 
19. Age restriction apply
Does the article include a sample with 
overlap of adults and adolescents
· Age 15 to 19 years old
· 17 to 21 years old
· Etc. 
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(6
4%
). 
no
t l
es
s 
ad
di
ct
iv
e 
th
an
 s
m
ok
in
g 
(2
7%
). 
cu
rr
en
t s
m
ok
er
s 
m
or
e 
lik
el
y 
th
at
 e
-c
ig
ar
et
te
s 
co
ul
d 
he
lp
 s
m
ok
er
s 
qu
it 
(6
4%
). 
ev
er
 s
m
ok
er
s 
m
or
e 
lik
el
y 
th
an
 n
ev
er
 s
m
ok
er
s 
to
 b
el
ie
ve
 th
at
 e
-c
ig
ar
et
te
s 
ar
e 
ch
ea
pe
r t
ha
n 
re
gu
la
r c
ig
ar
et
te
s.
 
RE
A
SO
N
S 
to
p 
re
as
on
s:
 to
 re
du
ce
 o
r q
ui
t s
m
ok
in
g 
(5
8%
), 
cu
rio
si
ty
 (1
9%
), 
le
ss
 s
m
el
ly
 th
an
 c
ig
ar
et
te
s 
(1
9%
). 
Pe
rc
ei
ve
d 
he
al
th
ie
r (
13
%
) c
an
 re
pl
ac
e 
sm
ok
in
g 
ce
ss
at
io
n 
pr
od
uc
ts
 (1
3%
). 
ta
b
le
 c
o
nt
in
ue
s
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
7
B
aw
ej
a,
 
C
ur
ci
, 
Yi
ng
st
, e
t 
al
. 7
n=
20
0
U
S
M
ix
ed
 m
et
ho
ds
, s
el
f-
re
po
rt
 w
ith
 o
pe
n-
en
de
d 
qu
es
tio
ns
 
(n
=
20
0)
.
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 a
du
lt 
e-
ci
g 
us
er
s 
(c
ur
re
nt
 u
se
r i
s 
no
t s
pe
ci
fie
d)
.’ 
A
ll 
ad
ul
t 
(1
8 
ye
ar
s 
or
 o
ld
er
) e
-c
ig
ar
et
te
 u
se
rs
, m
ed
ia
n 
ag
e 
40
.5
 
ye
ar
s.
PE
RC
EP
TI
O
N
S 
pe
rc
ei
ve
d 
as
 le
ss
 h
ar
m
fu
l t
ha
n 
sm
ok
in
g 
(3
6.
5%
). 
Sa
fe
 w
ay
 to
 u
se
 n
ic
ot
in
e 
RE
A
SO
N
S 
he
al
th
 b
en
efi
t (
36
.5
%
), 
sm
ok
in
g 
ce
ss
at
io
n 
(2
5%
), 
va
pe
 q
ua
lit
y 
(9
4%
), 
ba
tt
er
y 
lif
e 
(8
2%
) a
nd
 
liq
ui
ds
 (5
9%
). 
St
ar
tin
g 
e-
ci
g 
us
e 
to
 q
ui
t t
ob
ac
co
 s
oo
n 
(7
3.
5%
), 
e-
ci
gs
 h
el
p 
qu
it 
sm
ok
in
g 
(9
3.
5%
).P
le
as
ur
ab
le
, 
im
pr
ov
e 
se
ns
e 
of
 s
m
el
l a
nd
 ta
st
e,
 c
os
ts
, r
ou
tin
e 
m
ai
nt
en
an
ce
, n
o 
od
or
s,
 s
oc
ia
l e
nv
iro
nm
en
t. 
D
ev
ic
e 
ch
ar
ac
te
ris
tic
s 
(d
es
ig
n;
 a
bi
lit
y 
to
 c
on
tr
ol
 v
ol
ta
ge
, 
si
m
pl
e 
to
 o
pe
ra
te
 a
nd
 m
ai
nt
ai
n,
 d
ur
ab
ili
ty
, c
on
si
st
en
t 
pe
rf
or
m
an
ce
 o
f e
-c
ig
 d
ev
ic
e 
an
d 
ex
pe
rie
nc
e,
 ta
st
e 
an
d 
va
rie
ty
 o
f fl
av
or
s;
 th
ro
at
 h
it,
 c
om
pa
tib
ili
tie
s 
of
 
va
rie
ty
 o
f e
-c
ig
 c
om
po
ne
nt
s,
 m
ac
hi
ne
 q
ua
lit
y,
 c
os
t 
of
 e
-c
ig
ar
et
te
 d
ev
ic
e,
 b
at
te
ry
 li
fe
, t
an
k 
si
ze
, s
af
et
y 
fe
at
ur
es
, e
as
y 
av
ai
la
bi
lit
y 
of
 e
-c
ig
s,
 a
nd
 th
e
ab
ili
ty
 to
 c
us
to
m
iz
e 
liq
ui
ds
 a
nd
 c
oi
ls
), 
sm
ok
in
g 
ce
ss
at
io
n 
an
d 
re
du
ce
d 
ci
ga
re
tt
e 
co
ns
um
pt
io
n;
 
un
ex
pe
ct
ed
 h
ea
lth
 e
ffe
ct
s;
 im
pr
ov
ed
 b
re
at
hi
ng
; 
de
cr
ea
se
d 
co
ug
h,
 fe
w
er
 s
or
e 
th
ro
at
s;
 p
le
as
ur
e 
&
 
sm
ok
in
g-
re
la
te
d 
ac
tio
ns
; l
es
s 
to
xi
c 
th
an
 s
m
ok
in
g 
to
ba
cc
o;
 s
en
se
 o
f s
m
el
l a
nd
 ta
st
e;
 le
ss
 e
xp
en
si
ve
 
th
an
 c
ig
ar
et
te
s;
 fe
as
ib
ili
ty
 to
 u
se
 e
-c
ig
s;
 s
im
ila
r 
ge
st
ur
es
 o
r a
ct
io
n 
of
 s
m
ok
in
g 
ci
ga
re
tt
e;
 n
o 
un
pl
ea
sa
nt
 
od
or
s;
 ta
st
e 
an
d 
va
rie
ty
 o
f fl
av
or
s;
 s
af
e 
fo
r o
th
er
s 
or
 b
ys
ta
nd
er
 w
ith
 n
o 
se
co
nd
 h
an
d 
sm
ok
e;
 c
ra
vi
ng
s;
 
de
nt
al
 h
ea
lth
. 
8
B
er
g 
8
n=
1,
56
7
U
S
C
ro
ss
-s
ec
tio
na
l (
n=
1,
56
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
; 
sm
ok
ed
 in
 th
e 
pa
st
 3
0 
da
ys
. F
or
m
er
 s
m
ok
er
; s
m
ok
ed
 
m
or
e 
th
an
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
ife
tim
e 
bu
t d
id
 n
ot
 
sm
ok
e 
in
 th
e 
pa
st
 3
0 
da
ys
.’ 
18
-3
4 
ye
ar
s 
ol
d;
 R
EA
SO
N
S 
fo
r u
se
 a
m
on
g 
cu
rr
en
t e
-c
ig
ar
et
te
 u
se
rs
PE
RC
EP
TI
O
N
S 
el
ec
tr
on
ic
 c
ig
ar
et
te
s 
w
er
e 
pe
rc
ei
ve
d 
as
 o
ne
 o
f t
he
 le
as
t h
ar
m
fu
l (
41
%
), 
ad
di
ct
iv
e 
an
d 
m
os
t 
so
ci
al
ly
 a
cc
ep
ta
bl
e.
RE
A
SO
N
S 
le
ss
 h
ar
m
fu
l t
ha
n 
ci
ga
re
tt
es
 (7
7%
), 
do
 n
ot
 
sm
el
l (
77
%
), 
sm
ok
in
g 
ce
ss
at
io
n 
(6
6%
), 
co
st
s 
(6
2%
), 
w
ei
gh
t m
an
ag
em
en
t (
6.
6%
) a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
 
(2
5.
2%
), 
so
ci
al
ly
 a
cc
ep
ta
bl
e 
(4
8.
7%
), 
fla
vo
rs
 (6
0.
2%
).
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ta
b
le
 c
o
nt
in
ue
s
Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
9
B
ie
ne
r, 
H
ar
gr
av
es
 9
n=
69
5
U
S
M
ix
ed
 m
et
ho
ds
, s
el
f-
re
po
rt
 (n
=
1,
37
4)
 a
nd
 in
te
rv
ie
w
s 
(n
=
69
5)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘L
ev
el
 3
 =
 
in
te
ns
iv
e 
us
er
s:
 u
se
d 
da
ily
 fo
r a
t l
ea
st
 1
 m
on
th
. L
ev
el
 2
 
=
 in
te
rm
itt
en
t u
se
rs
: u
se
d 
m
or
e 
th
an
 o
nc
e 
or
 tw
ic
e 
bu
t 
no
t d
ai
ly
 fo
r a
 m
on
th
 o
r m
or
e.
 L
ev
er
 1
 =
 n
on
-u
se
rs
 o
r a
t 
m
os
t o
nc
e 
or
 tw
ic
e.
’ A
du
lt 
sm
ok
er
s 
(1
8 
- 6
5 
ye
ar
s 
ol
d)
; 
m
ot
iv
at
io
n 
am
on
g 
e-
ci
ga
re
tt
e 
us
er
s
RE
A
SO
N
S 
to
 s
m
ok
in
g 
ce
ss
at
io
n 
52
.6
%
, a
vo
id
 
sm
ok
in
g 
re
st
ric
tio
n 
5.
6%
, s
oc
ia
l e
nv
iro
nm
en
t (
16
.1
%
), 
C
ut
 b
ac
k 
4.
5%
, h
ea
lth
 b
en
efi
t 8
%
. 
PE
RC
EP
TI
O
N
S 
e-
ci
g 
he
al
th
ie
r t
ha
n 
re
gu
la
r c
ig
ar
et
te
s 
(1
6.
1%
).
10
B
ie
ne
r, 
So
ng
, S
ut
fin
, 
Sp
an
gl
er
, 
W
ol
fs
on
 10
n=
4,
74
0
U
S
Se
lf-
re
po
rt
 (n
=
47
40
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
s:
 
th
os
e 
w
ho
 h
ad
 a
t l
ea
st
 s
m
ok
ed
 1
00
 c
ig
ar
et
te
s 
an
d 
ei
th
er
 s
m
ok
ed
 e
ve
ry
 d
ay
 o
r s
om
e 
da
ys
. F
or
m
er
 
sm
ok
er
s:
 th
os
e 
w
ho
 h
ad
 a
t l
ea
st
 s
m
ok
ed
 1
00
 c
ig
ar
et
te
s 
bu
t n
ow
 s
m
ok
ed
 n
ot
 a
t a
ll.
 N
ev
er
 s
m
ok
er
s:
 th
os
e 
w
ho
 
de
ni
ed
 h
av
in
g 
sm
ok
ed
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
ife
tim
e 
or
 n
ev
er
 u
se
d 
an
y 
to
ba
cc
o 
pr
od
uc
ts
.’ 
18
-3
5 
ye
ar
s 
ol
d;
 
m
ot
iv
at
io
n 
as
ke
d 
am
on
g 
sm
ok
er
s
RE
A
SO
N
S 
C
ur
io
us
 6
1.
2%
 C
ur
re
nt
 s
m
ok
er
s;
 5
9.
1%
 
fo
rm
er
 s
m
ok
er
s;
 7
7.
3%
 N
ev
er
 s
m
ok
er
s;
 B
et
te
r f
or
 
he
al
th
 th
an
 c
ig
s 
55
.1
%
 C
ur
re
nt
 s
m
ok
er
s;
 4
2.
7%
 
Fo
rm
er
 s
m
ok
er
s;
 1
7.
2%
 N
ev
er
 s
m
ok
er
s;
 F
rie
nd
s 
us
e 
it 
30
.9
%
 C
ur
re
nt
 s
m
ok
er
s;
 2
8.
1%
 F
or
m
er
 s
m
ok
er
s;
 
46
.0
%
 N
ev
er
 s
m
ok
er
s;
 C
an
 u
se
 in
 n
o-
sm
ok
in
g 
ar
ea
s 
43
.1
%
 C
ur
re
nt
 s
m
ok
er
s;
 3
3.
8%
 F
or
m
er
 s
m
ok
er
s;
 
H
el
p 
to
 q
ui
t s
m
ok
in
g 
35
.9
%
 C
ur
re
nt
 s
m
ok
er
s;
 4
0.
1%
 
Fo
rm
er
 s
m
ok
er
s 
; C
ut
 d
ow
n 
on
 s
m
ok
in
g 
41
.1
%
 
C
ur
re
nt
 s
m
ok
er
s;
 1
8.
5%
 F
or
m
er
 s
m
ok
er
s;
 D
oe
sn
’t 
sm
el
l b
ad
 4
2.
7%
 C
ur
re
nt
 s
m
ok
er
s;
 3
7.
8%
 F
or
m
er
 
sm
ok
er
s;
 2
5.
9%
 N
ev
er
 s
m
ok
er
s.
11
B
ol
d,
 K
on
g,
 
C
av
al
lo
, 
C
am
en
ga
, 
K
ris
hn
an
-
Sa
rin
 11
N
=
34
0
U
S
Lo
ng
itu
di
na
l s
ur
ve
y 
ev
er
 u
se
rs
, a
ge
 1
4 
– 
17
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
tu
de
nt
s 
w
er
e 
se
le
ct
ed
 a
s 
ev
er
e-
ci
ga
re
tt
e 
us
er
s 
if 
th
ey
 re
sp
on
de
d
“y
es
” 
to
 th
e 
qu
es
tio
n 
“h
av
e 
yo
u
ev
er
 tr
ie
d 
an
 e
-c
ig
ar
et
te
”.
 ’
RE
A
SO
N
S 
In
te
re
st
: C
ur
io
si
ty
, I
t i
s 
co
ol
. D
es
ira
bl
e 
at
tr
ib
ut
es
: G
oo
d 
fla
vo
rs
, D
oe
s 
no
t s
m
el
l b
ad
, a
nd
 
H
id
e 
fro
m
 a
du
lts
, L
ow
 c
os
t. 
So
ci
al
 n
or
m
s:
 F
rie
nd
s 
us
e,
 
Pa
re
nt
s/
fa
m
ily
 u
se
, C
an
 u
se
 a
ny
w
he
re
. G
oa
l-d
ire
ct
ed
: 
To
 q
ui
t s
m
ok
in
g 
ci
ga
re
tt
es
, H
ea
lth
ie
r t
ha
n 
ci
ga
re
tt
es
.
12
B
ro
se
, 
B
ro
w
n,
 
H
itc
hm
an
, 
M
cN
ei
ll 
12
20
12
 
n=
4,
55
3,
 
20
13
 
n=
1,
58
8,
 
20
14
 
n=
1,
20
4
U
K
U
K
 c
oh
or
t s
tu
dy
 (n
=
4,
55
3 
in
 2
01
2,
 n
=
1,
58
8 
in
 2
01
3 
&
 
n=
1,
20
4 
in
 2
01
4)
.
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: u
se
d 
e-
ci
ga
re
tt
e 
da
ily
, l
es
s 
th
an
 d
ai
ly
 b
ut
 a
t l
ea
st
 o
nc
e 
a 
w
ee
k,
 le
ss
 th
an
 w
ee
kl
y 
bu
t a
t l
ea
st
 o
nc
e 
a 
m
on
th
 a
nd
 
le
ss
 th
an
 m
on
th
ly
. C
ur
re
nt
 s
m
ok
er
: S
m
ok
e 
ci
ga
re
tt
es
 
ev
er
y 
da
y,
 n
ot
 e
ve
ry
 d
ay
, o
r s
m
ok
e 
to
ba
cc
o 
of
 s
om
e 
ki
nd
. E
x-
sm
ok
er
: s
to
pp
ed
 s
m
ok
in
g 
in
 th
e 
pa
st
 y
ea
r o
r 
m
or
e 
th
an
 a
 y
ea
r a
go
.’ 
sm
ok
er
s 
an
d 
fo
rm
er
 s
m
ok
er
s 
18
 
ye
ar
s 
or
 o
ld
er
PE
RC
EP
TI
O
N
S 
E-
ci
ga
re
tt
es
 p
er
ce
iv
ed
 a
s 
le
ss
 h
ar
m
fu
l 
th
an
 c
om
bu
st
ib
le
 c
ig
ar
et
te
s,
 b
ut
 c
ha
ng
ed
 o
ve
rt
im
e 
(6
6.
6%
: 2
01
2;
 6
6.
5%
: 2
01
3;
 6
0.
4%
: 2
01
4)
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
13
B
ro
w
n,
 
W
es
t, 
B
ea
rd
, 
et
 a
l. 
13
n=
4,
11
7
U
K
C
ro
ss
-s
ec
tio
na
l (
n=
4,
11
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
s:
 
sm
ok
e 
ev
er
y 
da
y,
 n
ot
 e
ve
ry
 d
ay
 o
r s
m
ok
e 
to
ba
cc
o 
of
 s
om
e 
ki
nd
 b
ut
 n
ot
 c
ig
ar
et
te
s.
 R
ec
en
t e
x-
sm
ok
er
s:
 
st
op
pe
d 
sm
ok
in
g 
co
m
pl
et
el
y 
in
 th
e 
la
st
 y
ea
r.’
 1
8 
ye
ar
s 
or
 o
ld
er
 C
ur
re
nt
 s
m
ok
er
s 
an
d 
re
ce
nt
 e
x-
sm
ok
er
s
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
as
 le
ss
 h
ar
m
fu
l 
C
ur
re
nt
 s
m
ok
er
s 
67
.6
%
 b
el
ie
ve
 le
ss
 h
ar
m
fu
l; 
ex
-
sm
ok
er
s 
63
.2
%
 le
ss
 h
ar
m
fu
l
RE
A
SO
N
S 
H
ea
lth
 b
en
efi
t, 
cu
tt
in
g 
do
w
n 
&
 q
ui
tt
in
g 
(c
ur
re
nt
 u
se
s)
, t
as
te
 (e
x-
sm
ok
er
s)
A
m
on
g 
C
ur
re
nt
 u
se
rs
 o
f e
-c
ig
ar
et
te
s:
he
al
th
 b
en
efi
t:8
2.
6%
 c
ur
re
nt
 s
m
ok
er
s,
 8
3.
5%
 re
ce
nt
 
ex
-s
m
ok
er
s;
 ta
st
e:
24
.4
%
 c
ur
re
nt
 s
m
ok
er
s,
 3
9.
4%
 
re
ce
nt
 e
x-
sm
ok
er
s;
 c
ut
tin
g 
do
w
n:
83
.0
%
 c
ur
re
nt
 
sm
ok
er
s,
 7
8.
9%
 re
ce
nt
 e
x-
sm
ok
er
s;
 te
m
po
ra
ry
 
ab
st
in
en
ce
:7
0.
2%
 c
ur
re
nt
 s
m
ok
er
s;
 4
7.
7%
 re
ce
nt
 
ex
-s
m
ok
er
s;
 q
ui
tt
in
g:
82
.8
%
 c
ur
re
nt
 s
m
ok
er
s,
 8
4.
4%
 
re
ce
nt
 e
x-
sm
ok
er
s
14
C
ha
ffe
e,
 
G
an
sk
y,
 
H
al
pe
rn
-
Fe
ls
he
r, 
et
 
al
. 1
4
n=
10
4
U
S
C
ro
ss
-s
ec
tio
na
l (
n=
10
4)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: 
pa
rt
ic
ip
an
ts
 w
ho
 h
ad
 u
se
 e
-c
ig
ar
et
te
s 
on
 o
ne
 o
r 
m
or
e 
da
ys
 in
 th
e 
pa
st
 3
0 
da
ys
 E
ve
r u
se
: p
ar
tic
ip
an
ts
 
w
ho
 h
ad
 h
ea
r o
f e
le
ct
ro
ni
c 
ci
ga
re
tt
es
 a
nd
 e
ve
r u
se
d 
e-
ci
ga
re
tt
es
, e
ve
n 
on
ce
 o
r t
w
ic
e.
’ A
ll 
m
al
e 
13
-1
8 
ye
ar
s 
ol
d;
 e
-c
ig
ar
et
te
 u
se
rs
 a
nd
 n
on
-u
se
rs
PE
RC
EP
TI
O
N
S 
B
el
ie
ve
d 
to
 b
e 
lik
el
y 
(4
0%
 - 
75
%
): 
de
cr
ea
se
d 
at
hl
et
ic
 p
er
fo
rm
an
ce
, t
ro
ub
le
 b
re
at
hi
ng
, 
co
ug
hi
ng
, l
un
g 
ca
nc
er
, h
ea
rt
 a
tt
ac
k 
m
ou
th
 c
an
ce
r, 
m
ou
th
 s
or
es
. B
el
ie
ve
d 
to
 b
e 
lik
el
y 
(4
0%
 - 
80
%
): 
up
se
t 
yo
ur
 fa
m
ily
, g
et
 in
to
 tr
ou
bl
e,
 u
ps
et
 fr
ie
nd
s,
 b
ad
 
br
ea
th
, a
dd
ic
tiv
e,
 d
en
ta
l i
ss
ue
s,
 h
ar
m
fu
l f
or
 o
th
er
s.
 
B
el
ie
ve
d 
to
 b
e 
be
ne
fic
ia
l (
15
%
 - 
60
%
): 
re
la
xe
d,
 c
oo
l, 
fit
 in
 m
or
e,
 fe
el
 a
le
rt
, a
nd
 in
cr
ea
se
d 
pe
rf
or
m
an
ce
. 
D
ec
re
as
ed
 a
th
le
tic
 p
er
fo
rm
an
ce
 5
7.
3%
 n
ev
er
 u
se
rs
, 
28
.0
%
 e
ve
r u
se
rs
; T
ro
ub
le
 c
at
ch
in
g 
yo
ur
 b
re
at
h 
54
.7
%
 
ne
ve
r u
se
rs
, 1
9.
2%
 e
ve
r u
se
rs
; B
ad
 c
ou
gh
 5
3.
2%
 
ne
ve
r u
se
rs
, 2
3.
9%
 e
ve
r u
se
rs
; L
un
g 
ca
nc
er
 5
2.
2%
 
ne
ve
r u
se
rs
, 2
1.
8%
 e
ve
r u
se
rs
; H
ea
rt
 a
tt
ac
k 
48
.7
%
 
ne
ve
r u
se
rs
, 1
6.
8%
 e
ve
r u
se
rs
; M
ou
th
 c
an
ce
r 4
6.
4%
 
ne
ve
r u
se
rs
, 1
5.
0%
 e
ve
r u
se
rs
; M
ou
th
 s
or
es
 4
5.
5%
 
ne
ve
r u
se
rs
, 2
0.
8%
 e
ve
r u
se
rs
; U
ps
et
 y
ou
r f
am
ily
 
68
.2
%
 n
ev
er
 u
se
rs
, 3
8.
2%
 e
ve
r u
se
rs
; G
et
 in
to
 tr
ou
bl
e 
56
.8
%
 n
ev
er
 u
se
rs
, 5
4.
0%
 e
ve
r u
se
rs
; U
ps
et
 y
ou
r 
fr
ie
nd
s 
50
.2
%
 n
ev
er
 u
se
rs
, 1
8.
4 
%
 e
ve
r u
se
rs
; B
ad
 
br
ea
th
 4
9.
9%
 n
ev
er
 u
se
rs
, 2
3.
8%
 e
ve
r u
se
rs
; B
ec
om
e 
ad
di
ct
ed
 4
9.
7%
 n
ev
er
 u
se
rs
, 3
7.
6%
 e
ve
r u
se
rs
; B
ro
w
n 
te
et
h 
41
.5
%
 n
ev
er
 u
se
rs
, 1
7.
2%
 e
ve
r u
se
rs
; H
ar
m
 
so
m
eo
ne
 n
ea
rb
y 
38
.7
 n
ev
er
 u
se
rs
, 1
9.
7%
 e
ve
r u
se
rs
.
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ta
b
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 c
o
nt
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s
Fi
rs
t A
ut
ho
r
N
Co
un
tr
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Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
RE
A
SO
N
S 
Fe
el
 m
or
e 
re
la
xe
d 
44
.6
%
 n
ev
er
 u
se
rs
, 
50
.2
%
 e
ve
r u
se
rs
; L
oo
k 
co
ol
 3
9.
2 
%
 n
ev
er
 u
se
rs
, 4
5.
8 
%
 e
ve
r u
se
rs
; F
it 
in
 m
or
e 
33
.2
%
 n
ev
er
 u
se
rs
, 3
6.
4%
 
ev
er
 u
se
rs
; F
ee
l m
or
e 
al
er
t 2
7.
7%
 n
ev
er
 u
se
rs
, 2
6.
4%
 
ev
er
 u
se
rs
; I
nc
re
as
ed
 a
th
le
tic
 p
er
fo
rm
an
ce
 1
8.
0%
 
ne
ve
r u
se
rs
, 1
9.
2%
 e
ve
r u
se
rs
; 
15
C
he
ne
y,
 
G
ow
in
, 
W
an
n 
15
N
=
30
U
S
Q
ua
lit
at
iv
e 
in
te
rv
ie
w
s 
(n
=
 3
0)
 in
 th
e 
U
S.
 A
ge
d 
19
 -2
4 
ye
ar
s 
ol
d.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
-c
ig
ar
et
te
 a
nd
 
du
al
 u
se
rs
. (
2)
 c
ur
re
nt
 u
se
 (w
ith
in
 th
e 
pa
st
 w
ee
k)
 o
f 
e-
ci
ga
re
tt
es
.’
RE
A
SO
N
S 
Yo
un
g 
ad
ul
ts
: t
o 
co
nt
in
ue
 e
-c
ig
ar
et
te
 u
se
 
w
as
 th
at
 it
 k
ep
t t
he
m
 fr
om
 s
m
ok
in
g,
 to
 h
el
p 
th
em
 
co
pe
 w
ith
 s
tr
es
s,
 re
w
ar
di
ng
 fe
el
in
gs
 o
f h
an
d-
to
-m
ou
th
 
m
ot
io
ns
, f
or
m
 o
f e
nt
er
ta
in
m
en
t, 
im
m
ed
ia
te
 h
ea
lth
 
be
ne
fit
s,
 n
ot
 s
m
el
lin
g 
lik
e 
sm
ok
e.
 F
la
vo
rs
 fi
lle
d 
a 
po
si
tiv
e 
ro
le
 a
s 
th
ey
 w
er
e 
of
te
n 
a 
w
ay
 to
 c
on
ne
ct
 w
ith
 
ot
he
r e
-c
ig
ar
et
te
 u
se
rs
, a
nd
 a
 re
as
on
 fo
r c
on
tin
ui
ng
 
to
 u
se
 e
-c
ig
ar
et
te
s,
 a
lw
ay
s 
m
an
y 
m
or
e 
to
 tr
y,
 fl
av
or
 
m
ad
e 
e-
ci
g 
us
e 
m
or
e 
at
tr
ac
tiv
e 
th
an
 s
m
ok
in
g.
 D
ua
l 
us
e:
 h
el
p 
to
 c
op
e 
w
ith
 s
tr
es
s 
w
he
n 
ex
cl
us
iv
e 
us
e 
is
 
no
t e
no
ug
h,
 b
on
d 
w
ith
 o
th
er
 s
m
ok
er
s,
 c
on
ve
ni
en
ce
 
in
 a
 p
ar
tic
ul
ar
 s
itu
at
io
n,
 in
flu
en
ce
 y
ou
ng
 a
du
lt 
sm
ok
er
s 
w
ith
 p
os
iti
ve
 c
om
m
en
ts
 a
bo
ut
 e
-c
ig
s,
 fa
m
ily
 
m
em
be
rs
 in
tr
od
uc
ed
 y
ou
ng
 a
du
lts
 to
 e
-c
ig
ar
et
te
s,
 
fa
m
ily
 m
em
be
r i
nfl
ue
nc
e 
de
ci
si
on
 to
 s
ta
rt
 e
-c
ig
ar
et
te
 
us
e,
 fr
ie
nd
s 
pl
ay
ed
 a
 s
up
po
rt
iv
e 
ro
le
 in
 in
iti
at
io
n 
of
 
e-
ci
g 
us
e 
an
d 
co
nt
in
ua
tio
n.
 It
 is
 p
er
ce
iv
ed
 a
s 
so
ci
al
ly
 
ac
ce
pt
ab
le
 b
eh
av
io
r. 
16
C
ol
em
an
, 
Jo
hn
so
n,
 
Te
ss
m
an
, e
t 
al
. 1
6
n=
11
6
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
11
6)
.
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: u
se
 
of
 a
n 
e-
ci
ga
re
tt
e 
pr
od
uc
t i
n 
th
e 
pa
st
 3
0 
da
ys
.’ 
18
-3
0 
ye
ar
s 
ol
d;
 c
ur
re
nt
 e
-c
ig
 u
se
rs
 
PE
RC
EP
TI
O
N
S 
Pe
rs
is
te
d 
th
at
 e
-c
ig
ar
et
te
s 
ar
e 
le
ss
 h
ar
m
fu
l. 
E-
ci
ga
re
tt
es
 a
 m
et
ho
d 
to
 re
du
ce
 o
r 
qu
it 
sm
ok
in
g,
 w
he
re
 s
m
ok
in
g 
is
 n
ot
 p
er
m
itt
ed
, 
th
e 
pe
rc
ep
tio
n 
of
 e
-c
ig
ar
et
te
s 
as
 m
or
e 
so
ci
al
ly
 
ac
ce
pt
ab
le
, a
nd
 th
e 
av
ai
la
bi
lit
y 
of
 a
 v
ar
ie
ty
 o
f fl
av
or
s.
 
La
ck
 o
f k
no
w
le
dg
e 
ab
ou
t e
-c
ig
ar
et
te
s 
in
gr
ed
ie
nt
s 
af
fe
ct
 in
 g
en
er
al
 a
nd
 o
n 
he
al
th
. M
os
t t
rie
d 
e-
ci
ga
re
tt
es
 
fo
r t
he
 fi
rs
t t
im
e 
w
ith
 fr
ie
nd
s,
 a
nd
 o
ve
ra
ll,
 fr
ie
nd
s 
ar
e 
po
si
tiv
e.
RE
A
SO
N
S 
A
bi
lit
y 
to
 u
se
 a
s 
a 
sm
ok
in
g 
ce
ss
at
io
n 
m
et
ho
d,
 a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
n,
 s
oc
ia
lly
 
ac
ce
pt
ab
le
, h
ea
lth
 b
en
efi
t. 
H
ow
ev
er
, n
ot
 m
im
ic
 
sm
ok
in
g.
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
17
D
oc
kr
el
l, 
M
or
ris
on
, 
B
au
ld
, 
M
cN
ei
ll 
17
St
ru
ct
ur
ed
 
in
te
rv
ie
w
, 
n=
1,
38
0 
&
 
se
lf-
re
po
rt
, 
n=
25
,0
29
 
(2
01
0 
n=
12
,5
87
; 
20
12
 
n=
12
,4
32
)
U
K
M
ix
ed
 m
et
ho
ds
 (s
tr
uc
tu
re
d 
in
te
rv
ie
w
, n
=
1,
38
0 
&
 s
el
f-
re
po
rt
, n
=
25
,0
29
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘s
m
ok
in
g 
st
at
us
: 
ne
ve
r-s
m
ok
in
g,
 e
x-
sm
ok
in
g,
 o
cc
as
io
na
l, 
an
d 
da
ily
 
sm
ok
in
g.
 1
8 
ye
ar
s 
or
 o
ld
er
; b
ot
h 
sm
ok
er
s 
(s
m
ok
er
s’
 
su
rv
ey
) a
nd
 g
en
er
al
 p
op
ul
at
io
n 
(p
op
ul
at
io
n 
su
rv
ey
).’
PE
RC
EP
TI
O
N
S 
B
el
ie
ve
d 
to
 a
id
 s
m
ok
in
g 
ce
ss
at
io
n 
ef
fo
rt
s:
 6
0%
 s
at
is
fy
 th
e 
de
si
re
 to
 s
m
ok
e,
 5
5%
 C
ut
 b
ac
k 
on
 e
-c
ig
ar
et
te
s,
 5
3%
 b
el
ie
ve
d 
it 
ex
pe
ns
iv
e,
 5
1%
 h
el
p 
qu
it 
en
tir
el
y,
 3
9%
 b
el
ie
ve
d 
it 
m
ig
ht
 n
ot
 s
at
is
fy
 th
e 
de
si
re
 to
 s
m
ok
e,
 7
1%
 p
er
ce
iv
ed
 e
-c
ig
ar
et
te
s 
as
 le
ss
 
ha
rm
fu
l t
ha
n 
co
m
bu
st
ib
le
 c
ig
ar
et
te
s.
 2
8%
 c
on
si
de
re
d 
th
em
 le
ss
 h
ar
m
fu
l t
ha
n 
N
ic
ot
in
e 
Re
pl
ac
em
en
t T
he
ra
py
 
(N
RT
). 
RE
A
SO
N
S 
A
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
 (4
3%
), 
35
%
 to
 
sm
ok
in
g 
ce
ss
at
io
n,
 3
1%
 c
ut
 b
ac
k 
on
 s
m
ok
in
g.
18
D
ut
ra
, 
G
la
nt
z 
18
20
11
 
n=
17
,3
53
, 
20
12
 n
=
 
22
,5
29
U
S
N
at
io
na
l Y
ou
th
 T
ob
ac
co
 S
ur
ve
y 
(n
=
17
,3
53
 in
 2
01
1 
&
 
n=
22
,5
29
 in
 2
01
2)
: T
yp
es
 o
f u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 
‘E
xp
er
im
en
te
rs
; H
av
e 
yo
u 
ev
er
 tr
ie
d 
ci
ga
re
tt
e 
sm
ok
in
g,
 
ev
en
 o
ne
 o
r t
w
o 
pu
ffs
? 
'Y
es
'. 
Ev
er
 s
m
ok
er
; 1
00
 o
r 
m
or
e 
ci
ga
re
tt
es
 (5
 o
r m
or
e 
pa
ck
s)
 o
f l
ife
tim
e 
sm
ok
in
g.
 
C
ur
re
nt
 s
m
ok
er
; h
ad
 s
m
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
an
d 
sm
ok
ed
 in
 th
e 
pa
st
 3
0 
da
ys
. 
Ev
er
 e
-c
ig
ar
et
te
 u
se
rs
: a
do
le
sc
en
ts
 w
ho
 re
sp
on
de
d 
‘e
le
ct
ro
ni
c 
ci
ga
re
tt
es
 o
r e
-c
ig
ar
et
te
s,
 s
uc
h 
as
 R
ay
an
 
or
 N
JO
Y’
 to
 th
e 
qu
es
tio
n 
‘w
hi
ch
 o
f t
he
 fo
llo
w
in
g 
to
ba
cc
o 
pr
od
uc
ts
 h
av
e 
yo
u 
ev
er
 tr
ie
d,
 e
ve
n 
ju
st
 1
 
tim
e?
’ C
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
: t
ho
se
 w
ho
 re
sp
on
de
d 
‘e
-c
ig
ar
et
te
s’
 to
 th
e 
qu
es
tio
n 
‘d
ur
in
g 
th
e 
pa
st
 3
0 
da
ys
, 
w
hi
ch
 o
f t
he
 fo
llo
w
in
g 
to
ba
cc
o 
pr
od
uc
ts
 d
id
 y
ou
 u
se
 
on
 a
t l
ea
st
 1
 d
ay
?’
 D
ua
l e
ve
r u
se
: w
ho
 h
av
e 
ev
er
 u
se
d 
e-
ci
ga
re
tt
es
 a
nd
 e
ve
r s
m
ok
ed
 c
on
ve
nt
io
na
l c
ig
ar
et
te
s.
 
D
ua
l c
ur
re
nt
 u
se
: w
ho
 a
re
 c
ur
re
nt
ly
 u
si
ng
 e
-c
ig
ar
et
te
s 
an
d 
co
nv
en
tio
na
l c
ig
ar
et
te
s?
 1
1-
18
 y
ea
rs
 o
ld
; E
ve
r a
nd
 
cu
rr
en
t e
-c
ig
ar
et
te
 u
se
rs
.’
RE
A
SO
N
S 
A
m
on
g 
cu
rr
en
t s
m
ok
er
s,
 m
ot
iv
es
 fo
r e
ve
r 
e-
ci
ga
re
tt
e 
us
e 
w
as
 re
la
te
d 
to
 q
ui
tt
in
g 
co
m
bu
st
ib
le
 
to
ba
cc
o 
us
e.
 s
m
ok
in
g 
ce
ss
at
io
n
19
Ea
st
w
oo
d,
 
D
oc
kr
el
l, 
A
rn
ot
t, 
et
 
al
. 1
9
20
13
 
n=
2,
06
2,
 
20
14
 
n=
1,
95
2 
U
K
 
11
-1
8 
ye
ar
s 
ol
d.
 T
yp
es
 o
f u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 
po
pu
la
tio
n 
no
t s
tr
at
ifi
ed
. 
ne
ve
r s
m
ok
er
s,
 fo
rm
er
 s
m
ok
er
s,
 c
ur
re
nt
 s
m
ok
er
s 
PE
RC
EP
TI
O
N
S 
So
m
e 
pe
rc
ei
ve
d 
e-
ci
ga
re
tt
es
 to
 b
e 
le
ss
 h
ar
m
fu
l t
o 
th
e 
us
er
 d
ec
re
as
ed
 s
ig
ni
fic
an
tly
, 
fro
m
 7
3.
4%
 in
 2
01
3 
to
 6
6.
9%
 in
 2
01
4.
 C
on
si
de
re
d 
e-
ci
ga
re
tt
es
 to
 c
au
se
 a
bo
ut
 th
e 
sa
m
e 
le
ve
l o
f h
ar
m
 
to
 th
e 
us
er
 in
cr
ea
se
d 
fro
m
 1
1.
8%
 in
 2
01
3 
to
 1
8.
2%
 in
 
20
14
. B
el
ie
vi
ng
 th
em
 to
 b
e 
le
ss
 h
ar
m
fu
l d
ec
re
as
ed
 
fro
m
 7
8.
5%
 in
 2
01
3 
to
 7
3.
1%
 to
 in
 2
01
4,
 a
nd
 s
im
ila
r 
le
ve
ls
 o
f h
ar
m
 in
cr
ea
se
d 
fro
m
 8
.0
%
 to
 1
2.
0%
.
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20
Et
te
r 2
0
n=
81
Fr
an
ce
, 
C
an
ad
a,
 
B
el
gi
um
 
&
 S
w
itz
er
-
la
nd
Se
lf-
re
po
rt
 (n
=
81
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘d
ai
ly
 u
se
r, 
no
n-
da
ily
 u
se
r, 
fo
rm
er
 u
se
r, 
ne
ve
r u
se
d.
 S
m
ok
in
g 
st
at
us
: 
da
ily
, n
on
-d
ai
ly
, f
or
m
er
 s
m
ok
er
, n
ev
er
 s
m
ok
er
.’ 
19
-6
5 
ye
ar
s 
ol
d;
 E
ve
r e
-c
ig
ar
et
te
 u
se
rs
RE
A
SO
N
S 
To
 q
ui
t s
m
ok
in
g,
 fo
r h
ea
lth
 b
en
efi
ts
 
(e
-c
ig
ar
et
te
s 
w
er
e 
pe
rc
ei
ve
d 
to
 b
e 
le
ss
 to
xi
c 
th
an
 
to
ba
cc
o)
, l
es
s 
ex
pe
ns
iv
e 
th
an
 re
gu
la
r c
ig
ar
et
te
s,
 c
an
 
be
 s
m
ok
ed
 e
ve
ry
w
he
re
 (i
nc
lu
di
ng
 s
m
ok
e-
fre
e 
pl
ac
es
), 
to
 a
vo
id
 d
is
tu
rb
in
g 
ot
he
r p
eo
pl
e,
 o
r p
ro
du
ci
ng
 
en
vi
ro
nm
en
ta
l t
ob
ac
co
 s
m
ok
e 
or
 th
e 
sm
el
l o
f s
ta
le
 
sm
ok
e,
 fo
r t
he
 p
le
as
ur
e 
of
 s
m
ok
in
g 
(in
cl
ud
in
g 
th
e 
pl
ea
su
re
 o
f i
nh
al
in
g 
an
d 
sm
ok
in
g 
re
la
te
d 
ac
tio
ns
), 
to
 
re
du
ce
 c
ig
ar
et
te
 c
on
su
m
pt
io
n,
 c
ur
io
us
 to
 te
st
 a
 n
ew
 
pr
od
uc
t, 
e-
ci
ga
re
tt
es
 ta
st
e 
an
d 
sm
el
l g
oo
d,
 p
re
vi
ou
sl
y 
fa
ile
d 
qu
it 
at
te
m
pt
s,
 to
 g
et
 n
ic
ot
in
e,
 u
ne
xp
ec
te
d 
he
al
th
 e
ffe
ct
s.
21
Et
te
r, 
B
ul
le
n 
21
n=
3,
58
7
62
%
 U
S,
 
14
%
 
Fr
an
ce
, 
6%
 U
K
, 
4%
 S
w
it-
ze
rla
nd
, 
3%
 C
an
-
ad
a,
 1
1%
 
ot
he
r 
co
un
tr
ie
s
Se
lf-
re
po
rt
 (n
=
3,
58
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘D
ai
ly
 u
se
rs
, 
oc
ca
si
on
al
 u
se
rs
 (n
ot
 d
ai
ly
), 
pa
st
 u
se
rs
 (u
se
d 
e-
ci
ga
re
tt
es
 in
 th
e 
pa
st
), 
an
d 
ne
ve
r u
se
rs
 (n
ev
er
 u
se
d 
e-
ci
ga
re
tt
es
). 
18
 y
ea
rs
 o
r o
ld
er
 e
-c
ig
ar
et
te
 u
se
rs
, 
sm
ok
er
s 
an
d 
no
n-
sm
ok
er
s.
’
PE
RC
EP
TI
O
N
S 
Le
ss
 h
ar
m
fu
l t
ha
n 
to
ba
cc
o 
83
.5
%
RE
A
SO
N
S 
Sm
ok
in
g 
ce
ss
at
io
n 
( 7
6.
8%
),d
ea
l w
ith
 
cr
av
in
gs
 (7
9%
), 
w
ith
dr
aw
al
 s
ym
pt
om
s 
(6
7%
), 
co
st
s 
(5
7.
3%
), 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
ns
 (3
4%
) (
av
oi
d 
go
in
g 
ou
ts
id
e 
is
 3
4.
4%
, a
vo
id
 s
itu
at
io
ns
 w
he
re
 y
ou
 
ca
nn
ot
 s
m
ok
e 
is
 3
9.
4%
, s
oc
ia
l e
nv
iro
nm
en
t (
to
 a
vo
id
 
bo
th
er
in
g 
ot
he
r p
eo
pl
e 
w
ith
 to
ba
cc
o 
sm
ok
e 
(4
4%
)),
 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
ns
 (3
9%
), 
cu
t d
ow
n 
to
ba
cc
o 
28
%
), 
un
ab
le
 to
 s
to
p 
us
in
g 
it 
(4
%
). 
C
ur
re
nt
 s
m
ok
er
s:
 
he
lp
ed
 th
em
 to
 re
du
ce
 th
ei
r s
m
ok
in
g 
(9
2%
). 
Fo
rm
er
 
sm
ok
er
s:
 (9
6%
) s
ai
d 
th
at
 it
 h
el
pe
d 
th
em
 to
 q
ui
t 
sm
ok
in
g.
 E
ve
r u
se
rs
: (
89
%
) s
ai
d 
th
at
 it
 w
as
 e
as
y 
to
 
ab
st
ai
n 
fro
m
 s
m
ok
in
g 
w
hi
le
 u
si
ng
 th
e 
e-
ci
ga
re
tt
e
22
Fa
le
ta
u,
 
G
lo
ve
r, 
N
os
a,
 P
ie
-
na
ar
 22
n=
20
N
ew
-Z
ea
-
la
nd
, 
A
uc
kl
an
d
Q
ua
lit
at
iv
e 
Re
se
ar
ch
 (F
oc
us
 g
ro
up
s 
n=
20
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 C
hi
ld
re
n 
ag
ed
 
6–
10
 y
ea
rs
; n
on
-u
se
rs
 
PE
RC
EP
TI
O
N
S 
C
hi
ld
re
n 
th
ou
gh
t i
t l
oo
ke
d 
co
ol
, 
vi
ew
ed
 is
 a
s 
an
 im
ita
tio
n 
ci
ga
re
tt
e,
 v
ie
w
ed
 a
s 
sm
ok
in
g.
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
23
Fo
rd
, 
M
ac
K
in
-
to
sh
, B
au
ld
, 
M
oo
di
e,
 
H
as
tin
gs
 23
n=
20
N
ew
-Z
ea
-
la
nd
, 
A
uc
kl
an
d
Yo
ut
h 
To
ba
cc
o 
Po
lic
y 
Su
rv
ey
 (n
=
12
05
); 
cr
os
s-
se
ct
io
na
l
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘R
eg
ul
ar
 s
m
ok
er
s:
 
at
 le
as
t o
ne
 c
ig
ar
et
te
 a
 w
ee
k.
 O
cc
as
io
na
l s
m
ok
er
’s 
le
ss
 
th
an
 o
ne
 c
ig
ar
et
te
 a
 w
ee
k.
 N
ev
er
 s
m
ok
er
s:
 th
os
e 
w
ho
 
ha
d 
ne
ve
r t
rie
d 
sm
ok
in
g,
 n
ot
 e
ve
n 
a 
pu
ff 
or
 tw
o.
 E
ve
r 
sm
ok
er
s:
 re
gu
la
r s
m
ok
er
s,
 o
cc
as
io
na
l s
m
ok
er
s,
 th
os
e 
w
ho
 u
se
d 
to
 s
m
ok
e 
an
d 
th
os
e 
w
ho
 h
ad
 tr
ie
d 
sm
ok
in
g 
on
ly
 o
nc
e.
 1
1-
16
 y
ea
rs
 o
ld
; e
ve
r (
at
 le
as
t o
ne
 c
ig
ar
et
te
 
a 
w
ee
k)
, o
cc
as
io
na
l s
m
ok
er
s 
(le
ss
 th
an
 o
ne
 a
 w
ee
k)
, 
th
os
e 
w
ho
 u
se
d 
to
 s
m
ok
e 
an
d 
th
os
e 
w
ho
 h
ad
 tr
ie
d 
sm
ok
in
g 
on
ly
 o
nc
e,
 a
nd
 n
ev
er
 s
m
ok
er
s.
’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
ha
rm
 d
iff
er
ed
 fo
r fl
av
or
s,
 
w
ith
 c
an
dy
 a
nd
 fr
ui
t fl
av
or
s 
co
ns
id
er
ed
 le
ss
 h
ar
m
fu
l 
th
an
 to
ba
cc
o 
fla
vo
rs
. P
er
ce
pt
io
n 
of
 fl
av
or
 m
at
ch
in
g 
go
al
 o
f u
si
ng
 e
-c
ig
ar
et
te
s 
(e
.g
., 
ad
ul
t s
m
ok
er
 g
iv
in
g 
up
 s
m
ok
in
g 
w
ou
ld
 fa
vo
r t
ob
ac
co
 fl
av
or
s)
.
24
G
ow
in
, 
C
he
ne
y,
 
W
an
n 
24
N
=
30
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (s
em
i-s
tr
uc
tu
re
d 
in
di
vi
du
al
 
in
te
rv
ie
w
s 
n=
30
) w
ith
 c
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
 o
f 
e-
ci
ga
re
tt
es
 (a
t l
ea
st
 o
nc
e 
pe
r w
ee
k)
. Y
ou
ng
 a
du
lts
 (1
9–
31
) w
ho
 g
o 
st
ra
ig
ht
 to
 w
or
k 
(S
TW
) f
ro
m
 h
ig
h 
sc
ho
ol
.’
PE
RC
EP
TI
O
N
S 
E-
ci
ga
re
tt
es
 a
re
 h
ea
lth
ie
r a
nd
 a
 s
af
er
, 
e-
ci
ga
re
tt
es
 a
re
 c
he
ap
er
, e
-c
ig
s 
ar
e 
he
al
th
ie
r a
nd
 s
af
er
 
fro
m
 th
em
se
lv
es
, i
t i
s 
a 
sa
fe
r o
pt
io
n 
th
an
 s
m
ok
in
g,
 it
 is
 
he
al
th
ie
r a
nd
 s
af
er
 fo
r o
th
er
s,
 n
o 
se
co
nd
ha
nd
 s
m
ok
e,
 
ni
ce
 s
m
el
l, 
le
ss
 h
ar
m
fu
l, 
en
vi
ro
nm
en
ta
l f
rie
nd
lie
r a
nd
 
re
du
ce
s 
le
ss
 w
as
te
.
RE
A
SO
N
S 
H
ea
lth
ie
r, 
sa
fe
r, 
ch
ea
pe
r, 
sa
fe
r f
or
 s
el
f a
nd
 
ot
he
r, 
en
vi
ro
nm
en
ta
l f
rie
nd
lie
r t
ha
n 
sm
ok
in
g 
25
H
es
s,
 A
nt
in
, 
A
nn
ec
hi
no
, 
H
un
t 2
5
N
=
46
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
46
). 
A
ge
 1
8 
– 
25
 
ye
ar
s 
ol
d.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 N
o 
ty
pe
 o
f u
se
r o
r 
fre
qu
en
cy
 s
pe
ci
fie
d.
PE
RC
EP
TI
O
N
S 
U
til
ita
ria
n 
fu
nc
tio
n 
an
d 
a 
so
ci
al
 
fu
nc
tio
n.
 S
oc
ia
l i
de
nt
ity
 o
f e
-c
ig
ar
et
te
s 
is
 d
es
cr
ib
ed
 
as
 d
iff
er
en
t f
or
m
 th
e 
pa
rt
ic
ip
an
ts
, d
es
cr
ib
ed
 w
ith
 a
n 
“u
s 
ve
rs
us
” 
th
em
 a
tt
itu
de
. U
til
ita
ria
n 
fu
nc
tio
n 
ne
ith
er
 
as
 s
m
ok
in
g 
re
du
ct
io
n 
or
 c
es
sa
tio
n 
no
r t
o 
m
in
im
iz
e 
cr
av
in
g 
w
he
n 
sm
ok
in
g 
is
 p
ro
hi
bi
te
d.
 
26
H
ilt
on
, 
W
ei
sh
aa
r, 
Sw
ee
tin
g,
 
Tr
ev
is
an
, 
K
at
ik
ire
dd
i 
26
N
=
86
U
K
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
86
). 
A
ge
 1
4 
– 
17
 
ye
ar
s 
ol
d.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
m
ok
in
g 
st
at
us
: 
do
 y
ou
 s
m
ok
e 
ci
ga
re
tt
es
 a
t a
ll 
no
w
ad
ay
s?
 A
nd
 w
hi
ch
 
st
at
em
en
t d
es
cr
ib
es
 y
ou
 b
es
t: 
ne
ve
r t
rie
d,
 n
ot
 e
ve
n 
a 
pu
ff 
or
 tw
o;
 o
nc
e 
ha
d 
a 
pu
ff 
or
 tw
o,
 b
ut
 n
ev
er
 s
m
ok
e 
no
w
; d
o 
yo
u 
so
m
et
im
es
 s
m
ok
e?
 
E-
ci
ga
re
tt
e 
us
e:
 d
o 
yo
u 
us
e 
e-
ci
ga
re
tt
es
 a
t a
ll 
no
w
ad
ay
s?
 A
nd
 w
hi
ch
 s
ta
te
m
en
t d
es
cr
ib
es
 y
ou
 b
es
t: 
ne
ve
r t
rie
d,
 n
ot
 e
ve
n 
a 
pu
ff 
or
 tw
o;
 o
nc
e 
ha
d 
a 
pu
ff 
or
 
tw
o,
 b
ut
 n
ev
er
 u
se
 e
-c
ig
ar
et
te
s 
no
w
; d
o 
yo
u 
so
m
et
im
es
 
us
e 
e-
ci
ga
re
tt
es
?’
PE
RC
EP
TI
O
N
S 
Po
te
nt
ia
l h
ea
lth
 h
ar
m
s 
an
d 
un
kn
ow
n 
ha
rm
fu
l i
ng
re
di
en
ts
. U
ns
ur
e 
w
he
th
er
 e
-c
ig
ar
et
te
s 
ar
e 
m
or
e 
or
 le
ss
 a
dd
ic
tiv
e 
th
an
 c
on
ve
nt
io
na
l c
ig
ar
et
te
s.
 
RE
A
SO
N
S 
G
re
at
 fl
av
or
, c
ol
or
s,
 fu
n 
tr
ic
ks
, fi
tt
in
g 
in
, 
lo
ok
in
g 
co
ol
. 
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ta
b
le
 c
o
nt
in
ue
s
Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
27
H
ue
rt
a,
 
W
al
ke
r, 
M
ul
le
n,
 
Jo
hn
so
n,
 
Fo
rd
 27
N
=
 3
63
0 
in
 
20
12
N
=
 3
18
5 
in
 
20
13
N
=
 3
67
7 
in
 
20
14
Po
ol
ed
 n
=
 
10
,2
73
U
S
H
ea
lth
 In
fo
rm
at
io
n 
N
at
io
na
l T
re
nd
s 
Su
rv
ey
 (H
IN
TS
) 
20
12
 -2
01
4.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
m
ok
in
g 
st
at
us
 
w
as
 d
efi
ne
d 
in
 th
e 
sa
m
e 
m
an
ne
r f
or
 th
is
 s
tu
dy
 a
nd
 th
e 
or
ig
in
al
 s
tu
dy
, d
efi
ni
ng
 n
on
-s
m
ok
er
s 
as
 th
os
e 
w
ho
 h
av
e 
sm
ok
ed
 <
10
0 
ci
ga
re
tt
es
 d
ur
in
g 
th
ei
r l
ife
tim
e,
 c
ur
re
nt
 
sm
ok
er
s 
as
 th
os
e 
w
ho
 h
av
e 
sm
ok
ed
 >
10
0 
ci
ga
re
tt
es
 
an
d 
ar
e 
st
ill
 
sm
ok
in
g 
ev
er
y 
da
y 
or
 m
os
t d
ay
s,
 a
nd
 fo
rm
er
 s
m
ok
er
s 
as
 th
os
e 
w
ho
 h
av
e 
sm
ok
ed
 >
10
0 
ci
ga
re
tt
es
 in
 th
ei
r 
lif
et
im
e 
an
d 
ar
e 
no
t s
m
ok
in
g 
no
w
. U
S 
ad
ul
ts
 (1
8>
) 
sm
ok
er
s,
 fo
rm
er
 s
m
ok
er
s 
an
d 
no
n-
us
er
s.
’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
ha
rm
 d
ec
lin
ed
 s
lig
ht
ly
 fr
om
 
20
12
 to
 2
01
4 
(5
0.
7%
 to
 4
3.
1%
). 
C
ur
re
nt
 a
nd
 fo
rm
er
 
sm
ok
er
s 
ha
d 
hi
gh
er
 o
dd
s 
of
 p
er
ce
iv
in
g 
e-
ci
ga
re
tt
es
 a
s 
le
ss
 h
ar
m
fu
l. 
28
K
ah
r, 
Pa
dg
et
t, 
Sh
op
e,
 e
t 
al
. 2
8
N
=
87
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
 n
=
87
); 
Ty
pe
s 
of
 u
se
r 
as
 d
efi
ne
d 
by
 a
ut
ho
rs
: ‘
pr
eg
na
nt
 w
om
en
’s 
be
lie
fs
 o
f 
e-
ci
ga
re
tt
e 
us
er
s 
du
rin
g 
pr
eg
na
nc
y;
 u
se
 n
ot
 s
pe
ci
fie
d.
’ 
ad
ul
t p
re
gn
an
t w
om
en
; n
on
-u
se
rs
.
PE
RC
EP
TI
O
N
S 
C
om
pa
re
d 
to
 c
om
bu
st
ib
le
 c
ig
ar
et
te
s,
 
e-
ci
ga
re
tt
es
 w
er
e 
pe
rc
ei
ve
d 
as
 le
ss
 h
ar
m
fu
l. 
H
ow
ev
er
, e
-c
ig
ar
et
te
s 
w
er
e 
no
t p
er
ce
iv
ed
 s
af
e 
du
rin
g 
a 
pr
eg
na
nc
y,
 d
am
ag
in
g 
to
 b
ab
y,
 n
ot
 s
af
e 
du
rin
g 
pr
eg
na
nc
y,
 m
ay
 b
e 
a 
sm
ok
in
g 
ce
ss
at
io
n 
to
ol
, 
be
tt
er
 a
lte
rn
at
iv
e 
th
an
 re
gu
la
r c
ig
ar
et
te
s.
 S
m
ok
in
g 
ca
us
es
 h
ea
lth
 p
ro
bl
em
s 
du
rin
g 
pr
eg
na
nc
y,
 s
m
ok
in
g 
is
 s
el
fis
h 
an
d 
irr
es
po
ns
ib
le
. S
m
ok
in
g 
is
 p
er
ce
iv
ed
 
as
 n
ot
 a
cc
ep
ta
bl
e 
du
rin
g 
pr
eg
na
nc
y;
 n
ot
 a
s 
st
ro
ng
 
fo
r e
-c
ig
ar
et
te
s.
 S
til
l r
is
ks
 a
nd
 n
ot
 ta
ki
ng
 c
ar
e 
of
 h
er
 
ba
by
’s 
he
al
th
 if
 u
se
d.
29
K
ho
ur
y,
 
M
an
lh
io
t, 
Fa
n,
 e
t a
l. 
29
N
=
33
12
C
an
ad
a
Se
lf-
re
po
rt
 (c
ro
ss
-s
ec
tio
na
l s
ur
ve
y 
n=
33
12
) w
ith
 n
=
23
8 
ad
ol
es
ce
nt
s 
w
ho
 tr
ie
d 
e-
ci
ga
re
tt
es
 a
t l
ea
st
 o
nc
e.
 (A
ge
 
14
-1
5 
ye
ar
s 
ol
d)
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
-c
ig
ar
et
te
 u
se
 
st
at
us
: “
H
av
e 
yo
u 
ev
er
 ta
ke
n 
at
 le
as
t o
ne
 p
uf
f f
ro
m
 a
n 
el
ec
tr
on
ic
 c
ig
ar
et
te
?”
 a
nd
 “
If 
ye
s,
 w
hy
 d
id
 y
ou
 tr
y 
an
 
e-
ci
ga
re
tt
e?
” 
(o
pt
io
ns
: “
a.
 It
’s 
co
ol
/f
un
/s
om
et
hi
ng
 n
ew
; 
b.
 F
or
 th
e 
bu
zz
; c
. T
o 
he
lp
 m
e 
qu
it 
sm
ok
in
g;
 d
. T
o 
he
lp
 
m
e 
sm
ok
e 
le
ss
; e
. T
o 
he
lp
 m
e 
w
he
n 
I’m
 n
ot
 a
llo
w
ed
 to
 
sm
ok
e”
). 
Sm
ok
in
g 
st
at
us
: “
D
o 
yo
u 
sm
ok
e 
no
w
?”
 a
nd
 “
Th
in
k 
ab
ou
t t
he
 la
st
 3
0 
da
ys
. D
id
 y
ou
 s
m
ok
e 
a 
ci
ga
re
tt
e,
 e
ve
n 
a 
pu
ff?
’
RE
A
SO
N
S 
(a
m
on
g 
23
8 
ad
ol
es
ce
nt
s 
ev
er
 u
se
rs
) c
oo
l/
fu
n/
ne
w
, f
or
 th
e 
bu
zz
, h
el
ps
 to
 q
ui
t s
m
ok
in
g,
 h
el
ps
 to
 
sm
ok
e 
le
ss
, h
el
ps
 w
he
n 
no
t a
llo
w
ed
 to
 s
m
ok
e.
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
30
K
im
, D
av
is
, 
D
oh
ac
k,
 
C
la
rk
 30
N
=
35
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s,
 n
=
 3
5)
.
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘w
ith
 a
du
lt 
e-
ci
ga
re
tt
e 
us
er
s 
(1
8 
– 
65
 y
ea
rs
 o
ld
) u
si
ng
 e
-c
ig
ar
et
te
s 
fo
r a
t l
ea
st
 tw
o 
m
on
th
 p
rio
r t
o 
th
e 
st
ud
y.
 
(1
)th
os
e 
w
ho
 w
er
e 
cu
rr
en
t u
se
rs
 o
f b
ot
h 
e-
ci
ga
re
tt
es
 
an
d 
co
m
bu
st
ib
le
 c
ig
ar
et
te
s;
 
(2
) t
ho
se
 w
ho
 w
er
e 
fo
rm
er
 c
om
bu
st
ib
le
 c
ig
ar
et
te
 u
se
rs
;
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
as
 h
ea
lth
ie
r, 
sa
fe
r, 
an
d 
cl
ea
ne
r a
lte
rn
at
iv
e 
co
m
pa
re
d 
to
 s
m
ok
in
g.
 
Re
sp
on
de
nt
s 
fe
el
 b
et
te
r; 
ha
ve
 m
or
e 
en
er
gy
; b
re
at
he
 
ea
si
er
; c
ou
gh
 le
ss
 s
in
ce
 u
si
ng
 e
-c
ig
ar
et
te
s.
 
31
K
in
nu
ne
n,
 
O
lli
la
, 
Li
nd
fo
rs
, 
Ri
m
pe
la
 31
N
=
10
,2
33
Fi
nl
an
d 
Th
e 
20
13
 a
nd
 2
01
5 
A
do
le
sc
en
t H
ea
lth
 a
nd
 L
ife
st
yl
e 
Su
rv
ey
, w
hi
ch
 is
 a
 c
ro
ss
-s
ec
tio
na
l p
os
ta
l s
ur
ve
y.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
el
f-
re
po
rt
 (s
ur
ve
y 
n=
 1
0,
23
3)
 a
m
on
g 
Fi
nn
is
h 
ad
ol
es
ce
nt
s 
(1
2-
, 1
4-
, 1
6-
 
an
d 
18
-y
ea
r-o
ld
s 
ob
ta
in
ed
 fr
om
 th
e 
po
pu
la
tio
n 
re
gi
st
er
 
ce
nt
er
). 
Tr
ie
d 
e-
ci
ga
re
tt
es
 a
t l
ea
st
 o
nc
e.
E-
ci
ga
re
tt
e 
us
e:
 “
H
av
e 
yo
u 
ev
er
 tr
ie
d 
el
ec
tr
on
ic
 
ci
ga
re
tt
es
? 
H
ow
 m
an
y 
tim
es
 a
lto
ge
th
er
?”
 T
he
 
op
tio
ns
 w
er
e:
 “
I d
o 
no
t k
no
w
 w
ha
t t
he
y 
ar
e”
, “
N
o”
, 
“I
 h
av
e 
tr
ie
d 
on
ce
 o
r t
w
ic
e”
, “
I h
av
e 
tr
ie
d 
20
 ti
m
es
 
or
 le
ss
” 
an
d 
“I
 h
av
e 
tr
ie
d 
m
or
e 
th
an
 2
0 
tim
es
”.
 
Fr
eq
ue
nc
y 
w
as
 e
st
im
at
ed
 in
 2
01
5:
 “
W
hi
ch
 o
ne
 o
f 
th
e 
fo
llo
w
in
g 
al
te
rn
at
iv
es
 b
es
t d
es
cr
ib
es
 y
ou
r c
ur
re
nt
 
us
e 
of
 e
-c
ig
ar
et
te
s?
” 
w
ith
 th
e 
op
tio
ns
 “
I d
o 
no
t u
se
 
e-
ci
ga
re
tt
es
”,
 “
I u
se
 e
-c
ig
ar
et
te
s 
le
ss
 th
an
 o
nc
e 
a 
w
ee
k”
, “
I u
se
 e
-c
ig
ar
et
te
s 
on
ce
 a
 w
ee
k 
or
 m
or
e 
of
te
n,
 
bu
t n
ot
 d
ai
ly
” 
an
d 
“I
 u
se
 e
-c
ig
ar
et
te
s 
on
ce
 a
 d
ay
 o
r 
m
or
e 
of
te
n”
.’
RE
A
SO
N
S 
To
 tr
y 
so
m
et
hi
ng
 n
ew
, t
o 
qu
it 
sm
ok
in
g,
 
fr
ie
nd
s 
us
e 
th
em
, s
om
et
hi
ng
 n
ew
 to
 tr
y.
 
32
K
is
tle
r, 
C
ru
tc
hfi
el
d,
 
Su
tfi
n,
 e
t 
al
. 3
2
N
=
34
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (n
=
34
). 
A
ge
 1
8 
– 
64
 y
ea
rs
 o
ld
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘U
se
d 
e-
ci
ga
re
tt
es
 
at
 le
as
t o
nc
e.
’ 
RE
A
SO
N
S 
Re
as
on
s 
in
cl
ud
ed
: U
se
r E
xp
er
ie
nc
e 
(T
he
 
od
or
, f
ee
l, 
te
xt
ur
e,
 a
pp
ea
ra
nc
e,
 ta
st
e,
 c
lo
ud
 c
ha
si
ng
, 
an
d 
no
ve
lty
); 
So
ci
al
 A
cc
ep
ta
bi
lit
y 
(e
nc
ou
ra
ge
m
en
t o
r 
ac
ce
pt
ab
ili
ty
 to
 u
se
 e
-c
ig
s 
an
d 
to
 c
on
ne
ct
 w
ith
 o
th
er
s 
w
ho
 v
ap
e 
vi
ce
 v
er
sa
 w
he
n 
th
er
e 
is
 s
tig
m
at
iz
at
io
n 
or
 
no
 a
cc
ep
ta
bi
lit
y 
to
 u
se
 e
-c
ig
s)
; C
os
t; 
H
ea
lth
 R
is
ks
/
B
en
efi
ts
 (h
ea
lth
 is
su
es
 o
r b
en
efi
ts
); 
Ea
se
 o
f U
se
 (T
he
 
di
ffi
cu
lty
 o
r e
as
e 
to
 m
an
ip
ul
at
e 
or
 u
se
 a
n 
e-
ci
g,
 
av
ai
la
bi
lit
y 
of
 p
ro
du
ct
s,
 a
nd
 s
et
tin
g 
in
 w
hi
ch
 it
 c
an
 b
e 
us
ed
); 
Fl
av
or
 (t
yp
e 
of
 fl
av
or
s,
 th
e 
m
ix
in
g 
of
 fl
av
or
s,
 
th
e 
sm
el
l o
f fl
av
or
s)
; S
m
ok
in
g 
C
es
sa
tio
n 
A
id
; N
ic
ot
in
e 
C
on
te
nt
 &
 th
e 
ab
ili
ty
 to
 c
on
tr
ol
 it
; M
od
ifi
ab
ili
ty
; e
-c
ig
s 
Re
gu
la
tio
n;
 D
ua
l u
se
; H
ob
by
 u
se
. 
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ta
b
le
 c
o
nt
in
ue
s
Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
33
Le
e,
 L
ee
, 
C
ho
 33
N
=
66
55
K
or
ea
 
20
15
 K
or
ea
n 
Yo
ut
h 
Ri
sk
 B
eh
av
io
r W
eb
-b
as
ed
 S
ur
ve
y 
(n
=
66
55
) a
ge
 1
3 
– 
18
 y
ea
rs
 o
ld
 e
ve
r e
-c
ig
ar
et
te
 u
se
rs
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
ve
r c
on
ve
nt
io
na
l 
ci
ga
re
tt
e 
sm
ok
er
s 
“y
es
” 
to
 th
e 
qu
es
tio
n:
 “
H
av
e 
yo
u 
ev
er
 tr
ie
d 
a 
ci
ga
re
tt
e,
 e
ve
n 
on
e 
pu
ff,
 in
 y
ou
r l
ife
?”
 
A
m
on
g 
ev
er
-s
m
ok
er
s,
 c
ur
re
nt
 c
on
ve
nt
io
na
l s
m
ok
er
s:
 
th
os
e 
w
ho
 re
pl
ie
d 
fro
m
 “
1 
an
d 
2 
da
ys
” 
to
 “
ev
er
y 
da
y”
 
fo
r t
he
 q
ue
st
io
n,
 “
D
ur
in
g 
th
e 
pa
st
 3
0 
da
ys
, h
ow
 m
an
y 
da
ys
 d
id
 y
ou
 s
m
ok
e 
ci
ga
re
tt
es
, e
ve
n 
on
e 
ci
ga
re
tt
e?
” 
Ev
er
 e
-c
ig
ar
et
te
 u
se
: “
ye
s”
 a
ns
w
er
 to
 th
e 
fo
llo
w
in
g 
qu
es
tio
n:
 “
H
av
e 
yo
u 
ev
er
 tr
ie
d 
e-
ci
ga
re
tt
es
?”
 C
ur
re
nt
 
e-
ci
ga
re
tt
e 
us
e:
 th
os
e 
w
ho
 re
pl
ie
d 
fro
m
 “
1 
an
d 
2 
da
ys
” 
to
 “
ev
er
y 
da
y”
 to
 th
e 
qu
es
tio
n,
 “
D
ur
in
g 
th
e 
pa
st
 3
0 
da
ys
, h
ow
 m
an
y 
da
ys
 d
id
 y
ou
 u
se
 e
- c
ig
ar
et
te
s?
” 
Th
e 
nu
m
be
r o
f d
ay
s 
th
at
 u
se
d 
e-
ci
ga
re
tt
e 
w
as
 re
-g
ro
up
ed
 
in
to
 0
–2
 d
ay
s/
m
on
th
, 3
–9
 d
ay
s/
m
on
th
, a
nd
 1
0 
da
ys
/
m
on
th
.’
RE
A
SO
N
S 
A
m
on
g 
ev
er
 e
-c
ig
ar
et
te
 u
se
rs
: c
ur
io
si
ty
 
(2
2.
9%
), 
be
lie
f t
ha
t t
he
y 
w
er
e 
le
ss
 h
ar
m
fu
l t
ha
n 
co
nv
en
tio
na
l c
ig
ar
et
te
s 
(1
8.
9%
), 
to
 q
ui
t s
m
ok
in
g 
(1
3.
1%
), 
to
 s
m
ok
e 
in
do
or
s 
(1
0.
7%
). 
Fo
r i
nf
re
qu
en
t 
e-
ci
ga
re
tt
e 
us
er
s 
(<
3 
pe
r m
on
th
), 
cu
rio
si
ty
 w
as
 th
e 
m
os
t f
re
qu
en
t r
ea
so
n 
fo
r e
-c
ig
ar
et
te
 u
se
 (2
8.
8%
). 
Fo
r 
m
or
e 
fre
qu
en
t e
-c
ig
ar
et
te
 u
se
rs
 (>
10
 p
er
 m
on
th
), 
to
 
qu
it 
sm
ok
in
g 
(2
1.
0%
) a
nd
 in
do
or
 u
se
 (1
9.
5%
) w
er
e 
th
e 
m
os
t f
re
qu
en
t r
ea
so
ns
 fo
r e
-c
ig
ar
et
te
 u
se
. T
he
 
be
lie
f t
ha
t e
-c
ig
ar
et
te
s 
ar
e 
le
ss
 h
ar
m
fu
l w
as
 a
 c
om
m
on
 
re
as
on
 fo
r u
se
 a
m
on
g 
bo
th
 le
ss
 (<
3 
pe
r m
on
th
) a
nd
 
m
or
e 
(>
10
 p
er
 m
on
th
) f
re
qu
en
t u
se
rs
 o
f e
-c
ig
ar
et
te
s 
(1
9.
3%
 a
nd
 1
7.
9%
, r
es
pe
ct
iv
el
y)
. 
34
Le
Va
ul
t, 
M
ue
lle
r-
Lu
ck
ey
, 
W
at
er
s,
 e
t 
al
. 3
4
N
=
30
9
U
S
B
as
ed
 o
n 
th
e 
M
in
ne
so
ta
 A
du
lt 
To
ba
cc
o 
Su
rv
ey
 (2
01
0)
 
an
d 
th
e 
B
rie
f S
m
ok
in
g 
co
ns
eq
ue
nc
es
 Q
ue
st
io
nn
ai
re
 
–A
du
lt.
 T
yp
es
 o
f u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘N
=
30
9;
 
th
er
e 
w
er
e 
23
5 
cu
rr
en
t c
ig
ar
et
te
 s
m
ok
er
s 
co
ns
is
tin
g 
of
 7
9 
w
ho
 s
m
ok
ed
 o
nl
y 
ci
ga
re
tt
es
 (s
m
ok
er
s)
; 1
22
 w
ho
 
us
ed
 b
ot
h 
ci
ga
re
tt
es
 a
nd
 e
-c
ig
ar
et
te
s 
(d
ua
l u
se
rs
); 
an
d 
34
 fo
rm
er
 e
-c
ig
ar
et
te
 u
se
rs
. O
nl
y 
sm
ok
er
s 
an
d 
du
al
 
us
er
s 
w
er
e 
in
cl
ud
ed
 in
 th
is
 a
na
ly
si
s.
 1
8 
ye
ar
s 
or
 o
ld
er
.’
RE
A
SO
N
S 
Re
as
on
s 
fo
r d
ua
l u
se
 w
er
e 
to
 re
du
ce
 o
r t
o 
qu
it 
sm
ok
in
g 
(7
9.
5%
). 
35
Li
, B
ul
le
n,
 
N
ew
co
m
be
, 
W
al
ke
r, 
W
al
-
to
n 
35
n=
84
0
N
ew
-Z
ea
-
la
nd
Th
e 
N
ew
 Z
ea
la
nd
 S
m
ok
in
g 
M
on
ito
r (
n=
84
0)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
am
pl
e 
of
 c
ur
re
nt
 
sm
ok
er
s:
 w
ho
 s
m
ok
ed
 a
t l
ea
st
 o
ne
 c
ig
ar
et
te
 a
 m
on
th
 
an
d 
w
ho
 h
ad
 n
ot
 m
ad
e 
a 
qu
it 
at
te
m
pt
 la
st
in
g 
24
 h
ou
rs
 
or
 m
or
e 
in
 th
e 
pa
st
 th
re
e 
m
on
th
s,
 a
nd
 th
os
e 
w
ho
 h
av
e 
m
ad
e 
a 
qu
it 
at
te
m
pt
 la
st
in
g 
24
 h
ou
rs
 o
r l
on
ge
r i
n 
th
e 
pa
st
 th
re
e 
m
on
th
s 
w
hi
ch
 m
ay
 o
r m
ay
 n
ot
 h
av
e 
be
en
 
su
st
ai
ne
d.
U
se
 o
f e
-c
ig
ar
et
te
s 
no
t s
pe
ci
fie
d.
’ C
ur
re
nt
 s
m
ok
er
s 
an
d 
re
ce
nt
 q
ui
tt
er
s 
18
 y
ea
rs
 o
r o
ld
er
PE
RC
EP
TI
O
N
S 
O
ne
-t
hi
rd
 a
gr
ee
d 
th
at
 e
-c
ig
ar
et
te
s 
w
er
e 
sa
fe
r t
ha
n 
to
ba
cc
o 
ci
ga
re
tt
es
 (n
=
15
8)
 a
nd
 
ag
re
ed
 e
-c
ig
ar
et
te
s 
co
ul
d 
he
lp
 p
eo
pl
e 
qu
it 
sm
ok
in
g 
(n
=
16
2)
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
36
Li
, N
ew
-
co
m
be
, W
al
-
to
n 
36
 (n
=
25
94
)
N
ew
-Z
ea
-
la
nd
Th
e 
N
ew
 Z
ea
la
nd
 S
m
ok
in
g 
M
on
ito
r (
n=
25
94
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
ve
r u
se
: H
av
e 
yo
u 
ev
er
 tr
ie
d 
an
 e
le
ct
ro
ni
c 
ci
ga
re
tt
e?
 C
ur
re
nt
 u
se
: 
w
hi
ch
 b
es
t d
es
cr
ib
es
 h
ow
 o
ft
en
 y
ou
 u
se
 a
n 
el
ec
tr
on
ic
 
ci
ga
re
tt
e 
no
w
? 
A
t l
ea
st
 o
nc
e 
a 
da
y/
at
 le
as
t o
nc
e 
a 
w
ee
k/
at
 le
as
t o
nc
e 
a 
m
on
th
.
C
ur
re
nt
 s
m
ok
er
’s 
no
n-
at
te
m
pt
er
: s
m
ok
ed
 a
t l
ea
st
 
on
e 
ci
ga
re
tt
e 
a 
m
on
th
 a
nd
 w
ho
 h
ad
 n
ot
 m
ad
e 
a 
qu
it 
at
te
m
pt
 la
st
in
g 
24
 h
ou
rs
 o
r m
or
e 
in
 th
e 
pa
st
 th
re
e 
m
on
th
s.
 R
ec
en
t q
ui
t a
tt
em
pt
er
s:
 th
os
e 
w
ho
 h
av
e 
m
ad
e 
a 
qu
it 
at
te
m
pt
 la
st
in
g 
24
 h
ou
rs
 o
r l
on
ge
r i
n 
th
e 
pa
st
 th
re
e 
m
on
th
s 
w
hi
ch
 m
ay
 o
r m
ay
 n
ot
 h
av
e 
be
en
 
su
st
ai
ne
d.
’ C
ur
re
nt
 s
m
ok
er
s 
an
d 
re
ce
nt
 q
ui
tt
er
s 
18
 
ye
ar
s 
or
 o
ld
er
.
RE
A
SO
N
S 
57
.1
%
 c
ur
io
si
ty
, 3
1.
3%
 w
an
te
d 
to
 q
ui
t,8
.4
%
 
al
te
rn
at
iv
e 
fo
r t
ob
ac
co
 c
ig
ar
et
te
s,
 2
.8
%
 d
ue
 to
 a
 
re
co
m
m
en
da
tio
n,
 2
.5
%
 s
af
er
, 2
.4
%
 a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
, 1
.2
%
 c
os
ts
 (a
m
on
g 
ev
er
 u
se
rs
). 
15
.4
%
 
cu
rio
si
ty
, 5
0.
9%
 w
an
te
d 
to
 q
ui
t, 
21
.7
%
 a
lte
rn
at
iv
e 
fo
r 
to
ba
cc
o 
ci
ga
re
tt
es
, 0
.8
%
 d
ue
 to
 a
 re
co
m
m
en
da
tio
n,
 
4.
9%
 s
af
er
, 1
0.
3%
 a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
, 6
.1
%
 
co
st
s 
(a
m
on
g 
cu
rr
en
t u
se
rs
).
37
Lo
tr
ea
n 
37
N
=
48
0
RO
M
A
N
IA
C
ro
ss
-s
ec
tio
na
l d
at
a 
fro
m
 R
om
an
ia
 (n
=
48
0)
 a
m
on
g 
st
ud
en
ts
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘S
m
ok
er
s:
 
in
di
vi
du
al
s 
w
ho
 h
ad
 s
m
ok
ed
 in
 th
e 
pa
st
 m
on
th
. E
x-
sm
ok
er
s:
 th
os
e 
w
ho
 h
ad
 s
m
ok
ed
 in
 th
ei
r l
ife
tim
e 
bu
t 
no
t i
n 
th
e 
pa
st
 m
on
th
. N
on
-s
m
ok
er
: t
ho
se
 w
ho
 h
ad
 n
ot
 
sm
ok
ed
 tr
ad
iti
on
al
 c
ig
ar
et
te
s.
 E
ve
r e
-c
ig
ar
et
te
 u
se
: h
ad
 
tr
ie
d 
at
 le
as
t o
nc
e 
in
 li
fe
tim
e.
 S
tu
de
nt
s 
ag
ed
 1
9–
24
. 
53
.3
%
 o
f t
he
 s
m
ok
er
s,
 2
5%
 o
f t
he
 e
x-
sm
ok
er
s 
an
d 
5.
5%
 
of
 th
e 
no
n-
sm
ok
er
s 
ha
d 
tr
ie
d 
e-
ci
ga
re
tt
es
. D
efi
ni
tio
n 
of
 
us
e 
is
 n
ot
 p
ro
vi
de
d.
’
PE
RC
EP
TI
O
N
S 
E-
ci
ga
re
tt
es
 a
re
 le
ss
 d
an
ge
ro
us
; 
ov
er
al
l 5
5.
9%
. E
ve
r u
se
rs
; 6
2.
3%
 s
m
ok
er
s;
 3
3.
3%
 
fo
rm
er
 s
m
ok
er
s;
 5
8.
7%
 n
on
-s
m
ok
er
s;
 E
-c
ig
ar
et
te
s 
ca
n 
he
lp
 s
m
ok
er
s 
to
 q
ui
t; 
ov
er
al
l 6
6.
4%
. E
ve
r u
se
rs
; 4
6.
1%
 
sm
ok
er
s;
 7
0.
8%
 fo
rm
er
 s
m
ok
er
s;
 7
9.
4%
 n
on
-s
m
ok
er
s;
 
E-
ci
ga
re
tt
es
 a
re
 u
se
d 
on
ly
 b
y 
sm
ok
er
s;
 4
8.
9%
 o
ve
ra
ll.
; 
51
.3
%
 s
m
ok
er
s;
 5
0.
0%
 fo
rm
er
 s
m
ok
er
s;
 4
6.
8%
 n
on
-
sm
ok
er
s.
RE
A
SO
N
S 
E-
ci
ga
re
tt
es
 a
re
 le
ss
 d
an
ge
ro
us
 8
%
 o
ve
ra
ll;
 
0%
 s
m
ok
er
s;
 5
0%
 fo
rm
er
 s
m
ok
er
s;
 0
%
 n
on
-s
m
ok
er
s;
 
To
 q
ui
t s
m
ok
in
g 
23
.2
%
 o
ve
ra
ll;
 3
1.
7%
 s
m
ok
er
s;
 
C
ur
io
si
ty
 6
2.
5%
 e
ve
r u
se
rs
; 6
5.
9%
 s
m
ok
er
s;
 5
0.
0%
 
fo
rm
er
 s
m
ok
er
s;
 5
8.
3%
 n
on
-s
m
ok
er
s;
 O
th
er
 fr
ie
nd
s 
al
so
 tr
ie
d 
e-
ci
ga
re
tt
es
 2
3.
2%
 o
ve
ra
ll;
 2
5.
6%
 s
m
ok
er
s;
 
0%
 fo
rm
er
 s
m
ok
er
s;
 4
1.
7%
 n
on
-s
m
ok
er
s.
38
M
aj
ee
d,
 
St
an
to
n,
 
D
ub
e,
 e
t 
al
. 3
8
N
=
14
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
(n
=
 1
4)
). 
Ty
pe
s 
of
 
us
er
 a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 c
ig
ar
et
te
 u
se
rs
 
(a
du
lts
: 1
8 
ye
ar
s 
or
 o
ld
er
) w
ho
 e
ve
r u
se
d 
e-
ci
ga
re
tt
es
. 
(s
el
f-
id
en
tifi
ed
 a
s 
cu
rr
en
t s
m
ok
er
s;
 h
ad
 u
se
d 
e-
ci
ga
re
tt
es
, e
ve
n 
on
ce
).’
RE
A
SO
N
S 
fo
r e
xp
er
im
en
ta
tio
n:
 C
ur
io
si
ty
, c
ra
vi
ng
s,
 
co
ol
ne
ss
, c
on
ve
ni
en
ce
, p
er
su
as
iv
e 
pe
rs
on
s.
 R
ea
so
ns
 
fo
r r
eg
ul
ar
 u
se
: c
ra
vi
ng
s,
 s
en
so
ry
 e
xp
er
ie
nc
e,
 
co
ol
ne
ss
, p
er
ce
iv
ed
 re
du
ce
d 
ha
rm
, c
on
ve
ni
en
ce
. 
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ta
b
le
 c
o
nt
in
ue
s
Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
39
M
aj
ee
d,
 
W
ea
ve
r, 
G
re
go
ry
, e
t 
al
. 3
9
A
 to
ta
l o
f 
4,
17
0;
 5
,7
17
; 
an
d 
6,
05
1 
re
sp
on
de
nt
s 
co
m
pl
et
ed
 
th
e 
20
12
, 
20
14
, a
nd
 
20
15
U
S
To
ba
cc
o 
Pr
od
uc
ts
 a
nd
 R
is
k 
PE
RC
EP
TI
O
N
S 
Su
rv
ey
s,
 
cr
os
s-
se
ct
io
na
l, 
w
ith
 U
S 
ad
ul
ts
 (1
8>
). 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘N
on
-u
se
rs
, s
m
ok
er
s,
 a
nd
 fo
rm
er
 
sm
ok
er
s.
 C
ur
re
nt
 s
m
ok
er
s 
w
er
e 
de
fin
ed
 a
s 
ad
ul
ts
 w
ho
 
ha
d 
sm
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
du
rin
g 
th
ei
r l
ife
tim
e 
an
d 
re
po
rt
ed
 c
ur
re
nt
ly
 s
m
ok
in
g 
ev
er
y 
da
y 
or
 s
om
e 
da
ys
. F
or
m
er
 s
m
ok
er
s 
w
er
e 
de
fin
ed
 a
s 
ad
ul
ts
 w
ho
 h
ad
 
sm
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
an
d 
re
sp
on
de
d 
no
t a
t 
al
l t
o 
th
e 
qu
es
tio
n 
ab
ou
t c
ur
re
nt
 s
m
ok
in
g.
 T
ho
se
 w
ho
 
ha
d 
no
t s
m
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
ife
tim
e 
w
er
e 
de
fin
ed
 a
s 
ne
ve
r s
m
ok
er
s.
’
PE
RC
EP
TI
O
N
S 
Th
er
e 
is
 a
n 
in
cr
ea
se
 p
er
ce
pt
io
n 
th
at
 
e-
ci
ga
re
tt
es
 a
re
 “
ab
ou
t t
he
 s
am
e 
le
ve
l o
f h
ar
m
” 
as
 o
r 
to
 b
e 
“m
or
e 
ha
rm
fu
l”
 th
an
 c
ig
ar
et
te
s.
 U
nc
er
ta
in
 a
bo
ut
 
ha
rm
: d
ec
re
as
ed
 (4
7.
8%
) i
n 
20
12
 to
 2
9.
5%
 in
 2
01
5.
40
M
ar
k,
 
Fa
rq
uh
ar
, 
C
hi
so
lm
, 
C
ol
em
an
-
C
ow
ge
r, 
Te
rp
la
n 
40
n=
31
6
U
S,
 U
ni
-
ve
rs
ity
 o
f 
M
ar
yl
an
d 
W
om
en
’s 
H
ea
lth
 
C
en
te
r
Se
lf-
re
po
rt
 (n
=
31
6)
 a
m
on
g 
pr
eg
na
nt
 w
om
en
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: p
as
t 
30
 d
ay
s.
 C
ur
re
nt
 s
m
ok
er
s:
 s
m
ok
ed
 w
ith
in
 th
e 
pa
st
 3
0 
da
ys
. 
Pr
eg
na
nt
 w
om
en
 (6
6.
1 
%
 re
po
rt
ed
 h
av
in
g 
ev
er
 h
ea
rd
 o
f 
e-
ci
ga
re
tt
es
, 1
3%
 re
po
rt
ed
 h
av
in
g 
an
y 
pr
io
r o
r c
ur
re
nt
 
us
e 
of
 e
-c
ig
ar
et
te
s 
(e
ve
r u
se
rs
), 
w
ith
 0
.6
%
 re
po
rt
in
g 
cu
rr
en
t d
ai
ly
 u
se
); 
18
 y
ea
rs
 o
r o
ld
er
.’
PE
RC
EP
TI
O
N
S 
Le
ss
 h
ar
m
fu
l f
or
 b
ab
y 
43
%
, l
es
s 
ha
rm
fu
l t
o 
se
lf 
(4
5%
), 
ch
ea
pe
r (
31
%
), 
fa
sh
io
na
bl
e 
(1
8%
), 
co
nt
ai
n 
ni
co
tin
e 
(5
7%
), 
ad
di
ct
iv
e 
(6
1%
), 
co
nt
ai
ns
 to
ba
cc
o 
(3
1%
), 
no
t a
s 
ba
d 
fo
r h
ea
lth
 (7
4%
), 
ta
st
e 
be
tt
er
 (5
4%
), 
cu
t d
ow
n 
(7
2%
), 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
ns
 (5
5%
), 
sm
ok
in
g 
ce
ss
at
io
n 
to
ol
 (7
3%
).
41
M
cK
eg
an
ey
, 
D
ic
ks
on
 41
N
=
65
0
U
K
Se
lf-
re
po
rt
 (s
ur
ve
y 
n=
 6
50
) a
m
on
g 
sm
ok
er
s.
 1
8 
ye
ar
s 
or
 o
ld
er
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘3
36
 p
ar
tic
ip
an
ts
 
re
po
rt
ed
 h
av
in
g 
tr
ie
d/
us
ed
 e
-c
ig
ar
et
te
s.
’ N
o 
cl
ea
r 
de
fin
iti
on
s 
pr
ov
id
ed
. 
RE
A
SO
N
S 
To
 a
vo
id
 s
m
ok
in
g 
ba
ns
, fl
av
or
s 
av
ai
la
bl
e,
 
ch
ea
pe
r t
ha
n 
ci
ga
re
tt
es
, l
es
s 
ha
rm
fu
l t
ha
n 
ci
ga
re
tt
es
, a
tt
ra
ct
iv
en
es
s 
of
 th
e 
de
vi
ce
 s
et
tin
gs
 a
nd
 
sp
ec
ifi
ca
tio
ns
. A
m
on
g 
sm
ok
er
s:
 s
w
itc
hi
ng
 to
 e
-c
ig
 u
se
 
w
as
 m
or
e 
en
jo
ya
bl
e 
th
an
 s
m
ok
in
g.
 If
 th
is
 e
xp
ec
ta
tio
n 
w
as
 n
ot
 m
et
, i
t l
ed
 to
 c
on
tin
ue
d 
sm
ok
in
g.
 A
ls
o,
 it
 w
as
 
im
po
rt
an
t h
ow
 th
e 
te
ch
no
lo
gy
 w
or
ke
d,
 h
ow
 it
 lo
ok
ed
 
w
he
n 
us
in
g 
e-
ci
gs
, h
ow
 p
eo
pl
e 
re
ac
te
d 
to
 th
em
 
va
pi
ng
, w
he
th
er
 it
 w
as
 a
 p
oo
r s
ub
st
itu
te
 fo
r s
m
ok
in
g,
 
if 
th
ey
 fe
lt 
em
ba
rr
as
se
d.
 
42
M
cQ
ue
en
, 
To
w
er
, 
Su
m
ne
r 4
2
n=
15
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (i
nt
er
vi
ew
s 
n=
15
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘p
as
t y
ea
r u
se
rs
, 
e-
ci
ga
re
tt
e 
us
er
s 
w
ho
 s
ta
rt
ed
 u
si
ng
 in
 th
e 
pa
st
 y
ea
r. 
20
-
60
 y
ea
rs
 o
ld
; e
-c
ig
ar
et
te
 u
se
rs
’
RE
A
SO
N
S 
A
lte
rn
at
iv
e 
w
ay
 o
f t
ob
ac
co
 c
on
su
m
pt
io
n,
 
sm
ok
in
g 
ce
ss
at
io
n,
 c
os
ts
, m
ai
nt
ai
n 
w
ei
gh
t, 
se
ns
e 
of
 ta
st
e,
 s
m
el
l, 
ab
ili
ty
 to
 b
e 
ph
ys
ic
al
ly
 a
ct
iv
e,
 h
ea
lth
 
be
ne
fit
 (u
ne
xp
ec
te
d 
an
d 
ex
pe
rie
nc
ed
), 
C
ut
 b
ac
k 
on
 n
ic
ot
in
e 
fix
, n
ot
 s
m
el
lin
g 
of
 c
ig
ar
et
te
 s
m
ok
e,
 
im
m
ed
ia
te
 e
ffe
ct
s 
ou
tw
ei
gh
 p
ot
en
tia
l l
on
g-
te
rm
 h
ar
m
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
43
Pa
te
l, 
D
av
is
, 
C
ox
, e
t a
l. 
43
N
=
13
,3
04
U
S
In
te
rn
et
 s
ur
ve
ys
 o
f U
.S
. a
du
lt 
co
nv
en
tio
na
l c
ig
ar
et
te
 
sm
ok
er
s 
an
d 
no
ns
m
ok
er
s.
 N
=
 1
0,
18
1 
cu
rr
en
t c
ig
ar
et
te
 
sm
ok
er
s;
 N
=
31
23
 n
on
sm
ok
er
s 
ag
ed
 1
8 
or
 o
ld
er
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 c
ig
ar
et
te
 
sm
ok
er
s 
=
 p
er
so
ns
 w
ho
 h
ad
 s
m
ok
ed
 a
t l
ea
st
 1
00
 
co
nv
en
tio
na
l c
ig
ar
et
te
s 
in
 th
ei
r l
ife
tim
e 
an
d 
cu
rr
en
tly
 
sm
ok
ed
 e
ith
er
 “
so
m
e 
da
ys
” 
or
 “
ev
er
y 
da
y”
 a
t t
he
 ti
m
e 
of
 th
e 
su
rv
ey
. 
N
on
-s
m
ok
er
s 
w
er
e 
de
fin
ed
 a
s 
pe
rs
on
s 
w
ho
 re
po
rt
ed
 
sm
ok
in
g 
“n
ot
 a
t a
ll”
 a
t t
he
 ti
m
e 
of
 th
e 
su
rv
ey
, 
re
ga
rd
le
ss
 o
f l
ife
tim
e 
nu
m
be
r o
f c
on
ve
nt
io
na
l 
ci
ga
re
tt
es
 s
m
ok
ed
. 
C
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
 w
er
e 
de
fin
ed
 a
s 
th
os
e 
w
ho
 re
sp
on
de
d 
“e
ve
ry
 d
ay
” 
or
 “
so
m
e 
da
ys
” 
to
 th
e 
qu
es
tio
n,
 “
D
o 
yo
u 
no
w
 u
se
 e
-c
ig
ar
et
te
s 
ev
er
y 
da
y,
 
so
m
e 
da
ys
, o
r n
ot
 a
ll?
”’
RE
A
SO
N
S 
A
m
on
g 
cu
rr
en
t u
se
rs
: c
es
sa
tio
n/
he
al
th
 
(8
4.
5%
) (
le
ss
 h
ar
m
fu
l, 
re
du
ce
 n
um
be
r o
f c
ig
ar
et
te
s,
 
ot
he
r f
rie
nd
s 
us
e 
th
em
 to
o)
; c
on
si
de
ra
tio
n 
of
 o
th
er
s 
(le
ss
 h
ar
m
fu
l, 
do
n’
t s
m
el
l);
 c
on
ve
ni
en
ce
 (t
o 
av
oi
d 
sm
ok
in
g 
ba
ns
), 
cu
rio
si
ty
, fl
av
or
s,
 c
os
ts
, s
im
ul
at
io
n 
of
 
ci
ga
re
tt
es
. 
N
on
-s
m
ok
er
s:
 c
ur
io
si
ty
, t
an
k 
us
er
s 
m
en
tio
ne
d 
co
st
s,
 
ce
ss
at
io
n,
 a
nd
 s
im
ul
at
io
n 
of
 c
ig
ar
et
te
 s
en
sa
tio
n.
44
Pe
ar
so
n,
 
Ri
ch
ar
ds
on
, 
N
ia
ur
a,
 
Va
llo
ne
, 
A
br
am
s 
44
n=
2,
64
9 
(o
nl
in
e 
st
ud
y)
 
&
 n
=
3,
65
8 
(c
oh
or
t) 
U
S
Le
ga
cy
 L
on
gi
tu
di
na
l S
m
ok
er
 C
oh
or
t (
LL
SC
) (
n=
3,
65
8)
 
an
d 
na
tio
na
l c
oh
or
t (
n=
2,
64
9)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘i
n 
bo
th
 s
ur
ve
ys
: 
N
ev
er
 s
m
ok
er
s:
 h
av
in
g 
ne
ve
r s
m
ok
ed
 u
p 
to
 1
00
 
ci
ga
re
tt
es
 in
 th
ei
r l
iv
es
. F
or
m
er
 s
m
ok
er
s:
 h
av
in
g 
sm
ok
ed
 1
00
 c
ig
ar
et
te
s 
or
 m
or
e 
in
 th
ei
r l
iv
es
 b
ut
 
cu
rr
en
tly
 s
m
ok
in
g 
no
t a
t a
ll.
 C
ur
re
nt
 s
m
ok
er
s:
 h
av
in
g 
sm
ok
ed
 in
 e
xc
es
s 
of
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
iv
es
 a
nd
 
cu
rr
en
tly
 s
m
ok
in
g 
ev
er
y 
da
y 
or
 s
m
ok
e 
da
ys
. 1
8-
49
 
ye
ar
s 
ol
d 
re
ce
nt
 q
ui
tt
er
s 
an
d 
cu
rr
en
t s
m
ok
er
s 
(n
=
3,
65
8)
 
an
d 
18
 y
ea
rs
 o
r o
ld
er
 n
ev
er
, f
or
m
er
, a
nd
 c
ur
re
nt
 
sm
ok
er
s 
(n
=
2,
64
9)
.’
PE
RC
EP
TI
O
N
S 
70
.6
%
 o
f t
ho
se
 a
w
ar
e 
in
 th
e 
on
lin
e 
su
rv
ey
 a
nd
 8
4.
7%
 in
 th
e 
LL
SC
 b
el
ie
ve
d 
e-
ci
gs
 a
re
 le
ss
 
ha
rm
fu
l t
ha
n 
co
m
bu
st
ib
le
 c
ig
ar
et
te
s.
45
Pe
pp
er
, 
Em
er
y,
 
Ri
bi
sl
, R
in
i, 
B
re
w
er
 45
n=
6,
60
7
U
S
To
ba
cc
o 
C
on
tr
ol
 in
 a
 R
ap
id
ly
 C
ha
ng
in
g 
M
ed
ia
 
En
vi
ro
nm
en
t (
TC
M
E)
 (n
=
6,
60
7 
cu
rr
en
t s
m
ok
er
s)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
 
of
 e
-c
ig
ar
et
te
: u
si
ng
 th
em
 e
ve
ry
 d
ay
 o
r s
om
e 
da
ys
. 
Ev
er
 u
se
: t
rie
d 
e-
ci
ga
re
tt
es
, e
ve
n 
ju
st
 o
ne
 p
uf
f. 
A
du
lt 
sm
ok
er
s;
 1
8 
ye
ar
s 
or
 o
ld
er
 (m
ea
n 
ag
e 
44
.2
 y
ea
rs
 o
ld
)’
PE
RC
EP
TI
O
N
S 
Pa
rt
ic
ip
an
ts
 p
er
ce
iv
ed
 e
-c
ig
ar
et
te
s 
le
ss
 li
ke
ly
 to
 c
au
se
 lu
ng
 c
an
ce
r, 
he
ar
t d
is
ea
se
, a
nd
 o
ra
l 
ca
nc
er
 c
om
pa
re
d 
to
 re
gu
la
r c
ig
ar
et
te
s.
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
46
Pe
pp
er
, 
Ri
bi
sl
, 
B
re
w
er
 46
N
=
11
25
U
S
Se
lf-
re
po
rt
 (s
ur
ve
y 
n=
11
25
) a
ge
 1
3 
– 
17
 y
ea
rs
 o
ld
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘n
ev
er
 s
m
ok
er
s/
e-
ci
ga
re
tt
e 
us
er
s 
(8
9%
), 
4%
 c
ur
re
nt
 s
m
ok
er
s 
an
d 
5%
 
cu
rr
en
t e
-c
ig
ar
et
te
 u
se
rs
. 3
 c
at
eg
or
ie
s 
of
 e
-c
ig
ar
et
te
 
us
er
s:
 n
ev
er
 u
se
rs
, e
ve
r u
se
rs
 (u
se
d 
≥
1 
tim
e 
bu
t n
ot
 in
 
th
e 
pa
st
 3
0 
da
ys
), 
an
d 
cu
rr
en
t u
se
rs
 (u
se
d 
≥
1 
tim
e 
in
 
th
e 
pa
st
 3
0 
da
ys
).’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
fr
ui
t-
fla
vo
re
d 
to
 b
e 
le
ss
 
ha
rm
fu
l, 
an
d 
w
er
e 
m
or
e 
lik
el
y 
to
 tr
y 
m
en
th
ol
, c
an
dy
 o
r 
fr
ui
t fl
av
or
ed
 e
-c
ig
ar
et
te
s.
47
Pe
pp
er
, 
Ri
bi
sl
, 
Em
er
y,
 
B
re
w
er
 47
n=
3,
87
8
U
S
Se
lf-
re
po
rt
 (n
=
3,
87
8)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: u
si
ng
 
e-
ci
ga
re
tt
es
 e
ith
er
 e
ve
ry
 d
ay
 o
r s
om
e 
da
ys
. E
ve
r u
se
: 
tr
yi
ng
 o
r s
ta
rt
in
g,
 e
ve
n 
on
e 
pu
ff.
 A
du
lts
 (1
8 
ye
ar
s 
or
 
ol
de
r) 
w
ho
 e
ve
r t
rie
d 
e-
ci
ga
re
tt
es
.’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
as
 le
ss
 h
ar
m
fu
l (
29
%
) a
nd
 
le
ss
 h
ar
m
fu
l t
o 
ot
he
rs
 (2
3%
) 
RE
A
SO
N
S 
C
ur
io
si
ty
 (5
3%
), 
so
ci
al
 e
nv
iro
nm
en
t (
34
%
), 
to
 q
ui
t o
r c
ut
 b
ac
k 
(3
0%
), 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
n 
(2
6%
), 
un
ex
pe
ct
ed
 b
en
efi
ts
 (4
2%
), 
cr
av
in
gs
 (3
8%
), 
af
fo
rd
ab
le
 (2
8%
), 
fla
vo
rs
 (3
0%
), 
ro
ut
in
e 
m
ai
nt
en
an
ce
 
(3
6%
). 
48
Pe
te
rs
, 
M
es
ha
ck
, 
Li
n,
 H
ill
, 
A
bu
gh
os
h 
48
N
=
47
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
47
) 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 a
ge
 1
5 
– 
17
 y
ea
rs
 
ol
d 
m
al
e 
ad
ol
es
ce
nt
 c
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
 in
 T
ex
as
, 
U
S.
 
RE
A
SO
N
S 
A
es
th
et
ic
s,
 a
cc
es
si
bi
lit
y,
 h
ea
lth
ie
r 
th
an
 C
ig
ar
et
te
s,
 O
do
rle
ss
, H
ig
h 
So
ci
al
 A
pp
ro
va
l, 
Ex
pe
di
tio
us
 C
on
su
m
pt
io
n 
an
d 
C
on
ce
al
m
en
t, 
Sa
fe
 
H
ig
h.
49
Pi
ne
iro
, 
C
or
re
a,
 
Si
m
m
on
s,
 e
t 
al
. 4
9
N
=
18
15
U
S
Se
lf-
re
po
rt
 (n
=
1,
81
5)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘D
ua
l u
se
rs
: 
pa
rt
ic
ip
an
ts
 re
po
rt
in
g 
us
in
g 
to
ba
cc
o 
ci
ga
re
tt
es
 in
 th
e 
pa
st
 3
0 
da
ys
, t
ha
t i
s,
 u
se
rs
 o
f b
ot
h 
to
ba
cc
o 
ci
ga
re
tt
es
 
an
d 
e-
ci
ga
re
tt
es
. E
-c
ig
ar
et
te
s 
us
er
s:
 re
po
rt
ed
 s
m
ok
in
g 
no
 to
ba
cc
o 
ci
ga
re
tt
es
 in
 th
e 
pa
st
 m
on
th
.’ 
18
 y
ea
rs
 o
r 
ol
de
r; 
E-
ci
ga
re
tt
e 
us
er
s
PE
RC
EP
TI
O
N
S 
Ta
st
e,
 s
oc
ia
l e
nv
iro
nm
en
t, 
th
ro
at
 h
it,
 
w
ei
gh
t c
on
tr
ol
, a
dd
ic
tio
n.
 
RE
A
SO
N
S 
Sm
ok
in
g 
ce
ss
at
io
n 
to
ol
, h
ea
lth
 b
en
efi
t, 
cu
rio
si
ty
, d
ue
 to
 fa
m
ily
/f
rie
nd
s,
 C
ut
 b
ac
k 
sm
ok
in
g,
 
en
jo
y 
ta
st
e,
 d
ea
l w
ith
 s
tr
es
s.
 S
el
f-
re
gu
la
tio
n.
 
50
Po
kh
re
l, 
H
er
zo
g,
 
M
ur
an
ak
a,
 
Fa
ga
n 
50
n=
62
U
S,
 H
aw
ai
i
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
62
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘A
ll 
pa
rt
ic
ip
an
ts
’ 
cu
rr
en
t d
ai
ly
 e
-c
ig
ar
et
te
 u
se
rs
.’ 
18
 - 
35
 y
ea
rs
 o
ld
; 
C
ur
re
nt
 d
ai
ly
 e
-c
ig
ar
et
te
 u
se
rs
 a
nd
 d
ua
l u
se
rs
RE
A
SO
N
S 
Sm
ok
in
g 
ce
ss
at
io
n,
 h
ea
lth
 b
en
efi
t, 
sa
tis
fa
ct
io
n,
 m
im
ic
 s
m
ok
in
g,
 c
ut
 b
ac
k,
 a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
, d
is
cr
ee
t (
hi
di
ng
 u
se
), 
ho
bb
y,
 s
oc
ia
l 
en
vi
ro
nm
en
t, 
co
st
s
ta
b
le
 c
o
nt
in
ue
s
Appendices294
Fi
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t A
ut
ho
r
N
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Br
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f s
tu
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 d
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cr
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tio
n
M
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 re
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va
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 fi
nd
in
gs
 
51
Po
kh
re
l, 
H
er
zo
g,
 
M
ur
an
ak
a,
 
Re
gm
i, 
Fa
ga
n 
51
n=
62
U
S,
 H
aw
ai
i
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
62
):
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘A
ll 
pa
rt
ic
ip
an
ts
’ 
cu
rr
en
t d
ai
ly
 e
-c
ig
ar
et
te
 u
se
rs
. F
or
m
er
 s
m
ok
er
s:
 
re
po
rt
ed
 h
av
in
g 
sm
ok
ed
 m
or
e 
th
an
 1
00
 c
ig
ar
et
te
s 
in
 th
e 
lif
et
im
e 
an
d 
no
n 
in
 th
e 
pa
st
 3
0 
da
ys
. C
ur
re
nt
 
no
n-
sm
ok
er
s:
 n
ev
er
 s
m
ok
ed
 c
ig
ar
et
te
s 
or
 w
er
e 
fo
rm
er
 
ci
ga
re
tt
e 
sm
ok
er
s.
 1
8 
- 3
5 
ye
ar
s 
ol
d;
 C
ur
re
nt
 d
ai
ly
 
e-
ci
ga
re
tt
e 
us
er
s 
an
d 
cu
rr
en
t d
ua
l u
se
rs
.’ 
D
ua
l u
se
rs
, 1
8 
ye
ar
s 
or
 o
ld
er
RE
A
SO
N
S 
D
ua
l u
se
: t
o 
he
lp
 w
ith
 c
ra
vi
ng
s,
 s
itu
at
io
na
l 
us
e,
 p
la
ce
s,
 w
he
n 
ot
he
r s
ub
st
an
ce
s 
ar
e 
us
ed
, n
ee
d 
of
 
an
 e
-c
ig
ar
et
te
 s
ub
st
itu
te
. A
ct
iv
iti
es
 (w
or
ki
ng
, b
ef
or
e 
w
or
k 
ou
t),
 p
la
ce
s/
si
tu
at
io
ns
 (h
om
e,
 in
si
de
 a
 v
eh
ic
le
, 
w
he
n 
yo
u 
do
n’
t w
an
t t
o 
sm
el
l),
 to
 a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
52
Ra
ss
, P
ac
ek
, 
Jo
hn
so
n,
 
Jo
hn
so
n 
52
n=
35
0
U
S
C
ro
ss
-s
ec
tio
na
l (
n=
35
0)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘a
ll 
pa
rt
ic
ip
an
ts
 
w
er
e 
du
al
 u
se
rs
 o
f e
-c
ig
ar
et
te
s 
an
d 
to
ba
cc
o 
ci
ga
re
tt
es
.’ 
D
ua
l u
se
rs
, 1
8 
ye
ar
s 
or
 o
ld
er
PE
RC
EP
TI
O
N
S 
Le
ss
 h
ar
m
fu
l (
57
%
 m
uc
h 
le
ss
, 3
0%
 
so
m
e 
le
ss
), 
le
ss
 h
ar
m
fu
l t
o 
ot
he
rs
, l
es
s 
en
jo
ya
bl
e 
th
an
 c
ig
ar
et
te
s,
 a
dd
ic
tiv
e,
 N
RT
 p
er
ce
iv
ed
 a
s 
eq
ua
lly
 
ha
rm
fu
l a
s 
e-
ci
ga
re
tt
es
 (5
9%
). 
30
%
 n
ot
 a
t a
ll 
ad
di
ct
iv
e,
 
un
su
re
 a
bo
ut
 th
e 
da
ng
er
s 
of
 e
-c
ig
ar
et
te
s 
(2
2%
), 
un
su
re
 a
bo
ut
 th
e 
da
ng
er
s 
22
.0
%
RE
A
SO
N
S 
Le
ss
 h
ar
m
fu
l 6
4%
; T
o 
cu
t d
ow
n 
sm
ok
in
g 
to
ba
cc
o 
40
%
; A
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
 4
5%
; T
o 
qu
it 
sm
ok
in
g 
34
%
; c
ra
vi
ng
s 
57
%
; l
es
s 
ha
rm
fu
l t
o 
ot
he
rs
 
52
%
; e
xp
er
ie
nc
ed
 h
ea
lth
 b
en
efi
ts
 3
0%
; c
os
ts
 2
7%
; 
ta
st
e 
22
%
; O
th
er
 (e
.g
., 
pr
ef
er
 th
e 
sm
el
l, 
re
du
ce
 s
tr
es
s)
 
3%
; w
ith
dr
aw
al
 3
5%
; f
oc
us
 8
%
; I
 c
an
’t 
st
op
 u
si
ng
 it
 
1%
; W
ith
 a
n 
e-
ci
ga
re
tt
e,
 it
 is
 e
as
ie
r t
o 
ju
st
 s
m
ok
e 
on
e 
or
 a
 fe
w
 p
uf
fs
 a
t a
 ti
m
e 
ra
th
er
 th
an
 a
 w
ho
le
 c
ig
ar
et
te
 
45
%
. 
53
Ri
ch
ar
ds
on
, 
Pe
ar
so
n,
 
X
ia
o,
 
St
al
ga
iti
s,
 
Va
llo
ne
 53
n=
1,
48
7
U
S
Le
ga
cy
 L
on
gi
tu
di
na
l S
m
ok
er
 C
oh
or
t (
n=
1,
48
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
: 
th
os
e 
w
ho
 re
po
rt
ed
 s
m
ok
in
g 
'e
ve
ry
 d
ay
' o
r '
so
m
e 
da
ys
'. 
Fo
rm
er
 s
m
ok
er
: t
ho
se
 w
ho
 re
po
rt
ed
 s
m
ok
in
g 
'n
ot
 a
t a
ll'
. C
ur
re
nt
 a
nd
 fo
rm
er
 s
m
ok
er
s 
18
-4
9 
ye
ar
s 
ol
d’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
as
 le
ss
 h
ar
m
fu
l t
ha
n 
co
m
bu
st
ib
le
 c
ig
ar
et
te
s 
ov
er
al
l (
61
.6
%
 a
m
on
g 
sm
ok
er
s,
 7
9.
2%
 a
m
on
g 
ev
er
 u
se
rs
, a
nd
 6
5.
4 
%
 a
m
on
g 
aw
ar
e 
bu
t n
on
-u
se
rs
). 
RE
A
SO
N
S 
55
.3
%
 c
ut
 b
ac
k 
or
 s
m
ok
in
g 
ce
ss
at
io
n,
 
38
.1
%
, a
vo
id
 s
m
ok
in
g 
re
st
ric
tio
ns
, f
ee
ls
 li
ke
 
sm
ok
in
g(
62
.8
%
), 
w
ith
 fo
rm
er
 s
m
ok
er
s 
m
or
e 
lik
el
y 
th
an
 
cu
rr
en
t s
m
ok
er
s 
(3
5.
5%
 v
s.
 1
6.
8%
). 
co
st
 (5
9.
6%
), 
so
ci
al
 
en
vi
ro
nm
en
t (
69
.6
%
), 
no
 li
ng
er
in
g 
od
or
 (6
1.
7%
). 
av
oi
d 
sm
ok
in
g 
ba
ns
 (6
9.
0%
), 
w
ith
 fo
rm
er
 s
m
ok
er
s 
m
or
e 
lik
el
y 
th
an
 c
ur
re
nt
 s
m
ok
er
s 
to
 c
ite
 th
is
 a
s 
a 
re
as
on
 fo
r 
us
e 
(9
2.
6%
 v
s.
 6
5.
4%
). 
Appendices 295
Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
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54
Ru
tt
en
, B
la
-
ke
, A
gu
n-
w
am
ba
, e
t 
al
. 5
4
n=
2,
25
4
U
S
C
ro
ss
-s
ec
tio
na
l (
n=
2,
25
4)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
s:
 
ha
d 
sm
ok
ed
 1
00
 o
r m
or
e 
ci
ga
re
tt
es
 d
ur
in
g 
th
ei
r l
ife
 
an
d 
sm
ok
e 
ci
ga
re
tt
es
 c
ur
re
nt
ly
. E
-c
ig
ar
et
te
 u
se
rs
: u
se
 
e-
ci
g 
on
 s
om
e 
da
ys
 o
r e
ve
ry
 d
ay
. 1
8 
ye
ar
s 
or
 o
ld
er
; 
C
ur
re
nt
 s
m
ok
er
s’
RE
A
SO
N
S 
Re
du
ce
 h
ea
lth
 ri
sk
s 
51
.9
%
; Q
ui
t s
m
ok
in
g 
58
.4
%
; R
ed
uc
e 
sm
ok
in
g 
57
.9
%
; A
pp
ea
lin
g 
fla
vo
r 
14
.7
%
; N
ot
 a
s 
st
ro
ng
, l
ig
ht
er
 1
5.
9%
; A
dd
ic
te
d 
to
 
e-
ci
ga
re
tt
es
 7
.0
99
%
; C
ur
io
us
 1
6.
0%
; S
tr
es
s 
re
du
ct
io
n 
11
.9
%
; C
os
t l
es
s 
24
.5
%
; C
an
 s
m
ok
e 
in
do
or
s 
46
.8
%
; 
Le
ss
 h
ar
m
fu
l t
o 
ot
he
rs
 3
2.
9%
;
55
Sa
dd
le
so
n,
 
K
oz
lo
w
sk
i, 
G
io
vi
no
, e
t 
al
. 5
5
(n
=
42
9)
U
S 
C
ro
ss
-s
ec
tio
na
l (
n=
1,
43
7)
 s
ub
sa
m
pl
e 
(n
=
42
9)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘c
ur
re
nt
 u
se
: p
as
t 
30
 d
ay
s 
di
vi
de
d 
in
 c
ur
re
nt
 d
ai
ly
 (a
ll 
30
 d
ay
s)
 a
nd
 c
ur
re
nt
 
no
n-
da
ily
 (1
 to
 2
9 
da
ys
 o
f t
he
 p
re
vi
ou
s 
30
 d
ay
s)
 u
se
rs
. 
D
is
co
nt
in
ue
d 
e-
ci
ga
re
tt
e 
us
er
: e
ve
r u
se
d,
 b
ut
 n
ot
 in
 
th
e 
pr
ev
io
us
 2
0 
da
ys
. N
ev
er
 s
m
ok
er
s:
 n
ev
er
 tr
ie
d 
a 
to
ba
cc
o 
ci
ga
re
tt
e,
 n
ot
 e
ve
n 
a 
pu
ff.
 E
xp
er
im
en
te
rs
: h
av
e 
sm
ok
ed
 le
ss
 th
an
 1
00
 c
ig
ar
et
te
s 
in
 li
fe
tim
e,
 a
nd
 d
id
 n
ot
 
sm
ok
e 
an
y 
ci
ga
re
tt
es
 in
 th
e 
pa
st
 3
0 
da
ys
. D
is
co
nt
in
ue
d 
sm
ok
er
s:
 s
m
ok
ed
 1
00
 o
r m
or
e 
ci
ga
re
tt
es
 in
 li
fe
tim
e,
 
bu
t d
id
 n
ot
 s
m
ok
e 
an
y 
ci
ga
re
tt
es
 in
 th
e 
pa
st
 3
0 
da
ys
. 
C
ur
re
nt
 s
m
ok
er
s:
 h
av
e 
sm
ok
ed
 a
t l
ea
st
 1
 d
ay
 o
ut
 o
f t
he
 
pa
st
 3
0 
da
ys
. 1
8-
23
 y
ea
rs
 o
ld
 , 
29
.8
%
 e
-c
ig
 e
ve
r u
se
rs
.’
PE
RC
EP
TI
O
N
S 
Le
ss
 to
xi
c 
(4
6.
5%
)
RE
A
SO
N
S 
Pl
ea
su
re
/e
nj
oy
in
g 
us
e 
57
.9
%
, s
oc
ia
l 
en
vi
ro
nm
en
t (
20
.4
%
), 
al
te
rn
at
iv
e 
w
ay
 o
f t
ob
ac
co
 
co
ns
um
pt
io
n 
(1
8.
5%
), 
sm
ok
in
g 
ce
ss
at
io
n 
(1
4.
1%
), 
cr
av
in
gs
 (1
3.
6%
), 
do
 n
ot
 s
m
el
l l
ik
e 
sm
ok
e 
(3
9.
2%
), 
co
st
s 
(2
4.
9%
), 
to
 tr
y 
so
m
et
hi
ng
 n
ew
 (7
1.
6%
), 
to
 tr
y 
so
m
et
hi
ng
 n
ew
 a
nd
 to
 h
el
p 
co
nt
ro
l a
pp
et
ite
 (9
.1
%
), 
I a
m
 a
dd
ic
te
d 
to
 th
e 
e-
ci
g 
an
d 
be
ca
us
e 
al
l o
th
er
 
sm
ok
in
g 
ce
ss
at
io
n 
m
et
ho
ds
 h
ad
 fa
ile
d 
(5
.3
%
).
56
Sa
dd
le
so
n,
 
K
oz
lo
w
sk
i, 
G
io
vi
no
, e
t 
al
. 5
6
n=
1,
43
7
U
S
Se
lf-
re
po
rt
 (n
=
1,
43
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 u
se
: u
se
 
on
 o
ne
 o
r m
or
e 
da
ys
 th
e 
pa
st
 3
0 
da
ys
. E
ve
r u
se
: H
av
e 
yo
u 
ev
er
 tr
ie
d 
or
 e
xp
er
im
en
te
d 
w
ith
 a
n 
e-
ci
ga
re
tt
e,
 
ev
en
 o
ne
 o
r t
w
o 
pu
ffs
? 
N
ev
er
 s
m
ok
er
: n
ev
er
 tr
ie
d 
a 
to
-
ba
cc
o 
ci
ga
re
tt
e.
 F
or
m
er
 s
m
ok
er
s:
 s
m
ok
ed
 1
00
 o
r m
or
e 
ci
ga
re
tt
es
 in
 li
fe
tim
e,
 a
nd
 h
av
e 
sm
ok
ed
 0
 o
ut
 o
f p
as
t 3
0 
da
ys
. E
xp
er
im
en
te
rs
: h
av
e 
ev
er
 tr
ie
d 
a 
ci
ga
re
tt
e,
 h
av
e 
sm
ok
ed
 le
ss
 th
an
 1
00
 c
ig
ar
et
te
s 
in
 li
fe
tim
e 
an
d 
ha
ve
 
sm
ok
ed
 0
 o
f t
he
 p
as
t 3
0 
da
ys
. C
ur
re
nt
 s
m
ok
er
: h
av
e 
sm
ok
ed
 a
t l
ea
st
 1
 d
ay
 o
ut
 o
f t
he
 p
as
t 3
0.
 1
8-
23
 y
ea
rs
 
ol
d;
 g
en
er
al
 p
op
ul
at
io
n;
 re
po
rt
s 
du
al
 u
se
 fo
r s
m
ok
er
s’
PE
RC
EP
TI
O
N
S 
E-
ci
ga
re
tt
es
 a
re
 le
ss
 h
ar
m
fu
l t
ha
n 
to
ba
cc
o 
ci
ga
re
tt
es
: e
ve
r e
-c
ig
 u
se
rs
 (3
2.
8%
), 
cu
rr
en
t 
(1
6.
3%
), 
ne
ve
r (
42
.4
%
).
ta
b
le
 c
o
nt
in
ue
s
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57
Sc
hm
id
t, 
Re
id
m
oh
r, 
H
ar
w
el
l, 
H
el
ge
rs
on
 57
N
=
5,
06
7
U
S
A
du
lt 
To
ba
cc
o 
Su
rv
ey
 (
se
lf-
re
po
rt
) 
cr
os
s 
se
ct
io
na
l 
da
ta
 
of
 n
on
in
st
itu
tio
na
liz
ed
 M
on
ta
na
 a
du
lts
. T
yp
es
 o
f u
se
r 
as
 
de
fin
ed
 b
y 
au
th
or
s:
 ‘ 
“H
av
e 
yo
u 
ev
er
 u
se
d 
an
 e
le
ct
ro
ni
c 
ci
ga
re
tt
e,
 e
ve
n 
ju
st
 o
ne
 ti
m
e 
in
 y
ou
r e
nt
ire
 li
fe
?”
 ?
 e
ve
r u
se
“D
o 
yo
u 
no
w
 u
se
 e
le
ct
ro
ni
c 
ci
ga
re
tt
es
 e
ve
ry
 d
ay
, s
om
e 
da
ys
 ?
 c
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
. A
du
lt 
(1
8+
) e
ve
r u
se
rs
 
of
 e
-c
ig
ar
et
te
s 
(w
ho
 a
ns
w
er
ed
 th
e 
qu
es
tio
ns
 re
ga
rd
in
g 
RE
A
SO
N
S)
’
RE
A
SO
N
S 
C
ur
io
si
ty
, t
o 
qu
it,
 le
ss
 h
ar
m
fu
l, 
le
ss
 
di
st
ur
bi
ng
, t
o 
av
oi
d 
sm
ok
in
g 
ba
ns
, t
as
te
, c
os
ts
. 
58
Sh
er
ra
tt
, 
M
ar
cu
s,
 
Ro
bi
ns
on
, 
N
ew
so
n,
 
Fi
el
d 
58
n=
31
9 
U
K
C
ro
ss
-s
ec
tio
na
l (
n=
31
9)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 s
m
ok
er
s:
 
sm
ok
ed
 o
ne
 o
r m
or
e 
ci
ga
re
tt
es
 w
ith
in
 th
e 
pa
st
 w
ee
k.
 
Re
ce
nt
 fo
rm
er
 s
m
ok
er
s:
 d
id
 n
ot
 s
m
ok
e 
on
e 
or
 m
or
e 
ci
ga
re
tt
es
 w
ith
in
 th
e 
pa
st
 w
ee
k.
 E
ve
r e
-c
ig
ar
et
te
 
us
e:
 h
av
e 
ev
er
 u
se
d 
an
 e
le
ct
ro
ni
c 
ci
ga
re
tt
e.
 C
ur
re
nt
 
e-
ci
ga
re
tt
e 
us
e:
 h
av
in
g 
us
ed
 a
n 
e-
ci
ga
re
tt
e 
w
ith
in
 th
e 
pa
st
 m
on
th
. F
or
m
er
 e
-c
ig
 u
se
r: 
us
ed
 w
ith
in
 th
e 
pa
st
 1
-6
 
m
on
th
s 
or
 m
or
e 
th
an
 6
 m
on
th
s 
ag
o.
 c
ur
re
nt
 s
m
ok
er
s:
 
St
op
 s
m
ok
in
g 
se
rv
ic
e,
 1
8-
60
 y
ea
rs
 o
ld
’
PE
RC
EP
TI
O
N
S 
48
.2
%
 p
er
ce
iv
ed
 e
-c
ig
 a
s 
le
ss
 h
ar
m
fu
l 
th
an
 to
ba
cc
o.
 3
8.
8%
 fe
lt 
un
ce
rt
ai
n 
ab
ou
t e
-c
ig
 s
af
er
 
th
an
 to
ba
cc
o.
 C
ur
re
nt
 u
se
rs
 v
ie
w
ed
 e
-c
ig
 a
s 
le
ss
 
ha
rm
fu
l t
ha
n 
fo
rm
er
 o
r n
ev
er
 u
se
rs
.
59
Sh
er
ra
tt
, 
N
ew
so
n,
 
M
ar
cu
s,
 
Fi
el
d,
 
Ro
bi
ns
on
 59
N
=
20
U
K
Q
ua
lit
at
iv
e 
in
te
rv
ie
w
s 
(n
=
20
).
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘W
ith
 p
ar
tic
ip
an
ts
 
of
 S
to
p 
Sm
ok
in
g 
Se
rv
ic
es
 in
 n
or
th
-w
es
t E
ng
la
nd
. B
ot
h 
in
di
vi
du
al
s 
w
ho
 h
ad
 tr
ie
d 
e-
ci
ga
re
tt
es
 (n
 =
 6
) a
nd
 th
os
e 
w
ho
 h
ad
 n
ot
 (n
 =
 1
4)
. M
ed
ia
n 
ag
e 
w
as
 5
1.
5 
ye
ar
s 
(ra
ng
e 
25
–5
9)
. R
ec
en
t f
or
m
er
 s
m
ok
er
s:
 th
ey
 h
ad
 n
ot
 
sm
ok
ed
 w
ith
in
 a
t l
ea
st
 th
e 
la
st
 7
 d
ay
s)
’
PE
RC
EP
TI
O
N
S 
E-
ci
ga
re
tt
e 
us
er
s 
pe
rc
ei
ve
 e
-c
ig
ar
et
te
s 
as
 s
af
er
 th
an
 s
m
ok
er
s.
 E
-c
ig
ar
et
te
s 
w
er
e 
pe
rc
ei
ve
d 
as
 
an
 e
ffe
ct
iv
e 
sm
ok
in
g 
ce
ss
at
io
n 
ai
d.
 R
ed
uc
e 
cr
av
in
gs
 
an
d 
he
lp
s 
to
 s
us
ta
in
 a
bs
tin
en
t f
ro
m
 to
ba
cc
o.
 
60
Si
m
m
on
s,
 
Q
ui
nn
, 
H
ar
re
ll,
 e
t 
al
. 6
0
N
=
31
U
S
Q
ua
lit
at
iv
e 
re
se
ar
ch
 (f
oc
us
 g
ro
up
s 
n=
31
). 
W
ith
 
e-
ci
ga
re
tt
e 
us
er
s.
 T
yp
es
 o
f u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 
‘ (
1)
 ≥
 1
8 
ye
ar
s 
ol
d;
 (2
) h
ad
 s
m
ok
ed
 c
ig
ar
et
te
s 
da
ily
 fo
r 
at
 le
as
t 1
 y
ea
r; 
an
d 
(3
) h
ad
 u
se
d 
e-
ci
ga
re
tt
es
 in
 th
e 
pa
st
 
30
 d
ay
s.
’
PE
RC
EP
TI
O
N
S 
Pe
rc
ei
ve
d 
he
al
th
 b
en
efi
ts
RE
A
SO
N
S 
to
 q
ui
t s
m
ok
in
g 
in
iti
al
ly
. I
nt
er
es
t a
nd
 
sa
tis
fa
ct
io
n 
fro
m
 e
xp
er
im
en
tin
g 
w
ith
 s
ev
er
al
 a
sp
ec
ts
 
of
 e
-c
ig
ar
et
te
 d
ev
ic
es
. 
61
So
ul
e,
 
Ro
sa
s,
 
N
as
im
 61
N
=
10
8
U
S
C
on
ce
pt
 m
ap
pi
ng
 (C
M
) t
o 
ch
ar
ac
te
riz
e 
an
d 
de
sc
rib
e 
ad
ul
ts
’ R
EA
SO
N
S 
fo
r u
si
ng
 E
C
IG
s.
 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘A
 to
ta
l o
f 1
08
 
ad
ul
ts
 c
om
pl
et
ed
 a
 m
ul
ti-
m
od
ul
e 
on
lin
e 
C
M
 s
tu
dy
 th
at
 
co
ns
is
te
d 
of
 b
ra
in
st
or
m
in
g 
st
at
em
en
ts
. E
-c
ig
ar
et
te
 u
se
 
w
as
 d
es
cr
ib
ed
 a
s 
pa
st
 3
0-
da
y 
us
e.
 1
8 
ye
ar
s 
or
 o
ld
er
 
an
d 
us
ed
 e
-c
ig
ar
et
te
s 
in
 th
e 
pa
st
 m
on
th
.’
RE
A
SO
N
S 
C
es
sa
tio
n 
M
et
ho
ds
, p
er
ce
iv
ed
 
he
al
th
 b
en
efi
ts
, p
riv
at
e 
re
ga
rd
, c
on
ve
ni
en
ce
, 
co
ns
ci
en
tio
us
ne
ss
, a
nd
 p
le
as
ur
ab
le
 e
ffe
ct
s,
 p
er
ce
iv
ed
 
ag
en
cy
, t
he
ra
pe
ut
ic
, h
ob
by
, a
nd
 s
oc
ia
l i
m
pa
ct
s.
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
62
Su
ris
, 
B
er
ch
to
ld
, 
A
kr
e 
62
N
=
 6
21
 (2
48
 
e-
ci
ga
re
tt
e 
us
er
s)
Sw
itz
er
-
la
nd
Lo
ng
itu
di
na
l r
es
ea
rc
h 
(s
el
f-
re
po
rt
 (n
=
62
1)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 
sm
ok
er
: s
m
ok
in
g 
at
 le
as
t w
ee
kl
y.
 E
xp
er
im
en
te
rs
: 
on
ly
 u
se
d 
on
ce
. A
do
le
sc
en
t (
14
- 1
6 
ye
ar
s 
ol
d)
. U
se
rs
 
(e
xp
er
im
en
te
rs
 a
nd
 re
gu
la
r u
se
rs
) w
er
e 
as
ke
d 
ab
ou
t 
RE
A
SO
N
s’
RE
A
SO
N
S 
C
ur
io
si
ty
 9
3.
1%
 (e
xp
er
im
en
te
rs
) -
 
76
.8
%
 (u
se
rs
); 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
ns
 3
.2
%
 
(e
xp
er
im
en
te
rs
) -
 1
4.
4%
 (u
se
rs
); 
To
 re
du
ce
 s
m
ok
in
g 
3.
6%
 (e
xp
er
im
en
te
rs
) -
10
.4
%
 (u
se
rs
); 
To
 d
o 
lik
e 
m
y 
fr
ie
nd
s 
5.
1%
 (e
xp
er
im
en
te
rs
) -
 6
.0
%
 (u
se
rs
); 
To
 
sm
ok
in
g 
ce
ss
at
io
n 
0.
0%
 (e
xp
er
im
en
te
rs
) -
 3
.3
%
 
(u
se
rs
).
63
Ta
n,
 B
ig
m
an
 
63
n=
3,
63
0
U
S
H
ea
lth
 In
fo
rm
at
io
n 
N
at
io
na
l T
re
nd
s 
Su
rv
ey
 (n
=
3,
63
0)
; 
cr
os
s-
se
ct
io
na
l
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘N
on
-s
m
ok
er
: 
re
sp
on
de
nt
s 
w
ho
 h
av
e 
ne
ve
r s
m
ok
ed
 u
p 
to
 1
00
 
ci
ga
re
tt
es
 in
 th
ei
r l
iv
es
. F
or
m
er
 s
m
ok
er
s:
 T
ho
se
 w
ho
 
sm
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
iv
es
 b
ut
 w
er
e 
cu
rr
en
tly
 n
ot
 s
m
ok
in
g 
at
 a
ll.
 C
ur
re
nt
 s
m
ok
er
s:
 th
os
e 
w
ho
 s
m
ok
ed
 a
t l
ea
st
 1
00
 c
ig
ar
et
te
s 
in
 th
ei
r l
iv
es
 a
nd
 
w
er
e 
sm
ok
in
g 
da
ily
 o
r o
n 
so
m
e 
da
ys
. 1
8 
ye
ar
s 
or
 o
ld
er
; 
ge
ne
ra
l p
op
ul
at
io
n’
PE
RC
EP
TI
O
N
S 
D
ec
lin
e 
in
 h
ar
m
 p
er
ce
pt
io
n 
am
on
g 
cu
rr
en
t: 
be
lie
ve
d 
e-
ci
ga
re
tt
es
 a
re
 le
ss
 h
ar
m
fu
l t
ha
n 
sm
ok
in
g 
(8
4.
7%
 in
 2
01
0 
to
 6
5.
0%
 in
 2
01
4)
. B
el
ie
ve
 
e-
ci
ga
re
tt
e 
as
 le
ss
 h
ar
m
fu
l 4
9.
5%
fo
rm
er
 s
m
ok
er
s,
 4
5.
9 
%
 n
on
-s
m
ok
er
s,
 a
nd
 6
5.
0%
 c
ur
re
nt
 s
m
ok
er
s.
64
Ta
n,
 L
ee
, 
B
ig
m
an
 64
n=
52
7
U
S
Se
lf-
re
po
rt
 (n
=
52
7)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
ve
r u
se
rs
: 
co
m
pr
is
in
g 
th
os
e 
tr
ie
d 
bu
t n
ot
 in
 th
e 
pa
st
 3
0 
da
ys
, a
nd
 
th
os
e 
us
ed
 in
 th
e 
pa
st
 3
0 
da
ys
, e
ve
n 
ju
st
 o
ne
 ti
m
e.
’ 1
8-
87
 y
ea
rs
 o
ld
; g
en
er
al
 p
op
ul
at
io
n.
PE
RC
EP
TI
O
N
S 
H
ar
m
fu
l t
o 
ot
he
rs
 4
2.
8%
 N
on
-u
se
rs
; 
26
.2
%
 e
ve
r-u
se
rs
; a
dd
ic
tiv
e 
52
.5
%
 N
on
-u
se
rs
; 4
0.
9%
 
ev
er
-u
se
rs
; G
at
ew
ay
 e
ffe
ct
 5
5.
1%
 N
on
-u
se
rs
; 4
3.
1%
 
ev
er
-u
se
rs
; S
oc
ia
lly
 a
cc
ep
ta
bl
e 
61
.6
%
 N
on
-u
se
rs
; 
38
.5
%
 e
ve
r-u
se
rs
; L
es
s 
ha
rm
fu
l t
ha
n 
sm
ok
in
g 
32
.4
%
 
N
on
-u
se
rs
; 5
6.
9%
 e
ve
r-u
se
rs
; S
m
ok
in
g 
ce
ss
at
io
n 
31
.9
%
 N
on
-u
se
rs
; 5
2.
3%
 e
ve
r-u
se
rs
; L
es
s 
ha
rm
fu
l 
to
 o
th
er
s 
38
.9
%
 N
on
-u
se
rs
; 5
7.
6%
 e
ve
r-u
se
rs
; 
m
ak
e 
sm
ok
in
g 
lo
ok
 a
cc
ep
ta
bl
e 
to
 y
ou
th
 n
ev
er
 
sm
ok
er
s;
35
.7
%
, f
or
m
er
 s
m
ok
er
s 
46
.7
%
, c
ur
re
nt
 
sm
ok
er
s 
36
.1
%
 
65
Tr
um
bo
, 
H
ar
pe
r 6
5
n=
24
4
N
ew
-Z
ea
-
la
nd
C
ro
ss
-s
ec
tio
na
l (
n=
24
4)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 E
ve
r t
rie
d 
an
d 
re
gu
la
r u
se
 n
ot
 s
pe
ci
fie
d;
 1
9-
22
 y
ea
rs
 o
ld
; n
ot
 s
pe
ci
fie
d
PE
RC
EP
TI
O
N
S 
St
ud
en
ts
 fo
un
d 
it 
so
ci
al
ly
 a
cc
ep
ta
bl
e 
to
 u
se
 e
-c
ig
ar
et
te
s 
in
 p
ub
lic
 p
la
ce
s.
 O
ve
ra
ll 
ne
ga
tiv
e 
at
tit
ud
e,
 p
re
ss
ur
e 
to
 u
se
 a
n 
e-
ci
ga
re
tt
e
66
66
N
=
 3
24
1
U
S
Lo
ng
itu
di
na
l r
es
ea
rc
h 
(s
ur
ve
y 
7-
m
on
gh
t f
ol
lo
w
-u
p)
. 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘E
ve
r u
se
 o
f 
e-
ci
ga
re
tt
es
 (n
=
24
76
 a
re
 in
cl
ud
ed
 in
 th
e 
an
al
ys
is
). 
“H
av
e 
yo
u 
ev
er
 u
se
d 
e-
ci
ga
re
tt
es
, e
le
ct
ro
ni
c,
 o
r v
ap
or
 
ci
ga
re
tt
es
?”
 a
du
lt 
ev
er
 u
se
rs
 o
f e
-c
ig
ar
et
te
s 
(1
8 
+
)’
RE
A
SO
N
S 
To
 q
ui
t, 
to
 re
pl
ac
e 
to
ba
cc
o 
ci
ga
re
tt
es
, t
o 
cu
t d
ow
n,
 to
 a
vo
id
 s
m
ok
in
g 
ba
ns
, c
ur
io
si
ty
, d
ea
l w
ith
 
cr
av
in
gs
, l
es
s 
ha
rm
fu
l, 
re
co
m
m
en
da
tio
n,
 c
os
ts
ta
b
le
 c
o
nt
in
ue
s
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Fi
rs
t A
ut
ho
r
N
Co
un
tr
y 
Br
ie
f s
tu
dy
 d
es
cr
ip
tio
n
M
ay
or
 re
le
va
nt
 fi
nd
in
gs
 
67
W
ac
ko
w
sk
i, 
B
ov
er
 
M
an
de
rs
ki
, 
D
el
ne
vo
 67
n=
51
9
U
S
C
ro
ss
-s
ec
tio
na
l (
n=
51
9)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘c
ur
re
nt
 s
m
ok
er
s:
 
ha
ve
 e
ve
r s
m
ok
ed
 1
00
 c
ig
ar
et
te
s 
an
d 
no
w
 s
m
ok
e 
so
m
e 
da
ys
 o
r e
ve
ry
 d
ay
. C
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
: t
ho
se
 
w
ho
 h
ad
 u
se
d 
e-
ci
ga
re
tt
es
 in
 th
e 
pa
st
 3
0 
da
ys
. F
or
m
er
 
e-
ci
ga
re
tt
e 
us
er
s/
tr
ie
rs
: t
ho
se
 w
ho
 h
ad
 e
ve
r t
rie
d 
e-
ci
ga
re
tt
es
 b
ut
 n
ot
 u
se
d 
th
em
 in
 th
e 
pa
st
 3
0 
da
ys
. 
C
ur
re
nt
 C
ig
ar
et
te
 s
m
ok
er
s 
18
 y
ea
rs
 o
r o
ld
er
.’
PE
RC
EP
TI
O
N
S 
59
.9
%
 o
f s
m
ok
er
s 
be
lie
ve
d 
e-
ci
ga
re
tt
es
 a
re
 le
ss
 h
ar
m
fu
l. 
M
or
e 
pr
ev
al
en
t a
m
on
g 
cu
rr
en
t e
-c
ig
 u
se
rs
 (8
2.
8%
) t
ha
n 
fo
rm
er
 (6
3.
9%
) o
r 
ne
ve
r (
48
.6
%
)
68
W
ac
ko
w
sk
i, 
B
ov
er
 
M
an
de
rs
ki
, 
D
el
ne
vo
, 
G
io
ve
nc
o,
 
Le
w
is
 68
N
=
50
9
U
S
Se
lf-
re
po
rt
 (s
ur
ve
y 
n=
50
9)
 a
m
on
g 
ad
ul
t (
18
 y
ea
rs
 o
r 
ol
de
r) 
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘c
ur
re
nt
 s
m
ok
er
s 
de
fin
ed
 a
s 
ha
vi
ng
 e
ve
r s
m
ok
ed
 1
00
 c
ig
ar
et
te
s 
an
d 
no
w
 
sm
ok
in
g 
“s
om
e 
da
ys
” 
or
 “
ev
er
yd
ay
” 
in
 th
e 
U
S.
 T
ho
se
 
sm
ok
er
s 
w
ho
 h
ad
 a
ls
o 
us
ed
 e
-c
ig
ar
et
te
s 
in
 th
e 
pa
st
 3
0 
da
ys
 a
s 
“c
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
/t
rie
rs
”.
 T
ho
se
 w
ho
 
ha
d 
ev
er
 tr
ie
d 
e-
ci
ga
re
tt
es
 b
ut
 n
ot
 u
se
d 
th
em
 in
 th
e 
pa
st
 3
0 
da
ys
 a
s 
“f
or
m
er
 e
-c
ig
ar
et
te
 u
se
rs
/t
rie
rs
”.
 ‘
RE
A
SO
N
S 
B
el
ie
ve
d 
it 
w
as
 le
ss
 h
ar
m
fu
l t
ha
n 
re
gu
la
r 
ci
ga
re
tt
es
 (7
7.
2%
), 
ou
t o
f c
ur
io
si
ty
 (7
6.
5%
), 
as
 a
 w
ay
 
to
 c
ut
 d
ow
n 
on
 s
m
ok
in
g 
(7
2.
7%
), 
ci
ga
re
tt
e 
sm
ok
in
g 
ce
ss
at
io
n 
(6
4.
9%
), 
to
 u
se
 in
 p
la
ce
s 
w
he
re
 th
ey
 c
an
’t 
sm
ok
e 
(6
6.
7%
). 
C
ur
re
nt
 e
-c
ig
ar
et
te
 u
se
rs
/t
rie
rs
 
re
po
rt
ed
 m
or
e 
of
te
n 
cu
tt
in
g 
do
w
n 
on
 s
m
ok
in
g,
 s
av
in
g 
m
on
ey
 a
nd
 c
on
si
de
ra
tio
n 
fo
r o
th
er
s 
as
 R
EA
SO
N
S 
fo
r 
tr
yi
ng
 e
-c
ig
ar
et
te
s.
 C
ur
io
si
ty
 w
as
 th
e 
m
ai
n 
re
as
on
 fo
r 
tr
yi
ng
 e
-c
ig
ar
et
te
s 
am
on
g 
fo
rm
er
 u
se
rs
/t
rie
rs
 (7
7.
1%
). 
69
W
an
g,
 L
i, 
Ji
an
g,
 e
t 
al
. 6
9
n=
1,
30
7
H
on
g 
K
on
g
C
ro
ss
-s
ec
tio
na
l (
n=
13
07
)
Ty
pe
s 
of
 u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘D
ai
ly
 s
m
ok
er
s;
 
4 
pp
m
 o
r a
bo
ve
 e
xh
al
ed
 c
ar
bo
n 
m
on
ox
id
e.
 E
ve
r u
se
: 
ev
er
 u
se
d,
 e
ve
n 
a 
si
ng
le
 p
uf
f, 
ag
e 
18
 y
ea
rs
 o
r o
ld
er
. 1
8 
ye
ar
s 
or
 o
ld
er
; d
ai
ly
 s
m
ok
er
s’
PE
RC
EP
TI
O
N
S 
11
.0
%
 p
er
ce
iv
ed
 is
 a
s 
an
 e
ffe
ct
iv
e 
sm
ok
in
g 
ce
ss
at
io
n 
to
ol
. 7
4.
1%
 (u
se
rs
) a
nd
 9
1.
2%
 (n
on
-
us
er
s)
 d
id
 n
ot
 th
in
k 
of
 th
em
 a
s 
ef
fe
ct
iv
e 
fo
r s
m
ok
in
g 
ce
ss
at
io
n.
70
W
hi
te
, L
i, 
N
ew
co
m
be
, 
W
al
to
n 
70
20
12
 
n=
3,
12
7,
 
20
14
 
n=
2,
91
9
N
ew
-Z
ea
-
la
nd
Yo
ut
h 
In
si
gh
ts
 S
ur
ve
y 
(2
01
2:
 n
=
3,
12
7;
 2
01
4:
 n
=
2,
91
9)
; 
co
ho
rt
 T
yp
es
 o
f u
se
r a
s 
de
fin
ed
 b
y 
au
th
or
s:
 ‘C
ur
re
nt
 
sm
ok
er
s;
 s
m
ok
ed
 a
t l
ea
st
 o
nc
e 
a 
m
on
th
 o
r m
or
e 
of
te
n.
 
In
fre
qu
en
t s
m
ok
er
s;
 le
ss
 o
ft
en
 th
an
 o
nc
e 
a 
m
on
th
. 
Ex
-s
m
ok
er
s;
 h
ad
 s
m
ok
ed
 a
 c
ig
ar
et
te
, b
ut
 n
o 
lo
ng
er
 
sm
ok
e.
 E
ve
r u
se
: h
av
e 
ev
er
 tr
ie
d 
el
ec
tr
on
ic
 c
ig
ar
et
te
s.
 
14
-1
5 
ye
ar
s 
ol
d;
 n
ot
 s
tr
at
ifi
ed
 (e
ve
r u
se
rs
 a
re
 a
sk
ed
 
re
as
on
s 
w
hy
)’
RE
A
SO
N
S 
C
ur
io
si
ty
 (6
4.
5%
), 
re
co
m
m
en
de
d 
by
 
so
m
eo
ne
 (2
4.
2%
), 
sa
fe
r t
ha
n 
to
ba
cc
o 
(2
7.
8%
), 
av
oi
d 
sm
ok
in
g 
re
st
ric
tio
ns
 (1
6.
3%
), 
cu
t b
ac
k 
on
 c
ig
ar
et
te
s 
(1
8.
4%
), 
sm
ok
in
g 
ce
ss
at
io
n 
(1
6.
6%
), 
co
st
s 
(n
ot
 
sp
ec
ifi
ed
). 
C
ur
io
si
ty
: i
nf
re
qu
en
t s
m
ok
er
s 
(6
7.
1%
) 
an
d 
ex
-s
m
ok
er
s 
(6
2.
4%
). 
H
ar
m
 re
du
ct
io
n:
 4
2.
5%
 
in
fre
qu
en
t s
m
ok
er
s 
ha
vi
ng
 fi
rs
t t
rie
d 
e-
ci
ga
re
tt
es
 fo
r 
th
is
 re
as
on
.
71
Yo
ng
, 
B
or
la
nd
, 
B
al
m
fo
rd
, e
t 
al
. 7
1
N
=
21
05
A
us
tr
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Appendix 5 Topic guide: exploring decision making 
process of e-cigarette use initiation
Chapter 3
A Deliberate Choice? Exploring the Decision to Switch from Cigarettes to 
E-Cigarettes 
Note: All participants have to sign an informed consent before the start of the 
introduction.
Introduction by interviewer
Welcome! My name is … and this is …, who will be helping me with the discussion 
today. I work for … and I my research is about…. 
Today we are discussing e-cigarettes. Your opinion as user/smoker/non-user is very 
important. We would like to talk to you about e-cigarettes and this discussion will take 
approximately two hours, with a break. At the end of our discussion we have time for 
general questions about e-cigarettes.
We would like to stress that there are no correct or wrong answers. Today is all about 
your experiences and your ideas. We will be hearing a lot of different ideas and 
experiences, so I would like to ask you to respect each other. Please listen carefully to 
each other and please let each other finish speaking. 
This group discussion will be audio recorded. – Turn on audio recording— All personal 
information will be made anonymous, and please remember that your participation 
is voluntary. This means that you can leave at all times, you do not have to explain 
yourself. 
Are there any remaining questions before we start?
Introduction participants
Please introduce yourself shortly. Do you use e-cigarettes exclusively? Or do you also 
use cigarettes or something else? What do you enjoy doing?
· Make name tags
General prompts
· What do you mean?
· Can you tell me more about that?
· What comes to mind?
· Can you explain that to me?
· Is there anything else that you can think of?
table continues
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Topic guide: exploring decision making process of e-cigarette use initiation
Knowledge about e-cigarettes
 What do you know about e-cigarettes?
Prompts Risks, batteries, taxes, different 
e-cigarettes, costs, health benefits
Attitude
 What did you think when you used it?
 What do you think of e-cigarettes?
Prompts How does it feel? Do you compare 
it to cigarette smoking? What do 
you think of the action of using 
e-cigarettes?
Deliberation 
 Did you ever try an e-cigarette?
 When did you try an e-cigarette?
 How did you consider e-cigarette use?
 Who played a role in your decision?
 What played a role in your decision?
 How difficult was it to make a decision?
Prompts Did you consider using something 
else, like an NRT? Did you ask for 
advice? Did you go to a shop? Are 
you happy with your decision? Would 
you do it differently? What would 
have made it easier for you to make a 
decision about e-cigarette use?
[use these prompts to link to next 
topic]
Information need
 What information is important to make a decision about e-cigarette use?
 Where did you look for information about e-cigarettes?
Prompts Which information was important to 
you? Which source was important to 
you? How do you know how to trust 
information? Which information do you 
still miss?
Closing
Is there anything we did not cover today that you find important related to 
e-cigarettes?
Do you have any questions left?
Note: due to the semi-structured protocol these questions are examples and may vary 
slightly in each focus group in both style and order.
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w
ee
t, 
va
ni
lla
), 
ca
nd
y 
(s
ur
ve
y 
ite
m
s:
 
sw
ee
t, 
ca
nd
y)
, o
th
er
 fl
av
or
s 
(s
ur
ve
y 
ite
m
s:
 fl
or
al
; o
th
er
) 
an
d 
un
fla
vo
re
d 
(s
ur
ve
y 
ite
m
: 
un
fla
vo
re
d)
. F
or
 e
xa
m
pl
e,
 if
 a
 
no
n-
us
er
 o
r s
m
ok
er
 re
po
rt
ed
 
an
 in
te
re
st
 in
 th
e 
su
rv
ey
 it
em
s 
“s
w
ee
t, 
ca
nd
y”
 a
nd
 “
al
co
ho
l, 
co
ck
ta
il”
, t
he
ir 
an
sw
er
s 
w
er
e 
re
co
de
d 
as
 a
 p
re
fe
re
nc
e 
fo
r t
he
 
ca
te
go
rie
s 
ca
nd
y 
an
d 
al
co
ho
l, 
re
sp
ec
tiv
el
y.
 O
pe
n 
an
sw
er
s 
fro
m
 d
ua
l a
nd
 E
-c
ig
ar
et
te
 u
se
rs
 
w
er
e 
as
se
ss
ed
 fo
r r
ec
od
in
g 
of
 th
ei
r c
lo
se
d 
an
sw
er
s 
in
 
ac
co
rd
an
ce
 w
ith
 th
e 
ca
te
go
rie
s 
of
 th
e 
e-
liq
ui
d 
fla
vo
r w
he
el
 8 .
Fl
av
or
 p
re
fe
re
nc
e 
of
 d
ua
l u
se
rs
 a
nd
 
e-
ci
ga
re
tt
e 
us
er
s
W
hi
ch
 e
-li
qu
id
 fl
av
or
 d
id
 
yo
u 
tr
y 
fir
st
?
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nc
ep
t
Ite
m
An
sw
er
 o
pt
io
ns
Ex
pl
an
at
io
n 
an
d 
fo
rm
at
io
n 
of
 
th
e 
co
nc
ep
t
Re
fe
re
nc
e
W
hi
ch
 e
-li
qu
id
 fl
av
or
 d
o 
yo
u 
cu
rr
en
tly
 u
se
 m
os
t?
Sm
ok
in
g 
ce
ss
at
io
n 
in
fo
rm
at
io
n
B
y 
m
ea
ns
 o
f t
he
 fo
llo
w
in
g
 q
ue
st
io
ns
 w
e 
w
ou
ld
 li
ke
 t
o 
fo
rm
 a
n 
im
p
re
ss
io
n 
of
 t
he
 w
ay
 y
ou
 m
ay
 p
ot
en
tia
lly
 q
ui
t 
sm
ok
in
g
. T
he
se
 q
ue
st
io
ns
 o
nl
y 
co
nc
er
n 
st
op
p
in
g
 s
m
ok
in
g
 c
ig
ar
et
te
s.
 
H
ow
 m
an
y 
tim
es
 h
av
e 
yo
u 
tr
ie
d 
to
 s
to
p 
sm
ok
in
g?
 
· 
N
ev
er
· 
O
nc
e
· 
Tw
ic
e 
· 
Th
re
e 
tim
es
 
· 
M
or
e 
th
an
 th
re
e 
tim
es
 
· 
I d
on
’t 
kn
ow
Si
ng
le
 it
em
In
te
rn
at
io
na
l T
ob
ac
co
 
C
on
tr
ol
 P
ol
ic
y 
Ev
al
ua
tio
n 
Pr
oj
ec
t 4
H
av
e 
yo
u 
ha
d 
an
yt
hi
ng
 to
 
he
lp
 y
ou
 s
to
p 
sm
ok
in
g?
 
(m
or
e 
th
an
 o
ne
 a
ns
w
er
 is
 
po
ss
ib
le
) 
· 
N
o,
 I 
ha
ve
n’
t u
se
d 
an
 a
id
· 
I h
av
e 
us
ed
 th
e 
el
ec
tr
on
ic
 c
ig
ar
et
te
 a
s 
an
 
ai
d 
· 
M
ed
ic
in
es
· 
N
ic
ot
in
e 
re
pl
ac
em
en
t t
he
ra
py
 
· 
Se
lf-
he
lp
 p
ro
gr
am
 
· 
D
is
cu
ss
ed
 s
to
pp
in
g 
sm
ok
in
g 
w
ith
 th
e 
fa
m
ily
 d
oc
to
r 
· 
B
eh
av
io
ra
l s
up
po
rt
 p
ro
gr
am
s
· 
St
op
 s
m
ok
in
g 
co
ur
se
 o
r g
ro
up
 th
er
ap
y
· 
O
th
er
 th
er
ap
ie
s 
or
 a
id
s
· 
O
th
er
 a
id
s 
or
 m
et
ho
ds
 
Si
ng
le
 it
em
Va
pi
ng
 c
es
sa
tio
n 
in
fo
rm
at
io
n
B
y 
m
ea
ns
 o
f t
he
 
fo
llo
w
in
g
 q
ue
st
io
ns
, w
e 
w
ou
ld
 li
ke
 t
o 
fo
rm
 a
n 
im
p
re
ss
io
n 
of
 t
he
 w
ay
 
yo
u 
m
ay
 p
ot
en
tia
lly
 q
ui
t 
sm
ok
in
g
. T
he
se
 q
ue
st
io
ns
 
on
ly
 c
on
ce
rn
 v
ap
er
s/
 
E-
ci
g
ar
et
te
s.
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Co
nc
ep
t
Ite
m
An
sw
er
 o
pt
io
ns
Ex
pl
an
at
io
n 
an
d 
fo
rm
at
io
n 
of
 
th
e 
co
nc
ep
t
Re
fe
re
nc
e
H
ow
 o
ft
en
 h
av
e 
yo
u 
tr
ie
d 
to
 s
to
p 
va
pi
ng
? 
· 
N
ev
er
· 
O
nc
e
· 
Tw
ic
e 
· 
Th
re
e 
tim
es
 
· 
M
or
e 
th
an
 th
re
e 
tim
es
 
· 
I d
on
’t 
kn
ow
Si
ng
le
 it
em
In
te
rn
at
io
na
l T
ob
ac
co
 
C
on
tr
ol
 P
ol
ic
y 
Ev
al
ua
tio
n 
Pr
oj
ec
t 4
C
ho
os
e 
th
e 
op
tio
n 
or
 o
p
tio
ns
 t
ha
t 
ar
e 
ap
p
lic
ab
le
 t
o 
yo
u 
(m
or
e 
th
an
 o
ne
 a
ns
w
er
 
p
os
si
b
le
). 
Si
nc
e 
I h
av
e 
be
en
 v
ap
in
g 
E-
ci
ga
re
tt
es
 c
ig
ar
et
te
s…
· 
…
 I 
am
 s
m
ok
in
g 
fe
w
er
 to
ba
cc
o 
ci
ga
re
tt
es
· 
…
 I 
sm
ok
e 
ju
st
 a
s 
m
an
y 
ci
ga
re
tt
es
 a
s 
I u
se
d 
to
 
· 
…
 I 
no
 lo
ng
er
 s
m
ok
e 
an
y 
ci
ga
re
tt
es
 a
t a
ll 
· 
…
 I 
sm
ok
e 
m
or
e/
fo
r l
on
ge
r i
n 
co
m
pa
ris
on
 
w
ith
 c
ig
ar
et
te
s
· 
…
 I 
fe
el
 p
hy
si
ca
lly
 m
or
e 
he
al
th
y
· 
…
 I 
ha
ve
 m
or
e 
of
 a
 c
ra
vi
ng
 to
 u
se
 n
ic
ot
in
e
· 
…
 I 
fe
el
 m
en
ta
lly
 m
or
e 
he
al
th
y 
Si
ng
le
 it
em
In
te
rn
at
io
na
l T
ob
ac
co
 
C
on
tr
ol
 P
ol
ic
y 
Ev
al
ua
tio
n 
Pr
oj
ec
t 4
Re
as
on
s 
fo
r 
to
ba
cc
o 
pr
od
uc
t 
us
e 
or
 e
-c
ig
ar
et
te
 
us
e
W
hi
ch
 o
f t
he
 fo
llo
w
in
g
 
st
at
em
en
ts
 a
p
p
lie
s 
to
 
yo
u?
 I 
sm
ok
e/
sm
ok
ed
/
us
ed
 e
-c
ig
ar
et
te
s/
va
p
er
s:
 
(m
or
e 
th
an
 o
ne
 a
ns
w
er
 
p
os
si
b
le
)
B
ec
au
se
 E
-c
ig
ar
et
te
s/
va
pe
rs
 a
re
 e
as
y 
to
 g
et
.
Si
ng
le
 it
em
Ro
m
ijn
de
rs
, v
an
 O
sc
h,
 d
e 
Vr
ie
s,
 T
al
ho
ut
 6,
Ro
m
ijn
de
rs
, 
va
n 
O
sc
h,
 d
e 
Vr
ie
s,
 
Ta
lh
ou
t 7
B
ec
au
se
 th
ey
 a
re
 e
as
y 
to
 u
se
. 
D
ue
 to
 th
e 
co
st
: l
es
s 
ex
pe
ns
iv
e 
th
an
 c
ig
ar
et
te
s/
af
fo
rd
ab
le
 
Fo
r t
he
ir 
he
al
th
 a
dv
an
ta
ge
s:
 e
ffe
ct
s 
on
 h
ea
lth
, 
fe
w
er
 in
gr
ed
ie
nt
s 
th
an
 a
 c
ig
ar
et
te
.
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Co
nc
ep
t
Ite
m
An
sw
er
 o
pt
io
ns
Ex
pl
an
at
io
n 
an
d 
fo
rm
at
io
n 
of
 
th
e 
co
nc
ep
t
Re
fe
re
nc
e
A
s 
an
 a
id
 to
 s
m
ok
in
g 
fe
w
er
 c
ig
ar
et
te
s 
or
 
gi
vi
ng
 th
em
 u
p 
co
m
pl
et
el
y:
 a
 m
et
ho
d 
of
 
st
op
pi
ng
 s
m
ok
in
g,
 to
 p
re
ve
nt
 m
e 
go
in
g 
ba
ck
 
to
 c
ig
ar
et
te
s.
B
ec
au
se
 it
 is
 le
ss
 a
dd
ic
tiv
e 
th
an
 c
ig
ar
et
te
s,
 
va
ria
tio
n 
in
 n
ic
ot
in
e 
le
ve
l i
s 
po
ss
ib
le
. 
To
 c
op
e 
w
ith
 c
ra
vi
ng
s 
an
d 
to
 p
re
ve
nt
/c
op
e 
w
ith
 w
ith
dr
aw
al
 s
ym
pt
om
s 
A
s 
an
 a
lte
rn
at
iv
e 
to
 c
ig
ar
et
te
s:
 it
 is
 li
ke
 th
e 
sm
ok
in
g 
or
 b
ec
au
se
 o
f t
he
 th
ro
at
 h
it 
(a
dd
 in
fo
-
bu
tt
on
).
To
 g
et
 a
ro
un
d 
th
e 
sm
ok
in
g 
ba
n 
(to
 b
e 
ab
le
 
to
 v
ap
e 
in
 p
la
ce
s 
w
he
re
 s
m
ok
in
g 
is
 n
or
m
al
ly
 
fo
rb
id
de
n)
.
To
 h
el
p 
m
e 
to
 fo
cu
s 
an
d 
im
pr
ov
e 
m
y 
pe
rf
or
m
an
ce
, t
o 
re
du
ce
 s
tr
es
s 
or
 to
 p
re
ve
nt
 
w
ei
gh
t g
ai
n.
D
ue
 to
 im
pr
ov
ed
 s
en
se
 o
f t
as
te
 a
nd
 s
m
el
l: 
be
ca
us
e 
it 
ta
st
es
 b
et
te
r t
ha
n 
ci
ga
re
tt
es
, a
nd
 
to
 b
e 
di
sc
re
et
 (y
ou
 c
an
 h
id
e 
th
e 
fa
ct
 th
at
 y
ou
 
sm
ok
e,
 n
o 
un
pl
ea
sa
nt
 s
m
el
ls
).
Th
is
 is
 a
 re
al
 e
xp
er
ie
nc
e,
 o
ne
 th
at
 c
an
 o
nl
y 
be
 
ex
pe
rie
nc
ed
 b
y 
do
in
g 
it.
To
 tr
y 
so
m
et
hi
ng
 n
ew
: o
ut
 o
f c
ur
io
si
ty
 a
bo
ut
 
ne
w
 p
ro
du
ct
s,
 d
iff
er
en
t fl
av
or
s,
 d
iff
er
en
t 
ap
pa
ra
tu
s/
de
si
gn
s,
 fo
r p
le
as
ur
e,
 a
s 
a 
ho
bb
y,
 o
r 
be
ca
us
e 
it 
is
 c
oo
l/t
re
nd
y/
cl
as
sy
. 
Fo
r s
oc
ia
l r
ea
so
ns
: b
ec
au
se
 it
 w
as
 
re
co
m
m
en
de
d 
by
 fr
ie
nd
s 
or
 fa
m
ily
, d
ue
 to
 
pr
es
su
re
 fr
om
 th
e 
pe
op
le
 a
ro
un
d 
m
et
, t
o 
ex
te
nd
 m
y 
so
ci
al
 n
et
w
or
k 
or
 b
ec
au
se
 it
 is
 
so
ci
al
ly
 a
cc
ep
ta
bl
e.
 
ta
b
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 c
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Co
nc
ep
t
Ite
m
An
sw
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 o
pt
io
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Ex
pl
an
at
io
n 
an
d 
fo
rm
at
io
n 
of
 
th
e 
co
nc
ep
t
Re
fe
re
nc
e
W
hi
ch
 o
f t
he
 fo
llo
w
in
g
 
st
at
em
en
ts
 is
 a
p
p
lic
ab
le
 
to
 y
ou
? 
I d
o 
no
t/
no
 lo
ng
er
 v
ap
e/
us
e 
E-
ci
g
ar
et
te
s/
va
p
er
s)
: 
(m
or
e 
th
an
 o
ne
 a
ns
w
er
 
p
os
si
b
le
)
B
ec
au
se
 it
 is
 a
dd
ic
tiv
e.
Si
ng
le
 it
em
Ro
m
ijn
de
rs
, v
an
 O
sc
h,
 d
e 
Vr
ie
s,
 T
al
ho
ut
 6,
Ro
m
ijn
de
rs
, 
va
n 
O
sc
h,
 d
e 
Vr
ie
s,
 
Ta
lh
ou
t 7
B
ec
au
se
 o
f t
he
 d
is
ad
va
nt
ag
es
 to
 h
ea
lth
: 
U
ns
af
e 
du
rin
g 
pr
eg
na
nc
y,
 in
ju
rio
us
, i
nj
ur
io
us
 to
 
ot
he
r p
eo
pl
e,
 e
ffe
ct
s 
on
 h
ea
lth
, a
no
th
er
 s
te
p 
to
w
ar
ds
 s
m
ok
in
g 
ci
ga
re
tt
es
, t
he
 in
gr
ed
ie
nt
s 
in
 
E-
liq
ui
d,
 in
cr
ea
se
 in
 w
ei
gh
t. 
B
ec
au
se
 o
f t
he
 c
os
t: 
co
st
s 
to
o 
m
uc
h 
or
 m
or
e 
ex
pe
ns
iv
e 
th
an
 c
ig
ar
et
te
s.
 
D
ue
 to
 p
ra
ct
ic
al
 fa
ili
ng
s:
 d
iffi
cu
lt 
to
 u
se
, 
di
ffi
cu
lt 
to
 o
bt
ai
n,
 to
o 
di
ffe
re
nt
 fr
om
 s
m
ok
in
g 
a 
ci
ga
re
tt
e,
 c
ha
ng
in
g 
to
 o
th
er
 N
RT
s 
do
es
 n
ot
 
he
lp
 to
 s
to
p 
sm
ok
in
g 
or
 c
ra
vi
ng
s,
 te
ch
ni
ca
l 
as
pe
ct
 (p
oo
r q
ua
lit
y 
pr
od
uc
t),
 n
o 
th
ro
at
 h
it.
B
ec
au
se
 it
 is
n’
t c
oo
l
B
ec
au
se
 m
y 
fr
ie
nd
s 
do
n’
t d
o 
it 
ei
th
er
N
ot
 in
te
re
st
ed
, n
ot
 c
ur
io
us
 
W
hi
ch
 o
f t
he
 fo
llo
w
in
g
 
st
at
em
en
ts
 a
p
p
lie
s 
to
 
yo
u?
 I 
sm
ok
e/
I u
se
d
 t
o 
sm
ok
e:
 (m
or
e 
th
an
 o
ne
 
an
sw
er
 p
os
si
b
le
)
B
ec
au
se
 c
ig
ar
et
te
s 
ar
e 
ea
sy
 to
 o
bt
ai
n.
Si
ng
le
 it
em
Ro
m
ijn
de
rs
, v
an
 O
sc
h,
 d
e 
Vr
ie
s,
 T
al
ho
ut
 6,
Ro
m
ijn
de
rs
, 
va
n 
O
sc
h,
 d
e 
Vr
ie
s,
 
Ta
lh
ou
t 7
B
ec
au
se
 th
ey
 a
re
 e
as
y 
to
 u
se
. 
To
 h
el
p 
m
e 
to
 fo
cu
s 
an
d 
im
pr
ov
e 
m
y 
pe
rf
or
m
an
ce
, t
o 
re
du
ce
 s
tr
es
s 
or
 to
 p
re
ve
nt
 
w
ei
gh
t g
ai
n.
Th
is
 is
 a
 re
al
 e
xp
er
ie
nc
e,
 o
ne
 th
at
 c
an
 o
nl
y 
be
 
ex
pe
rie
nc
ed
 b
y 
do
in
g 
it.
 
Fo
r s
oc
ia
l r
ea
so
ns
: b
ec
au
se
 it
 w
as
 
re
co
m
m
en
de
d 
by
 fr
ie
nd
s 
an
d 
fa
m
ily
, d
ue
 
to
 p
re
ss
ur
e 
fro
m
 th
e 
pe
op
le
 a
ro
un
d 
m
e,
 to
 
ex
te
nd
 m
y 
so
ci
al
 n
et
w
or
k 
or
 b
ec
au
se
 it
 is
 
so
ci
al
ly
 a
cc
ep
ta
bl
e.
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Co
nc
ep
t
Ite
m
An
sw
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 o
pt
io
ns
Ex
pl
an
at
io
n 
an
d 
fo
rm
at
io
n 
of
 
th
e 
co
nc
ep
t
Re
fe
re
nc
e
To
 h
av
e 
a 
m
om
en
t f
or
 m
ys
el
f: 
a 
br
ea
k 
fro
m
 
w
or
ki
ng
 o
r s
tu
dy
in
g,
 ju
st
 to
 d
o 
so
m
et
hi
ng
 
co
m
pl
et
el
y 
di
ffe
re
nt
 e
tc
. 
B
ec
au
se
 a
 c
ig
ar
et
te
 ta
st
es
 s
o 
go
od
.
D
ue
 to
 s
tr
es
s:
 a
t w
or
k 
or
 a
t h
om
e,
 fo
r e
xa
m
pl
e.
B
ec
au
se
 it
 g
iv
es
 m
e 
a 
go
od
 fe
el
in
g.
 
Sm
ok
in
g 
is
 n
o 
m
or
e 
ris
ky
 th
an
 a
 lo
t o
f o
th
er
 
th
in
gs
 th
at
 p
eo
pl
e 
do
. 
D
ue
 to
 th
e 
si
tu
at
io
n:
 A
ft
er
 a
 m
ea
l, 
w
ith
 a
 c
up
 
of
 c
of
fe
e,
 w
ith
 a
lc
oh
ol
, o
n 
so
ci
al
 o
cc
as
io
ns
. 
W
hi
ch
 o
f t
he
 fo
llo
w
in
g
 
st
at
em
en
ts
 a
p
p
lie
s 
to
 
yo
u?
 I 
d
o 
no
t 
sm
ok
e 
/ 
I 
no
 lo
ng
er
 s
m
ok
e:
 (m
or
e 
th
an
 o
ne
 a
ns
w
er
 p
os
si
b
le
)
B
ec
au
se
 it
 d
am
ag
es
 th
e 
he
al
th
 o
f t
he
 p
eo
pl
e 
ar
ou
nd
 m
e.
 
Si
ng
le
 it
em
Ro
m
ijn
de
rs
, v
an
 O
sc
h,
 d
e 
Vr
ie
s,
 T
al
ho
ut
 6,
Ro
m
ijn
de
rs
, 
va
n 
O
sc
h,
 d
e 
Vr
ie
s,
 
Ta
lh
ou
t 7
B
ec
au
se
 it
 is
 u
nh
ea
lth
y.
 
B
ec
au
se
 it
 c
os
ts
 m
e 
a 
lo
t o
f m
on
ey
. 
B
ec
au
se
 I 
am
 a
sh
am
ed
 o
f s
m
ok
in
g.
 
B
ec
au
se
 it
 ta
ke
s 
a 
lo
t o
f m
y 
tim
e.
 
B
ec
au
se
 it
 is
 a
dd
ic
tiv
e.
 
At
tr
ac
tiv
en
es
s 
of
 
to
ba
cc
o 
pr
od
uc
ts
 
an
d 
e-
ci
ga
re
tt
es
 
Th
e 
E-
ci
g
ar
et
te
/v
ap
er
 is
 
at
tr
ac
tiv
e 
b
ec
au
se
 (m
or
e 
th
an
 o
ne
 a
ns
w
er
 p
os
si
b
le
)
Th
e 
pr
od
uc
t l
oo
ks
 n
ic
e 
Si
ng
le
 it
em
Ro
m
ijn
de
rs
, v
an
 O
sc
h,
 d
e 
Vr
ie
s,
 T
al
ho
ut
 6,
Ro
m
ijn
de
rs
, 
va
n 
O
sc
h,
 d
e 
Vr
ie
s,
 
Ta
lh
ou
t 7
D
ue
 to
 a
ll 
th
e 
di
ffe
re
nt
 fl
av
or
s 
B
ec
au
se
 it
 is
 p
os
si
bl
e 
to
 a
lte
r t
he
 s
et
tin
g 
of
 th
e 
E-
ci
ga
re
tt
e 
to
 m
y 
w
is
he
s
D
ue
 to
 it
s 
va
ry
in
g 
de
si
gn
s 
D
ue
 to
 th
e 
pr
ic
e 
of
 th
e 
pr
od
uc
t 
D
ue
 to
 th
e 
pr
ic
e 
of
 th
e 
E-
liq
ui
ds
B
ec
au
se
 th
e 
ni
co
tin
e 
le
ve
l c
an
 b
e 
va
rie
d 
B
ec
au
se
 y
ou
 c
an
 b
lo
w
 n
ic
e 
sm
ok
e 
cl
ou
ds
 w
ith
 it
ta
b
le
 c
o
nt
in
ue
s
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Ex
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fo
rm
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Appendix 7 differences between dual users and exclusive 
e-cigarette users
Chapter 5 
A Combination of Factors Related to Smoking Behavior, Attractive Product Characteristics, and 
Socio-Cognitive Factors are Important to Distinguish a Dual User from an Exclusive E-Cigarette 
User 
Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Participant Characteristics
Age 80 47.8 13.40 36 51.9 9.80 0.10
Gender 80 36 0.31
male 46.3% 36.1%
female 53.8% 63.9%
Education 80 36 0.70
low 30.0% 19.4%
middle 40.0% 55.6%
high 30.0% 25.0%
Differences in past and current smoking and vaping behavior
lifetime status of 
tobacco smoking 
(Fagerstrom index)
80 36 0.02
< 100 cigarettes 
in life
6.30% 0.00%
> 100 cigarettes 
in life
93.70% 100.00%
onset of tobacco 
smoking
80 36 0.06
< 6 months 1.3% 2.8%
6-12 months 1.3% 0.0%
1-5 years 8.8% 0.0%
5-10 years 11.3% 0.0%
> 10 years 77.5% 97.2%
quantity of tobacco 
cigarettes smoked 
in their past 
(e-cigarette users) 
or current (dual 
users) smoking 
behavior
80 36 0.00
< ½ package/day 16.3% 2.8%
½-1 package/day 63.7% 36.1%
1 package/day 13.8% 22.2%
> 1 package/day 6.3% 38.9%
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
onset of vaping 80 36 0.01
< 6 months 35.0% 13.9%
6-12 months 20.0% 16.7%
1-5 years 41.3% 61.1%
5-10 years 3.8% 8.3%
vaping status ml 80 18.35 18.99 36 16.78 18.92 0.68
vaping status liquid 80 36 0.75
less than half a 
container
67.5% 77.8%
a little bit more 
than half a 
container
15.0% 2.8%
about three 
quarters of a 
container
7.5% 11.1%
a little bit less than 
a container
2.5% 2.8%
a container at max 2.5% 0.0%
little more than 
one container
1.3% 0.0%
Differences in product characteristics used
Flavors situation 80 3.6 2.08 36 3.14 2.45 0.29
nicotine current 36 0.96
None 17.5% 8.30%
1-8 mg/mL 27.5% 41.70%
9-14 mg/mL 18.8% 16.70%
15-24 mg/mL 25.0% 25.00%
> 25 mg/mL 2.5% 0
> 36 mg/mL 1.3% 2.80%
nicotine first 80 36 0.48
None 13.8% 8.3%
1-8 mg/mL 17.5% 13.9%
9-14 mg/mL 25.0% 25.0%
15-24 mg/mL 26.3% 41.7%
> 25 mg/mL 3.8% 2.8%
> 36 mg/mL 1.3% 1.6%
future intention 
e-cigarette use
80 4.75 1.89 36 5.25 1.95 0.20
future intention 
e-cigarette nicotine 
content
80 4.24 1.94 36 4.33 1.80 0.80
quantity 
e-cigarettes used
80 36 0.32
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
I don't own my 
own e-cigarette
2.5% 5.6%
1 68.8% 52.8%
2 22.5% 30.6%
more than 3 6.3% 11.1%
type e-cigarette 
used
80 36 0.80
Disposable 
e-cigarettes
58.8% 58.3%
Refillable and 
chargeable 
e-cigarettes
18.8% 13.9%
Mods 8.8% 13.9%
other 13.8% 13.9%
AWARENESS 
FIRST
80 36 0.88
GP 0.0% 2.8%
Internet 32.5% 30.6%
Commercials on tv 7.5% 0.0%
Through my social 
network
47.5% 55.6%
Advertisements 6.3% 2.8%
Other 6.3% 8.3%
DRYHIT 80 61 0.13
very often 2.5% 5.6%
often 8.8% 16.7%
sometimes 17.5% 25.0%
rarely 20.0% 47.2%
never 40.0% 36.1%
unknown 11.3% 5.6%
Current e-liquid flavors used (% of flavor category used)
FLAVOR 
TOBACCO
79 55.7% 35 54.3% 0.89
FLAVOR 
MENTHOL
79 24.1% 35 11.4% 0.09
FLAVOR NUTS 79 0.0% 35 0.0% NA
FLAVOR SPICES 79 0.0% 35 0.0% NA
FLAVOR COFFEE 
or TEA
79 3.8% 35 2.9% 0.79
FLAVOR 
ALCOHOL
79 0.0% 35 0.0% NA
FLAVOR OTHER 
BEVERAGES
79 0.0% 35 0.0% NA
FLAVOR FRUIT 79 8.9% 35 11.4% 0.69
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
FLAVOR DESSERT 79 1.3% 35 2.9% 0.61
FLAVOR CANDY 79 0.0% 35 5.7% 0.16
FLAVOR OTHER 
SWEETS
79 6.3% 35 5.7% 0.90
FLAVOR 
UNFLAVORED
79 0.0% 35 2.9% 0.32
FLAVOR OTHER 
FLAVOR
79 0.0% 35 2.9% 0.32
First e-liquid flavors used (% of flavor category used)
FLAVOR 
TOBACCO
79 62.0% 35 74.3% 0.19
FLAVOR 
MENTHOL
79 19.0% 35 17.1% 0.81
FLAVOR NUTS 79 0.0% 35 0.0% NA
FLAVOR SPICES 79 0.0% 35 0.0% NA
FLAVOR COFFEE 
or TEA
79 2.5% 35 2.9% 0.92
FLAVOR 
ALCOHOL
79 1.3% 35 0.0% 0.32
FLAVOR OTHER 
BEVERAGES
79 0.0% 35 0.0% NA
FLAVOR FRUIT 79 6.3% 35 2.9% 0.38
FLAVOR DESSERT 79 0.0% 35 0.0% NA
FLAVOR CANDY 79 1.3% 35 0.0% 0.32
FLAVOR OTHER 
SWEETS
79 7.6% 35 0.0% 0.01
FLAVOR OTHER 
FLAVOR
79 0.0% 35 2.9% 0.32
FLAVOR 
UNFLAVORED
79 0.0% 35 0.0% NA
FLAVOR 
UNFLAVORED
79 0.0% 35 0.0% NA
Differences in attractiveness and reasons related to cigarettes and e-cigarettes
Attractiveness of 
e-cigarettes
The product looks 
nice 
80 18.8% 36 5.6% 0.03
Due to all the 
different flavors 
80 46.3% 36 25.0% 0.02
Because it is 
possible to alter 
the setting of the 
E-cigarette to my 
wishes
80 20.0% 36 38.9% 0.05
Due to its varying 
designs 
80 10.0% 36 2.8% 0.10
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Due to the price of 
the product 
80 22.5% 36 13.9% 0.25
Due to the price of 
the E-liquids
80 28.8% 36 36.1% 0.45
Because the 
nicotine level can 
be varied 
80 45.0% 36 66.7% 0.03
Because you can 
blow nice smoke 
clouds with it
80 2.5% 36 0.0% 0.16
Not applicable, 
I do not find the 
E-cigarette/vaper 
attractive 
80 8.8% 36 0.0% 0.01
Unattractiveness of e-cigarettes 
The appearance of 
the E-cigarette
80 17.5% 36 22.2% 0.57
Its many flavors 80 15.0% 36 11.1% 0.56
The price of the 
product 
80 22.5% 36 13.9% 0.25
The price of the 
E-liquids
80 15.0% 36 16.7% 0.82
The weight of the 
E-cigarette (the 
apparatus)
80 17.5% 36 8.3% 0.15
The shape of the 
E-cigarette
80 8.8% 36 11.1% 0.70
How the product 
feels in my hand, 
it is different to a 
cigarette
80 20.0% 36 19.4% 0.95
Not applicable, 
I do not find the 
E-cigarette/vaper 
attractive 
80 27.5% 36 36.1% 0.37
Attractiveness of cigarettes
The product looks 
nice 
80 7.5% 36 0.0% 0.01
Due to all the 
different flavors 
80 30.0% 36 11.1% 0.01
Because you can 
smoke different 
brands 
80 26.3% 36 5.6% 0.00
Due to the price of 
the product 
80 7.5% 36 2.8% 0.25
Because smoking 
looks cool and 
classy
80 6.3% 36 2.8% 0.37
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Because it looks 
cool when other 
people smoke
80 3.8% 36 0.0% 0.08
Because you can 
blow nice smoke 
clouds with it
80 1.3% 36 2.8% 0.62
Not applicable, 
I do not find the 
cigarette attractive 
80 28.8% 36 72.2% 0.00
Unattractiveness of cigarettes
The appearance of 
the cigarette
80 5.0% 36 2.8% 0.55
Its many flavors 80 8.8% 36 11.1% 0.70
The price of the 
product 
80 35.0% 36 58.3% 0.02
The many brands 80 8.8% 36 2.8% 0.16
The smell of 
cigarettes 
80 31.3% 36 38.9% 0.44
Packaging of 
cigarettes 
80 10.0% 36 5.6% 0.39
Because you stink 
after you have 
smoked a cigarette
80 43.8% 36 66.7% 0.02
Not applicable, I 
find the cigarette 
attractive 
80 13.8% 36 5.6% 0.14
Reasons for e-cigarette use
Because 
E-cigarettes/vapers 
are easy to get.
80.00 5.0% 36.00 11.1% 0.30
Because they are 
easy to use. 
80.00 27.5% 36.00 19.4% 0.34
Due to the cost: 
less expensive 
than cigarettes/
affordable 
80.00 41.3% 36.00 52.8% 0.26
For their health 
advantages: effects 
on health, fewer 
ingredients than a 
cigarette.
80.00 42.5% 36.00 72.2% 0.00
As an aid to 
smoking fewer 
cigarettes or 
giving them 
up completely: 
a method of 
stopping smoking, 
to prevent me 
going back to 
cigarettes.
80.00 42.5% 36.00 61.1% 0.07
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Because it is 
less addictive 
than cigarettes, 
variation in nicotine 
level is possible. 
80.00 28.8% 36.00 36.1% 0.45
To cope with 
cravings and to 
prevent/cope 
with withdrawal 
symptoms 
80.00 11.3% 36.00 13.9% 0.70
As an alternative 
to cigarettes: it is 
like the smoking 
or because of the 
throat hit (add info-
button).
80.00 28.8% 36.00 50.0% 0.04
To get around 
the smoking ban 
(to be able to 
vape in places 
where smoking 
is normally 
forbidden).
80.00 22.5% 36.00 5.6% 0.01
To help me to 
focus and improve 
my performance, 
to reduce stress or 
to prevent weight 
gain.
80.00 7.5% 36.00 5.6% 0.69
Due to improved 
sense of taste and 
smell: because it 
tastes better than 
cigarettes, and to 
be discreet (you 
can hide the fact 
that you smoke, no 
unpleasant smells).
80.00 13.8% 36.00 22.2% 0.30
This is a real 
experience, one 
that can only be 
experienced by 
doing it.
80.00 1.3% 36.00 5.6% 0.30
To try something 
new: out of 
curiosity about new 
products, different 
flavors, different 
apparatus/designs, 
for pleasure, as a 
hobby, or because 
it is cool/trendy/
classy. 
80.00 11.3% 36.00 0.0% 0.00
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
For social reasons: 
because it was 
recommended by 
friends or family, 
due to pressure 
from the people 
around met, 
to extend my 
social network 
or because it is 
socially acceptable. 
80.00 10.0% 36.00 5.6% 0.39
NA 80.00 2.5% 36.00 0.0% 0.16
Differences in socio-cognitive factors 
Socio-cognitive 
factors
Attitude never use 80 5.15 1.23 36 5.34 1.14 0.43
Attitude smoking 80 3.28 1.11 36 2.69 1.17 0.01
Attitude vaping 80 4.50 0.75 36 5.03 0.82 0.00
Barrier: 
accessibility of 
e-cigarettes
80 5.17 1.13 36 4.84 1.52 0.25
Deliberation 
about not using 
E-cigarettes or 
cigarettes
80 4.48 1.42 36 3.92 1.28 0.04
Deliberation about 
the pros and cons 
of tobacco product 
use
80 4.43 1.24 36 4.02 1.29 0.11
Deliberation of the 
pros and cons of 
smoking.
80 4.50 1.30 36 4.07 1.56 0.16
Deliberation on the 
pros and cons of 
E-cigarette use
80 4.32 1.31 36 4.07 1.33 0.37
Intention to quit 
vaping A. Please 
indicate on a 
scale from 1 to 7 
your intent to quit 
vaping in the next 
6 months.
80 3.76 2.00 36 2.86 1.82 0.02
Intention to quit 
vaping B. Please 
indicate which of 
the statements 
indicates your 
intention best
80 3.56 2.38 36 2.25 1.81 0.00
Knowledge 80 8.54 1.92 36 8.61 1.40 0.82
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Risk perception 
about e-cigarette 
use (cognitive): A. 
If I vape, then my 
risk of developing 
some form of 
cancer during my 
lifetime is…
80 4.29 1.17 36 4.25 1.02 0.86
Risk perception 
about e-cigarette 
use (cognitive): 
B. I think that if I 
vape, my risk of 
developing some 
form of cancer 
during my lifetime: 
80 4.30 1.32 36 4.28 1.34 0.93
Risk perception 
of e-cigarette use 
(affective): A. My 
feeling is that if I 
vape, the risk of 
developing some 
form of cancer 
during my lifetime:
80 4.34 1.30 36 4.22 0.99 0.60
Risk perception 
of not using 
E-cigarettes 
or cigarettes 
(affective) A. My 
feeling is that the 
risk of developing 
some form of 
cancer during my 
lifetime: 
80 4.44 1.29 36 4.36 1.13 0.75
Risk perception 
of not using 
E-cigarettes 
or cigarettes 
(affective): A. My 
feeling is that if 
don’t smoke or 
vape, then the 
risk of developing 
some form of 
cancer during my 
lifetime ….
80 4.13 1.19 36 4.19 1.28 0.78
Risk perception 
of not using 
E-cigarettes 
or cigarettes 
(cognitive): A. How 
big a risk do you 
think you have 
of developing 
some form of 
cancer during your 
lifetime?
80 4.54 1.26 36 4.83 1.21 0.23
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Risk perception 
of not using 
E-cigarettes 
or cigarettes 
(cognitive): B. If 
I don’t smoke or 
vape, then the risk 
that I will develop 
some form of 
cancer during my 
lifetime is…
80 3.93 1.24 36 4.08 1.11 0.49
Risk perception 
of not using 
E-cigarettes 
or cigarettes 
(cognitive): C. I 
think that my risk 
of developing 
some form of 
cancer during my 
lifetime:
80 4.29 1.32 36 4.36 1.05 0.75
Risk perception 
of smoking 
(cognitive): A. If I 
smoke, then my 
risk of developing 
some form of 
cancer during my 
lifetime is…
80 5.08 1.29 36 5.22 1.31 0.58
Risk perception 
smoking (affective): 
My feeling is that if 
I smoke, the risk of 
developing some 
form of cancer 
during my lifetime: 
80 4.71 1.34 36 5.11 1.30 0.14
Risk perception 
smoking 
(cognitive): B. 
I think that if I 
smoke, my risk of 
developing some 
form of cancer 
during my lifetime:
80 4.73 1.28 36 5.31 1.06 0.01
Self-efficacy: 
e-cigarette use
80 3.89 1.21 36 4.84 1.02 0.00
Self-efficacy: not 
using tobacco 
products or 
e-cigarettes
80 3.37 1.34 36 3.77 1.26 0.12
Self-efficacy: 
smoking
80 3.88 1.18 36 3.57 1.37 0.23
Social Influence A: 
Society thinks that 
you should not 
vape E-cigarettes.
80 4.21 1.68 36 3.22 1.57 0.00
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Social Influence B: 
Society thinks that 
you should not 
smoke.
80 5.56 1.52 36 5.31 2.05 0.50
Social Influence 
C: Vaping status 
partner (% of 
yes): My partner 
uses E-cigarettes/
vapers.
80 36 0.14
Social influence 
D: smoking status 
partner (% of 
yes): My partner 
smokes.
80 33.8% 36 13.9% 0.01
social influence 
E: How many of 
your family, friends 
or colleagues 
use E-cigarettes/
vapers?
80 4.41 0.98 36 4.61 0.93 0.30
social influence F: 
How many of your 
family, friends or 
colleagues use 
cigarettes?
80 3.59 1.13 36 4.06 1.12 0.04
SOCIAL TIES with 
other smokers
79 3.34 1.09 36 2.32 1.22 0.00
SOCIAL TIES with 
other vapers
80 3.00 1.24 36 3.09 0.99 0.68
TRUST in 
the National 
Institute of Public 
Health and the 
Environment
73 4.95 1.25 34 4.43 1.61 0.10
Information seeking behavior
Source of 
information used a: 
Television 
80.00 13.8% 36.00 8.3% 0.37
Source of 
information used 
b: Newspaper 
80.00 8.8% 36.00 8.3% 0.94
Source of 
information used c: 
Radio 
80.00 1.3% 36.00 2.8% 0.62
Source of 
information used d: 
Advertising (signs, 
shop displays, 
advertising folders, 
pop-ups, YouTube 
advertisements, 
advertising 
banners)
80.00 6.3% 36.00 2.8% 0.37
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Source of 
information used e: 
Internet 
80.00 67.5% 36.00 80.6% 0.13
Source of 
information used 
f: Dutch National 
Institute for Public 
Health and the 
Environment 
(RIVM) 
80.00 5.0% 36.00 2.8% 0.55
Source of 
information used 
g: Facebook or 
Twitter
80.00 1.3% 36.00 0.0% 0.32
Source of 
information used h: 
Dutch Vape forum 
or Acvoda (Active 
for vaping)
80.00 6.3% 36.00 22.2% 0.04
Source of 
information used 
i: Friends, family, 
acquaintances or 
colleagues
80.00 30.0% 36.00 33.3% 0.73
Source of 
information used 
j: Health care 
professionals, such 
as my family doctor 
or practice nurse 
80.00 5.0% 36.00 11.1% 0.30
Source of 
information used 
k: Not applicable. 
I never look for 
information about 
the E-cigarette/
vapers
80.00 6.3% 36.00 0.0% 0.02
Need of 
information a: The 
harmfulness of 
e-cigarettes
76.00 38.2% 36.00 47.2% 0.37
Need of 
information b: 
Where you can by 
e-cigarettes
76.00 11.8% 36.00 19.4% 0.33
Need of 
information c: 
E-liquids 
76.00 13.2% 36.00 8.3% 0.43
Need of 
information d: The 
different types 
of e-cigarettes 
available
76.00 9.2% 36.00 11.1% 0.76
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Need of 
information e: 
How an e-cigarette 
works
76.00 10.5% 36.00 8.3% 0.71
Need of 
information f: 
Whether the 
e-cigarette is an 
effective smoking 
cessation tool
76.00 21.1% 36.00 27.8% 0.45
Need of 
information g: 
How much e-liquid 
do you use on 
average with an 
e-cigarette
76.00 9.2% 36.00 8.3% 0.88
Need of 
information h: 
What settings 
to use with an 
e-cigarette
76.00 3.9% 36.00 0.0% 0.08
Need of 
information i: How 
often on a day 
you should use 
e-cigarettes
76.00 6.6% 36.00 2.8% 0.34
Need of 
information j: 
About the e-liquids 
available
76.00 7.9% 36.00 0.0% 0.01
Need of 
information all: All 
the above
76.00 15.8% 36.00 8.3% 0.24
Need of 
information 
none: I do not 
want additional 
information about 
the e-cigarette
76.00 21.1% 36.00 19.4% 0.84
Attitude towards 
information about 
e-cigarettes
76 4.54 1.11 36 4.42 1.39 0.63
Reliability of 
information a: Only 
if researchers have 
influence on how 
the research is 
carried out
80 32.5% 36 27.8% 0.61
Reliability of 
information b: Only 
if researchers have 
influence on how 
the research results 
are interpreted
80 26.3% 36 22.2% 0.64
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Reliability of 
information c: Only 
if researchers have 
influence on how 
the research results 
are communicated
80 27.5% 36 19.4% 0.34
Reliability of 
information d: If all 
the research results 
are made known 
and not just the 
desired results
80 66.3% 36 75.0% 0.34
Reliability of 
information e: If 
the researchers 
have no conflict of 
interest to declare 
80 51.3% 36 75.0% 0.01
Reliability of 
information f: If 
the research is not 
financed by the 
tobacco industry
80 37.5% 36 55.6% 0.08
Reliability of 
information g: If 
the research is 
under the auspices 
of the national 
government, 
if there is a 
governmental logo
80 16.3% 36 8.3% 0.21
Independence 
of information a: 
Only if researchers 
have influence on 
how the research is 
carried out. 
80 35.0% 36 36.1% 0.91
Independence of 
information b: Only 
if researchers have 
influence on how 
the research results 
are interpreted. 
80 27.5% 36 27.8% 0.98
Independence of 
information c: Only 
if researchers have 
influence on how 
the research results 
are communicated.
80 27.5% 36 22.2% 0.54
Independence of 
information d: If all 
the research results 
are made known 
and not just the 
desired results. 
80 62.5% 36 72.2% 0.30
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Scale and items Dual 
users 
(n)
Dual users 
(mean/
percentage)
Dual 
users 
(SD)
E-cigarette 
users (n)
E-cigarette 
users (mean/
percentage)
E-cigarette 
users (SD)
p-value
Independence of 
information e: If 
the researchers 
themselves have 
no vested interests 
in the results. 
80 50.0% 36 72.2% 0.02
Independence of 
information f: If 
the research is not 
financed by the 
tobacco industry. 
80 38.8% 36 50.0% 0.27
Independence 
of information h: 
If the research is 
under the auspices 
of the national 
government, 
if there is a 
governmental 
logo. 
80 18.8% 36 5.6% 0.03
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Appendix 8 Participants characteristics and alias
Chapter 6
A Deliberate Choice? Exploring factors related to informed decision-making about childhood 
vaccination among acceptors, refusers, and partial acceptors
Alias Gender Country of birth Level of education Year of birth
1_ACCEPT Female the Netherlands High 
2_ACCEPT Female the Netherlands High 1974
3_ACCEPT Female the Netherlands High 1977
4_ACCEPT Female the Netherlands High 1973
5_ACCEPT Female the Netherlands High 1986
6_ACCEPT Female the Netherlands High 1975
7_REFUSE Female the Netherlands High 1980
8_REFUSE Female the Netherlands High 1980
9_REFUSE Female the Netherlands High 1979
10_REFUSE Female the Netherlands High 1979
11_REFUSE Female the Netherlands High 1978
12_REFUSE Female the Netherlands High 1978
13_PARTIAL Female the Netherlands High 1972
14_PARTIAL Female the Netherlands High 1973
15_PARTIAL Female the Netherlands High 1968
16_PARTIAL Female the Netherlands High 1983
17_PARTIAL Female the Netherlands High 1977
18_PARTIAL Female the Netherlands High 1987
19_PARTIAL Female the Netherlands High 1982
20_PARTIAL Female the Netherlands High 1980
21_ACCEPT Female the Netherlands High 1983
22_ACCEPT Female Surinam High 1985
23_ACCEPT Female the Netherlands High 1982
24_ACCEPT Female Germany High 1973
25_ACCEPT Female Canada High 1974
26_ACCEPT Female the Netherlands High 1981
27_ACCEPT Female the Netherlands High 1976
28_REFUSE Female the Netherlands High 1971
29_REFUSE Female the Netherlands High 1980
30_PARTIAL Female the Netherlands High 1959
31_PARTIAL Female the Netherlands High 1990
32_PARTIAL Female the Netherlands High 
33_PARTIAL Female Slovakia High 1977
34_PARTIAL Female the Netherlands High 1976
35_PARTIAL Female the Netherlands High 1980
36_PARTIAL Female the Netherlands High 1977
table continues
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Alias Gender Country of birth Level of education Year of birth
37_PARTIAL Female the Netherlands High 1978
38_PARTIAL Female the Netherlands High 1970
39_PARTIAL Female the Netherlands High 1985
40_PARTIAL Female Seoul High 1977
41_PARTIAL Female the Netherlands Middle 1982
42_PARTIAL Female the Netherlands High 1971
43_ACCEPT Female the Netherlands High 1974
44_ACCEPT Female the Netherlands High 1978
45_ACCEPT Female the Netherlands High 1985
46_ACCEPT Female the Netherlands High 1974
47_ACCEPT Female the Netherlands High 1985
48_ACCEPT Female the Netherlands Low 1972
49_REFUSE Female the Netherlands High 
50_REFUSE Female the Netherlands High 1975
51_REFUSE Female the Netherlands High 1980
52_PARTIAL Female the Netherlands High 1983
53_PARTIAL Female the Netherlands High 1990
54_PARTIAL Female the Netherlands High 1977
55_REFUSE Female Australia High 1982
Note the alias reflects the decision about childhood vaccination of participants
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Appendix 9 Topic guide: exploring decision-making 
about childhood vaccination
Chapter 6
A Deliberate Choice? Exploring the Decision to Switch from Cigarettes to E-Cigarettes 
Note: All participants have to sign an informed consent before the start of the introduction.
Introduction by interviewer
Welcome! My name is … and this is …, who will be helping me with the discussion today. I work 
for … and I my research is about…. 
Today we are discussing childhood vaccination. Your opinion as a parent is very important. We 
would like to talk to you about childhood vaccination and this discussion will take approximately 
two hours, with a break. At the end of our discussion we have time for general questions about 
childhood vaccination.
We would like to stress that there are no correct or wrong answers. Today is all about your 
experiences and your ideas. We will be hearing a lot of different ideas and experiences, so I would 
like to ask you to respect each other. Please listen carefully to each other and please let each other 
finish speaking. 
This group discussion will be audio recorded. – Turn on audio recording— All personal information 
will be made anonymous, and please remember that your participation is voluntary. This means 
that you can leave at all times, you do not have to explain yourself. 
Are there any remaining questions before we start?
Introduction participants
Please introduce yourself shortly. Please share the vaccination status of your child. What do you 
enjoy doing in your daily live?
· Make name tags
General prompts
· What do you mean?
· Can you tell me more about that?
· What comes to mind?
· Can you explain that to me?
· Is there anything else that you can think of?
Topic guide: exploring decision making process of childhood vaccination 
Knowledge about childhood vaccination
 What do you know about childhood vaccination? [use flip-over to collect ideas]
Prompts Risks, NIP, different childhood vaccination schedules, 
religion, herd immunity, VPDs, side-effects
Attitude
 
 What is your opinion about childhood vaccination?
Prompts How do you feel about it? What are advantages and 
disadvantages?
table continues
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Deliberation 
 When did you start thinking about childhood vaccination?
 How did you consider the pros and cons of childhood vaccination?
 Who played a role in your decision?
 What played a role in your decision?
 How difficult was it to make a decision?
Did you have any doubts about your decision?
Prompts Did you consider an alternative (schedule)? How 
do you deal with the risks of refusing childhood 
vaccinations? Is it one big decision, or several small 
ones? Are you happy with your decision? Would you 
do it differently? What would have made it easier for 
you to make a decision about childhood vaccination?
[use these prompts to link to next topic]
Information need
 What information is important to make a decision about childhood vaccination?
 Where did you look for information about childhood vaccination?
Did you understand the information provided at the CWC?
Prompts Which information was important to you? Which 
source was important to you? How do you know how 
to trust information? Which information do you still 
miss? Could the CVPs answer your questions? Do you 
feel that the CVPs take your questions seriously?
Closing
Is there anything we did not cover today that you find important related to childhood vaccination?
Do you have any questions left?
Note: due to the semi-structured protocol these questions are examples and may slightly very in 
each focus group in both style and order.
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lly
 &
 n
ot
 
ap
p
lic
ab
le
 
 
I t
ho
ug
ht
 a
b
ou
t 
it 
lo
ng
 a
nd
 h
ar
d
 
b
ef
or
e 
I t
oo
k 
th
e 
d
ec
is
io
n 
to
 h
av
e 
m
y 
ch
ild
 n
ot
 
va
cc
in
at
ed
. 
(re
co
d
ed
) 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 &
 n
ot
 
ap
p
lic
ab
le
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el
ib
er
at
io
n 
of
 th
e 
pr
os
 
an
d 
co
ns
 o
f 
pa
rt
ia
lly
 
ac
ce
pt
in
g 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
Pl
ea
se
 k
ee
p
 y
ou
r 
ow
n 
d
ec
is
io
n 
ab
ou
t 
ch
ild
ho
od
 v
ac
ci
na
tio
n 
in
 
m
in
d
, b
ut
 d
id
 y
ou
 c
on
si
d
er
 t
he
 o
p
tio
n 
to
 p
ar
tia
lly
 a
cc
ep
t 
ch
ild
ho
od
 v
ac
ci
na
tio
ns
? 
1 
=
 n
o 
d
el
ib
er
at
io
n 
of
 
th
e 
d
ec
is
io
n 
to
 
p
ar
tia
lly
 a
cc
ep
t 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 t
o 
7 
=
 v
er
y 
ex
te
ns
iv
e 
d
el
ib
er
at
io
n 
of
 
th
e 
d
ec
is
io
n 
to
 
p
ar
tia
lly
 a
cc
ep
t 
ch
ild
ho
od
 
va
cc
in
at
io
ns
. 
  
Th
e 
th
re
e 
ite
m
s 
w
er
e 
su
m
m
ed
 a
nd
 
av
er
ag
ed
 t
o 
co
m
p
ut
e 
on
e 
sc
or
e 
of
 t
he
 
co
nc
ep
t 
D
el
ib
er
at
io
n 
of
 th
e 
pr
os
 a
nd
 c
on
s 
of
 p
ar
tia
lly
 a
cc
ep
tin
g 
ch
ild
ho
od
 
va
cc
in
at
io
ns
. 
- 
M
id
p
oi
nt
 o
f t
he
 
sc
al
e 
=
 (3
 +
 2
1)
 /
 2
 
à
 m
id
p
oi
nt
 o
f t
he
 
sc
al
e 
is
 1
2.
 
M
id
p
oi
nt
 o
f t
he
 s
ca
le
 
=
 lo
w
es
t 
sc
or
e 
+
 
hi
g
he
st
 p
os
si
b
le
 s
co
re
 
d
iv
id
ed
 b
y 
2.
 
0.
89
8 
Le
hm
an
n,
 d
e 
M
el
ke
r,
 
Ti
m
m
er
m
an
s,
 
M
ol
le
m
a 
3  
 
I h
av
e 
co
ns
id
er
ed
 
ho
w
 I 
w
ou
ld
 fe
el
 if
 I 
w
er
e 
to
 h
av
e 
m
y 
ch
ild
 p
ar
tia
lly
 
va
cc
in
at
ed
. 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 
I h
av
e 
tr
ie
d
 t
o 
co
ns
id
er
 t
he
 
co
ns
eq
ue
nc
es
 o
f 
ha
vi
ng
 m
y 
ch
ild
 
p
ar
tia
lly
 
va
cc
in
at
ed
. 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 
1.
 I 
am
 a
w
ar
e 
of
 t
he
 
ad
va
nt
ag
es
 a
nd
 
d
is
ad
va
nt
ag
es
 o
f 
ha
vi
ng
 m
y 
ch
ild
 
p
ar
tia
lly
 
va
cc
in
at
ed
. 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 
 
H
av
in
g
 m
y 
ch
ild
 
p
ar
tia
lly
 v
ac
ci
na
te
d
 
is
 s
om
et
hi
ng
 t
ha
t 
I 
w
ou
ld
 a
ut
om
at
ic
al
ly
 
d
o.
 (r
ec
od
ed
) 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t a
ll 
– 
7 
=
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 &
 n
ot
 
ap
p
lic
ab
le
 
 
To
 a
cc
om
m
od
at
e 
fo
r 
th
e 
la
rg
e 
p
ro
p
or
tio
ns
 o
f m
is
si
ng
 
an
sw
er
s 
(m
in
=
 5
.2
%
, m
ax
=
 4
8.
7%
, m
ed
ia
n=
35
.7
%
), 
sc
al
es
 fo
r 
d
el
ib
er
at
io
n 
of
 t
he
 p
ro
s 
an
d
 c
on
s 
of
 p
ar
tia
lly
 
ac
ce
p
tin
g
 c
hi
ld
ho
od
 v
ac
ci
na
tio
ns
 t
he
 c
on
ce
p
t 
w
as
 
co
m
p
ut
ed
 w
ith
ou
t 
th
es
e 
th
re
e 
ite
m
s.
 
 
 
I w
ou
ld
 n
ot
 h
av
e 
to
 
th
in
k 
fo
r 
ve
ry
 lo
ng
 
ab
ou
t 
ha
vi
ng
 m
y 
ch
ild
 p
ar
tia
lly
 
va
cc
in
at
ed
. 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 &
 n
ot
 
ap
p
lic
ab
le
 
 
I t
ho
ug
ht
 a
b
ou
t 
it 
lo
ng
 a
nd
 h
ar
d
 
b
ef
or
e 
I t
oo
k 
th
e 
d
ec
is
io
n 
to
 h
av
e 
m
y 
ch
ild
 p
ar
tia
lly
 
va
cc
in
at
ed
. 
(re
co
d
ed
) 
1=
 n
ot
 c
on
si
d
er
ed
 it
 a
t 
al
l –
 7
 =
 
co
ns
id
er
ed
 it
 v
er
y 
ca
re
fu
lly
 &
 n
ot
 
ap
p
lic
ab
le
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b
le
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o
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in
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 D
ec
isi
on
al
 
Co
nf
lic
t 
C
on
si
d
er
in
g
 t
he
 
op
tio
n 
yo
u 
p
re
fe
r 
ab
ou
t 
ch
ild
ho
od
 
va
cc
in
at
io
n,
 p
le
as
e 
an
sw
er
 t
he
 fo
llo
w
in
g
 
q
ue
st
io
ns
: 
1 
=
 t
ot
al
ly
 d
is
ag
re
e 
to
 7
 =
 t
ot
al
ly
 a
g
re
e 
1 
=
 n
o 
d
ec
is
io
na
l 
co
nf
lic
t 
– 
10
0 
=
 
ex
tr
em
el
y 
hi
g
h 
d
ec
is
io
na
l 
co
nf
lic
t.
 
Th
e 
d
ec
is
io
na
l c
on
fli
ct
 
ite
m
s 
w
er
e 
re
co
d
ed
 fr
om
 0
 
to
 6
, s
um
m
ed
, d
iv
id
ed
 b
y 
16
 (n
um
b
er
 o
f i
te
m
s)
, a
nd
 
m
ul
tip
lie
d
 b
y 
10
0/
6.
 
Sc
or
es
 c
an
 r
an
g
e 
fr
om
 n
o 
d
ec
is
io
na
l c
on
fli
ct
 (0
) t
o 
ex
tr
em
el
y 
hi
g
h 
d
ec
is
io
na
l 
co
nf
lic
t 
(1
00
) 6
. T
he
 
su
b
sc
al
es
 u
nc
er
ta
in
ty
, 
in
fo
rm
ed
, v
al
ue
 c
la
rit
y,
 
su
p
p
or
t,
 a
nd
 e
ffe
ct
iv
e 
d
ec
is
io
n 
w
er
e 
re
co
d
ed
 
fr
om
 0
 t
o 
6,
 s
um
m
ed
, 
d
iv
id
ed
 b
y 
th
e 
nu
m
b
er
 o
f 
ite
m
s 
sp
ec
ifi
c 
to
 t
he
 
su
b
sc
al
e,
 a
nd
 m
ul
tip
lie
d
 b
y 
10
0/
6 
6 .
 O
'C
on
no
r 
7  
st
at
es
 
th
at
 s
co
re
s 
on
 t
he
 
d
ec
is
io
na
l c
on
fli
ct
 s
ca
le
 
lo
w
er
 t
ha
n 
25
 o
ut
 o
f 1
00
 
ar
e 
as
so
ci
at
ed
 w
ith
 m
ak
in
g
 
an
 in
fo
rm
ed
 d
ec
is
io
n,
 
w
hi
le
 s
co
re
s 
ex
ce
ed
in
g
 
37
.5
 a
re
 a
ss
oc
ia
te
d
 w
ith
 
d
ec
is
io
na
l r
eg
re
t.
  
 
.9
14
 
O
'C
on
no
r 
6   
D
ec
isi
on
al
 
co
nf
lic
t: 
in
fo
rm
ed
 
su
bs
ca
le
 
I k
no
w
 w
hi
ch
 
op
tio
ns
 c
on
ce
rn
in
g
 
th
e 
va
cc
in
at
io
n 
of
 
m
y 
ch
ild
 a
re
 
p
os
si
b
le
 fo
r 
m
e 
1 
=
 fe
el
s 
ex
tr
em
el
y 
un
in
fo
rm
ed
 –
 1
00
 
=
 fe
el
s 
ex
tr
em
el
y 
in
fo
rm
ed
. 
Th
e 
an
sw
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
0-
6.
 T
he
 t
hr
ee
 
ite
m
s 
ar
e 
th
en
 s
um
m
ed
 
an
d
 d
iv
id
ed
 b
y 
th
re
e.
 T
he
 
sc
or
es
 w
er
e 
m
ul
tip
lie
d
 b
y 
10
0 /
6.
 T
he
 fi
na
l s
co
re
 w
as
 
re
co
d
ed
 s
o 
1 
m
ea
ns
 fe
el
s 
ex
tr
em
el
y 
un
in
fo
rm
ed
 a
nd
 
10
0 
fe
el
s 
ex
tr
em
el
y 
in
fo
rm
ed
.  
0.
84
9 
I k
no
w
 w
ha
t 
th
e 
ad
va
nt
ag
es
 o
f e
ac
h 
op
tio
n 
co
nc
er
ni
ng
 
th
e 
va
cc
in
at
io
n 
of
 
m
y 
ch
ild
 a
re
 
I k
no
w
 w
ha
t 
th
e 
ris
ks
 
an
d
 d
is
ad
va
nt
ag
es
 
of
 e
ac
h 
op
tio
n 
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co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 a
re
 
D
ec
isi
on
al
 
Co
nf
lic
t  
Va
lu
es
 C
la
rit
y 
I k
no
w
 w
hi
ch
 
ad
va
nt
ag
es
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 a
re
 m
os
t 
im
p
or
ta
nt
 t
o 
m
e 
Sc
or
es
 r
an
g
e 
fr
om
 
0 
=
 fe
el
s 
ex
tr
em
el
y 
cl
ea
r 
ab
ou
t 
p
er
so
na
l 
va
lu
es
 fo
r 
b
en
ef
its
 
&
ris
ks
/s
id
e 
ef
fe
ct
s 
to
 1
00
 =
 
ex
tr
em
el
y 
un
cl
ea
r 
ab
ou
t 
p
er
so
na
l 
va
lu
es
. 
 
.8
56
 
 
I k
no
w
 w
hi
ch
 r
is
ks
 
an
d
 d
is
ad
va
nt
ag
es
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 a
re
 m
os
t 
im
p
or
ta
nt
 t
o 
m
e 
 
 
 
 
I k
no
w
 w
ha
t 
is
 m
or
e 
im
p
or
ta
nt
 t
o 
m
e 
- 
th
e 
b
en
ef
its
 o
r 
th
e 
ris
ks
 a
nd
 
d
is
ad
va
nt
ag
es
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
 
 
 
D
ec
isi
on
al
 
Co
nf
lic
t 
Su
pp
or
t 
I g
et
 e
no
ug
h 
su
p
p
or
t 
fr
om
 o
th
er
 
p
eo
p
le
 w
he
n 
m
ak
in
g
 a
 c
ho
ic
e 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
Sc
or
es
 r
an
g
e 
fr
om
 
0 
=
 fe
el
s 
ex
tr
em
el
y 
su
p
p
or
te
d
 in
 
d
ec
is
io
n-
m
ak
in
g
 
to
 1
00
 =
 fe
el
s 
ex
tr
em
el
y 
un
su
p
p
or
te
d
 in
 
d
ec
is
io
n-
m
ak
in
g
. 
- A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 fr
om
 z
er
o 
=
 
to
ta
lly
 a
g
re
e 
to
 s
ix
 =
 
to
ta
lly
 d
is
ag
re
e.
 
- T
he
 t
hr
ee
 it
em
s 
w
er
e 
su
m
m
ed
 a
nd
 a
ve
ra
g
ed
.  
- T
hi
s 
sc
or
e 
w
as
 t
he
n 
m
ul
tip
lie
d
 1
6.
66
7.
 
Sc
or
es
 t
he
n 
ra
ng
e 
fr
om
 0
 
to
 1
00
. 
.7
07
 
 
I d
o 
no
t 
fe
el
 I 
am
 
b
ei
ng
 p
ut
 u
nd
er
 
p
re
ss
ur
e 
b
y 
ot
he
r 
 
 
 
ta
b
le
 c
o
nt
in
ue
s
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p
eo
p
le
 w
he
n 
m
ak
in
g
 a
 c
ho
ic
e 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
 
I h
av
e 
b
ee
n 
g
iv
en
 
en
ou
g
h 
ad
vi
ce
 t
o 
b
e 
ab
le
 t
o 
m
ak
e 
a 
ch
oi
ce
 c
on
ce
rn
in
g
 
th
e 
va
cc
in
at
io
n 
of
 
m
y 
ch
ild
 
 
 
 
D
ec
isi
on
al
 
Co
nf
lic
t 
Un
ce
rt
ai
nt
y 
Th
e 
b
es
t 
ch
oi
ce
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 is
 c
le
ar
 t
o 
m
e 
Sc
or
es
 r
an
g
e 
fr
om
 
0 
=
 fe
el
s 
ex
tr
em
el
y 
ce
rt
ai
n 
ab
ou
t 
b
es
t 
ch
oi
ce
 
to
 1
00
 =
 
ex
tr
em
el
y 
un
ce
rt
ai
n 
ab
ou
t 
b
es
t 
ch
oi
ce
. 
- A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 fr
om
 z
er
o 
=
 
to
ta
lly
 a
g
re
e 
to
 s
ix
 =
 
to
ta
lly
 d
is
ag
re
e.
 
- T
he
 t
hr
ee
 it
em
s 
w
er
e 
su
m
m
ed
 a
nd
 a
ve
ra
g
ed
.  
- T
hi
s 
sc
or
e 
w
as
 t
he
n 
m
ul
tip
lie
d
 1
6.
66
7.
 
Sc
or
es
 t
he
n 
ra
ng
e 
fr
om
 0
 
to
 1
00
. 
.7
88
 
 
I f
ee
l c
er
ta
in
 a
b
ou
t 
w
ha
t 
to
 c
ho
os
e 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
 
 
 
 
I f
in
d
 it
 e
as
y 
to
 m
ak
e 
a 
ch
oi
ce
 c
on
ce
rn
in
g
 
th
e 
va
cc
in
at
io
n 
of
 
m
y 
ch
ild
 
 
 
 
D
ec
isi
on
al
 
Co
nf
lic
t 
Ef
fe
ct
iv
e 
D
ec
isi
on
 
I h
av
e 
th
e 
fe
el
in
g
 
th
at
 I 
ha
ve
 m
ad
e 
an
 
in
fo
rm
ed
 c
ho
ic
e 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
Sc
or
es
 r
an
g
e 
fr
om
 
0 
=
 g
oo
d
 
d
ec
is
io
n 
to
 1
00
 =
 
b
ad
 d
ec
is
io
n.
 
- A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 fr
om
 z
er
o 
=
 
to
ta
lly
 a
g
re
e 
to
 s
ix
 =
 
to
ta
lly
 d
is
ag
re
e.
 
- T
he
 t
hr
ee
 it
em
s 
w
er
e 
su
m
m
ed
 a
nd
 a
ve
ra
g
ed
.  
- T
hi
s 
sc
or
e 
w
as
 t
he
n 
m
ul
tip
lie
d
 1
6.
66
7.
 
Sc
or
es
 t
he
n 
ra
ng
e 
fr
om
 0
 
to
 1
00
. 
.7
28
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I e
xp
ec
t 
to
 s
tic
k 
to
 
m
y 
ch
oi
ce
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
 
 
 
 
I a
m
 s
at
is
fie
d
 w
ith
 
m
y 
ch
oi
ce
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 
 
 
 
 
M
y 
ch
oi
ce
 
co
nc
er
ni
ng
 t
he
 
va
cc
in
at
io
n 
of
 m
y 
ch
ild
 s
ho
w
s 
w
ha
t 
I 
th
in
k 
is
 im
p
or
ta
nt
 
 
 
 
Su
sc
ep
tib
ili
ty
 re
ga
rd
in
g 
th
e 
Va
cc
in
e 
Pr
ev
en
ta
bl
e 
D
ise
as
es
 (V
PD
s)
 (c
og
ni
tiv
e)
 
Su
sc
ep
tib
ili
ty
 
re
ga
rd
in
g 
Fa
ct
ua
l 
Ch
an
ce
 o
f c
hi
ld
’s
 
su
sc
ep
tib
ili
ty
 o
f V
PD
s 
af
te
r a
cc
ep
tin
g 
al
l 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
If 
I f
ul
ly
 v
ac
ci
na
te
 m
y 
ch
ild
 in
 a
cc
or
d
an
ce
 
w
ith
 t
he
 N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
e 
ris
k 
th
at
 m
y 
ch
ild
 w
ill
 g
et
 
on
e 
of
 t
he
se
 
in
fe
ct
io
us
 d
is
ea
se
s 
is
 
1=
 v
er
y 
sm
al
l t
o 
7 
=
 v
er
y 
hi
g
h 
1=
 lo
w
 t
o 
7 
=
 h
ig
h 
ris
k 
p
er
ce
p
tio
n 
fo
r 
ch
ild
’s
 
su
sc
ep
tib
ili
ty
 fo
r 
V
PD
 
if 
al
l c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 a
re
 
ac
ce
p
te
d
 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
7 
is
 p
os
iti
ve
 a
nd
 1
 is
 
ne
g
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
V
PD
s 
co
ul
d
 n
ot
 b
e 
su
m
m
ed
 8
 b
ec
au
se
 
C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 
b
el
ow
 .6
. A
 c
on
ce
p
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, 
an
d
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
N
A
 
Ja
ns
se
n 
9  
d
e 
V
rie
s,
 
va
n 
O
sc
h,
 E
ijm
ae
l, 
Sm
er
ec
ni
k,
 C
an
d
el
 8
 
Su
sc
ep
tib
ili
ty
 
re
ga
rd
in
g 
Fa
ct
ua
l 
Ch
an
ce
 o
f c
hi
ld
’s
 
su
sc
ep
tib
ili
ty
 o
f V
PD
s 
af
te
r r
ef
us
in
g 
al
l 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
If 
I d
o 
no
t 
va
cc
in
at
e 
m
y 
ch
ild
 in
 
ac
co
rd
an
ce
 w
ith
 t
he
 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
e 
ris
k 
th
at
 m
y 
ch
ild
 w
ill
 g
et
 
1=
 v
er
y 
sm
al
l t
o 
7 
=
 v
er
y 
hi
g
h 
1=
 lo
w
 t
o 
7 
=
 h
ig
h 
ris
k 
p
er
ce
p
tio
n 
fo
r 
ch
ild
’s
 
su
sc
ep
tib
ili
ty
 fo
r 
V
PD
 
if 
al
l c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 a
re
 
re
fu
se
d
 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
7 
is
 p
os
iti
ve
 a
nd
 1
 is
 
ne
g
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
V
PD
s 
co
ul
d
 n
ot
 b
e 
N
A
 
ta
b
le
 c
o
nt
in
ue
s
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on
e 
of
 t
he
se
 
in
fe
ct
io
us
 d
is
ea
se
s 
is
 
su
m
m
ed
 8
 b
ec
au
se
 
C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 
b
el
ow
 .6
. A
 c
on
ce
p
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, 
an
d
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
Su
sc
ep
tib
ili
ty
 
re
ga
rd
in
g 
Fa
ct
ua
l 
Ch
an
ce
 o
f c
hi
ld
’s
 
su
sc
ep
tib
ili
ty
 o
f V
PD
s 
af
te
r p
ar
tia
lly
 
ac
ce
pt
in
g 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
If 
I p
ar
tia
lly
 v
ac
ci
na
te
 
m
y 
ch
ild
 in
 
ac
co
rd
an
ce
 w
ith
 t
he
 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
e 
ris
k 
th
at
 m
y 
ch
ild
 w
ill
 g
et
 
on
e 
of
 t
he
se
 
in
fe
ct
io
us
 d
is
ea
se
s 
is
 
1=
 v
er
y 
sm
al
l t
o 
7 
=
 v
er
y 
hi
g
h 
1=
 lo
w
 t
o 
7 
=
 h
ig
h 
ris
k 
p
er
ce
p
tio
n 
fo
r 
ch
ild
’s
 
su
sc
ep
tib
ili
ty
 fo
r 
V
PD
 
if 
al
l c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 a
re
 
re
fu
se
d
 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
7 
is
 p
os
iti
ve
 a
nd
 1
 is
 
ne
g
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
V
PD
s 
co
ul
d
 n
ot
 b
e 
su
m
m
ed
 8
 b
ec
au
se
 
C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 
b
el
ow
 .6
. A
 c
on
ce
p
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, 
an
d
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
N
A
 
 
Su
sc
ep
tib
ili
ty
 re
ga
rd
in
g 
th
e 
sid
e 
ef
fe
ct
s 
of
 v
ac
ci
ne
s 
(c
og
ni
tiv
e)
 
Su
sc
ep
tib
ili
ty
 
re
ga
rd
in
g 
Fa
ct
ua
l 
Ch
an
ce
 o
f c
hi
ld
’s
 
su
sc
ep
tib
ili
ty
 o
f s
id
e 
ef
fe
ct
s 
af
te
r 
ac
ce
pt
in
g 
al
l 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
If 
I f
ul
ly
 v
ac
ci
na
te
 m
y 
ch
ild
 in
 a
cc
or
d
an
ce
 
w
ith
 t
he
 N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
e 
ris
k 
th
at
 m
y 
ch
ild
 w
ou
ld
 
d
ev
el
op
 s
id
e 
ef
fe
ct
s 
is
 
1=
 v
er
y 
sm
al
l t
o 
7 
=
 v
er
y 
hi
g
h 
1=
 lo
w
 t
o 
7 
=
 h
ig
h 
ris
k 
p
er
ce
p
tio
n 
fo
r 
ch
ild
’s
 
su
sc
ep
tib
ili
ty
 fo
r 
V
PD
 
if 
al
l c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 a
re
 
ac
ce
p
te
d
 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
7 
is
 p
os
iti
ve
 a
nd
 1
 is
 
ne
g
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
si
d
e-
ef
fe
ct
s 
co
ul
d
 n
ot
 
b
e 
su
m
m
ed
 8
 
b
ec
au
se
 C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 b
el
ow
 .6
. A
 
co
nc
ep
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, a
nd
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
.  
N
A
 
Ja
ns
se
n 
9  
d
e 
V
rie
s,
 
va
n 
O
sc
h,
 E
ijm
ae
l, 
Sm
er
ec
ni
k,
 C
an
d
el
 8
 
Su
sc
ep
tib
ili
ty
 
re
ga
rd
in
g 
Fa
ct
ua
l 
If 
I p
ar
tia
lly
 v
ac
ci
na
te
 
m
y 
ch
ild
 in
 
 
1=
 lo
w
 t
o 
7 
=
 h
ig
h 
ris
k 
p
er
ce
p
tio
n 
fo
r 
ch
ild
’s
 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
N
a 
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 C
ha
nc
e 
of
 c
hi
ld
’s
 
su
sc
ep
tib
ili
ty
 o
f s
id
e 
ef
fe
ct
s 
af
te
r p
ar
tia
lly
 
ac
ce
pt
in
g 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 
ac
co
rd
an
ce
 w
ith
 t
he
 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
e 
ris
k 
th
at
 m
y 
ch
ild
 w
ou
ld
 
d
ev
el
op
 s
id
e 
ef
fe
ct
s 
as
 a
 r
es
ul
t 
of
 t
he
 
va
cc
in
at
io
n(
s)
 is
 
su
sc
ep
tib
ili
ty
 fo
r 
V
PD
 
if 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 a
re
 
ac
ce
p
te
d
 in
 p
ar
t 
7 
is
 p
os
iti
ve
 a
nd
 1
 is
 
ne
g
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
si
d
e-
ef
fe
ct
s 
co
ul
d
 n
ot
 
b
e 
su
m
m
ed
 8
 
b
ec
au
se
 C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 b
el
ow
 .6
. A
 
co
nc
ep
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, a
nd
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
Se
ve
rit
y 
of
 V
PD
s 
an
d 
sid
e-
ef
fe
ct
s 
 
1.
 H
ow
 s
er
io
us
 w
ou
ld
 
yo
u 
th
in
k 
it 
w
ou
ld
 b
e 
if 
yo
ur
 c
hi
ld
 g
ot
 o
ne
 
of
 t
he
 in
fe
ct
io
us
 
d
is
ea
se
s?
 
1 
=
 n
ot
 s
er
io
us
 a
t 
al
l t
o 
7 
=
 v
er
y 
se
rio
us
  
1 
=
 lo
w
 t
o 
7 
=
 h
ig
h 
p
er
ce
p
tio
n 
of
 s
ev
er
ity
 
of
 V
PD
s 
A
ns
w
er
 o
p
tio
ns
 w
er
e 
re
co
d
ed
 t
o 
m
ak
e 
su
re
 
7 
eq
ua
l a
 h
ig
h 
su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
of
 t
he
 r
is
ks
 
an
d
 1
 is
 n
eg
at
iv
e.
 
 Su
sc
ep
tib
ili
ty
 a
nd
 
se
ve
rit
y 
ite
m
s 
on
 
si
d
e-
ef
fe
ct
s 
co
ul
d
 n
ot
 
b
e 
su
m
m
ed
 8
 
b
ec
au
se
 C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 b
el
ow
 .6
. A
 
co
nc
ep
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, a
nd
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
 
Ja
ns
se
n 
9  
d
e 
V
rie
s,
 
va
n 
O
sc
h,
 E
ijm
ae
l, 
Sm
er
ec
ni
k,
 C
an
d
el
 8
 
 
2.
 If
 m
y 
ch
ild
 g
ot
 o
ne
 
of
 t
he
 in
fe
ct
io
us
 
d
is
ea
se
s,
 it
 c
ou
ld
 
ha
ve
 v
er
y 
se
rio
us
 
ef
fe
ct
s.
 
1 
=
 t
ot
al
ly
 d
is
ag
re
e 
to
 7
 
=
 t
ot
al
ly
 a
g
re
e 
 
 
 
 
 
3.
 H
ow
 s
er
io
us
 w
ou
ld
 
yo
u 
th
in
k 
it 
w
as
 if
 
1 
=
 n
ot
 s
er
io
us
 a
t 
al
l t
o 
7 
=
 v
er
y 
se
rio
us
 A
 
 
 
 
 
ta
b
le
 c
o
nt
in
ue
s
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yo
ur
 c
hi
ld
 d
ev
el
op
ed
 
si
d
e 
ef
fe
ct
s 
as
 a
 
co
ns
eq
ue
nc
e 
of
 
va
cc
in
at
io
n(
s)
 fr
om
 
th
e 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
? 
 
 
4.
 If
 m
y 
ch
ild
 
d
ev
el
op
ed
 s
id
e 
ef
fe
ct
s 
as
 a
 
co
ns
eq
ue
nc
e 
of
 
va
cc
in
at
io
n(
s)
 fr
om
 
th
e 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
, t
he
n 
th
is
 
co
ul
d
 h
av
e 
se
rio
us
 
co
ns
eq
ue
nc
es
 fo
r 
m
y 
ch
ild
.  
1 
=
 t
ot
al
ly
 d
is
ag
re
e 
to
 7
 
=
 t
ot
al
ly
 a
g
re
e 
 
 
 
 
Tr
us
t 
Pl
ea
se
 in
d
ic
at
e 
ho
w
 m
uc
h 
yo
u 
tr
us
t 
or
 d
is
tr
us
t 
th
e 
as
p
ec
ts
 
 
 
 
 
1.
 T
he
 v
ac
ci
na
tio
ns
 
th
at
 a
re
 p
ar
t 
of
 t
he
 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
  
1 
=
 n
o 
tr
us
t 
to
 7
 =
 a
 lo
t 
of
 t
ru
st
 
1 
=
 n
o 
tr
us
t 
in
 t
he
 N
IP
 
to
 7
 =
 a
 lo
t 
of
 t
ru
st
 in
 
th
e 
N
IP
 
Th
e 
te
n 
ite
m
s 
w
er
e 
su
m
m
ed
 a
nd
 
av
er
ag
ed
 t
o 
co
m
p
ut
e 
on
e 
sc
or
e 
of
 t
he
 
co
nc
ep
t 
Tr
us
t. 
0.
91
7 
Si
eg
ris
t,
 E
ar
le
, 
G
ut
sc
he
r 
10
 
2.
 T
he
 N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
  
3.
 T
he
 R
IV
M
  
4.
 In
 t
he
 D
ut
ch
 
g
ov
er
nm
en
t,
 I 
ha
ve
…
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 5.
 In
fo
rm
at
io
n 
fr
om
 
th
e 
g
ov
er
nm
en
t 
ab
ou
t 
th
e 
N
at
io
na
l 
Im
m
un
iz
at
io
n 
Pr
og
ra
m
 
6.
 T
he
 p
ha
rm
ac
eu
tic
al
 
in
d
us
tr
y 
 
7.
 c
hi
ld
 v
ac
ci
ne
 
p
ro
vi
d
er
s 
at
 t
he
 c
hi
ld
 
w
el
fa
re
 c
lin
ic
  
8.
 C
hi
ld
 w
el
fa
re
 c
lin
ic
  
9.
 T
he
 in
fo
rm
at
io
n 
th
at
 y
ou
 g
et
 fr
om
 t
he
 
C
hi
ld
 w
el
fa
re
 c
lin
ic
  
10
.  T
he
 D
ut
ch
 h
ea
lth
 
ca
re
 s
ys
te
m
 if
 y
ou
r 
ch
ild
 g
ot
 o
ne
 o
f t
he
 
12
 in
fe
ct
io
us
 
d
is
ea
se
s 
 
Va
lu
es
 
Pl
ea
se
 in
d
ic
at
e 
w
he
th
er
 t
he
 fo
llo
w
in
g
 s
ta
te
m
en
ts
 
ap
p
ly
 t
o 
yo
u 
 
In
d
iv
id
ua
l i
te
m
s 
w
er
e 
us
ed
 
N
A
 
N
A
 
Re
lig
io
n 
1 
=
 c
om
p
le
te
ly
 d
is
ag
re
e 
– 
7 
co
m
p
le
te
ly
 a
g
re
e 
1 
=
 t
hi
s 
va
lu
e 
d
oe
s 
no
t 
ap
p
ly
 t
o 
m
e 
to
 7
 =
 
th
is
 v
al
ue
 a
p
p
lie
s 
to
 
m
e 
 
 
 
H
om
eo
p
at
hy
 
 
 
 
N
at
ur
op
at
hy
 
 
 
 
A
nt
hr
op
os
op
hy
 
 
 
 
So
ci
al
 n
or
m
 re
ga
rd
in
g 
re
fu
sin
g 
ch
ild
ho
od
 
va
cc
in
at
io
n 
Pl
ea
se
 in
d
ic
at
e 
w
he
th
er
 t
he
 fo
llo
w
in
g
 s
ta
te
m
en
ts
 
ap
p
ly
 t
o 
yo
u 
 
 
 
 
1.
 O
th
er
 p
ar
en
ts
 t
ha
t 
I 
kn
ow
 t
hi
nk
 t
ha
t 
I 
1 
=
 c
om
p
le
te
ly
 d
is
ag
re
e 
– 
7 
co
m
p
le
te
ly
 a
g
re
e 
 
1 
=
 n
ot
 s
oc
ia
lly
 
ac
ce
p
ta
b
le
 t
o 
re
fu
se
 
St
at
em
en
ts
 a
b
ou
t 
ch
ild
 v
ac
ci
ne
 p
ro
vi
d
er
 
.7
54
 
M
on
ta
no
, K
as
p
rz
yk
 5
 
ta
b
le
 c
o
nt
in
ue
s
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sh
ou
ld
 n
ot
 v
ac
ci
na
te
 
m
y 
ch
ild
.  
&
 n
ot
 a
p
p
lic
ab
le
 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 t
o 
7 
=
 
so
ci
al
ly
 a
cc
ep
ta
b
le
 t
o 
re
fu
se
 c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 
(C
V
P)
 a
nd
 s
oc
ie
ty
 
th
in
ki
ng
 y
ou
 s
ho
ul
d
 
re
fu
se
 c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 w
er
e 
d
el
et
ed
 t
o 
im
p
ro
ve
 
th
e 
re
lia
b
ili
ty
 o
f t
he
 
sc
al
e 
(>
.6
). 
 
 Th
e 
no
t 
ap
p
lic
ab
le
 
an
sw
er
 o
p
tio
n 
re
su
lte
d
 in
 h
ig
h 
p
ro
p
or
tio
n 
of
 
m
is
si
ng
s 
(1
7%
). 
 
So
ci
al
 in
flu
en
ce
 w
as
 
al
so
 a
ss
es
se
d
 fo
r 
ac
ce
p
tin
g
 a
nd
 
p
ar
tia
lly
 a
cc
ep
tin
g
 
ch
ild
ho
od
 
va
cc
in
at
io
ns
, b
ut
 t
hi
s 
lin
e 
of
 q
ue
st
io
ni
ng
 
w
as
 m
ut
ua
lly
 
ex
cl
us
iv
e.
 M
ea
ni
ng
, i
f 
a 
p
ar
en
t 
to
ta
lly
 
d
is
ag
re
ed
 w
ith
 t
he
 
st
at
em
en
t 
th
at
 o
th
er
 
p
ar
en
ts
 t
hi
nk
 y
ou
 
sh
ou
ld
 r
ef
us
e 
al
l 
va
cc
in
at
io
ns
, t
he
y 
ag
re
ed
 w
ith
 t
he
 
st
at
em
en
ts
 t
ha
t 
ot
he
r 
p
ar
en
ts
 t
hi
nk
 t
ha
t 
yo
u 
sh
ou
ld
 a
cc
ep
t 
al
l 
ch
ild
ho
od
 
va
cc
in
at
io
ns
.  
Th
us
, q
ue
st
io
ns
 a
b
ou
t 
so
ci
al
 in
flu
en
ce
 
re
g
ar
d
in
g
 a
cc
ep
tin
g
 
an
d
 p
ar
tia
lly
 
ac
ce
p
tin
g
 c
hi
ld
ho
od
 
va
cc
in
at
io
ns
 w
er
e 
2.
 F
am
ily
 a
nd
 fr
ie
nd
s 
th
in
k 
th
at
 I 
sh
ou
ld
 
no
t 
va
cc
in
at
e 
m
y 
ch
ild
.  
3.
 M
y 
p
ar
tn
er
/c
o-
p
ar
en
t/
ca
re
r 
th
in
ks
 
th
at
 w
e 
sh
ou
ld
 n
ot
 
va
cc
in
at
e 
ou
r 
ch
ild
.  
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ex
cl
ud
ed
 fr
om
 t
hi
s 
an
al
ys
is
.  
So
ci
al
 n
or
m
 re
ga
rd
in
g 
ac
ce
pt
in
g 
ch
ild
ho
od
 
va
cc
in
at
io
n 
1.
 H
ow
 m
an
y 
of
 y
ou
r 
fa
m
ily
 a
nd
 fr
ie
nd
s 
fu
lly
 v
ac
ci
na
te
 t
he
ir 
ch
ild
re
n?
  
• 
al
l o
r 
ne
ar
ly
 a
ll 
• 
m
or
e 
th
an
 h
al
f 
• 
ju
st
 a
 li
tt
le
 m
or
e 
th
an
 
ha
lf 
• 
ha
lf 
• 
ju
st
 a
 li
tt
le
 le
ss
 t
ha
n 
ha
lf 
• 
le
ss
 t
ha
n 
ha
lf 
• 
no
ne
 o
r 
al
m
os
t 
no
ne
 
• 
no
t 
ap
p
lic
ab
le
 
(1
) a
lm
os
t 
no
ne
 o
f t
he
 
p
ar
en
ts
 in
 m
y 
so
ci
al
 
ne
tw
or
k 
ac
ce
p
t 
ch
ild
ho
od
 
va
cc
in
at
io
ns
 t
o 
(7
) 
al
m
os
t 
al
l p
ar
en
ts
 in
 
m
y 
so
ci
al
 n
et
w
or
k 
ac
ce
p
t 
ch
ild
ho
od
 
va
cc
in
at
io
ns
.  
Th
e 
tw
o 
ite
m
s 
w
er
e 
su
m
m
ed
 a
nd
 
av
er
ag
ed
 in
to
 a
 
co
nc
ep
t.
 
.8
64
 
M
on
ta
no
, K
as
p
rz
yk
 5
 
 
2.
 H
ow
 m
an
y 
of
 t
he
 
ot
he
r 
p
ar
en
ts
 y
ou
 
kn
ow
 fu
lly
 v
ac
ci
na
te
 
th
ei
r 
ch
ild
re
n?
  
 
• 
al
l o
r 
ne
ar
ly
 a
ll 
• 
m
or
e 
th
an
 h
al
f 
• 
ju
st
 a
 li
tt
le
 m
or
e 
th
an
 
ha
lf 
• 
ha
lf 
• 
ju
st
 a
 li
tt
le
 le
ss
 t
ha
n 
ha
lf 
• 
le
ss
 t
ha
n 
ha
lf 
• 
no
ne
 o
r 
al
m
os
t 
no
ne
 
• 
no
t 
ap
p
lic
ab
le
 
 
 
 
 
An
tic
ip
at
ed
 re
gr
et
 
1.
 If
 I 
ha
d
 h
ad
 m
y 
ch
ild
 fu
lly
 v
ac
ci
na
te
d
 
an
d
 m
y 
ch
ild
 
d
ev
el
op
ed
 p
ro
b
le
m
s 
w
ith
 t
he
 s
id
e 
ef
fe
ct
s 
of
 o
ne
 o
f t
he
 
va
cc
in
at
io
ns
, t
he
n 
I 
w
ou
ld
 fe
el
  
1=
 v
er
y 
so
rr
y 
in
d
ee
d
 –
 7
 
=
 n
ot
 s
or
ry
 a
t 
al
l 
1 
=
 e
xp
er
ie
nc
e 
a 
lo
t 
of
 
an
tic
ip
at
ed
 r
eg
re
t 
to
 7
 
=
 n
o 
an
tic
ip
at
ed
 
re
g
re
t 
is
 e
xp
er
ie
nc
ed
 
Re
lia
b
ili
ty
 a
na
ly
si
s 
sh
ow
ed
 t
ha
t 
th
e 
C
ro
nb
ac
h’
s 
al
p
ha
 w
as
 
b
el
ow
 .6
. A
 c
on
ce
p
t 
co
ul
d
 n
ot
 b
e 
cr
ea
te
d
, 
an
d
 t
hu
s,
 t
he
 
in
d
iv
id
ua
l i
te
m
 w
as
 
us
ed
. 
 
N
A
 
H
ar
m
se
n,
 L
am
b
oo
ij,
 
Ru
ite
r,
 e
t 
al
. 4
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